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Abstract 
 
A Systematic Approach to the Elimination of Co-Detection between Oppositely Charged 
Analytes and Applications of Dual- Opposite Injection Capillary Electrophoresis 
Donna Marie Blackney 
Dr. Joe P. Foley 
 
Dual- opposite injection capillary zone electrophoresis (DOI-CZE) is a separation 
technique that utilizes both ends of the capillary for sample introduction and a suppressed 
electroosmotic flow (EOF) to simultaneously separate analytes of opposite charge. In any 
experiment, precision is the key to reliable results in quantitative measurements. In 
Chapter 2, the first detailed study of precision between CZE and DOI-CZE experiments 
was investigated. Data for each technique was evaluated based on the precision of 
migration time, corrected area, and resolution. As many separation parameters as possible 
were kept the same or similar in order to facilitate a fair comparison.  
  
The ability of DOI-CZE to simultaneously separate oppositely charged active ingredients 
in an over-the-counter pharmaceutical drug is demonstrated in Chapter 3. Representative 
electropherograms from a separation of Advil® Allergy & Congestion Relief tablets are 
shown. Each tablet analyzed contains a 200 mg ibuprofen, 10 mg phenylephrine and 4 
mg chlorpheniramine. Due to the large difference in the active ingredient amounts 
between the analytes of interest, quantitative analysis under conventional CZE conditions 
would be more difficult than under the proposed DOI-CZE method. In DOI-CZE, a given 
charge of analytes can be subjected to appropriate amounts of pressure and time of 
injection while allowing analytes of opposite charge to utilize a different set of injection 
conditions. This can allow more representative concentrations of each active ingredient to 
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be introduced into the capillary. Validation of each separation technique was investigated 
and the resulting data are described. 
 
Depending on the individual electrophoretic mobilities of the analytes of interest and the 
effective length that each analyte travels to the detection window, the elution order of 
analytes in a DOI-CZE separation can vary widely. One consequence of a variable 
elution order is that co-detection of oppositely charged analytes becomes possible under 
certain experimental conditions. While several approaches currently exist to avoid co-
detection, they are often time consuming and inefficient. Chapter 4 describes a systematic 
approach to easily avoid co-detection by analyzing the net mobilities of the analytes of 
interest to aid in choosing appropriate capillary lengths for a particular separation. 
Simulated electropherograms that highlight various aspects of this new approach are 
shown. An electropherogram from the literature is replicated and the derived relationship 
is applied to show the potential advantages of this new technique.
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Chapter 1: Historical Development of Capillary Zone Electrophoresis 
 
 
 
1.1 Separation Science 
 
Separation science is the study of separating a mixture, partially or completely, using one 
or more techniques [1]. In a pharmaceutical drug product, a partial separation may be 
applicable for the isolation, identification, and/or quantification of an impurity. A 
complete separation may be used to identify and quantitate active ingredients and 
excipients (components added during formulation for a specific purpose) in comparison 
with known standards to screen for counterfeit products [2-5]. 
 
The techniques used for a particular separation take advantage of differences in the 
chemical and/or physical properties of the analytes of interest. Such properties may 
include, but are not limited to, solubility, volatility, size, polarity, degree of interaction 
with other molecules, and the rate of migration in a specific medium or under specific 
conditions [6]. As greater demands are placed on separation scientists to separate minute 
quantities of complex mixtures very rapidly and with great precision, separation 
methodologies must evolve to adapt to the ever-changing needs for analysis.  
 
1.2 Development of Capillary Electrophoresis 
 
Capillary electrophoresis (CE) is one of many techniques used to separate complex 
samples into their individual components for qualitative and quantitative analysis. One of 
the first instrumental versions of electrophoresis was a technique known as moving 
boundary electrophoresis. 
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1.2.1 Moving Boundary Electrophoresis 
Tiselius described a method to partially separate and identify the components of a 
mixture of proteins called moving boundary electrophoresis. In this technique, sample is 
dissolved in a buffer solution and introduced into a U-shaped quartz tube filled with the 
same buffer solution [7]. Electrodes are immersed into the buffer solution and a voltage is 
applied to generate an electric field that causes charged ions to migrate toward the 
electrode of opposite polarity [8]. Detection is achieved by photographing differences in 
the refractive index of light at the boundary between adjacent proteins passing the 
detector using ultraviolet light [9].  
 
One major limitation of moving boundary electrophoresis is its inability to counteract the 
convection that arises from the movement of ions in a solution under an electric field. 
Thermal convection results in temperature and density gradients that exist throughout the 
separation tube, making the complete separation of a mixture impossible [7,10]. In order 
to achieve a complete separation of ions into distinct “zones”, alternative electrophoretic 
techniques were investigated [10]. 
 
1.2.2 Zone Electrophoresis 
 
While the term “zone electrophoresis” was not introduced until the 1950’s [11], several 
approaches to reduce convection in electrophoresis experiments for more complete 
separations were previously studied [12-14]. The most common way to reduce 
convection is to utilize a stabilizing media, such as paper [13,15,16], glass wool [14], 
cellulose [17], cellulose acetate [18], gel [12], or starch [19,20]. While these approaches 
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stabilize migrating zones by increasing the convective resistance of the medium, 
adsorption effects are extremely problematic. If an ion becomes partially adsorbed to the 
support medium, peak tailing may occur; total adsorption will result in the ion becoming 
permanently retained on the medium and the ion will not be detected [10,15,21].  
 
In a separate approach to obtain a complete separation via zone electrophoresis, Hjerten 
performed experiments in a horizontal, rotating separation tube to stabilize zones against 
the influence of gravity and reduce sources of convection [21,22]. Due to the complexity 
of the instrumentation required for successful tube rotation, this approach was not readily 
adopted. 
 
An additional approach to achieve resolved peaks in zone electrophoresis is to utilize the 
inherent properties of the separation tube used for experimentation. When ions move 
through a conductive medium via an electric field, heat is generated throughout the 
separation tube; this is referred to as Joule heat. While heat is generated evenly, the rate 
of heat dissipation (transfer of heat through the surface) to the surroundings, increases 
with increasing distance from the cross sectional center of the tube; therefore, the fluid in 
the center of the separation tube will have a higher temperature than the fluid near the 
wall of the tube [23]. The amount of heat generated in the large inner diameter (i.d.) 
separation tubes used in the previously described experiments (>3 mm i.d.) cannot be 
fully dissipated, even with the use of a system to cool the tube [7,15,17,21,24]. Due to the 
differences in temperature, the warmer solution in the center of the tube is less viscous 
than the cooler solution near the wall of the separation tube. As a result, those ions in the 
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center of the separation tube will migrate faster towards the detector than those near the 
wall. This results in the spreading of analytes zones and limits the resolution between 
adjacent zones [23].   
 
Tiselius recognized that convective currents are quite pronounced in wide-bore separation 
tubes and that the use of narrower tubes would both reduce the total amount of heat 
generated and increase the amount of heat dissipation, although not necessarily in a 
proportional manner. However, narrow separation tubes restrict the amount of sample 
that can be introduced without overloading the system [7].  
 
For those separations using UV-visible absorption based detection, the absorbance, A, of 
a solution can be determined using the Beer-Lambert Law, which states that: 
 
                                                                      A = εbc                                                           (1.1) 
 
where  is the molar absorptivity, b is the path length, and c is the concentration. When 
using on-column methods of detection, the path length is proportional to the inner 
diameter of the separation tube [25]. Therefore, the absorbance of a solution will be low 
when using small inner diameter separation tubes. In order to detect low sample 
concentrations from a small amount of injected solution, a detection system with high 
sensitivity must be used [26,27]. Unfortunately, a detection system possessing this level 
of sensitivity was not available in early zone electrophoresis experiments.   
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1.2.3 Capillary Zone Electrophoresis 
 
Fluorescence detection is an extremely sensitive method of detection that gained 
popularity in other types of separation methods, such as high performance liquid 
chromatography in the 1970’s [28-31]. With this type of detection, smaller diameter 
separation tubes could be utilized in an attempt to improve separations in zone 
electrophoresis.   
 
In 1981, Jorgenson and Lukacs used a laboratory-built fluorescence detector and a 75 m 
i.d. separation tube to separate dansyl- and fluorescamine-derivatives of amino acids, 
dipeptides, and amines in a technique that is known today as capillary zone 
electrophoresis (CZE) [23,32].  
 
Since only compounds that fluoresce or can be derivatized into compounds that can 
fluoresce can be detected, fluorescence detection has limited applicability. However, this 
work highlighted the benefits of smaller diameter separation tubes in zone electrophoresis 
experiments compared to ones previously utilized [21,27]. 
  
These experiments showed that while the use of a capillary tube for an electrophoretic 
separation will not entirely eliminate temperature and density gradients, decreasing the 
inner diameter of the tube both reduces the total amount of heat generated and increases 
the rate of transfer of this heat to the surroundings [23,32]. In addition, the use of a 
smaller tube will allow an ion to diffuse back and forth across the inner diameter of the 
separation tube more often. As a result, an ion will be more likely to sample all regions of 
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the capillary; this will minimize deviations from the average velocity of the ion and 
reduce zone broadening [32]. 
 
Efficient and effective heat dissipation allows higher voltages to be applied. Higher 
voltages result in faster analysis times and narrower peaks yielding theoretical plate 
numbers as high as 400,000 [27]. A series of publications [23,32-34] quickly inspired 
further developmental research in the area of capillary zone electrophoresis and papers 
were soon published using other modes of detection [26,35-39] and separation [32,40-
49]. This research proved that CZE provides high efficiency, low sample and reagent 
consumption, and short analysis time. The increased interest in CZE led to the 
introduction of a commercial instrument in 1988 [50].  
 
1.3 Instrumentation and Operation 
 
Current commercially available instrumentation for CZE and some of its related 
techniques consists of a capillary, capillary cassette cartridge, power supply, two 
electrodes, and a spectroscopic detector as shown in Figure 1.1. Some commercial 
instruments may utilize mass spectrometry or capacitively-coupled contactless 
conductivity (C4D) as the detection method. An autosampler for more precise sample 
introduction, a temperature control device, and/or a buffer replenishment system are 
additional features available in some instrumentation [51,52]. 
 
For most applications, an open-tubular fused silica capillary with a polyimide outer 
coating (for flexibility and protection) is used and is shown in Figure 1.2A. While  
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Figure 1.1: Basic diagram of a standard capillary electrophoresis system. 
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A. 
 
B. 
 
Figure 1.2: A. A fused silica capillary with a polyimide outer coating. B. Inner surface of 
a fused silica capillary. 
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common capillary dimensions for a standard fused silica capillary are 30-100 cm total 
capillary length, 25-100 m i.d., and 360-550 m outer diameter (o.d.), capillaries of 2-
750 m i.d. and 90-880 m o.d. are also commercially available [53,54]. When on-
column detection methods such as ultraviolet-visible (UV-vis) absorbance are utilized, a 
portion of the outer coating must be removed to create a window for detection. This can 
be achieved through various thermal, laser, or mechanical techniques [55]. It is important 
to remove the outer polyimide coating without damage to the fused silica capillary 
underneath.  
 
The inside of a fused silica capillary is comprised of surface bound silanol (SiOH) groups 
as shown in Figure 1.2B [56]. In order to separate cations and anions in one run, a source 
of bulk flow must be generated inside the capillary. This can be achieved by ionizing the 
silanol groups on the capillary wall into negatively charged silanoate groups (SiO
-
). 
Experimentally, silanol groups can be dissociated by conditioning the capillary with a 
base such as lithium or sodium hydroxide. The number of silanol groups that are 
dissociated into silanoate groups is pH dependent and increases with increasing pH [57].  
 
The negatively charged silanoate groups attract positively charged cations from the 
buffer. Two distinct layers are formed near the capillary surface, an inner layer in which 
the cations are immobile due to very strong attractive electrostatic forces and an outer 
layer in which the cations can move in response to an applied force. The fixed, inner  
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layer of cations forms near the capillary wall as shown in Figure 1.3. The inner, fixed 
layer contains less than a stoichiometric amount of cations and therefore does not 
completely neutralize all of the negative charges from the silanoate groups. Therefore, a 
second, mobile layer of cations forms on top of the inner layer of cations and completes 
what is referred to as the electrical double layer (EDL) [58]. When an electric field is 
applied, the mobile layer of cations moves toward the cathode, bringing along the water 
molecules that are solvating them; these water molecules drag other water molecules that 
are solvating the rest of the components in the capillary. Due to frictional drag, the fluid 
filling the capillary begins to move almost all at the same velocity, which results in a 
primarily flat flow profile known as electroosmotic flow (EOF). 
 
Once EOF is established in the capillary, sample is introduced by an electric field 
(electrokinetic), pressure or vacuum (hydrodynamic), or a combination of these two 
techniques. If sample introduction occurs at the anode, cations will begin to migrate 
toward the opposite end of the capillary. These ions will be detected as they pass the 
detection window located near the cathodic end of the capillary. Separative transport is 
achieved in CZE as ions migrate through the capillary according to their charge/frictional 
drag ratio as shown in Figure 1.4. Smaller and more charged cations will reach the 
detection window before larger and less charged cations. If anions are introduced at the 
anode without a source of bulk flow, no detection of these ions would occur as anions are 
attracted to the anode and thus would not travel toward the detector. 
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Figure 1.3: Depiction of the formation of electroosmotic flow (EOF) along the capillary 
wall based on positively charged cations from the buffer solution interacting with the 
negatively charged capillary wall. 
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A. 
 
B. 
 
 
Figure 1.4: A. Depiction of the inside of the fused silica capillary at a given moment 
during a separation to show ion migration. B. Pictorial electropherogram of the moment 
shown in Figure 1.4A. 
 
Key:  
Cations of different charge/frictional drag ratio are denoted as the circle, square and 
triangle with positive charges. 
Anions of different charge/frictional drag ratio are denoted as the circle, square and 
triangle with negative charges. 
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When EOF is from anode to cathode, anions will be pushed toward the cathode and in 
time, will be detected if the electrophoretic mobility of the anion is not greater than the 
EOF generated. Due to their slower electrophoretic mobility, larger and less charged 
anions will be pushed toward the detector more rapidly than smaller and more charged 
anions. It is important to note that when using CZE, neutral molecules will not be 
separated from one another because they are carried through the capillary at the same 
velocity by the bulk electroosmotic flow due and are detected as one peak that elutes 
between the cations and anions. Common detection methods utilized in CZE include, but 
are not limited to, UV/Vis absorbance [26], fluorescence [23,32-34,36], conductivity 
[27,35], and mass spectrometry [37]. With any detection mode, a plot of signal response 
vs. time is referred to as an electropherogram.   
 
1.4 Principles of Separation and Related Calculations 
1.4.1 Electrophoretic Mobility 
 
When a constant electric field is applied to the capillary, the ions inside the capillary will 
be accelerated by a constant electrical force, FE [59]: 
 
             𝐹E = 𝑞𝐸                                         (1.2) 
 
where q is the net charge on the ion and E is the electric field strength, which can be 
determined by the equation [60]: 
 
 𝐸 =  
𝑉
𝐿t
                           (1.3) 
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where V is the applied voltage and Lt is the total capillary length.  
 
Ions will accelerate until the electrical force is balanced by the frictional force (or drag), 
FF, of the solution:  
 
𝐹E = 𝐹F                (1.4) 
 
Assuming the use of spherical ions, the frictional force can be described using Stoke’s 
law [59]:  
 
          𝐹F = 6𝜋𝑟vep           (1.5) 
 
where  is the viscosity of the solution, r is the hydrated radius of the ion, and vep is the 
migration velocity of the ion.  
 
When equations 1.2, 1.3, and 1.5 are substituted into equation 1.4, the following 
relationship is obtained: 
 
        𝑞
𝑉
𝐿𝑡
= 6𝜋η𝑟vep               (1.6) 
 
If equation 1.6 is rearranged to solve for vep, the relationship can be expressed by:  
 
       vep =  
𝑞
𝑉
𝐿𝑡
6𝜋𝑟
                (1.7) 
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The migration velocity of an ion through the capillary can also be determined by the 
equation [32]:  
 
                    vep = 𝜇ep𝐸                                                     (1.8)    
 
where ep is the electrophoretic mobility of the ion. 
 
By substituting the right hand side of equation 1.7 for vep, equation 1.8 can be rearranged 
to solve for ep, 
 
      𝜇ep =  
𝑞
6𝜋𝑟
          (1.9) 
 
From equation 1.9, it is apparent that electrophoretic mobility is directly proportional to 
the charge of an ion and inversely proportional to the hydrated radius of the ion. 
Therefore, a smaller ion with a higher charge state will have a faster electrophoretic 
mobility than a larger ion with a lower charge state as shown in Figure 1.4. 
 
When weak acids and bases are in solution, an equilibrium exists between a weak acid 
and its conjugate base and also between a weak base and its conjugate acid. The extent of 
ionization of a weak acid or base is based on its acid dissociation constant (pKa) and the 
pH of the solution. This relationship can be evaluated using the Henderson-Hasselbalch 
equation,  
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𝑝𝐻 = 𝑝𝐾𝑎 + 𝑙𝑜𝑔
[𝑏𝑎𝑠𝑒]
[𝑎𝑐𝑖𝑑]
      (1.10) 
 
where [base] and [acid] are the concentrations of the base and conjugate acid or acid and 
conjugate base, respectively [61].  
  
When the pKa of a molecule is equal to the pH of the solution, the charged and 
uncharged components are in equal concentration. If the pH is higher than the pKa, the 
solution is basic relative to the molecule; for a monoprotic weak acid, deprotonation will 
occur and the ion will exist primarily as a negatively charged anion. A monoprotic weak 
base will exist predominantly in its neutral form when the pH is larger than the pKa. If 
the pH is lower than the pKa, a weak acid will exist primarily in its neutral form due to 
protonation of the molecule. A weak base will exist primarily in its positively charged 
form (cation) when the pH is lower than the pKa [61]. 
 
1.4.2 Electroosmotic Mobility 
 
As described in Section 1.3, the electroosmotic flow (EOF), also referred to as 
electroendoosmotic flow, is a source of bulk flow that is generated in the capillary to 
move all analytes toward the detection window under an electric field. In order to 
determine the magnitude of EOF generated within the capillary, the potential () of the 
electrical double layer (EDL) must be determined. Popular models for determination of 
the potential of the EDL have been proposed by Helmholtz, Gouy, and Chapman and 
were combined by Stern [58]. 
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The inner layer of the EDL, the layer that is closest to the capillary wall, is formed via the 
strong attraction between cations from the buffer and exposed silanoate groups on the 
capillary wall. This immobile layer is also referred to as the compact, Helmholtz, or Stern 
layer. The inner layer can be further divided into two sublayers. The inner Helmholtz 
plane (IHP), as shown in Figure 1.5A, is the sublayer that originates at the negatively 
charged capillary wall and extends to the center of the non-solvated cation layer that are 
strongly bound to the capillary wall [54]. The negative electrical potential at the capillary 
wall, Ψ0, decreases linearly through the inner Helmholtz layer as shown in Figure 1.5B. 
The outer Helmholtz plane (OHP) is the sublayer that extends from the IHP to the center 
of the immobilized solvated cations that are attracted to the capillary wall via electrostatic 
forces [54]. The potential through the outer Helmholtz plane (ΨOHP) also decreases 
linearly because the ions in the inner Helmholtz plane do not fully neutralize the negative 
charge on the capillary surface. 
 
In the region past the OHP, a layer of solvated cations, referred to as the diffuse layer, 
forms on top of the inner, fixed layer of cations. These mobile solvated cations, although 
still attracted to the negatively charged capillary wall, are blocked from interaction with 
the inner layer of the capillary wall by steric hindrance. The negative potential of the 
diffuse layer decreases exponentially through the layer until it becomes zero at the bulk 
solution, where an equal number of mobile positive and negative ions from the buffer are 
present.  
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A. 
 
B.  
Figure 1.5: A. Magnification of the inside of a fused silica capillary to highlight the 
different bonding regions of the capillary. B. Potential in the capillary from the bulk 
solution (0) to the wall of the capillary (Ψ0). 
Key:  
Non-solvated cations are represented by a plus sign inside a circle. 
Solvated cations are represented by a plus sign inside a circle surrounded by small circles 
representing solvent molecules while solvated anions are represented by a negative sign. 
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The division between the inner Helmholtz layer and the diffuse layer is known as the 
plane of shear. The potential at the plane of shear is referred to as the zeta potential (ζ) 
and can be calculated by:  
 
    =
𝛿𝜎0
𝜀
       (1.11) 
 
where is the thickness of the electric double layer,0 is the charge density,  and  is the 
permittivity of the buffer (which is the sum of 0, the dielectric constant of vacuum and 
r, the relative permittivity of the liquid) [62]. The thickness of the electric double layer 
can be determined by:  
 
𝛿 = √
𝜀r𝜀0𝑘𝑇
2𝑒0
2𝐼
       (1.12) 
 
where k is the Boltzman constant, T is the temperature, e0 is the charge, and I is the ionic 
strength [63,64].  
 
Ionic strength, which is a measure of the total concentration of ions in solution, is defined 
by: 
 
𝐼 =
1
2
∑ 𝑐𝑖𝑧𝑖
2       (1.13) 
 
where c is the concentration and z is the charge [61].  
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The electroosmotic velocity (veo) is dependent upon the electroosmotic mobility (eo) and 
the electric field [32]: 
  
   veo =  𝜇eo𝐸        (1.14) 
 
In order to derive expressions for the electroosmotic mobility, the forces that act upon the 
buffer solution must be taken into account. The full derivation is available [65] but can be 
simplified to the Smoluchowski equation: 
 
   μeo =  
𝜀0𝜀r
𝑛
       (1.15) 
 
where  is the viscosity of the solution.  
 
From the relationships described in equations 1.11-1.15, it is apparent that experimental 
parameters, such as pH and concentration of the buffer, can modify the EOF. As the pH 
of the buffer is increased, an increased number of silanol groups are exposed along the 
capillary wall increasing the negative charge. This increased charge increases the zeta 
potential and, therefore, the EOF. As the ionic strength of the buffer is increased, the 
thickness of the double layer becomes reduced or compressed. As a result, both the zeta 
potential and EOF decrease in value.  
 
To measure eo experimentally a neutral compound, such as methanol, is pushed through 
the capillary to determine when the bulk solution passes through the detector window. 
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The electroosmotic mobility, commonly referred to as electroosmotic flow (EOF), can be 
calculated by:  
 
 𝜇eo =  
𝐿t𝐿d
𝑡0𝑉
       (1.16) 
 
where Lt is the total length of the capillary, Ld is the capillary length from the inlet to the 
detection window, t0 is the migration time of the neutral marker, and V is the applied 
voltage.  
 
1.4.3 Migration Time 
 
The migration time (tm) is the time required for an ion to travel from one end of the 
capillary to the detector [23]. Assuming a constant velocity, the migration time can be 
calculated by dividing the distance from the injection end of the capillary to the detector 
(Ld) by the net velocity (vnet): 
 
  𝑡m =  
𝐿d
vnet
          (1.17) 
 
The net velocity is the sum of the electrophoretic and electroosmotic velocities: 
 
          vnet = vep + veo                  (1.18) 
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If the right hand side of equation 1.18 is substituted into equation 1.17, the migration time 
can be expressed as: 
 
𝑡m =  
𝐿d
vep+ veo
       (1.19) 
 
By substituting the right hand side of equations 1.8 and 1.14 for vep and veo, respectively, 
the migration time can be expressed in terms of mobility: 
 
𝑡m =
𝐿t𝐿d
𝑉(𝜇ep+𝜇eo)
       (1.20) 
 
Based on equation 1.20, migration time can be decreased by using short capillary lengths 
and high voltages. 
 
1.4.3.1 Voltage Ramp Correction 
 
To obtain the most accurate migration time, a correction in the observed migration time is 
needed to account for the short linear voltage ramp that is typically applied at the 
beginning of an experiment [66,67].  
 
A linear voltage ramp is used to avoid the possibility of thermally-induced expulsion of 
sample from the capillary inlet that can occur when a voltage is applied due to Joule 
heating effects [67].  
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To correct for the applied voltage ramp, the migration time for all compounds is 
corrected by: 
 
        tVRC = 𝑡𝑚 −
𝑡VR
2
                   (1.21) 
 
where tVRC is the voltage ramp corrected migration time, tm is the observed migration 
time, and tVR is the amount of time that the voltage ramp is applied.  
 
The electroosmotic mobility is calculated with this correction and the relationship can be 
defined as:  
 
         𝜇eo =  
𝐿t𝐿d
𝑡0,VRC𝑉
         (1.22) 
 
where 𝑡0,VRC is the voltage-ramp-corrected migration time for the neutral marker. The net 
mobility, which is determined the migration time of the analyte of interest, is given by the 
equation: 
 
        𝜇net =  
𝐿t𝐿d
𝑡VRC𝑉
       (1.23) 
 
where tVRC is the voltage-ramp-corrected migration time.  
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To determine the electrophoretic mobility experimentally, the electroosmotic mobility is 
subtracted from the net mobility: 
  
𝜇ep =  𝜇net − 𝜇eo      (1.24) 
 
 
1.4.4 Selectivity  
 
The relative spacing between two analyte zones as they pass the detector can be described 
by selectivity, . Selectivity can be described in terms of velocity or mobility by: 
 
                                                          α =  
𝑣𝑒𝑝,2
𝑣𝑒𝑝,1
=
𝜇𝑒𝑝,2
𝜇𝑒𝑝,1
      (1.25) 
 
where vep and ep are the electrophoretic velocities and electrophoretic mobilities of two 
adjacent peaks (indicated by the subscripts 1 and 2), respectively.  
 
When = 1.0, no separation occurs as the migration times are the same. Depending on 
the ionizable groups on the analytes and their respective pKa values, the charge on the 
analytes can be altered by adjusting the pH of the electrolyte solution as described in 
Section 1.4.1.  
 
1.4.5 Efficiency 
Efficiency is a term used to describe the ability of a given separation to yield narrow 
peaks; analytes experience an increase in peak width as they travel through the capillary. 
Giddings used the number of theoretical plates as a measure of efficiency [1]. The plate 
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number or number of theoretical plates (N) for a given peak can be calculated by the 
equation: 
 
N =  
𝐿d2
𝜎2
       (1.26) 
 
where σ2 is the spatial variance. The spatial variance, calculated by the Einstein equation, 
depends on the diffusion coefficient of the solute, D, and the time available for diffusion 
to occur: 
 
         𝜎2 = 2𝐷𝑡m         (1.27) 
 
If the expression for tm (equation 1.20) is substituted into equation 1.27, the spatial 
variance can be determined by:  
 
       𝜎2 =  
2𝐷𝐿t𝐿d
𝑉(𝜇ep+𝜇eo)
                  (1.28) 
 
By substituting equation 1.28 into equation 1.26, the efficiency can be determined by: 
 
       N =  
𝑉(𝜇ep+𝜇eo)𝐿d
2𝐷𝐿t
       (1.29) 
 
From this equation, it is observed that an increase in the applied voltage will result in an 
increase in the theoretical plate number. Mobile ions with a high net mobility will 
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produce a larger theoretical plate number than less mobile ions because faster velocity 
through the capillary will minimize the time for diffusion to occur.  
 
Efficiency can be determined experimentally from an electropherogram by measuring the 
migration time and the peak width: 
 
   N =  
16𝑡𝑚
2
𝑊2
       (1.30) 
 
where W is the width of the peak at the baseline. Therefore, narrower peaks will yield 
higher theoretical plate numbers.  
 
1.4.6 Resolution 
 
Resolution is the measure of how well two analyte zones are separated from one another. 
The resolution between two sample zones can be calculated experimentally by [1]: 
 
  𝑅𝑠 =  
∆𝑡𝑚
𝑊avg
       (1.31) 
 
where tm is the difference in migration time between sample zone 1 and sample zone 2 
and Wavg is the average peak width of sample zones 1 and 2 in time units. 
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Resolution can also be determined by [1]:  
 
 𝑅𝑠 =  
√𝑁
4
∆𝑣
?̅?
       (1.32) 
 
where v is the difference in electrophoretic velocity between the two zones and ?̅? is the 
mean velocity of the two electrophoretic zones. Jorgenson and Lukacs showed that the 
relative difference in velocity could be determined by the equation [23]: 
 
             
∆𝑣
?̅?
=  
∆𝜇ep
(?̅?ep+𝜇eo)
       (1.33) 
 
where ep is the difference in electrophoretic mobilities and ?̅?ep is the average 
electrophoretic mobility.  
 
If equation 1.33 is substituted into equation 1.31, resolution can be determined by: 
 
𝑅𝑠 =  
√𝑁
4
∆𝜇ep
(?̅?ep+𝜇eo)
      (1.34) 
 
If equation 1.29 is substituted into equation 1.34 for theoretical plate number, the 
equation becomes: 
 
      𝑅𝑠 =  
√
(𝜇eo+𝜇ep)𝑉𝐿d
2𝐷𝐿t
4
∆𝜇ep
(?̅?ep+𝜇eo)
                (1.35) 
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Equation 1.35 can be further simplified to: 
 
        𝑅𝑠 =  
1
4√2
∆𝜇ep
√(?̅?ep+𝜇eo)
√
𝑉𝐿d
𝐷𝐿t
                 (1.36) 
 
From this equation, it is clear that resolution will be maximized when eo and ep are 
similar in magnitude but opposite in sign [23]. An increase in the applied voltage, due to 
the square root relationship, will not contribute as much to an increase in resolution. For 
example, a fourfold increase in applied voltage will only increase the resolution by a 
factor of two. Experimentally, a fourfold increase in applied voltage is extremely unlikely 
due to Joule heating effects and typical instrumental limits of 30 kV. 
 
1.5 Sources of Band Broadening 
 
In Section 1.4, it is assumed that diffusion is the primary source of zone broadening. 
However, there are additional sources of band broadening that may contribute to the 
overall variance of a given peak. The total variance can be determined by: 
 
             𝜎2total = 𝜎2diff + 𝜎2inj +  𝜎2ads +  𝜎2EMD +  𝜎2temp + 𝜎2det    (1.37) 
 
where variances are due to longitudinal diffusion2diff), injection plug length
2
inj), 
interactions between the analyte and the wall of the capillary (2ads), electromigration 
dispersion2EMD), temperature gradient effects (
 2
temp), and detection plug length 
2
det) 
[1,68,69]. 
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1.5.1 Longitudinal Diffusion 
 
Longitudinal diffusion is the spreading of an analyte zone as it migrates along the axis of 
the capillary [61]. The variance due to longitudinal diffusion can be determined by 
equations 1.27 and 1.28. From these equations, it is apparent that, for a given analyte, the 
effect of longitudinal diffusion can be reduced if the analyte spends the shortest amount 
of time possible in the capillary before reaching the detector. This can be achieved 
experimentally by reducing the migration distance and total length of the capillary or by 
increasing the applied voltage. While the use of a higher applied voltage will allow the 
analyte to move more quickly through the capillary and thus limit longitudinal diffusion, 
increases in voltage are limited by Joule heating.  
 
1.5.2 Injection Plug Length 
The length of a zone in capillary zone electrophoresis depends on the time that samples 
are in the column. Therefore, diffusion of a given zone is dependent upon the length of 
the sample plug injected [68]. The contribution to variance from the injection plug can be 
determined by [68,70,71]: 
 
𝜎2inj =
(𝑉𝑖𝑛𝑗)
2
12
        (1.38) 
 
where Vinj is the volume injected. To reduce variance from the injection plug length and 
avoid overloading the capillary, small injection plugs should be utilized; it is 
recommended that the injection plug be smaller than 1% of the total length of the 
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capillary [67]. However, if too small of an injection is made, detection becomes difficult 
unless a sensitive method is used as described in Section 1.2.2.  
 
 
1.5.3 Adsorption 
 
In fused silica capillaries, analyte interaction with the capillary wall can cause unwanted 
adsorption that results in band broadening and loss of efficiency. In addition, adsorption 
can alter the zeta potential, which causes the EOF to vary both within a run and between 
runs [72].  
 
The variance due to adsorption can be determined by: 
 
      𝜎𝑎𝑑𝑠
2 =  
2(1−)2
𝑘a
𝜇net2𝐸2𝑡𝑚     (1.39) 
 
where  is the fraction of non-adsorbed ions, ka is the mean lifetime free from adsorption, 
net is the net mobility, E is the electric field and tm is the migration time of an ion for a 
given experiment [73,74]. 
 
The mean lifetime free from adsorption (ka) can be determined by [73]: 
 
   𝑘a =
𝑧𝛼𝐴
𝑛𝑉m
                    (1.40) 
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where z is the number of molecules striking a unit surface area of fused silica per second, 
n is the number of molecules per unit volume inside the tube,  is the fraction of 
molecules that adsorb and A/Vm is the surface area per unit volume of the mobile phase. 
 
 
The possibility for analyte adsorption to the capillary wall increases as the radius of the 
tube and field strength are decreased and as the length of time is increased [69,73].  
 
1.5.4 Electromigration Dispersion 
 
Electromigration dispersion (EMD) is a type of zone broadening that occurs when the 
local field strength of a sample zone changes in comparison to the buffer solution. Upon 
applying voltage to a capillary filled with a buffer solution, a constant voltage is 
observed. When a sample is introduced into the capillary and a voltage is applied, 
components of the sample plug will separate into zones dependent on their mobilities.  
 
In sample zones of higher conductivity than the buffer co-ions (ions that migrate in the 
same direction as the sample), the voltage will be decreased; the solutes in this sample 
zone will diffuse forward into the buffer where they will experience a higher voltage. The 
solute ions will therefore continue to move forward and the leading edge of the solute 
zone will become diffuse, leading to peak fronting. The tailing edge of the zone 
accelerates forward maintain a sharp edge [75,76]. 
 
When the sample zone has a lower mobility than co-ions in the buffer solution, the 
conductivity of the sample zone will be lower than the zones of buffer surrounding the 
32 
 
sample zone. A lower conductivity results in higher resistance and electric field strength 
of the sample zone compared to the buffer zone. As sample ions diffuse out of the sample 
zone and into the buffer zone, where the field strength is lower, they migrate at a lower 
velocity.  
 
Ions that diffuse out of the front of the sample zone will re-enter the faster moving 
sample zone and maintain a sharp boundary. Ions that diffuse out of the rear of the 
sample zone experience a lower velocity in the buffer zone, cannot re-enter the sample 
zone, and thus result in a tailed peak [69].  
 
The variance due to EMD can be determined by [69]: 
 
         𝜎𝐸𝑀𝐷
2 =
(𝜇ep𝐸𝑡𝑛)
2
16
(
∆𝑘e
𝑘e
)
2
        (1.41) 
 
where ke is the conductivity difference between the buffer and sample zones and ke is 
the conductivity of the buffer. The conductivity difference between the buffer and sample 
zones can be determined by: 
 
           ∆𝑘e =  
𝑧𝑐𝐹
𝜇s
(𝜇A − 𝜇s)(𝜇B − 𝜇s)                            (1.42) 
 
where z is the valence charge of the sample, c is the concentration of the sample, F is the 
Faraday constant, s is the mobility of the sample ion, A is the mobility of the buffer co-
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ion and B is the mobility of the buffer counter-ion (an ion migrating in the opposite 
direction). 
 
From equation 1.41, it is observed that EMD can be minimized by decreasing the 
difference in conductivity between the buffer and sample. Experimentally, when the 
concentration of sample ions is more than two orders of magnitude lower with respect to 
the buffer solution, EMD is reduced [75,76]. If the desired ratio of sample to buffer is 
achieved by diluting the sample, more sensitive detection methods may be needed as 
described in Section 1.2.2. If instead, the buffer concentration is increased, the use of 
higher applied voltage may be limited by the rise of Joule heating and lack of adequate 
heat dissipation. An alternative approach to reducing EMD is to decrease the difference 
between the mobility of the co-ions in the buffer and the sample as shown by equation 
1.42 [69,76]. 
 
 
1.5.5 Temperature Gradients 
 
As described in Section 1.2.2, the movement of ions through a conductive medium by 
applying an electric field generates frictional heat throughout the capillary. The 
electrophoretic mobility of an ion increases by approximately 2% per degree Celsius; this 
can lead to substantial zone broadening if the capillary is not cooled evenly throughout 
the capillary [74].  
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The variance due to a parabolic temperature profile can be determined by:  
 
     𝜎𝑇𝐸𝑀𝑃
2 =  
𝑟6𝐸6𝑘𝑒
2𝜇𝑛𝑒𝑡
2 2t 
1536𝐷𝑘𝑏
2                  (1.43) 
 
 
where r is the radius of the capillary,  is the temperature coefficient of the 
electrophoretic mobility, D is the diffusion coefficient of the analyte and kb is the thermal 
conductivity of the buffer [66,77-79]. From this equation, it is apparent that the radius of 
the capillary tube and the electric field have the greatest influence on the magnitude of 
broadening experienced from the temperature gradient. While higher electric fields are 
desired for faster separations, the use of high voltage may be limited by parabolic zone 
broadening from the temperature gradient. The use of capillaries with a small inner 
diameter helps to both reduce the amount of heat generated and more evenly dissipate the 
heat generated so that reasonable voltages can be utilized. 
 
1.5.6 Detection 
 
While the type of detector used in CE does not affect the properties of a given zone, the 
apparent broadening of peaks for the finite size of the detector region that the zones move 
past must be taken into account by:  
 
𝜎2det =
(𝑊𝑑𝑒𝑡)
2
12
                         (1.44) 
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where Wdet is the width of the illuminated part of the capillary tube (detector cell). This 
type of broadening occurs when using on-column UV absorbance or fluorescence 
[66,80]. 
 
1.6 Summary 
Over the past eight decades, electrophoresis has developed into a well-established 
technique for a wide variety of complex mixtures. The use of a capillary separation tube 
for electrophoretic applications results in increased transfer of heat to surroundings that 
allows for the use of higher applied voltages. Higher voltage separations reduce 
migration time and peak broadening while increasing theoretical plate numbers. Factors 
such as background electrolyte (BGE) type, pH and BGE concentration allow for the 
modification of the electrophoretic and electroosmotic mobilities, which affect migration 
time, theoretical plate number, resolution, and selectivity of a given separation. 
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Chapter 2: A Comparison of Conventional Capillary Electrophoresis to Dual-
Opposite Injection Capillary Electrophoresis with a Focus on Precision  
 
 
2.1 Introduction   
As described in Chapter 1, capillary zone electrophoresis (CZE) is a voltage-driven 
separation technique pioneered by Jorgenson and Lukacs [1] in 1981 as a method to 
eliminate convection and reduce peak broadening in voltage-driven separations by 
utilizing 100 m i.d. or less capillary tubes. This separation technique provides high 
efficiency, low sample and reagent consumption, and short analysis time, making it an 
attractive method of analysis for a wide variety of complex mixtures [1,2].  
 
2.2 Bias in Simultaneous Analysis 
There is an observable bias in resolution and migration time between cations and anions 
when EOF is present in a fused silica capillary. This phenomenon was first reported by 
Jorgenson and Lukacs and is illustrated in Figure 1.4 [1]. When EOF flows from anode to 
cathode, cations travel rapidly toward the detector and as a result, may not be well 
resolved from one another. In contrast, anions migrate toward the detector with a lower 
net mobility than cations due to electrophoretic movement in opposition of the EOF. 
Consequently, anions will be detected later than cations. In the case of an anion whose 
electrophoretic mobility exceeds the EOF, detection will not occur. However, due to their 
increased time in the capillary, anions are more resolved from one another than cations. If 
the conditions are modified so that the EOF is reversed, then the reverse conditions occur 
(anions elute quickly but are poorly resolved and cations elute slowly or not at all with 
better resolution).  
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2.3 Alternative Method of Simultaneous Analysis 
Dual-opposite injection capillary zone electrophoresis (DOI-CZE) is a simultaneous 
separation method introduced in 1998 by Kuban and Karlberg [3] and soon after by 
Padarauskas and co-workers [4,5]. This technique utilizes sample introduction on both 
ends of the capillary under suppressed EOF. DOI-CZE presents an excellent alternative 
method of simultaneous analysis to CZE while avoiding bias in resolution and analysis 
time between oppositely charged analytes.  
 
2.4 Comparison of Capillary Zone Electrophoresis and Dual-Opposite Injection  
      Capillary Zone Electrophoresis  
 
CZE and DOI-CZE are techniques that rely on differences in the charge to frictional drag 
ratio of analytes under an applied electric field. The same type of capillary, 
instrumentation, and software can be used for both types of analysis. However, there are 
several differences between the two techniques that will be described in detail below.  
 
2.4.1 Sample Introduction 
The most apparent difference between CZE and DOI-CZE is sample introduction. In 
CZE, sample is introduced from one end of the capillary, most commonly from the end of 
the capillary that is farthest from the detector to provide a resolution greater than 1.5 
between analytes of like charge. As the name implies, dual-opposite injection capillary 
electrophoresis utilizes both ends of the capillary for sample introduction. In each of 
these techniques, samples can be introduced via an applied voltage (electrokinetic), 
pressure or vacuum (hydrodynamic) [6].  
 
46 
 
One advantage of DOI-CZE compared to CZE is that there are several ways to utilize 
electrokinetic and hydrodynamic injection to introduce sample into the capillary: 
simultaneous electrokinetic injection (SimEI), sequential electrokinetic injection (SeqEI), 
and sequential hydrodynamic injection (SeqHI) [7]. In SimEI, a voltage is applied for a 
specified amount of time while both ends of the capillary are placed in separate, identical 
vials containing sample. Although it is probably the easiest and fastest method of sample 
introduction, SimEI is not practical for samples in which the total sample volume is 
extremely limited since two sample vials are required for injection. When electrokinetic 
injection is used, the amount of a given analyte injected into the capillary is the sum of 
their electrophoretic and electroosmotic mobilities; therefore, analytes with a higher 
electrophoretic mobility are introduced in larger quantity than analytes with lower 
electrophoretic mobility. This bias can be corrected for in both CZE [8] and DOI-CZE 
[9].  
 
The two additional methods of sample introduction in DOI-CZE utilize a sequential 
method of injection. In sequential electrokinetic (SeqEI) and sequential hydrodynamic 
injection (SeqHI), sample is introduced first at one end of the capillary and then at the 
other. When either of these techniques is employed, the same sample vial can be used for 
injection at both ends of the capillary. When a sequential procedure is employed, it is 
essential that the ions from the first injection are moved far enough into the capillary by a 
preliminary transport (PT) step prior to the second injection; if not, the ions from the first 
injection would be expelled by the second injection. The PT step is achieved by applying 
a voltage, pressure, or both for an appropriate length of time [7,10].  
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A further advantage of DOI-CZE over CZE with respect to sample introduction is the 
ability to inject different amounts of oppositely charged analytes when using a sequential 
introduction of sample. This is particularly useful when there is a large difference in 
concentration between cations and anions; a larger amount of sample can be injected for 
analytes with lower concentration [10,11]. The technique will be further described in 
Chapter 3.  
 
2.4.2 Electroosmotic Flow  
 
The primary difference between CZE and DOI-CZE is the mandatory suppression of 
electroosmotic flow for the latter. In DOI-CZE, it is essential that analytes injected from 
each end of the capillary can reach the detection window. This concept is further 
demonstrated in Figure 2.1A. In Figure 2.1A, EOF flows from anode to cathode. Anions 
of different charge to frictional drag ratio are denoted in Figure 2.1A as the circle, square 
and triangle with negative charges. The negatively charged anions migrate against the 
EOF from the anode toward the cathode. The individual electrophoretic mobilities of the 
anions in Figure 2.1A are differentiated by the arrow underneath the shape; a larger arrow 
denotes a larger electrophoretic mobility. To ensure that all anions are able to reach the 
detector, the electrophoretic mobility of each anion must exceed the EOF. If the 
magnitude of EOF exceeds the mobility of any of the sample anions, that anion will not 
be detected. It is important to note that due to suppressed EOF in DOI-CZE, 
electrophoretic mobility primarily determines the elution of analytes. Therefore, the 
fastest anion will be eluted first as it can quickly overcome the EOF to reach the detection 
window.   
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A. 
 
B. 
 
 
Figure 2.1: A. Depiction of the inside of the fused silica capillary at a given moment 
during a separation in dual-opposite injection capillary zone electrophoresis to show ion 
migration. B. Pictorial electropherogram of the moment shown in Figure 2.1A. 
 
Key:  
Cations of different charge/frictional drag ratio are denoted as the circle, square and 
triangle with positive charge. 
Anions of different charge/frictional drag ratio are denoted as the circle, square and 
triangle with negative charges. 
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It is important to note that EOF does not need to be completely suppressed (i.e., EOF of 
zero) for a successful separation in DOI-CZE. The amount of EOF suppression should be 
based on the electrophoretic mobilities of the analytes requiring separation. 
 
2.4.3 Placement of the Detection Window  
In CZE, the length that analytes travel to the detector can be modified by increasing or 
decreasing the migration distance. When an increase in the migration distance is required, 
a new capillary must be used. A window for detection may need to be created depending 
on the detector and the new capillary must be conditioned before use. This process can be 
both time-consuming and expensive. 
 
In DOI-CZE, there are two migration distances that must be taken into account, migration 
from the inlet to the detector and migration from the outlet to the detector. Although the 
position of the actual detector in the instrument does not move, the detection window for 
spectroscopic methods of detection is modified via an extension of the length of capillary 
on the cathodic side as shown by Weekley and Foley [10].  
 
The commercially available capillary cartridge design constrains, to a certain degree, the 
given lengths possible for ions to travel on either side of the detector window. Additional 
ways to modify the elution order can be achieved by use of a PT step or time displaced 
injection. These steps provide a somewhat easier and faster alternative to making a new 
capillary with a repositioned window each time co-detection occurs. However, it is 
important to note that with any of the above-mentioned techniques to avoid co-detection, 
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co-detection between different ions may occur under the new separation conditions. 
Calculations can be done to determine the appropriate migration distances required to 
ensure the avoidance of co-detection, as described in Chapter 4 [12].  
 
Unlike CZE, shown in Figure 1.4B, where the elution order is cations, neutrals, then 
anions, the elution order of a DOI-CZE separation can vary based on the electrophoretic 
mobility of the analyte of interest and the migration distance that each analyte travels 
toward the detector as shown in Figure 2.1B.  
 
2.4.4 Selectivity 
In CZE, analytical selectivity is defined as the relative difference in effective 
electrophoretic mobilities between two analytes [13]. Changes in parameters, such as pH, 
temperature, buffer composition, buffer concentration, and buffer additives, are ways in 
which selectivity can be adjusted in CZE [13-15].  
 
All of the above parameters can also be used to adjust electrophoretic selectivity in DOI-
CZE. The exception to using any of the above parameters for adjustment of selectivity is 
when one of these parameters is being employed to suppress EOF. For example, when pH 
is used as the method of EOF suppression, pH cannot then be used to adjust selectivity. In 
addition, the use of either of the sequential injection procedures with a PT step provides 
an opportunity to optimize the separation selectivity because a time delay, voltage, and/or 
pressure change can be utilized.  
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2.4.5 Selected Figures of Merit 
In 1983, Foley and Dorsey coined the term chromatographic figures of merit to describe 
parameters that aid in the characterization of experimental separations [16]. Selected 
figures of merit for the comparison between CZE and DOI-CZE are resolution and peak 
capacity.     
 
As described in Section 2.2, there is a bias in resolution between cations and anions in 
CZE. Ions that migrate in the same direction as the EOF, termed co-EOF ions, experience 
a lower resolution between like-charge ions in comparison to ions that migration against 
the EOF (counter-EOF ions). In DOI-CZE, the reduced (or nearly eliminated) EOF 
allows migration toward the detector based primarily on the electrophoretic mobility of 
each ion; therefore, bias in resolution is eliminated. One potential disadvantage of DOI-
CZE is that the resolution of a particular charge of ions can be reduced based on the 
migration distances selected for a given separation. 
 
Peak capacity (n) is defined as the maximum number of components that can be resolved, 
under a specified resolution, within a separation space. According to Grushka [17], the 
peak capacity can be derived by 
 
 
  𝑑𝑛 =
𝑑𝑡𝑚
𝑊𝑅𝑠
                                                          (2.1) 
 
 
where tm is the migration time, Rs is the resolution, and W is the width of the peak.  
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The peak width can be defined as 
 
     𝑊 = 4𝜎         
 
where  is the standard deviation of the peak, a measure of peak dispersion. If the only 
significant source of zone broadening is longitudinal diffusion, the dispersion can be 
modeled using the Einstein equation,
 
    𝜎2 = 2𝐷𝑡𝑚            (2.3) 
 
Substitution of the square root of equation 2.3 into equation 2.2 leads to, 
 
 𝑊 = 4√2𝐷𝑡𝑚                   (2.4) 
 
The peak width in equations 2.2 and 2.4 are presented in units of length (cm). In order to 
use the expression for peak width to determine peak capacity, units of time must be used. 
The conversion from units of length to units of time can be achieved by dividing the 
width by the migration velocity, the latter of which can be expressed as the quotient of 
the migration distance and the migration time, 
 
𝑊𝑡𝑖𝑚𝑒 =
𝑊
𝑚𝑖𝑔𝑟𝑎𝑡𝑖𝑜𝑛 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦
=
4√2𝐷𝑡𝑚
𝐿𝑑
𝑡𝑚
=
4√2𝐷𝑡𝑚
3
2
𝐿𝑑
         (2.5) 
 
Substitution of equation 2.5 into equation 2.1 yields 
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 𝑑𝑛 =  
𝑑𝑡𝑚
𝑊𝑡𝑖𝑚𝑒𝑅𝑠
=
𝑑𝑡𝑚
4𝑅𝑠√2𝐷𝑡𝑚
3
2
𝐿𝑑
=
𝑑𝑡𝑚 𝐿𝑑
4𝑅𝑠√2𝐷𝑡𝑚
3
2
          (2.6) 
 
 
Integration with the limits suggested by Grushka gives, 
 
 
∫ 𝑑𝑛 =  
𝐿𝑑
4𝑅𝑠√2𝐷
∫ 𝑡𝑚
−
3
2𝑑𝑡
𝑡𝑛
𝑡𝐴
𝑛
1
        (2.7) 
 
 
This integration yields an expression that can be used to calculate the peak capacity in 
CZE, 
 
        𝑛 − 1 =  
𝐿𝑑
4𝑅𝑠√2𝐷
(−2)(𝑡𝑛
−
1
2 − 𝑡𝐴
−
1
2)       (2.8) 
 
 
Equation 2.8 can be simplified to 
 
 
  𝑛 = 1 −
𝐿𝑑
2𝑅𝑠√2𝐷
(
1
√𝑡𝑛
−
1
√𝑡𝐴
)                 (2.9a) 
 
 
or 
 
  𝑛 = 1 +
𝐿𝑑
2𝑅𝑠√2𝐷
(
1
√𝑡𝐴
−
1
√𝑡𝑛
)      (2.9b) 
 
where tA is migration time of the first eluting peak and tn is the migration time of the last 
eluting peak. 
 
Peak capacity can be expressed in terms of total peak capacity or sample peak capacity. 
The total peak capacity, as shown in Figure 2.2A, is defined as the total number of peaks 
that can fit into a separation space in terms of total time or length of capillary. This 
calculation often overestimates the peak capacity as it assumes that the first eluting peak   
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A. 
  
B. 
 
Figure 2.2: A. Simulation of the total peak capacity for a hypothetical CZE separation. 
B. Simulation of a sample peak capacity for a hypothetical CZE separation.  
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has an elution time close to zero. In CZE, the ion with the largest electrophoretic mobility 
has to travel from the anode to the cathode, a distance of at least 23.6 cm when using a 
commercial Agilent 
3D
CE instrument. It takes a finite time for an analyte to migrate this 
distance and therefore will not be zero. Likewise, the last eluting peak, with respect to the 
total peak capacity, would take hours or days to elute as its electrophoretic mobility 
would be almost equal in magnitude, but opposite in direction to the EOF. Therefore, a 
more realistic calculation of peak capacity is known as the sample peak capacity (nc**) 
[18]. 
 
The sample peak capacity determines the number of peaks that could fit in a separation 
space, defined by the elution of the first and last eluting peaks, under a given set of 
compounds, resolution, and separation conditions. Therefore, sample peak capacity in 
DOI-CZE is determined by 
 
       𝑛𝑐
∗∗ = [1 +
𝐿𝑐
2𝑅𝑠√2𝐷
(
1
√𝑡𝐴,𝑐
−
1
√𝑡𝑛,𝑐
)] + [1 +
𝐿𝑎
2𝑅𝑠√2𝐷
(
1
√𝑡𝐴,𝑎
−
1
√𝑡𝑛,𝑎
)]            (2.10) 
 
where Lc is the cation migration distance, La is the anion migration distance, tn,c and tn,a 
are the n
th
 eluting component for cations and anions, respectively, and tA,c and tA,a are the 
first eluting cation and anion, respectively. As shown in Figure 2.2B, the sample peak 
capacity (9) is less than the total peak capacity (12).   
 
It is well known that capillary electrophoresis often yields a large peak capacity due to 
the large theoretical plate numbers typically observed in CE [19-21]. While the total peak 
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capacity will remain the same for a fixed total capillary length, the sample peak capacity 
can vary depending on the migration distances selected and the degree of EOF 
suppression.  
 
Figure 2.3 illustrates how the peak capacity can vary for a separation of six cations (blue 
diamonds) and six anions (green triangles) using CZE. This figure shows a plot of 
migration distance versus time. The electrophoretic mobility values for the analytes 
studied are provided in Table 4.1. In Figure 2.3, fixed values of 55 cm for the total 
capillary length (Lt), 5.50 x 10
-4
 cm
2
/Vs for the electroosmotic mobility (EOF), and +30 
kV for the applied voltage (V) were used. The migration distance was varied from 13.00 
to 27.50 cm. The numerical values of migration distance used for each separation are 
shown in Table 2.1. The resulting sample and total peak capacity values are also provided 
in this table. It is observed from both the table and the related figure that as the migration 
distance increases, the sample peak capacity increases for both cations and anions in 
CZE. 
 
Figure 2.4 illustrates a separation of the same six cations (blue diamonds) and six anions 
(green triangles) described above using DOI-CZE. The same type of plot (migration 
distance versus time) was used for these data. In Figure 2.4, fixed values of 55 cm for Lt, 
1.75 x 10
-5
 cm
2
/Vs for EOF, and +30 kV for V were employed. The numerical values for 
the migration distances used for both cations and anions can be found in Table 2.2. The 
resulting sample and total peak capacity values are also provided in this table. 
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Figure 2.3: Simulated electropherogram of six cations and six anions (whose 
electrophoretic mobilities are provided in Table 4.1) using CZE under a voltage of +30 
kV, 5.50 x 10
-4
 cm
2
/Vs for the EOF, and a total capillary length of 55.00 cm. The 
migration distance, Ld, ranges from 27.50 cm in the top-most separation to 13.00 cm in 
the bottom-most separation for all analytes. With the exception of the top-most figure 
which decreases by 0.50 cm from separation 1 to separation 2, the capillary length 
decreases by 1.00 cm with each subsequent separation.  
 
Key: Cations are represented by blue diamonds. Anions are represented by green 
triangles. 
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Table 2.1: Sample peak capacity calculations for the CZE simulations shown in Figure 
2.3.  
 
 
 
 
 
 
  
Total
D (cm
2
/s) Lc (cm) tfirst (s) tlast (s) Peak Capacity La (cm) tfirst (s) tlast (s) Peak Capacity Peak Capacity
1.00E-05 13.0 27.94 33.62 17 13.0 68.10 136.19 38 56
14.0 30.09 36.20 18 14.0 73.33 146.67 37 54
15.0 32.24 38.79 18 15.0 78.57 157.14 38 56
16.0 34.39 41.37 19 16.0 83.81 167.62 39 58
17.0 36.54 43.96 20 17.0 89.05 178.10 40 60
18.0 38.69 46.54 20 18.0 94.29 188.57 41 62
19.0 40.84 49.13 21 19.0 99.52 199.05 43 63
20.0 42.99 51.72 21 20.0 104.76 209.52 44 65
21.0 45.13 54.30 22 21.0 110.00 220.00 45 66
22.0 47.28 56.89 22 22.0 115.24 230.48 46 68
23.0 49.43 59.47 23 23.0 120.48 240.95 47 69
24.0 51.58 62.06 23 24.0 125.71 251.43 48 71
25.0 53.73 64.65 23 25.0 130.95 261.90 49 72
26.0 55.88 67.23 24 26.0 136.19 272.38 50 74
27.5 59.11 71.11 25 27.5 144.05 288.10 51 76
AnionsCations
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Figure 2.4:  Simulated electropherogram of six cations and six anions (whose 
electrophoretic mobilities are provided in Table 4.1) using DOI-CZE under positive 
polarity (+30 kV) and a total capillary length of 55.00 cm. The value for Lc ranges from 
27.50 cm in the top-most separation to 13.00 cm in the bottom-most separation. With the 
exception of the top-most scenario, which decreases by 0.50 cm from separation 1 to 
separation 2, the capillary length decreases by 1.00 cm with each subsequent separation. 
The value for La ranges from 27.50 cm in the top-most separation to 42.00 cm in the 
bottom-most separation. With the exception of the top-most figure, which increases by 
0.50 cm from separation 1 to separation 2, the capillary length increases by 1.00 cm with 
each subsequent separation. 
 
Key: Cations are represented by blue diamonds. Anions are represented by green 
triangles. 
 
  
nc= 27.5 
nc= 26 
nc= 25 
nc= 24 
nc= 23 
nc= 22 
nc= 13 
nc= 14 
nc= 15 
nc= 16 
nc= 17 
nc= 18 
nc= 21 
nc= 20 
nc= 19 
na= 27.5 
na= 29 
na= 42 
na= 30 
na= 31 
na= 32 
na= 33 
na= 34 
na= 41 
na= 40 
na= 39 
na= 38 
na= 37 
na= 36 
na= 35 
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It is observed from Figure 2.4 that the sample peak capacity for cations decreases with 
decreasing migration distance. As the migration distance for cations decreases, the 
migration distance for anions increases. Subsequently, the peak capacity of anions 
increases as the migration distance increases. However, the total sample peak capacity 
remains fairly constant, in the range of 88-89 for all separations, due to the offset in 
migration distances for each separation. It is clear that another definition of peak capacity 
should be developed to address the visible differences in the separation space available in 
Figure 2.4. This phenomenon affects both CZE and DOI-CZE separations.  
 
The available separation space for a given starting and ending peak will be referred to as 
the potential peak capacity. The potential peak capacity takes into account gaps in the 
separation space in both CZE and DOI-CZE and any regions of overlap between cations 
and anions as can occur in DOI-CZE. In CZE, the potential peak capacity is calculated by 
using the elution time of the first eluting cation and last eluting anion and the migration 
distance of interest. In Figure 2.3, a migration distance of 27.5 cm for all analytes yields a 
potential peak capacity of 147 and sample peak capacities of 25 and 51 for cations and 
anions, respectively.  
 
In comparison, a separation using migration distances for 27.5 cm for both cations and 
anions in DOI-CZE yields sample peak capacities of 43 and 50 for cations and anions, 
respectively, as shown in Table 2.3. The difference in sample peak capacities observed 
for cations and anions is related to the small cathodic EOF that makes the effective 
migration distance longer for the counter-electroosmotic anions. The potential peak 
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Table 2.2: Sample peak capacity calculations for the DOI-CZE simulation shown in 
Figure 2.4.  
 
 
 
  
Total
D (cm
2
/s) Lc (cm) tfirst (s) tlast (s) Peak Capacity La (cm) tfirst (s) tlast (s) Peak Capacity Peak Capacity
1.00E-05 27.5 187.63 348.06 41 27.5 167.28 336.32 48 88
27.0 184.06 341.57 40 28.0 170.49 342.60 48 89
26.0 176.91 328.58 40 29.0 176.90 355.16 49 89
25.0 169.76 315.60 39 30.0 183.31 367.71 50 89
24.0 162.61 302.61 38 31.0 189.72 380.26 50 89
23.0 155.46 289.63 38 32.0 196.13 392.83 51 89
22.0 148.31 276.65 37 33.0 202.54 405.38 52 89
21.0 141.16 263.66 36 34.0 208.95 417.94 52 89
20.0 134.01 250.68 36 35.0 215.36 430.50 53 89
19.0 126.86 237.69 35 36.0 221.77 443.05 54 89
18.0 119.71 228.18 35 37.0 228.18 455.61 54 89
17.0 112.55 211.73 33 38.0 234.59 468.17 55 88
16.0 105.40 198.74 33 39.0 241.00 480.73 56 88
15.0 98.25 185.76 32 40.0 247.41 493.28 56 88
14.0 91.10 172.78 31 41.0 253.82 505.84 57 88
13.0 83.95 159.79 30 42.0 260.23 518.4 58 88
AnionsCations
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capacity in DOI-CZE can be determined by using the first and last eluting analytes and 
the geometric mean migration distance. The potential peak capacity value of 52 accounts 
for any overlap in the elution order between oppositely charged analytes. If the migration 
distances are modified so that cations migrate 13 cm to the detector and anions migrate 
42 cm to the detector, the potential peak capacity increases to 118. Based on the above 
example, the migration distances in DOI-CZE can be used to modify the potential and 
sample peak capacities. The larger the difference in migration distance, the larger the 
potential peak capacity. 
 
2.5 Purpose of Study  
Many DOI-CZE papers have reported statistical data (in the form of relative standard 
deviation) on the migration time and/or corrected area of individual DOI-CZE 
experiments [3-5,9,22-33]. A comparison of the precision of migration time and peak 
area for the three different modes of sample introduction in DOI-CZE was performed by 
Zhou and Foley [9]. However, few papers have compared these data experimentally to 
data from comparable methods, namely conventional CZE from which this technique was 
developed. Kuban has compared experimental DOI-CZE results to ion chromatography 
[27] and other papers have referenced experiments performed by others for the analytes 
of interest [28,31]. 
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Table 2.3: Comparison of peak capacity values between CZE and DOI-CZE. 
ep, first cation,CZE (cm
2
/Vs) 3.03 x 10
-4
 
ep, last anion,CZE (cm
2
/Vs) -3.34 x 10
-4
 
ep, first cation,DOI-CZE (cm
2
/Vs) 3.03 x 10
-4
 
ep,last anion,DOI-CZE (cm
2
/Vs) -2.00 x 10-4 
 CZE DOI-CZE 
eo (cm
2
/Vs) 5.50 x 10
-4
 1.75 x 10
-5
 
Lt 55 55 55 
Lc 27.5 27.5 13 
La 27.5 27.5 42 
Sample peak capacity 
Cations – 25  
Anions – 51  
Cations – 43  
Anions – 50 
Cations – 30  
Anions – 62 
Potential peak capacity 147 52 118 
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Resolution as a topic in DOI-CZE is rarely discussed. This is rather unusual given the 
possibility of co-detection for two compounds migrating from opposite ends of the 
capillary [10]. If run-to-run variations are observed in the suppressed (but not completely 
eliminated) EOF, analyte migration will be affected. Therefore, the resolution between 
oppositely migrating analytes could vary significantly, especially for closely eluting 
oppositely charged analytes.  
 
Precision is the key to reliable results in quantitative measurements. To the best of our 
knowledge, a detailed study of precision in CZE and DOI-CZE experiments and the 
comparison between them has not been reported before. In this chapter, we present an 
evaluation of the precision of migration time, peak area, and resolution between CZE and 
DOI-CZE, keeping as many parameters as possible the same or similar in order to 
facilitate a fair comparison.  
 
2.6 Materials and Methods  
 
2.6.1 Instrumentation 
 
All experiments were performed on an Agilent 
3D
CE instrument, model G1600AX, 
(Agilent Technologies, Waldbronn, Germany), equipped with a diode array detector; the 
primary wavelength monitored was 214 nm. ChemStation software, version B.03.02, was 
used for data acquisition (at 10 Hz) and analysis [34]. Fused-silica capillaries (50 m 
I.D., 365 m O.D., 55 cm total length) from Polymicro Technologies (Phoenix, AZ) were 
employed in all experiments. A window was burned for UV detection; the position of the 
window varied with the type of separation used. Unless otherwise specified, detection 
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windows were burned 46.6 and 25 cm from the anode in CZE and DOI-CZE, 
respectively. The cartridge temperature was maintained at 25°C for all experiments. 
 
UV-visible absorbance spectra were obtained for each analyte using an Agilent 8453 UV-
visible Spectroscopy System. A quartz sample cell with a 1-cm pathlength was used to 
contain all measured samples. The instrument was run in spectrum/peaks mode, where 
wavelength range from 190- 900 nm was obtained. The spectral slit width on this 
instrument is fixed at 1 nm. Buffer was used as the blank (reference) sample. Data were 
recorded every 1 nm. 
 
2.6.2 Reagents 
Distilled deionized water was obtained from a Barnstead E-Pure Water System 
(Dubuque, IA) with a resistance of at least 18 MΩ. Lithium hydroxide (LiOH), ephedrine 
hydrochloride, disopyramide, chlorpheniramine maleate and benzene sulfonic acid were 
purchased from Sigma (St. Louis, MO). Disodium hydrogen phosphate (Na2HPO4), 
sodium dihydrogen phosphate (NaH2PO4), and p-toluene sulfonic acid were purchased 
from J.T. Baker (Phillipsburg, NJ). Phosphoric (H3PO4) and hydrochloric (HCl) acids 
were purchased from Pharmco-Aaper (Shelbyville, KY). Structures of the analytes 
studied are shown in Figure 2.5 and the selected properties of pKa and molecular weight 
(in g/mol) are shown in Table 2.4. 
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Ephedrine            Disopyramide 
 
 
 
 
 
                                       Chlorpheniramine           
 
 
 
 
 
Benzenesulfonic acid           p-toluenesulfonic acid 
 
Figure 2.5: Structures of model analytes.  
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Table 2.4. Selected properties of the analytes of interest. 
 
Analyte pKa Molecular weight (g/mol) 
Ephedrine 9.6 [35,36] 164.23 
Chlorpheniramine  9.13-9.20 [37-42] 274.78 
Disopyramide 10.2 [43] 339.48 
Benzene sulfonic acid 0.70 [44] 158.18 
p-toluene sulfonic acid -1.3 [45] 172.20 
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2.6.3 Buffer and Sample Preparation 
The CZE buffer contained a mixture of NaH2PO4 and Na2HPO4 to yield a concentration 
of 15 mM. To adjust the pH of the buffer used for CZE, lithium hydroxide was added 
until the pH reached 7. The DOI-CZE buffer was composed of H3PO4 and NaH2PO4 to 
yield a concentration of 50 mM. In the buffer for DOI-CZE, hydrochloric acid was added 
until the pH of the buffer reached 2.5. In each preparation, water was added to bring the 
solution to final volume. The test solutions were prepared by dissolving the analytes in 
the desired running buffer to obtain a final concentration at or below 0.5 mg/mL; 
appropriate dilutions were made from this stock solution. All solutions were filtered 
through a Gelman Acrodisc® polytetrafluoroethylene (PTFE) 0.45 m membrane filter. 
 
2.6.4 Capillary Preparation and Sample Introduction  
New capillaries for CZE were conditioned with distilled deionized water for 10 min, 1 M 
LiOH for 10 min, 0.1 M LiOH for 5 min, distilled deionized water for 3 min and 15 mM 
phosphate buffer solution (pH 7) for 15 min. This conditioning was also run at the start of 
each day. Capillaries were flushed with buffer for 2 min between runs. Injections were 
performed hydrodynamically at +15 mbar for 2 seconds. An applied voltage of +30 kV 
(1.35 W/m) was used for all CZE experiments.  
 
In DOI-CZE, new capillaries were conditioned with distilled deionized water for 10 min, 
0.1 M LiOH for 10 min, distilled deionized water for 5 min, 0.1 M HCl for 10 min, and 
50 mM phosphate buffer solution (pH 2.5) for 15 min. In order to maintain suppressed 
EOF conditions in the capillary, a shortened version of the initial conditioning method 
was used between injections in which the run time for each of the conditioning steps was 
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reduced to one-fifth of the duration of the original conditioning step. Injections were 
performed via a sequential hydrodynamic injection; this consisted of an initial injection 
of sample at +15 mbar for 2 seconds, followed by an injection of buffer behind the 
sample at +25 mbar for 3 seconds. Sample was then introduced to the opposite end of the 
capillary at -15 mbar for 2 seconds. An applied voltage of +16 kV (1.43 W/m) was used 
for all DOI-CZE experiments. 
  
A voltage ramp of 0.3 minutes was applied at the onset of each separation to avoid Joule-
heating induced thermal expulsion of the sample. The use of a voltage ramp will slightly 
increase the migration time observed from the electropherogram. Therefore, the 
migration time of the analytes were corrected for the voltage ramp time that occurs at the 
start of every application of voltage by, 
 
𝑡𝑉𝑅𝐶 = 𝑡𝑚 −
𝑡𝑉𝑅
2
                 (2.11) 
 
where tVRC is the voltage ramp corrected migration time, tm is the migration time 
determined from peak integration, and tVR is the length of time that the voltage ramp is 
applied. The statistical data presented below are based on the voltage ramp corrected 
migration times of all peaks. 
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2.7 Results and Discussion  
 
2.7.1 Evaluation of Precision 
 
To evaluate the precision of experiments, both repeatability and intermediate precision 
were assessed. Repeatability is defined as the scatter of replicate measurements over a 
short time interval under the same experimental conditions, such as sample preparation, 
analyst, instrument, and day. Therefore, experiments were run with at least five replicate 
injections. One set of five injections were made at least once per day. The objective of 
intermediate precision is to verify that the experimental conditions will provide the same 
results on multiple days of analysis. Therefore, the same conditions were run over at least 
two days.  
 
As the same experimental conditions are applied to all sets of data for a given separation 
technique (CZE vs. DOI-CZE), assessment of the collected data was processed using 
one-way analysis of variance (ANOVA) at the 95% confidence level. This test assumes 
that group means are normally distributed with a common variance and that the deviation 
of an individual outcome for a given group is independent from other groups. The null 
hypothesis is that all means are equal.     
 
The sample variance can be evaluated by the mean square, which is the sum of squared 
deviations from the mean divided by the degrees of freedom. The mean square between 
groups (MSbetween) represents the variance between the different groups. The within 
groups mean square (MSwithin) is an estimate of the variance due to random error. 
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To evaluate the mean squares, the F-test can be calculated by, 
 
𝐹𝑐𝑎𝑙𝑐 =
𝑀𝑆𝑏𝑒𝑡𝑤𝑒𝑒𝑛
𝑀𝑆𝑤𝑖𝑡ℎ𝑖𝑛
         (2.12) 
 
To evaluate the F-test, the calculated F-value (Fcalc) is compared to the table value (Ftable). 
The Ftable value is based on the numerator DF (k-1) and the denominator DF (N-k) for a 
given confidence level, where N is the total number of data points and k is the number of 
groups studied. If the Fcalc value exceeds the Ftable value, the null hypothesis is rejected 
and the means between data sets are not the same.   
 
When the ANOVA test shows that the null hypothesis is rejected, this indicates that at 
least one group differs from the other groups. However, this test does not indicate which 
data set(s) is/are different. In order to compare data sets pairwise, the Fisher’s Least 
Significant Difference (LSD) test is used. This analysis determines the smallest 
significant difference between two means. 
 
The difference between the means of two sets of data a and b will be significant if, 
 
|?̅?𝑎 − ?̅?𝑏| > 𝐿𝑆𝐷       (2.13) 
 
where ?̅?𝑎 and ?̅?𝑏 are the means of data sets a and b, respectively. The critical value for 
LSD can be determined by, 
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    𝐿𝑆𝐷 =  𝑡(𝛼,𝐷𝐹𝑤𝑖𝑡ℎ𝑖𝑛)√𝑀𝑆𝑤𝑖𝑡ℎ𝑖𝑛(
1
𝑁𝑎
+
1
𝑁𝑏
)       (2.14) 
 
where t(,DFwithin) is the ttable value for a given confidence level, , and the within-groups 
degrees of freedom.  
 
The ANOVA and Fisher’s LSD test (if necessary) were used to evaluate the data using 
both CZE and DOI-CZE, whose separation conditions are described above. 
 
2.7.2 Determination of Appropriate Wavelength(s) for Analysis  
 
To determine the appropriate wavelength(s) to monitor in CE with a diode array detector 
(DAD), UV-visible absorbance spectrum were analyzed for each analyte of interest. The 
15 mM phosphate at pH 7 was used as the solvent. The individual spectra obtained for 
each of the cationic analytes are shown in Figures 2.6- 2.8. The maximum UV-
absorbances were determined to be 211 nm for both ephedrine and disopyramide, 
respectively. Figure 2.7 shows the spectra for chlorpheniramine, which has a maximum 
absorbance of 211 nm. Figure 2.8A-B shows the spectra for benzenesulfonic acid and p-
toluenesulfonic acid; the maximum absorbance for each of these analytes is 213 nm.  
 
The wavelengths chosen for all CZE and DOI-CZE experiments were 200 nm, 205 nm 
and 214 nm. Each analyte shows a small amount of absorbance at approximately 254 nm; 
therefore, this wavelength was selected as the fourth wavelength for analysis. The final   
73 
 
A. 
 
B. 
 
Figure 2.6: UV-visible spectrum of A. ephedrine (maximum at 211 nm) and B. 
disopyramide (maxima at 211 nm and 261 nm) using an Agilent 8453 UV-visible 
spectrometer. A quartz sample cell with a 1-cm pathlength was used for all samples. The 
instrument was run in spectrum/peaks mode in a range of 190-900 nm. The range 200-
400 nm is shown in the figure. The spectral slit width is 1 nm. Buffer was used as the 
blank (reference) sample. Absorbance data were recorded every 1 nm. The solvent was 
15 mM phosphate buffer at pH 7. 
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Figure 2.7: UV-visible spectrum of chlorpheniramine (maxima at 211 nm and 261 nm). 
Conditions as in Figure 2.6. 
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A. 
 
B. 
 
Figure 2.8: UV-visible spectrum of A. benzenesulfonic acid (maxima at 213 nm and 263 
nm) and B. p-toluenesulfonic acid (maxima at 211 nm and 263 nm). Conditions as in 
Figure 2.6. 
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 wavelength monitored was 280 nm where no absorbance should occur for any of the 
analytes studied. A bandwidth of 10 nm was chosen for each wavelength studied.  
 
2.7.3 Dual-Opposite Injection Capillary Zone Electrophoresis Separation 
Using the DOI-CZE conditions described in Section 2.6, the separation shown in Figure 
2.9 was obtained. The elution order is ephedrine, chlorpheniramine, benzenesulfonic 
acid, p-toluenesulfonic acid, and disopyramide. The elution order was confirmed by 
matching the migration times of individually prepared standards to the standard mixture. 
The UV spectrum for each individually run standard was recorded and stored in a library 
in the ChemStation software to match with spectra taken from the mixture as an 
additional means of peak identification.  
 
It is important to note that the anions, benzenesulfonic acid and p-toluenesulfonic acid, 
exhibit excellent peak shape compared to the severe electromigration dispersion observed 
under CZE conditions (vide infra). The superior anion peak shape under DOI-CZE 
demonstrates that the mobility of the like-charged buffer ion(s) at pH 2.5 more closely 
match the mobilities of the anions of interest compared to the mobility of like-charged 
buffer components present at pH 7 in the CZE separation.  
 
It is also noted that peak tailing of the cations is observed in both CZE and DOI-CZE 
separations, a known phenomenon that can occur when using a fused silica capillary. 
While not shown, the amount of tailing experienced by cations appears to worsen with 
increasing use of the capillary. This is likely related to an increase in the number of 
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Figure 2.9: Dual-opposite injection capillary zone electrophoresis separation using a 
positive polarity of +16 kV, 50 mM phosphate buffer, pH 2.5, Lt: 55 cm, Lc: 25 cm, La: 
30 cm, and wavelength of 214 nm. Approximate concentration for each analyte: 0.1 
mg/mL. Elution order: (1) ephedrine, (2) chlorpheniramine, (3) benzenesulfonic acid, (4) 
p-toluenesulfonic acid, and (5) disopyramide.   
1 
2 
3 
5 
4 
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exposed silanol sites on the capillary wall due to a lack of reproducible capillary 
conditioning. The inability to recondition the capillary in a reproducible manner can lead 
to an increase in the interaction between the positively charged analytes and the 
negatively charged capillary wall. The use of a competing positively charged compound, 
such as triethanolamine, can be used to improve the peak shape of these cations. This 
approach was not employed under the separations described below in order to minimize 
the differences between separation techniques.   
 
This DOI-CZE separation was designed so that the elution order can vary between 
cations or anions in order to adequately analyze the precision of resolution between 
oppositely charged analytes. It is hypothesized that the precision of resolution between 
oppositely charged analytes will largely depend on the precision of the EOF. If the 
magnitude of EOF increases with each run, cations will elute faster and anions will elute 
slower. On the other hand, if the magnitude of EOF decreases with each run, cations will 
elute slower and anions will elute faster. Therefore, the resolution between oppositely 
charged ions could increase or decrease, depending on the elution order of analytes and 
the change observed in the EOF. 
 
In order for anions to migrate from the cathode to the anode in DOI-CZE, the EOF must 
be suppressed. However, the magnitude of the EOF cannot be easily determined using the 
neutral marker method as common in CZE as the marker would take several hours to 
reach the detector. Therefore, to determine the approximate value of EOF, a method 
described by Williams and Vigh was employed [46]. This approach is utilized to measure 
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EOF of solutions in which there is no interaction between analytes and the components of 
the running buffer.  
 
In this method, a sample containing 1 mg/mL propiophenone in the running buffer is 
injected using several hydrodynamic injections into the capillary as described below. 
First, a plug of sample is introduced into the capillary using a pressure of +25 mbar for 3 
seconds. Then, the sample plug is moved forward a short distance into the capillary by 
applying a pressure of +40 mbar for 15 seconds using the buffer solution. This process of 
sample injection and moving the sample plug further into the column with the buffer 
solution was repeated. Then, a positive voltage of 16 kV was applied for 180 seconds. 
Finally, a third injection of the sample at +25 mbar for 3 seconds was made and followed 
by a push with the buffer solution at +40 mbar until all three sample peaks elute.  
 
To determine the magnitude of EOF, the following calculation was employed,  
 
𝑢𝑒𝑜 =
(𝑡3+𝑡1−2𝑡2)
(𝑡3+
𝑡𝑖𝑛𝑗
2
−𝑡𝑑)
∗
𝐿𝑑∗𝐿𝑡
𝑉∗𝑡𝑣
      (2.15) 
 
where t1, t2, and t3 are the migration times of the first, second and third sample injections, 
respectively, tinj is the injection time per sample, tv is the time used for voltage 
application, td is the electronic delay time that was 0.1 seconds, Ld is the migration 
distance, Lt is the total capillary length, and V is the applied voltage. 
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An average value of 2.38 x 10
-5
 cm
2
/Vs was determined for the EOF using a 50 mM 
phosphate buffer at pH 2.5. This average value of EOF was based on 10 successive 
injections. The percent relative standard deviation (%RSD) for this data set is 7.40%. 
 
2.7.3.1 Evaluation of Migration Time Precision in DOI-CZE 
The ChemStation software (version B.04.03) determines the migration time of a given 
peak by using the integration features available in the data analysis portion of the 
software. Integrating a peak determines the start and stop time of the peak. The apex of 
the peak is identified as the migration time.  
 
The first capillary was used for a total of 50 runs. These runs were comprised of data sets 
that include five successive injections. On days 1 and 2, three sets of data were collected 
throughout each day. On day 3, only one data set was collected. After the runs on day 3 
were completed, the capillary was cleaned and stored. To test the viability of the capillary 
after not being run for a considerable amount of time, another three sets of five injections 
were completed on day 12. 
 
A second capillary, which used the same buffer and sample as capillary 1, was run to test 
variability between capillaries of the same batch. These runs were also comprised of data 
sets that include five successive injections. For this capillary, only one set of data was 
collected on the first day of runs (day 1); the capillary was then conditioned and stored 
for 9 days. The capillary was then run for at least two sets of data from day 10 to day 16 
for a total of 95 runs.  
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To focus on the general trends observed during the runs on capillary 1, peak 1 was 
selected to serve as a representative peak. Any deviations from the trends observed for 
peak 1 will be described below as applicable. The voltage ramp corrected migration time 
for peak 1 is shown in Table 2.5. The data and statistical analysis for peaks 2-5 can be 
found in Appendix A. 
 
On day 1, there is an observable decrease in the migration time for the first three 
injections of data set 1. However, the RSD for the 15 runs completed on day 1 is 0.197% 
for peak 1, indicating a high level of precision. The average migration time for peak 1 
decreased from 2.656 minutes on day 1 to 2.623 minutes on day 2, a decrease of 
approximately 1.231%. A slight decrease in migration time over subsequent data sets was 
observed on day 2. While peaks 2 and 5 (the other cations studied) showed a similar trend 
to peak 1, the average migration time of the anions (peaks 3 and 4) slowly decreased 
from set 1 on day 1 to set 3 on day 2. 
 
Only one set of data was run on day 3. The average migration time for the five successive 
runs was 2.621 minutes, a decrease of 0.002 minutes from day 2. However, this set 
yielded an RSD of 0.102%, indicating that perhaps the EOF had stabilized. After the 
completion of the runs on day 3, the capillary was conditioned and stored for nine days. 
 
On day 12, three sets of data were run. The average for this set of 15 injections was 2.610 
minutes, a decrease of 1.764% from the average obtained on day 1. Peaks 3 and 4 each 
showed a slight increase in average migration time from day 3 to day 12. Collectively,  
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Table 2.5: Migration time (minutes) for peak 1 (ephedrine) using DOI-CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 2.667 2.659 2.653 2.650 2.651 2.656 0.005 0.197 
 
2 2.652 2.649 2.653 2.651 2.653 
   
 
3 2.661 2.658 2.656 2.659 2.662    
Day 2 1 2.656 2.646 2.640 2.636 2.635 2.623 0.016 0.602 
 
2 2.625 2.618 2.617 2.618 2.616 
   
 
3 2.615 2.609 2.606 2.604 2.608    
Day 3 1 2.624 2.618 2.621 2.624 2.619 2.621 0.003 0.102 
Day 12 1 2.608 2.602 2.604 2.602 2.601 2.610 0.006 0.239 
 
2 2.616 2.609 2.607 2.607 2.608 
   
 
3 2.620 2.614 2.615 2.616 2.617 
   
 
     
Overall 2.629 0.021 0.795 
 
      
   
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 2.670 2.668 2.667 2.668 2.668 2.668 0.001 0.048 
Day 10 1 2.682 2.672 2.670 2.669 2.667 2.674 0.005 0.180 
 
2 2.678 2.675 2.675 2.677 2.681 
   Day 11 1 2.686 2.680 2.679 2.679 2.678 2.680 0.005 0.197 
 
2 2.680 2.675 2.674 2.673 2.673 
   
 
3 2.688 2.678 2.682 2.686 2.690 
   Day 12 1 2.671 2.666 2.665 2.665 2.667 2.668 0.003 0.110 
 
2 2.673 2.670 2.668 2.668 2.671 
   Day 13 1 2.675 2.667 2.661 2.656 2.656 2.657 0.022 0.832 
 
2 2.648 2.646 2.647 2.646 2.650 
   
 
3 2.663 2.658 2.657 2.658 2.660 
   Day 14 1 2.692 2.685 2.685 2.682 2.684 2.685 0.004 0.137 
 
2 2.690 2.685 2.683 2.681 2.681 
   Day 15 1 2.659 2.657 2.654 2.653 2.654 2.663 0.007 0.261 
 
2 2.665 2.660 2.660 2.661 2.662 
   
 
3 2.676 2.669 2.669 2.669 2.672 
   Day 16 1 2.690 2.682 2.679 2.677 2.675 2.669 0.009 0.343 
 
2 2.666 2.663 2.664 2.664 2.665 
   
 
3 2.667 2.662 2.661 2.661 2.661 
   
      
Overall 2.670 0.011 0.407 
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peak 1 yielded an RSD of 0.795% for the 50 injections run on capillary 1. The RSD for 
peaks 2-5 were 0.822%, 1.443%, 1.492% and 0.788%, respectively. It is observed that for 
capillary 1, the anions (peaks 3 and 4) yielded slightly less precise migration times 
compared to the cations. 
 
The results for peak 1 suggest that the EOF was likely imprecise during a portion of the 
runs for capillary 1. However, as described above, it is impractical to measure suppressed 
EOF during a run as it may take hours for a neutral marker to elute. Therefore, it is 
difficult to comment on the changes to the EOF under DOI-CZE conditions. Based on the 
migration time data obtained, it appears as though the magnitude of EOF decreased 
slightly from day to day. This idea is supported by the sharper decrease in migration time 
for anions compared to cations. As the EOF decreases, anions are able to more quickly 
reach the detector. Due to the low magnitude of EOF selected, the cations are less 
affected by the slight decrease in bulk flow.        
 
Figure 2.10A shows the change in migration time for peak 1 with capillary 1. On day 1, 
there is a slow decrease in migration time for the first three injections and then a steady 
migration time is observed for runs 4- 9. A downward trend is also observed for all of the 
injections on day 2 (runs 15- 30). In general, there is a slight decrease in migration time 
for runs 1-3 and then an increase in migration time for runs 4 and 5 for injections 10- 15 
and 31- 50. This U-shaped trend suggests that there are somewhat reproducible variations 
in the EOF within each set of injections made with this capillary. 
  
84 
 
A. 
 
B. 
 
Figure 2.10: Migration time variation (minutes) for peak 1 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table 2.6: Migration time (minutes) ANOVA for peak 1 capillary 1.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 13.280 2.656 4.831 x 10
-5
 
Day 1 Set 2 5 13.257 2.651 2.684 x 10
-6
 
Day 1 Set 3 5 13.296 2.659 5.369 x 10
-6
 
Day 2 Set 1 5 13.212 2.642 7.635 x 10
-5
 
Day 2 Set 2 5 13.095 2.619 1.323 x 10
-5
 
Day 2 Set 3 5 13.041 2.608 1.811 x 10
-5
 
Day 9 Set 1 5 13.107 2.621 7.217 x 10
-6
 
Day 12 Set 1 5 13.016 2.603 9.004 x 10
-6
 
Day 12 Set 2 5 13.047 2.609 1.360 x 10
-5
 
Day 12 Set 3 5 13.082 2.616 4.820 x 10
-6
 
     
     ANOVA 
    Source of Variation SS DF MS Fcalc 
Between Groups 2.059 x 10
-2
 9 2.288 x 10
-3
 115.127 
Within Groups 7.948 x 10
-2
 40 1.987 x 10
-5
 
 
     Total 2.138 x 10
-2
 49   
 
   
P-value Ftable 
   
9.945 x 10
-26
 2.124 
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A statistical evaluation of each peak’s migration time over the course of the 50 samples 
injected on capillary 1 was employed using the ANOVA analysis described in Section 
2.7.1. The ANOVA data for peak 1 on capillary 1 is shown in Table 2.6. These results 
indicate that the null hypothesis is rejected as Fcalc value (115.127) exceeds the Ftable value 
(2.12). This indicates that at least one data set differs from the others. The individual 
ANOVA analysis for peaks 2-5 each indicate that the null hypothesis is to be rejected. In 
order to compare the data sets pairwise, the Fisher’s Least Significant Difference (LSD) 
test was used. This test determines the least significant difference between two means. 
The differences between means are shown in Table 2.7. The critical LSD value for this 
data set is 0.006. From this analysis, it is clear that there are three separate averages of 
data: 2.656, 2.619, and 2.607 minutes. The average migration time of 2.642 minutes does 
not fit within any of the mean groups.  
 
 
It is important to note that the groups of average migration times do not necessarily align 
with a particular day of runs. For example, the averages of 2.619 and 2.607 minutes are 
each a combination of days 2, 3, and 12. However, the average of 2.656 minutes comes 
from only runs completed on day 1. While it would appear that the simple exclusion of 
the day 1 data sets would improve the ANOVA results, a statistically significant 
difference is still observed (results not shown). The slow but consistent decrease in the 
migration time (particularly on day 2) due to assumed changes in the EOF, perhaps as a 
result of inadequate capillary conditioning, results in the average migration time of the 
data sets remaining statistically significantly different from one another.   
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Table 2.7: Migration time adjacent mean differences (minutes) for peak 1 capillary 1. 
 
 
 
 
  
Mean
Day 1 
Set 3
Day 1 
Set 1
Day 1 
Set 2
Day 2 
Set 1
Day 9 
Set 1
Day 2 
Set 2
Day 12 
Set 3
Day 12 
Set 2
Day 2 
Set 3
Day 12 
Set 1
Day 1 Set 3 2.659 -
Day 1 Set 1 2.656 0.003 -
Day 1 Set 2 2.651 0.008 0.005 -
Day 2 Set 1 2.642 0.017 0.014 0.000 -
Day 9 Set 1 2.621 0.038 0.035 0.030 0.021 -
Day 2 Set 2 2.619 0.040 0.037 0.032 0.023 0.002 -
Day 12 Set 3 2.616 0.043 0.040 0.035 0.026 0.005 0.003 -
Day 12 Set 2 2.609 0.050 0.047 0.042 0.033 0.012 0.010 0.007 -
Day 2 Set 3 2.608 0.051 0.048 0.043 0.034 0.013 0.011 0.008 0.001 -
Day 12 Set 1 2.603 0.056 0.053 0.048 0.039 0.018 0.016 0.013 0.006 0.005 -
LSD 0.006
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While the statistical data show that there are “breaks” in the data where the means are 
significantly different, an RSD of 0.795% for 50 total injections is generally considered 
quite good for an electrophoretic separation. Peaks 2-5 each follow a similar trend. It is 
important to note that for peaks 3 and 4, benzenesulfonic acid and p-toluenesulfonic acid, 
respectively, the decrease in migration time is more pronounced but still precise. 
 
The average migration time for peak 1 on day 1 using capillary 2 was 2.668 minutes with 
an RSD of 0.048%, indicating a high level of precision. The capillary was then 
conditioned and stored for nine days. On day 10, the average migration time had 
decreased from the average time calculated on day 1 by 0.228%. The migration time for 
peaks 2 and 5 (the two other cations) increased slightly from day 1 to day 10. From day 
10 to day 15, at least two sets of 5 injections were run each day. The migration time 
average for peak 1 during this time ranged from 2.657- 2.685 minutes. Figure 2.10B 
shows that the migration time for a given set of 5 injections displays a similar decrease 
and then increase as described above for capillary 1. 
 
The RSD for all 95 injections is 0.407% for peak 1. Based on these data, it appears as 
though capillary 2 was more reproducibly conditioned, the EOF more stable, compared to 
capillary 1. This is somewhat unexpected as the separation procedure and conditions 
remained the same for each capillary.  
 
The RSD for peaks 2-5 were 0.485%, 0.418%, 0.426% and 0.557%, respectively. It is 
important to note that unlike capillary 1, there does not appear to be a noticeable 
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difference in the migration times of anions compared to the cations in capillary 2. These 
data also support that there was a more reproducible EOF and/or capillary conditioning 
for capillary 2 compared to capillary 1 as suggested above. 
 
A statistical evaluation of each peak’s migration time over the course of the 95 samples 
injected on capillary 2 was employed using the ANOVA analysis. The ANOVA data for 
peak 1 on capillary 2 are shown in Table 2.8. The results indicate that at least one data set 
differs from another as the Fcalc value (40.877) exceeds the Ftable value (1.741).  
The differences between means using the Fisher’s Least Significant Difference (LSD) 
test are shown in Table 2.9. The critical LSD value for this data set is 0.005. Similar to 
capillary 1, capillary 2 does not show a particular trend with respect to breaks in the data 
based on day. After sorting by decreasing average time, days 1, 10, 11, and 14 generally 
show longer migration times while days 12, 13, 15 and 16 each show a slightly shorter 
average for migration time.  
 
Finally, a comparison between the results from capillary 1 to capillary 2 was achieved by 
using an F-test to compare the variances at the 95% confidence level. The F-test for peak 
1 is shown in Table 2.10. The Fcalc exceeds the Ftable value and therefore, the null 
hypothesis is rejected in this analysis. This indicates that there are significant differences 
in the variances between capillary 1 and capillary 2. It is observed from this analysis that 
for capillary 2, peak 1 yielded a smaller variance (1.181 x 10
-4 
minutes) compared to   
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Table 2.8: Migration time (minutes) ANOVA for peak 1 capillary 2. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 13.342 2.668 1.654 x 10
-6
 
Day 10 Set 1 5 13.360 2.672 3.171 x 10
-5
 
Day 10 Set 2 5 13.384 2.677 6.161 x 10
-6
 
Day 11 Set 1 5 13.402 2.680 9.188 x 10
-6
 
Day 11 Set 2 5 13.375 2.675 7.502 x 10
-6
 
Day 11 Set 3 5 13.424 2.685 2.131 x 10
-5
 
Day 12 Set 1 5 13.334 2.667 7.514 x 10
-6
 
Day 12 Set 2 5 13.350 2.670 5.392 x 10
-6
 
Day 13 Set 1 5 13.315 2.663 6.778 x 10
-5
 
Day 13 Set 2 5 13.236 2.647 2.964 x 10
-6
 
Day 13 Set 3 5 13.296 2.659 5.392 x 10
-6
 
Day 14 Set 1 5 13.427 2.685 1.476 x 10
-5
 
Day 14 Set 2 5 13.420 2.684 1.454 x 10
-5
 
Day 15 Set 1 5 13.277 2.655 6.105 x 10
-6
 
Day 15 Set 2 5 13.309 2.662 4.070 x 10
-6
 
Day 15 Set 3 5 13.354 2.671 9.031 x 10
-6
 
Day 16 Set 1 5 13.403 2.681 3.688 x 10
-5
 
Day 16 Set 2 5 13.322 2.664 2.292 x 10
-6
 
Day 16 Set 3 5 13.312 2.662 5.661 x 10
-6
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 1.006 x 10
-2
 18 5.591 x 10
-4
 40.877 
Within Groups 1.040 x 10
-3
 76 1.368 x 10
-5
 
 
     Total 1.110 x 10
-2
 94     
   
P-value Ftable 
   
9.917 x 10
-32
 1.741 
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Table 2.10: Migration time (minutes) F-test two- sample for variances of peak 1. 
 
  Capillary 1 Capillary 2 
Mean 2.629 2.670 
Variance 4.364 x 10
-4
 1.181 x 10
-4
 
Observations 50 95 
DF 49 94 
Fcalc 3.694 
 P-value 2.714 x 10
-8
 
 Ftable 1.488 
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capillary 1 (4.364 x 10
-4
 minutes). This is likely related to more adequate capillary 
conditioning achieved in capillary 2 compared to capillary 1.  
 
To compare the average migration time of capillary 1 to capillary 2, a t-test at the 95% 
confidence level with unequal variances (based on the F-test above) was used. The results 
of the analysis for peak 1 are shown in Table 2.11. The tcalc value of 13.055 exceeds the 
ttable value of 1.998. Therefore, the mean values of migration time between capillaries 1 
(2.629 minutes) and 2 (2.670 minutes) are statistically different. Peaks 2-5 also resulted 
in statistically significant variance and mean values between capillaries.  
 
An internal standard, where a known amount of a standard is added to each sample prior 
to injection, can be used to improve the precision of a given separation because neither 
the quantity injected nor the detector response needs to remain constant. In DOI-CZE, 
two internal standards, one cationic and one anionic, are employed. This is because the 
conditions of the injection, such as the position of the capillary or the angle of the 
capillary ends, could vary. These factors could cause higher RSD values when the analyte 
and internal standard are injected from opposite ends of the capillary. 
 
Using peaks 1 (ephedrine) and 3 (benzenesulfonic acid) as internal standards, the 
migration time of the remaining peaks were calculated as 
 
   𝑟𝑚𝑡 =
𝑡𝑚
𝑡𝐼𝑆
       (2.16) 
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Table 2.11: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 1.  
 
  Capillary 1 Capillary 2 
Mean 2.629 2.670 
Variance 4.364 x 10
-4
 1.181 x 10
-4
 
Observations 50 95 
Hypothesized Mean Difference 0 
 DF 63 
 tcalc 13.055 
 P-value 1.409 x 10
-19
 
 ttable 1.998 
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where rmt is the relative ratio of migration times, tm is the migration time for the peak of 
interest, and tIS is the migration time of the internal standard.  
 
For peak 2 (chlorpheniramine), the migration time RSD improved from 0.98% originally 
to 0.10% when using peak 1 as an internal standard. Likewise, peak 5 (disopyramide) 
improved from 1.05% to 0.21%. These results indicate that cations each experience a 
similar change in migration time as the conditions in the capillary are modified. The 
migration time RSD for peak 4 improves from 0.98% originally to 0.06% when using 
peak 3 as an internal standard, which indicates that each of the anions experience similar 
changes in migration time as the conditions in the capillary are modified and the EOF 
varies from run to run. However, in each capillary, the ANOVA still shows a statistically 
significant variability in the data for all peaks. Statistical results can be found in 
Appendix A. 
 
2.7.3.2 Evaluation of Corrected Area Precision in DOI-CZE 
The ChemStation software determines the area of a peak by using integration. First, the 
baseline is determined by a moving average equal to the initial peak width setting 
specified in the method. The beginning of a peak is detected when the signal curvature 
exceeds the noise threshold curve; conversely, the end of a peak is detected when the 
signal curvature is below the noise threshold curve.  
 
Once a baseline is constructed and peaks are confirmed, the peak area, height and width 
are calculated for each peak. The software evaluates a peak with the use of integration 
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events. These event parameters include the initial slope sensitivity (peak sensitivity), 
peak width (initial sampling interval for the integrator to distinguish peaks from baseline 
noise), area reject (all peaks whose areas are below this value will not be integrated) and 
height reject (all peaks whose heights are below this value will not be integrated). 
 
The two most important integration events with respect to the reported value of peak area 
are slope sensitivity and peak width. When the slope sensitivity value is decreased, 
broader, shorter peaks will be detected. All peaks in the sample mixture described in 
Section 2.6 have a concentration of at least 0.1 mg/mL and therefore produce large 
signals. As a result, the slope sensitivity parameter was not modified from the auto 
integration settings during any separations or data processing.  
 
The peak width setting controls the ability of the integrator to distinguish peaks from 
baseline noise. The area of a peak is determined by integrating from the beginning of the 
peak to its end, i.e., from ‘peak start’ to ‘peak stop’. Increasing the peak width will result 
in a larger reported peak area as a wider portion of the detector signal is used for the 
calculation. To choose an appropriate peak width value for the calculation of peak area, 
Agilent recommends a value equal to or less than the narrowest peak width; this process 
was done for each separation.  
 
The rate at which a given compound passes the detector window is based on its migration 
velocity. As a result, early-eluting peaks move through the detection window more 
rapidly than later-eluting peaks; later-eluting peaks appear to be larger than earlier-
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eluting peaks because they are moving more slowly. Therefore, a corrected area is 
employed that normalizes the reported peak area by the migration time.  
As with migration time, corrected area will be described using peak 1 as a representative 
peak of the results for this separation. The corrected area data were collected using the 
same runs described above. Any deviations from the trends observed in peak 1 will be 
described as applicable. The data analysis for peak 1 is shown in Tables 2.12-2.18. 
Statistical results for peaks 2-5 can be found in Appendix A.  
 
As shown in Table 2.12, the average corrected area for peak 1 on day 1 was 5.43 mAU 
with an RSD of 2.96%. The average area decreased from 5.43 mAU on day 1 to 5.33 
mAU on day 2. On day 2, an RSD of 2.86% was reported. There was an increase in 
corrected area for peaks 3 and 4 from days 1 to 2. On day 3, the average area for peak 1 
was 5.25 mAU. The RSD for this data set was 1.71%; this reinforces the suggestion that 
the EOF had stabilized during this set of runs. It is important to note that based on a 
visual comparison (not shown), the peak shape for cations were much less tailed on day 3 
compared to all of the other days. On day 12, the average area increased slightly to 5.30 
mAU with an RSD of 3.22%. On this day, data sets 2 and 3 yielded statistical outliers, 
which were removed from the data sets.   
 
Collectively, peak 1 yielded an RSD of 3.04% for the injections introduced on capillary 
1. The RSD values for peaks 2-5 were 3.18%, 2.56%, 2.74% and 4.27%, respectively. 
These results show that the corrected area precision for anions was better than for cations; 
this may be related to the less tailed peak shaped observed for the anions. While the   
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Table 2.12: Corrected area (mAU) for peak 1 (ephedrine) using DOI-CZE. 
       
Day 
Capillary 
1 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 5.30 5.59 5.25 5.49 5.47 5.43 0.16 2.96 
 
2 5.62 5.50 5.25 5.55 5.64 
   
 
3 5.39 5.63 5.24 5.27 5.22 
   Day 2 1 5.32 5.43 5.50 5.36 5.31 5.33 0.15 2.86 
 
2 5.20 5.41 5.22 5.29 4.93 
   
 
3 5.50 5.56 5.34 5.28 5.30 
   Day 3 1 5.15 5.29 5.37 5.29 5.17 5.25 0.09 1.71 
Day 12 1 5.11 5.59 5.55 5.31 5.42 5.30 0.17 3.22 
 
2 
 
5.21 5.13 5.38 5.50 
   
 
3 5.20 
 
5.15 5.25 5.12 
   
      
Overall 5.34 0.16 3.04 
       
Day 
Capillary 
2 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 5.92 6.02 5.71 5.83 5.61 5.82 0.16 2.81 
Day 10 1 6.16 5.68 5.96 5.92 6.33 5.96 0.18 3.01 
 
2 5.97 5.91 5.83 5.99 5.83 
   Day 11 1 5.92 5.99 5.86 5.71 5.99 6.01 0.13 2.22 
 
2 
 
5.892 6.12 6.14 6.15 
   
 
3 5.98 6.06 6.06 6.15 6.18 
   Day 12 1 6.21 6.14 5.87 5.79 5.92 6.04 0.22 3.60 
 
2 6.48 6.11 5.79 6.11 5.92 
   Day 13 1 5.88 6.02 5.86 6.37 5.87 6.06 0.21 3.54 
 
2 6.07 6.28 6.24 5.91 6.01 
   
 
3 6.41 6.27 6.16 5.86 5.71 
   Day 14 1 6.57 6.21 6.45 6.06 5.96 6.13 0.30 4.97 
 
2 6.29 6.27 6.19 5.75 5.58 
   Day 15 1 6.49 6.54 6.34 6.48 6.38 6.37 0.17 2.72 
 
2 6.29 6.45 6.34 5.92 6.22 
   
 
3 6.56 6.55 6.48 6.31 6.19 
   Day 16 1 6.44 6.29 6.16 6.60 6.40 6.37 0.15 2.36 
 
2 6.34 6.11 6.29 6.38 6.40 
   
 
3 6.47 6.30 6.27 6.70 6.38 
   
      
Overall 6.13 0.26 4.18 
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migration time data indicated that the EOF was likely imprecise during a portion of the   
runs using this capillary, the good precision of the corrected area data shows that the 
uncorrected area response was generally proportional to time for all peaks. This is further 
evidenced by analyzing the corrected peak area over each injection as shown in Figure 
2.11A which shows a random but small variation in the corrected area over each 
injection. 
 
The ANOVA data for peak 1 on capillary 1 are shown in Table 2.13; the statistical data 
for the remaining peaks (2-5) can be found in Appendix A. Based on the ANOVA for 
peak 1 on capillary 1, the null hypothesis is rejected. This indicates that at least one data 
set differs from the others; peaks 2-5 each also indicated that at least one data set differed 
significantly from the others. In order to compare the data sets pairwise, the Fisher’s 
Least Significant Difference (LSD) test was used. The differences between means for 
peak 1 are shown in Table 2.14. As with migration time, the differences between average 
corrected areas did not show that any particular day resulted in much higher or much 
lower results from the average. However, from this analysis, it is observed that for peak 
1, in general (2 out of 3 data sets), day 1 yielded the largest corrected area.  
 
Unlike peak 1, peaks 2-5, chlorpheniramine, benzenesulfonic acid, p-toluenesulfonic 
acid, and disopyramide, respectively, showed the largest average corrected areas for day 
12 and the smallest corrected areas for day 3. Because the capillary was only used for one 
day after storage, it is difficult to comment on the reasons for the increased corrected  
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A. 
 
B. 
 
Figure 2.11: Corrected area variations (mAU) for peak 1 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table 2.13: Corrected area (mAU) ANOVA for peak 1 capillary 1.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 27.09 5.42 0.02 
Day 1 Set 2 5 27.57 5.51 0.02 
Day 1 Set 3 5 26.76 5.35 0.03 
Day 2 Set 1 5 26.92 5.38 0.01 
Day 2 Set 2 5 26.05 5.21 0.03 
Day 2 Set 3 5 26.98 5.40 0.02 
Day 3 Set 1 5 26.27 5.25 0.01 
Day 12 Set 1 5 26.98 5.40 0.04 
Day 12 Set 2 4 21.21 5.30 0.03 
Day 12 Set 3 4 20.72 5.179 0.003 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.46 9 0.051 2.45 
Within Groups 0.79 38 0.021 
 
     Total 1.24 47 
  
   
P-value Ftable 
   
0.026 2.14 
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Table 2.14: Corrected area adjacent mean differences (mAU) for peak 1 capillary 1.  
 
 
 
 
 
 
 
 
 
 
  
Mean
Day 1 
Set 2
Day 1 
Set 1
Day 12 
Set 1
Day 2 
Set 3
Day 2 
Set 1
Day 1 
Set 3
Day 12 
Set 2
Day 3 
Set 1
Day 2 
Set 2
Day 12 
Set 3
Day 1 Set 2 5.51 -
Day 1 Set 1 5.42 0.10 -
Day 12 Set 1 5.40 0.12 0.02 -
Day 2 Set 3 5.40 0.12 0.02 0.00 -
Day 2 Set 1 5.38 0.13 0.03 0.01 0.01 -
Day 1 Set 3 5.35 0.16 0.07 0.05 0.05 0.03 -
Day 12 Set 2 5.30 0.21 0.12 0.09 0.09 0.08 0.05 -
Day 3 Set 1 5.25 0.26 0.16 0.14 0.14 0.13 0.10 0.05 -
Day 2 Set 2 5.21 0.31 0.21 0.19 0.19 0.18 0.14 0.09 0.04 -
Day 12 Set 3 5.18 0.34 0.24 0.22 0.22 0.21 0.17 0.12 0.07 0.03 -
LSD 0.18
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areas observed on day 12. Based on a visual inspection of the electropherograms, day 3 
yielded very symmetrical peaks while the peaks on day 12 exhibited tailing.  
 
The symmetry of a given peak may be influenced by solute adsorption onto and/or 
desorption from the capillary wall. The United States Pharmacopeial Convention (USP) 
calculates the tailing factor (t) as 
 
                               𝑡 =
𝑊5
2𝑡𝑤
                                                                   (2.17) 
 
where W5 is the peak width at 5% of the peak height and tw is the distance in minutes 
between the peak front and the migration time. Analysis of the peak tailing over the 
course of the runs for a given capillary would allow further comment on both the 
reproducibility and trend in the corrected area of each analyte. 
 
Table 2.15 shows the ANOVA data for peak 1 on capillary 2. The results show that there 
is a statistically significant difference between data sets. Based on the data in Table 2.16 
there is an observable increase in corrected area, particularly for days 15 and 16. This is 
further shown in Figure 2.11B where a slow but steady increase in the corrected area is 
observed over each injection. The removal of the data sets from days 15 and 16 result in 
no statistically significant difference between data sets. As each of the remaining peaks 
showed a slightly different result, they will be discussed individually below. All data and 
statistics for peaks 2-5 can be found in Appendix A.   
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Table 2.15: Corrected area (mAU) ANOVA for peak 1 capillary 2. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 29.10 5.82 0.03 
Day 10 Set 1 5 30.05 6.01 0.06 
Day 10 Set 2 5 29.52 5.90 0.01 
Day 11 Set 1 5 29.48 5.90 0.01 
Day 11 Set 2 4 24.30 6.07 0.01 
Day 11 Set 3 5 30.43 6.09 0.01 
Day 12 Set 1 5 29.93 5.99 0.03 
Day 12 Set 2 5 30.42 6.08 0.07 
Day 13 Set 1 5 30.00 6.00 0.05 
Day 13 Set 2 5 30.51 6.10 0.02 
Day 13 Set 3 5 30.41 6.08 0.08 
Day 14 Set 1 5 31.26 6.25 0.07 
Day 14 Set 2 5 30.1 6.0 0.1 
Day 15 Set 1 5 32.23 6.45 0.01 
Day 15 Set 2 5 31.20 6.24 0.04 
Day 15 Set 3 5 32.10 6.42 0.03 
Day 16 Set 1 5 31.89 6.38 0.03 
Day 16 Set 2 5 31.52 6.30 0.01 
Day 16 Set 3 5 32.11 6.42 0.03 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 3.32 18 0.18 4.98 
Within Groups 2.78 75 3.7 x 10
-2
 
 
     Total 6.10 93     
   
P-value Ftable 
   
3.48 x 10
-7
 1.74 
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The ANOVA data for peaks 2 and 5, chlorpheniramine and disopyramide, respectively, 
show no statistically significant differences among their respective corrected areas 
observed with capillary 2. As described in Section 2.7.3.1, capillary 2 appeared to be 
more reproducibly conditioned compared to capillary 1. The corrected area results for 
capillary 2 reinforce this statement. It is likely that the tailing of peak 1 contributed to its 
increased peak area during days 15 and 16. In both CZE and DOI-CZE, each of the 
cations appeared to tail, a trait that appeared to increase slightly over time. The tailing of 
a peak can contribute to additional peak area. It is extremely important that the peak 
integration is properly completed to ensure the correct amount of area is accounted. To  
do this, an auto-integration step is first performed. Next, the peak width setting in the 
integration events tab is changed to reflect the width of the first eluting analyte. This 
change results in a recalculation of the peak width values of all peaks based on a software 
algorithm. It is possible that using the first peak as a reference resulted in the 
reproducible responses for peaks 2 and 5, although given these conditions, peak 1 should 
also be reproducible. It is unclear how the algorithm determines the values for the widths 
of peaks 2 and 5 once the value for peak 1 is selected due to proprietary methods 
employed by the software. 
 
Peaks 3 and 4, benzenesulfonic acid and p-toluenesulfonic acid, respectively, display an 
entirely different response with respect to corrected area. The most notable difference 
between cations and anions is the outlier observed from the first run of many sets of the 
latter. It appears as though a systematic error related to injection is present for these ions. 
In the outlying data, the injection resulted in a reduction of the corrected area by almost 
one-half of the other amounts calculated. This may be attributed to differences in the 
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capillary alignment. In order to extend the capillary length from the outlet to the detector 
to allow anions a longer migration distance, a portion of the plastic cartridge was 
removed. When the capillary is placed into a vial, it passes through a small hole in the 
cap and goes into the vial to obtain sample. Usually, the capillary is held in place by the 
guides milled into the plastic of the capillary cartridge. However, in DOI-CZE this guide 
must be removed to extend the capillary length at the outlet. Therefore, it is possible that 
the capillary can move once placed inside the vial. If the capillary did not enter the vial to 
a low enough point where it was immersed into the liquid, it is possible that an inaccurate 
amount of sample was introduced onto the capillary. In order to determine whether or not 
this was a systematic error, the polarity should be reversed. If cations begin to exhibit 
peak areas that are statistical outliers and anions do not, it is clear that the cartridge 
design is at fault and a new design should be employed.  
 
Finally, the variance and average corrected area between capillaries 1 and 2 were 
compared using an F-test and t-test, respectively. The F-test for peak 1 is shown in Table 
2.17. The null hypothesis is rejected in this analysis, indicating that there are significant 
differences in the variances between capillary 1 and capillary 2. It is observed from this 
analysis that capillary 1 yielded a smaller variance (0.03 mAU) compared to capillary 2 
(0.07 mAU) for peak 1. In each of the ANOVA tests for the remaining peaks 2-5, whose 
results are shown in Appendix A, the differences in variance between capillaries 1 and 2 
are also statistically significant. This is likely related to the increase in average peak area 
values observed in capillary 2 compared to capillary 1. 
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Table 2.17: Corrected area (mAU) F-test two- sample for variances for peak 1. 
  
Capillary 
2 
Capillary 
1 
Mean 6.13 5.34 
Variance 0.07 0.03 
Observations 94 48 
DF 93 47 
Fcalc 2.48 
 P-value 4.29 x 10
-4
 
 Ftable 1.55   
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Next, the average corrected area for each capillary was compared using a t-test with 
unequal variances. The results of the analysis for peak 1 are shown in Table 2.18. The 
tcalc value of 22.31 exceeds the ttable value of 1.66. Therefore, the mean values of area for 
capillaries 1 (5.34 mAU) and 2 (6.13 mAU) are statistically different. Peaks 2-5 also 
resulted in statistically different mean values between capillaries. To evaluate the 
response similarity of like-charge ions with respect to corrected area, the internal 
standard approach described in Section 2.7.3.1 was employed by using peaks 1 
(chlopheniramine) and 3 (benzenesulfonic acid) as the cationic and anionic internal 
standards, respectively. The statistical data can be found in Appendix A. 
 
When peak 1 is employed as an internal standard for peak 2, the RSD for corrected area 
is 4.25% for capillary 1. The RSD improved to 3.18% when peak 1 is not referenced. 
Likewise, the RSD for peak 5 decreased from 4.66% when peak 1 is referenced to 4.27% 
when peak 1 is not referenced. For capillary 2, a similar trend is observed; the RSD for 
peak 2 decreased from 5.38% to 3.80% and peak 5 decreased from 4.81% to 2.85%. By 
referencing peak 1 as the internal standard, the RSD for peaks 2 and 5 are worsened. 
These data support the previous discussion that peaks 2 and 5 respond similarly to one 
another but differently than peak 1 with respect to corrected area. Manual integration may 
provide further insight on why peak 1 responds differently to corrected area calculations.   
 
The use of peak 3 as the internal standard for the remaining anion (peak 4) results in a 
RSD for peak 4 of 2.28% for capillary 1. The RSD increased slightly to 2.74% when 
peak 3 is not referenced. These data demonstrate that peaks 3 and 4 respond somewhat 
similarly to one another with respect to corrected area. This is also evidenced by the   
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Table 2.18: Corrected area (mAU) t-test: two sample assuming unequal variances peak 1. 
  Capillary 2 Capillary 1 
Mean 6.13 5.34 
Variance 0.07 0.03 
Observations 94 48 
Hypothesized Mean Difference 0 
 DF 133 
 tcalc 22.31 
 P-value 8.84 x 10
-47
 
 ttable 1.98   
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ANOVA analysis in which capillary 1 shows no statistically significantly difference 
between data sets. 
 
For capillary 2, the RSD for peak 4 decreased from 6.95% originally to 4.70% when peak 
3 is referenced. Capillary 2 does show a statistically significant difference between the 
ratio of corrected areas for peak 4 and peak 3. The data show an increase in the corrected 
area for peak 4 compared to peak 3, particularly for days 14-16. As described above, 
there is a systematic error related to sample introduction; however, both anions should 
exhibit a similar change in the peak area response.  
 
2.7.3.3 Evaluation of Resolution Precision in DOI-CZE  
The ChemStation software evaluates the resolution in several ways. Calculations for 
resolution using the tangent, 5 sigma, half-width, and statistical moments methods are 
each available to view once a report is generated. The tangent, 5 sigma, and half-width 
approaches were not selected to analyze resolution precision due to the tailing peaks 
observed in the electropherogram. If these calculations had been used, the reported 
resolution values would likely be more precise but less accurate as the width contribution 
from the tailing peaks would be not factored into the calculations. The statistical 
moments approach was ultimately chosen to provide the most representative resolution 
data. This calculation is determined by,  
 
        𝑅𝑠 =
2∗(𝑀1,𝑏−𝑀1,𝑎)
𝑊𝑠,𝑏+𝑊𝑠,𝑎
      (2.18) 
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where M1 is the mean retention time for a given peak determined by its 1
st
 statistical 
moment, Ws is the square root of the 2
nd
 statistical moment, and a and b are the first and 
second adjacent eluting peaks, respectively.  
 
The 1
st
 statistical moment, as calculated by ChemStation, is,  
 
         𝑀1 = 𝑡0 + 𝑑𝑡 ∗
𝑋
𝑌
       (2.19) 
 
where t0 is the time of the first area slice, dt is the time interval between adjacent area 
slices, and X and Y are, 
 
    𝑋 = ∑ 𝐴𝑖
𝑁
𝑖=1       (2.20) 
 
and  
 
           𝑌 = ∑ (𝑖 − 1) ∗ 𝐴𝑖
𝑁
𝑖=1                  (2.21) 
 
where Ai is the value of the area slice indexed by i. 
 
Moment 2 is determined by, 
 
𝑀2 =
𝑑𝑡
2
𝑋
∗ ∑ ((𝑖 − 1 −
𝑌
𝑋
)
2
∗ 𝐴𝑖)
𝑁
𝑖=1      (2.22) 
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It is proposed that the resolution between oppositely charged analytes can be statistically 
significantly different and its precision poor, particularly if the electroosmotic flow is not 
reproducible. As the anions begin to elute more rapidly due to the decreased EOF 
(hypothesized based on the migration time data), the resolution between peaks 2 and 3 is 
expected to decrease and the resolution between peaks 4 and 5 is expected to increase. 
Therefore, the resolution between peaks 2 and 3 and also between peaks 4 and 5 for 
capillary 1 may be adversely affected by any changes observed in EOF.   
 
The resolution data between peak 1 (ephedrine) and peak 2 (chlorpheniramine) are shown 
in Table 2.19. These data along with Figure 2.12A show that for capillary 1, the 
resolution data appear to correlate well with respect to both the migration time and peak 
area data, with the exception of a decrease in resolution during the last several runs. The 
data in Section 2.7.3.2 showed that the corrected areas for peaks 1 and 2 decreased on 
days 1 and 2, increased on day 3, and decreased again on day 12. As the peak width 
increases, the resolution decreases; subsequently, as the peak width decreases, the 
resolution between these analytes increases.  
 
The ANOVA for capillary 1 is shown in Table 2.20. Based on the ANOVA analysis for 
resolution between peaks 1 and 2, there is a statistically significant difference in the data. 
The adjacent mean differences used to evaluate the Fisher’s Least Significant Difference, 
shown in Table 2.21, indicate that days 1 and 3 are among the days with the highest 
average resolution values while day 12 was the lowest. On day 3, the migration time and 
the corrected areas were among the lowest values observed over the 12 days that this  
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Table 2.19: Resolution between peak 1 (ephedrine) and peak 2 (chlorpheniramine) using 
DOI-CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 24.73 23.51 23.62 24.13 24.17 24.38 0.44 4.00 
 
2 24.82 24.56 24.78 24.22 24.27 
   
 
3 25.13 24.45 24.71 24.30 24.25 
   Day 2 1 24.87 24.84 24.15 24.09 24.41 24.23 0.35 1.45 
 
2 24.02 24.26 24.17 24.34 24.36 
   
 
3 23.85 23.98 23.95 23.60 24.58 
   Day 3 1 24.52 24.42 24.85 24.71 25.03 24.71 0.24 0.99 
Day 12 1 24.46 24.41 24.31 23.39 24.45 23.68 0.58 2.44 
 
2 
 
23.43 23.01 23.41 24.02 
   
 
3 23.67 
 
22.86 23.24 23.19 
   
      
Overall 24.18 0.54 2.25 
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 23.23 23.20 23.03 23.02 23.49 23.19 0.19 0.83 
Day 10 1 23.02 22.84 22.93 23.05 22.96 23.01 0.12 0.52 
 
2 23.05 22.98 23.19 22.85 23.18 
   Day 11 1 22.92 23.09 23.03 22.81 23.13 22.83 0.23 1.00 
 
2 
 
22.86 23.07 22.91 22.89 
   
 
3 22.70 22.75 22.60 22.55 22.34 
   Day 12 1 22.57 22.60 22.60 22.46 22.45 22.41 0.20 0.89 
 
2 21.91 22.34 22.40 22.40 22.41 
   Day 13 1 22.29 22.30 22.10 22.21 22.42 22.12 0.18 0.80 
 
2 22.04 22.01 21.94 22.25 22.28 
   
 
3 21.83 21.83 21.99 22.06 22.19 
   Day 14 1 21.80 21.87 21.88 21.71 21.79 22.02 0.29 1.31 
 
2 21.94 22.66 22.16 22.13 22.26 
   Day 15 1 21.31 21.37 21.27 21.69 21.46 21.60 0.19 0.88 
 
2 21.80 21.66 21.63 21.70 21.88 
   
 
3 21.64 21.47 21.61 21.65 21.87 
   Day 16 1 21.30 21.19 21.05 21.40 21.66 21.56 0.54 2.49 
 
2 21.00 20.83 21.00 21.33 21.54 
   
 
3 22.40 22.22 22.12 21.92 22.42 
   
      
Overall 22.22 0.63 2.82 
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A. 
 
B. 
 
 
Figure 2.12: Resolution for peak 1 over the sample injections completed for A. capillary 
1 and B. capillary 2. 
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Table 2.20: Resolution between peak 1 and peak 2 ANOVA for capillary 1. 
 
 
      Groups Count Sum Average Variance 
  Day 1 Set 1 5 120.2 24.0 0.2 
  Day 1 Set 2 5 122.6 24.5 0.1 
  Day 1 Set 3 5 122.8 24.6 0.1 
  Day 2 Set 1 5 122.4 24.5 0.1 
  Day 2 Set 2 5 121.15 24.23 0.02 
  Day 2 Set 3 5 120.0 24.0 0.1 
  Day 3 Set 1 5 123.5 24.7 0.1 
  Day 12 Set 1 5 121.0 24.2 0.2 
  Day 12 Set 2 4 93.9 23.5 0.2 
  Day 12 Set 3 4 93.0 23.2 0.1 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 9.0 9 1.0 7.8 2.0 x 10
-6
 2.1 
Within Groups 4.9 38 0.1 
   
       Total 13.9 47         
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Table 2.21: Resolution between peak 1 and peak 2 adjacent mean differences for 
capillary 1. 
 
 
  
Mean
Day 3 
Set 1
Day 1 
Set 3
Day 1 
Set 2
Day 2 
Set 1
Day 2 
Set 2
Day 12 
Set 1
Day 1 
Set 1
Day 2 
Set 3
Day 12 
Set 2
Day 12 
Set 3
Day 3 Set 1 24.71 -
Day 1 Set 3 24.57 0.14 -
Day 1 Set 2 24.53 0.18 0.04 -
Day 2 Set 1 24.47 0.23 0.10 0.06 -
Day 2 Set 2 24.23 0.48 0.34 0.30 0.24 -
Day 12 Set 1 24.20 0.50 0.37 0.33 0.27 0.03 -
Day 1 Set 1 24.03 0.67 0.54 0.50 0.44 0.20 0.17 -
Day 2 Set 3 23.99 0.71 0.58 0.54 0.48 0.24 0.21 0.04 -
Day 12 Set 2 23.47 1.24 1.10 1.06 1.00 0.76 0.73 0.56 0.52 -
Day 12 Set 3 23.24 1.47 1.33 1.29 1.23 0.99 0.96 0.79 0.75 0.23 -
LSD 0.46
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capillary was studied. Therefore, it was expected that the resolution values for this day 
would be the highest. Likewise, the corrected area values on day 12 for each peak were 
among the largest while the migration time had slightly decreased; therefore, the decrease 
in resolution was anticipated. 
 
For capillary 2, a general decrease in the resolution values over time was observed until 
the last set of 5 injections as shown in Figure 2.12B. This is because for both peak 1 and 
peak 2, the average corrected area values typically increased slightly over the days in 
which the capillary was run. The increase in the area between the two peaks decreased 
the resolution. The ANOVA data, shown in Table 2.22 indicate a statistical difference 
between data sets. Table 2.23 shows the adjacent mean differences for the resolution 
between peaks 1 and 2 for capillary 2. As anticipated based on the large Fcalc value from 
the ANOVA data, there are many “breaks” in the data sets. However, it is important to 
note that the RSD for the runs completed for capillary 2 yield an RSD of 2.82%, 
indicating very reproducible results for this capillary.  
 
To evaluate the variances in resolution between the two capillaries, an F-test was 
employed; the results are shown in Table 2.24. This table shows that the variances 
between data sets are not statistically different. As the F-test indicated there was no 
difference between the variances in capillaries 1 and 2, a t-test assuming equal variances 
was calculated to evaluate the similarity of the means between the two capillaries. The 
results of the t-test are shown in Table 2.25. As evidenced by the fact that the tcalc value 
exceeds the ttable value, there is a statistically significant difference in the average   
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Table 2.22: Resolution between peak 1 and peak 2 ANOVA for capillary 2. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 5 115.97 23.19 0.04 
  Day 10 Set 1 5 114.79 22.96 0.01 
  Day 10 Set 2 5 115.26 23.05 0.02 
  Day 11 Set 1 5 114.98 23.00 0.02 
  Day 11 Set 2 4 91.73 22.93 0.01 
  Day 11 Set 3 5 112.93 22.59 0.02 
  Day 12 Set 1 5 112.68 22.54 0.01 
  Day 12 Set 2 5 111.46 22.29 0.05 
  Day 13 Set 1 5 111.32 22.26 0.01 
  Day 13 Set 2 5 110.51 22.10 0.02 
  Day 13 Set 3 5 109.90 21.98 0.02 
  Day 14 Set 1 5 109.05 21.809 0.005 
  Day 14 Set 2 5 111.1 22.2 0.1 
  Day 15 Set 1 5 107.09 21.42 0.03 
  Day 15 Set 2 5 108.67 21.73 0.01 
  Day 15 Set 3 5 108.24 21.65 0.02 
  Day 16 Set 1 5 106.6 21.3 0.1 
  Day 16 Set 2 5 105.7 21.1 0.1 
  Day 16 Set 3 5 111.08 22.22 0.04 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 34.3 18 1.9 66.0 1.5 x 10
-8
 1.7 
Within Groups 2.2 75 2.9 x 10
-2
 
   
       Total 36.5 93         
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Table 2.24: Resolution F-test two- sample for variances of peaks 1 and 2. 
 
  
Capillary 
2 
Capillary 
1 
Mean 22.2 24.2 
Variance 0.4 0.3 
Observations 94 48 
DF 93 47 
Fcalc 1.3 
 P-value 0.1 
 Ftable 1.5   
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Table 2.25: Resolution t-test: two sample assuming equal variances for peak 1 and peak 
2.  
 
  Capillary 1 Capillary 2 
Mean 24.2 22.2 
Variance 0.3 0.4 
Observations 48 94 
Pooled Variance 0.4 
 Hypothesized Mean Difference 0 
 DF 140 
 tcalc 18.4 
 P-value 4.6 x 10
-39
 
 ttable 2.0   
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resolution values between peaks 1 and 2 for capillaries 1 (24.2) and 2 (22.2). The larger 
peak areas observed with capillary 2 led to a decrease in resolution between the peaks. 
 
Peaks 3 (benzensulfonic acid) and 4 (p-toluenesulfonic acid), the two anions studied, 
experienced a similar trend to peaks 1 and 2 with respect to resolution; the statistical data 
for these data sets can be found in Appendix A. RSD values of 2.16% and 3.46% were 
determined for capillaries 1 and 2, respectively; these values indicate precise resolution 
values.  
 
The ANOVA for the resolution between peak 3 and 4 for each capillary showed a 
statistically significantly difference in the resolution between data sets. Days 1 and 12 for 
capillary 1 and day 10 and 16 for capillary 2 appeared to have the highest and lowest 
resolution values, respectively. 
 
The F-test indicated that the variances between capillaries 1 (0.03) and 2 (0.07) are 
different from one another. The t-test indicated that the means for capillaries 1 and 2 are 
also different from one another; the average resolution for capillary 2 was lower (7.71) 
than capillary 1 (8.25). As the corrected areas for peaks 3 and 4 were much larger for 
capillary 2, it was hypothesized that the resolution between these two peaks would be 
lower compared to capillary 1.  
 
The oppositely charged peaks chlorpheniramine (peak 2) and benezenesulfonic acid 
(peak 3) displayed a different response to resolution precision than the ions of like-charge 
described above. The average resolution between peaks 2 and 3 decreased from 8.43 on 
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day 1 to 8.29 on day 2, a decrease of approximately 1.74%. From day 2 to day 3, there 
was a large increase (+6.26%) in resolution, which is reflective of the narrower peaks 
observed on day 3. The resolution decreased to 7.81 on day 12 as a result of the larger 
peak widths. The result of these changes yielded a RSD of 4.81%, a much larger variance 
compared to the ions of like-charge. This trend was also observed in capillary 2 where a 
RSD for 5.76% was reported. Similar to the resolution for like-charge ions, the average 
resolution for capillary 1 was larger than for capillary 2, a result of the larger peak widths 
and corresponding areas observed for in the latter.  
 
When analyzing the resolution data for peaks 4 (p-toluenesulfonic acid) and 5 
(disopyramide), the RSD values determined were 5.25% and 7.19% for capillaries 1 and 
2, respectively. These data indicate poor precision even in comparison to the other 
oppositely charged pair of analytes (peaks 2 and 3). For capillary 1, peak 4 eluted more 
quickly over time compared to peak 5; therefore, it was anticipated that the resolution 
between these peaks would increase. However, it was determined that the variations in 
peak area resulted in average resolution values that mirror the trends for resolution 
described above for peaks 2 and 3. For capillary 2, the migration times for peaks 4 and 5 
decreased, then increased. This resulted in the resolution values increasing, then 
decreasing over subsequent days of runs.    
 
2.7.3.4 Conclusions Regarding Precision in DOI-CZE  
With respect to migration time, the overall variation was minimal for all analytes even 
though statistical analysis indicated a significant difference between days and also 
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between capillaries. A larger variation in time for anions compared to cations was 
observed for capillary 1; this may be related to an irreproducible EOF as a small drift was 
noted. As capillary 2 yielded a more reproducible EOF, migrations times were improved 
for all analytes. 
 
There was a general increase in peak area, and subsequent corrected area values, for all 
ions over time in both capillaries studied. Peak tailing may have caused larger than 
anticipated areas due to the proprietary algorithms employed by the software. A 
systematic error with respect to sample introduction for anions is likely caused by the 
capillary design required to extend the capillary length on the outlet side. The reversal of 
the polarity can verify this problem and a new cartridge design may be required to avoid 
this problem in the future.  
 
The resolution between like-charge ions was more reproducible than oppositely-charged 
ions. While none of the adjacent pairs of analytes yielded extremely poor resolution 
precision, designing an experiment with closer eluting oppositely-charged ions may 
provide more insight on subtle EOF changes, and the effect on resolution that may cause.  
 
2.7.4 Capillary Zone Electrophoresis Separation  
For comparison, a CZE separation was performed using the same analytes as in the 
previously described DOI-CZE experiments. The CZE conditions described in Section 
2.6 were employed for this separation. A representative CZE electropherogram is shown 
in Figure 2.13. Based on the pKa’s of the cations studied and the pH of interest  
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Figure 2.13: Capillary zone electrophoresis. Positive polarity, +30 kV. 15 mM phosphate 
buffer, pH 7.0. Lt: 55 cm; Ld: 46.6 cm, and wavelength of 214 nm. Elution order: (1) 
ephedrine, (2) disopyramide, (3) p-toluene sulfonic acid, (4) benzene sulfonic acid. 
Methanol was used as a neutral marker.  
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(pH = 7), ephedrine is approximately 99.74% ionized, chlorpheniramine is approximately 
99.65% ionized, and disopyramide is approximately 92.64% ionized. The anions in this 
study, benzenesulfonic acid and p-toluenesulfonic acid, are nearly 100% ionized at pH 7.  
 
The elution order for this experiment is ephedrine, disopyramide, p-toluene sulfonic acid 
and benzene sulfonic acid. It is important to note that chlorpheniramine co-elutes with 
disopyramide and was therefore removed from the sample mixture for a clear analysis of 
the remaining components. The elution order was confirmed by matching the times of 
individually prepared standards to the standard mixture and the UV spectrum for each 
individually run standard was recorded and stored in a library in the ChemStation 
software to match with spectra taken from the mixture as an additional means of peak 
identification.  
 
The electroosmotic mobility (EOF) under the conditions described in Section 2.4 was 
calculated by 
 
𝐸𝑂𝐹 =
𝐿𝑡𝐿𝑑
𝑉∗𝑡0
                                                   (2.23) 
 
where Lt is the total capillary length, Ld is the migration distance, V is the applied 
voltage, and t0 is the migration time in seconds of the neutral marker, methanol. An 
average value, based on 10 injections, of 5.12 x 10
-4
 cm
2
/Vs (RSD 5.24%) was 
determined.  
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The electrophoretic mobilities of the analytes of interest (ep) were determined by  
 
    𝜇𝑒𝑝 =
𝐿𝑡𝐿𝑑
𝑉∗𝑡𝐸𝑂𝐹
−
𝐿𝑡𝐿𝑑
𝑉∗𝑡𝑚
                                       (2.24) 
 
where tm is the migration time in seconds of the analyte. Average electrophoretic mobility 
values, based on 10 injections, of 2.03 x 10
-4
, 1.47 x 10
-4
, -2.86 x 10
-4
, and -3.09 x 10
-4 
cm
2
/Vs were determined for ephedrine, disopyramide, p-toluenesulfonate, and 
benzenesulfonate, respectively.  
 
It is important to note that due to the large electrophoretic mobility values of the anions, a 
higher buffer concentration than the one described above is not amenable to this 
separation. When 25 mM phosphate buffer is used for the background electrolyte (results 
not shown) instead of a concentration of 15 mM, the EOF is not of high enough 
magnitude to move the anions to the detector.  
 
It appears that benzene sulfonic acid (peak 4) experiences electromigration dispersion 
under CZE conditions; this is related to the electrophoretic mobility of the analyte 
differing significantly from any of the like-charged ions in the buffer. The efficiency and 
peak shape of this analyte could be improved by selecting a buffer ion whose mobility 
more closely matches the analyte. At pH 7.0, anions in the phosphate buffer include OH
-
 
(~1.00 x 10
-4
 mM) H2PO4
- 
(~9.18 mM), HPO4
2-
 (~5.82 mM), and PO4
3-
 (~2.45 x 10
-5
 
mM) with the primary buffer anions being H2PO4
-
 and HPO4
2-
. Based on the tailing of the 
benzenesulfonic acid peak, it appears as if this anion migrates slower than the buffer 
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anions. To minimize the detrimental effects to peak shape due to electromigration 
dispersion without modifying the choice of background electrolyte, a reduction of the 
concentration of the sample (~ 0.1 mg/mL in this study) so than it is at least 50 times 
lower than the concentration of buffer should be employed in future experiments [47].   
 
2.7.4.1 Evaluation of Migration Time Precision in CZE  
The first capillary was analyzed based on a total of 50 separations; one of these 
separations was rejected as a statistical outlier. These runs were comprised of data sets in 
which each data set includes five successive injections. On days 1, 8 and 9, three sets of 
data were collected throughout each day. On day 10, only one data set was collected. 
After the runs on day 1 were completed, the capillary was conditioned and stored. To test 
the viability of the capillary after not being run for a considerable amount of time, 
injections were completed on days 8-10. 
 
A second capillary, which used the same buffer and sample as capillary 1, was run to test 
the variability between capillaries of the same batch. These runs are comprised of data 
sets that also include five successive injections in each data set. This capillary was run for 
at least two sets of data from day 1 to day 3 for a total of 40 runs with two data points 
rejected as statistical outliers.  
 
To focus on the general trends observed during the runs on capillary 1, peak 1 was 
selected to serve as a representative peak. Any deviations from the trends observed for 
peak 1 will be described below as applicable. The voltage ramp corrected migration time 
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for peak 1 is shown in Table 2.26. The data and statistical analysis for peaks 2-5 can be 
found in Appendix A. 
 
On day 1, the average migration time was 2.027 minutes. As observed from Table 2.26 
and Figure 2.14A, there was a slow decrease (about 3% total) in migration time over 
subsequent runs and subsequent data sets on day 1. This may be related to an incomplete 
equilibration of the capillary surface, resulting in irreproducible changes to the magnitude 
of electroosmotic flow observed. These changes in migration time were also observed for 
peaks 2-4; however, a more pronounced decrease in time was noted for the anions 
compared to the cations.  
 
The capillary was cleaned and then stored. After storage of the capillary for seven days, a 
faster average migration time was observed. On day 8, an average value of 1.866 minutes 
was determined, reflecting an 7.928% decrease in time from day 1. There were minimal 
changes from the average time observed after day 8 as averages of 1.873 and 1.861 
minutes were determined for days 9 and 10, respectively. The negligible changes to the 
average migration time between days 8-10 indicate a more stable EOF. A similar 
decrease in migration time from day 1 was also observed for peaks 2-4. A larger decrease 
in time from day 1 to day 8 was observed for peaks 3 and 4, p-toluenesulfonic acid and 
benezensulfonic acid, respectively. These results indicate that the capillary surface 
between days 1 and 8 was different. As a result, an increased EOF occurred on days 8-10 
that pushed the anions toward the detector more quickly.   
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Table 2.26: Migration time (minutes) data for peak 1 (ephedrine) using CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 2.060 2.060 2.055 2.052 2.047 2.027 0.023 1.145 
 
2 2.024 2.025 2.021 2.022 2.020 
   
 
3 2.014 2.008 2.001 1.994 1.994 
   Day 8 1 1.824 1.831 1.843 1.882 1.898 1.866 0.020 1.078 
 
2 1.872 1.869 1.872 1.864 1.872 
   
 
3 1.884 1.872 1.871 1.869 
    Day 9 1 1.875 1.872 1.869 1.869 1.869 1.873 0.005 0.288 
 
2 1.868 1.877 1.880 1.879 1.879 
   
 
3 1.868 1.873 1.875 1.862 1.879 
   Day 10 1 1.874 1.864 1.859 1.856 1.854 1.861 0.008 0.431 
      
Overall 1.917 0.076 3.946 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 2.034 2.034 2.027 2.024 2.020 2.015 0.014 0.695 
 
2 2.002 2.010 2.005 2.004 1.995 
   Day 2 1 1.993 1.990 1.992 1.988 
 
1.975 0.018 0.922 
 
2 1.987 1.986 1.994 1.954 1.950 
   
 
3 1.984 1.967 1.960 1.952 1.948 
   Day 3 1 1.992 1.995 1.988 1.986 
 
1.938 0.035 1.829 
 
2 1.937 1.929 1.927 1.918 1.915 
   
 
3 1.914 1.907 1.907 1.908 1.908 
   
      
Overall 1.972 0.039 2.002 
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A. 
 
B. 
 
Figure 2.14: Migration time (minutes) variation for peak 1 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table 2.27 shows the ANOVA results for peak 1 (ephedrine) on capillary 1. As 
anticipated based on the large difference between day 1 and the remaining days of 
analysis, there is a statistically significant difference between data sets. In order to 
compare the data sets pairwise, the Fisher’s Least Significant Difference (LSD) test was 
used. The differences between adjacent means are shown in Table 2.28. The critical LSD 
value for this data set is 0.014. From this analysis, it is clear that day 1 yielded 
consistently longer times in each data set compared to the runs from days 8-10.  
 
For all runs evaluated with capillary 1 the RSD for the average migration time is 3.946%, 
indicating a somewhat high level of imprecision. However, the removal of the data sets 
from day 1 improved the reported RSD value to 0.756%. Additionally, an ANOVA 
analysis completed for days 8-10 only (data not shown) revealed that there were no 
statistically significant differences between data sets. It is important to note that similar 
ANOVA analysis for peaks 2-4 still showed a statistically significant difference between 
data sets despite the exclusion of the data sets from day 1. However, RSD values were 
also greatly improved upon the removal of the runs completed on day 1 as values of 
1.332% (from 4.163%), 1.412% (from 5.074%), and 1.638% (from 4.656%) were 
observed for peaks 2-4, respectively.  
 
To study the effect that changes to the capillary surface have on precision in the first 
several runs of a new fused silica capillary, capillary 2 was run for 3 successive days with 
2-3 sets of 5 injections completed each day. A total of 40 runs were completed; two runs 
were rejected as statistical outliers. The average migration time for peak 1 on day 1 was 
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Table 2.27: Migration time (minutes) ANOVA for peak 1 capillary 1 CZE. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 4 8.214 2.054 3.220 x 10
-5
 
Day 1 Set 2 4 8.088 2.022 3.627 x 10
-6
 
Day 1 Set 3 4 7.997 1.999 4.171 x 10
-5
 
Day 8 Set 1 4 7.454 1.864 9.854 x 10
-4
 
Day 8 Set 2 4 7.476 1.869 1.442 x 10
-5
 
Day 8 Set 3 3 5.612 1.871 3.325 x 10
-6
 
Day 9 Set 1 4 7.478 1.870 1.868 x 10
-6
 
Day 9 Set 2 4 7.516 1.879 1.314 x 10
-6
 
Day 9 Set 3 4 7.489 1.872 4.975 x 10
-5
 
Day 10 Set 1 4 7.432 1.858 1.759 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.21 9 0.023 195.67 
Within Groups 3.450 x 10
-3
 29 1.190 x 10
-4
 
 
     Total 0.213 38     
   
P-value Ftable 
   
1.702 x 10
-23
 2.223 
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Table 2.28: Migration time adjacent mean differences (minutes) for peak 1 capillary 1 
CZE. 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 9 
Set 2
Day 9 
Set 3
Day 8 
Set 3
Day 9 
Set 1
Day 8 
Set 2
Day 8 
Set 1
Day 10 
Set 1
Day 1 Set 1 2.054 -
Day 1 Set 2 2.022 0.032 -
Day 1 Set 3 1.999 0.054 0.023 -
Day 9 Set 2 1.879 0.175 0.143 0.000 -
Day 9 Set 3 1.872 0.181 0.150 0.127 0.007 -
Day 8 Set 3 1.871 0.183 0.151 0.129 0.008 0.002 -
Day 9 Set 1 1.870 0.184 0.152 0.130 0.009 0.003 0.001 -
Day 8 Set 2 1.869 0.185 0.153 0.130 0.010 0.003 0.001 0.000 -
Day 8 Set 1 1.864 0.190 0.158 0.136 0.015 0.009 0.007 0.006 0.006 -
Day 10 Set 1 1.858 0.195 0.164 0.141 0.021 0.014 0.012 0.011 0.011 0.005 -
LSD 0.014
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2.015 minutes. On day 2, this value decreased by 0.040 minutes to 1.975 minutes, a 
decrease of 2.029%. On day 3, the average migration time was 1.938 minutes, a further 
decrease in average migration time from days 1 and 2. Figure 2.14B illustrates the 
general decrease in migration time for peak 1 that is observed for capillary 2.  
 
The RSD for all separations evaluated for peak 1 on capillary 2 was 2.002%. Values of 
0.984%, 1.734%, and 1.664% were determined for peaks 2-4, respectively. These values 
indicate that capillary 2 yielded more reproducible results with respect to migration time 
compared to capillary 1 when all data points are taken into consideration. However, when 
the data sets from day 1 of capillary 1 are excluded from analysis, the precision of 
capillary 1 resembles that of capillary 2. 
 
The ANOVA for peak 1 (ephedrine) on capillary 2 is shown in Table 2.29. The Fcalc 
value of 67.669 significantly exceeds the Ftable value of 2.464, indicating differences for 
at least one data set. Analysis of the migration time adjacent mean differences for 
capillary 2 (shown in Table 2.30), showed a slow decrease in the migration time for each 
set and each day, with the exception of day 3 set 1. This spread contributed to the larger 
Fcalc value. Peaks 2-4 showed a similar trend, although more variability with respect to 
data set and day were observed for the adjacent mean differences analysis. 
 
Finally, a comparison between the variance in data between capillaries 1 and 2 was 
performed by using an F-test. The F-test for peak 1 is shown in Table 2.31. Since Fcalc 
(3.672) exceeds the Ftable value (1.690), the null hypothesis is rejected in this analysis.  
137 
 
Table 2.29: Migration time (minutes) ANOVA for peak 1 capillary 2 CZE. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 4 8.105 2.026 3.367 x 10
-5
 
Day 1 Set 2 4 8.014 2.003 3.646 x 10
-5
 
Day 2 Set 1 3 5.970 1.990 4.649 x 10
-6
 
Day 2 Set 2 4 7.885 1.971 4.864 x 10
-4
 
Day 2 Set 3 4 7.826 1.957 7.197 x 10
-5
 
Day 3 Set 1 3 5.968 1.989 2.364 x 10
-5
 
Day 3 Set 2 4 7.689 1.922 4.601 x 10
-5
 
Day 3 Set 3 4 7.631 1.908 3.388 x 10
-7
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.045 7 6.401 x 10
-3
 67.669 
Within Groups 0.002 22 9.459 x 10
-5
 
 
     Total 0.047 29     
   
P-value Ftable 
   
2.066 x 10
-13
 2.464 
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Table 2.30: Migration time adjacent mean differences (minutes) for peak 1 capillary 2 
CZE. 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 2 
Set 1
Day 3 
Set 1
Day 2 
Set 2
Day 2 
Set 3
Day 3 
Set 2
Day 3 
Set 3
Day 1 Set 1 2.026 -
Day 1 Set 2 2.003 0.023 -
Day 2 Set 1 1.990 0.036 0.014 -
Day 3 Set 1 1.989 0.037 0.014 0.000 -
Day 2 Set 2 1.971 0.055 0.032 0.019 0.018 -
Day 2 Set 3 1.957 0.070 0.047 0.033 0.033 0.015 -
Day 3 Set 2 1.922 0.104 0.081 0.068 0.067 0.049 0.034 -
Day 3 Set 3 1.908 0.118 0.096 0.082 0.082 0.063 0.049 0.014 -
LSD 0.013
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Table 2.31: Migration time (minutes) F-test two- sample for variances for peak 1 CZE.  
 
  Capillary 1 Capillary 2 
Mean 1.917 1.972 
Variance 0.006 0.002 
Observations 49 38 
DF 48 37 
Fcalc 3.672 
 P-value 4.193 x 10
-5
 
 Ftable 1.690   
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This indicates that there are significant differences in the variances between capillary 1 
and capillary 2. It is observed from this analysis that capillary 2 yielded a smaller 
variance (0.002 minutes) compared to capillary 1 (0.006 minutes). This is likely related to 
more adequate capillary conditioning achieved for capillary 2 compared to capillary 1. 
However, the variance for capillary 1 improves to 0.0002 minutes when the sets from day 
1 are removed. In each of the F-tests for the remaining peaks 2-4, whose results are 
shown in Appendix A, the differences in variance between capillaries 1 and 2 were also 
statistically different.  
 
Next, the average migration time for each capillary was compared using a t-test with 
unequal variances. The results of the analysis for peak 1 are shown in Table 2.32. The 
tcalc value of 4.388 exceeds the ttable value of 1.992. Therefore, the mean values of average 
migration time between capillaries 1 (1.917 minutes) and 2 (1.972 minutes) are 
statistically different. The removal of the data sets from day 1 also yields a statistically 
significant difference between capillaries as the average time for capillary 1 is reduced 
from 1.917 minutes initially to 1.868 minutes upon the removal of these data sets. Peaks 
2-4 also showed statistically significant differences in average migration times between 
capillaries. It is possible that the averages may have been more similar if each capillary 
were run for exactly the same number of days. Additional capillaries should be studied to 
observe the possible trends more critically.  
 
The internal standard approach, where the ratio of migration times for a given peak and 
peak 1 are used to evaluate precision, was then employed; data and resulting statistics can  
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Table 2.32: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 1 CZE.  
 
  Capillary 1 Capillary 2 
Mean 1.972 1.917 
Variance 0.002 0.006 
Observations 38 49 
Hypothesized Mean Difference 0 
 DF 76 
 tcalc 4.388 
 P-value 3.638 x 10
-5
 
 ttable 1.992   
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be found in Appendix A. Only one internal standard, ephedrine (peak 1), was employed 
for this separation as all analytes are introduced from the same side of the capillary. For 
peak 2 (disopyramide), the migration time RSD improved from 3.794% originally to 
1.278% when using peak 1 as an internal standard. Peak 3 (p-toluenesulfonic acid) 
improved from 3.976% to 2.497%; likewise, peak 4 (benzenesulfonic acid) improved 
from 3.899% to 1.526%. These results indicate that each of analytes experience similar 
changes in migration time as conditions in the capillary are modified (with respect to 
conditioning of the capillary and exposing sites on the capillary wall). However, in each 
capillary, the ANOVA test still shows a statistically significant variability in the data. 
 
2.7.4.2 Evaluation of Corrected Area Precision in CZE 
As with migration time, the results for corrected area will be described using peak 1 as an 
example. The corrected area data for peak 1 with capillaries 1 and 2 is shown in Table 
2.33; data and statistics for peaks 2-4 can be found in Appendix A. Deviations from the 
trends described for peak 1 will be discussed below for peaks 2-4 as applicable.  
 
On day 1, the average corrected area for peak 1 was 10.00 mAU with an RSD of 2.40%. 
This average decreased substantially to 9.45 mAU on day 8 although a similar level of 
precision (2.02% RSD) was observed. The average area remained fairly constant, with 
values of 9.44 mAU (1.87% RSD) and 9.40 (1.22% RSD) on days 9 and 10, respectively.  
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Table 2.33: Corrected area data (mAU) for peak 1 (ephedrine) using CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 10.54 10.23 10.13 10.32 10.23 10.00 0.24 2.40 
 
2 9.98 10.03 9.94 9.88 9.90 
   
 
3 9.80 9.76 9.84 9.76 9.72 
   Day 8 1 9.16 9.22 9.28 9.52 9.66 9.45 0.19 2.01 
 
2 9.54 9.49 9.39 9.30 9.23 
   
 
3 9.80 9.57 9.55 9.59 
    Day 9 1 9.49 9.22 9.25 9.32 9.59 9.44 0.18 1.87 
 
2 9.27 9.42 9.66 9.56 9.59 
   
 
3 9.32 9.58 9.63 9.10 9.54 
   Day 10 1 9.45 9.41 9.53 9.40 9.22 9.40 0.11 1.22 
      
Overall 9.44 0.17 1.82 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 10.10 10.15 10.10 10.10 10.06 9.99 0.14 1.41 
 
2 9.83 9.92 10.03 9.92 9.71 
   Day 2 1 10.07 10.13 10.10 10.05 
 
9.66 0.31 3.22 
 
2 9.66 9.62 9.63 9.51 9.51 
   
 
3 9.60 9.55 9.38 9.25 9.19 
   Day 3 1 9.96 9.89 9.64 9.41 
 
9.63 0.27 2.78 
 
2 9.71 9.36 9.58 9.68 9.95 
   
 
3 9.22 10.01 9.21 9.49 9.73 
   
      
Overall 9.74 0.30 3.04 
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Collectively, peak 1 yielded an average area of 9.61 mAU with an RSD of 3.40% for the 
injections introduced on capillary 1. The RSD values for peaks 2-4 were 2.22%, 4.90%, 
and 2.95%, respectively. With the exception of peak 3 (p-toluenesulfonic acid), there is 
not a large difference in the precision values between anions and cations. Figure 2.15A 
shows that the corrected area data was generally proportional to migration time. 
 
A statistical evaluation of each peak’s corrected area for the samples injected on capillary 
1 was employed using the ANOVA analysis described in Section 2.7.1. The ANOVA 
data for peak 1 on capillary 1 is shown in Table 2.34; the statistical data for the remaining 
peaks (2-4) can be found in Appendix A. Based on the ANOVA for peak 1 on capillary 1, 
the null hypothesis is rejected. This indicates that at least one data set differs from the 
others; peaks 2-4 each also indicated this trend.  
 
In order to compare the data sets pairwise, the Fisher’s LSD test was used. The 
differences between means for peak 1 are shown in Table 2.35. This table reveals that the 
corrected area averages observed on day 1 are significantly different from each of the 
other days; this trend is also observed for peaks 3 (p-toluenesulfonic acid) and 4 
(benzenesulfonic acid). Peak 2 (disopyramide) did not yield any noticeable trend in 
average peak area with respect to sets of data run each day.  
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A. 
 
 B. 
 
 
Figure 2.15: Corrected area (mAU) variation for peak 1 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table 2.34: Corrected area (mAU) ANOVA for peak 1 capillary 1 CZE. 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 40.91 10.23 5.75 x 10
-3
 
  Day 1 Set 2 4 39.75 9.94 4.40 x 10
-3
 
  Day 1 Set 3 4 39.08 9.77 2.74 x 10
-3
 
  Day 8 Set 1 4 37.67 9.42 4.25 x 10
-2
 
  Day 8 Set 2 4 37.41 9.35 1.29 x 10
-2
 
  Day 8 Set 3 3 28.70 9.57 3.84 x 10
-4
 
  Day 9 Set 1 4 37.37 9.34 2.90 x 10
-2
 
  Day 9 Set 1 4 38.23 9.56 1.02 x 10
-2
 
  Day 9 Set 2 4 37.85 9.46 5.96 x 10
-2
 
  Day 10 Set 1 4 37.56 9.39 1.64 x 10
-2
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 3.04 9 0.34 17.79 1.49 x 10
-9
 2.22 
Within Groups 0.55 29 0.03 
   
       Total 3.60 38         
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Table 2.35: Corrected area adjacent mean differences (mAU) for peak 1 capillary 1 CZE. 
 
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 8 
Set 3
Day 9 
Set 1
Day 9 
Set 2
Day 8 
Set 1
Day 10 
Set 1
Day 8 
Set 2
Day 9 
Set 1
Day 1 Set 1 10.23 -
Day 1 Set 2 9.94 0.29 -
Day 1 Set 3 9.77 0.46 0.17 -
Day 8 Set 3 9.57 0.66 0.37 0.00 -
Day 9 Set 1 9.56 0.67 0.38 0.21 0.01 -
Day 9 Set 2 9.46 0.76 0.47 0.31 0.10 0.10 -
Day 8 Set 1 9.42 0.81 0.52 0.35 0.15 0.14 0.05 -
Day 10 Set 1 9.39 0.84 0.55 0.38 0.18 0.17 0.07 0.03 -
Day 8 Set 2 9.35 0.88 0.58 0.42 0.22 0.21 0.11 0.07 0.04 -
Day 9 Set 1 9.34 0.88 0.59 0.43 0.22 0.22 0.12 0.07 0.05 0.01 -
LSD 0.18
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After removal of the data from day 1 (data not shown), the ANOVA indicated that there 
were no statistical differences between data sets for days 8-10 for peaks 1, 3 and 4. The 
general spread of data for peak 2 yielded a significant difference between data sets even 
with the removal of the data sets from day 1.  
 
Analysis of the data for peak 1 on capillary 2 yielded an average corrected area of 9.99 
mAU with an RSD of 1.41%. This average decreased to 9.66 mAU on day 2 with a 
slightly lower precision (3.22% RSD). The average area remained fairly constant on day 
3, with a value of 9.63 mAU (2.78% RSD). Figure 2.15B illustrates the larger variability 
in corrected area for days 2 and 3. 
 
Collectively, peak 1 yielded an average area of 9.74 mAU with an RSD of 3.04% for the 
injections introduced on capillary 2. The RSD values for peaks 2-4 were 2.57%, 2.57%, 
and 1.45%, respectively. Based on these results, there is not a large difference in the 
percent relative standard deviation values between anions and cations. The overall 
precision of the corrected area data shows that the uncorrected area response was 
generally proportional with respect to time.   
 
Table 2.36 shows the ANOVA data for peak 1 on capillary 2. The results show that there 
is a statistical differences between data sets; peak 4 also indicated this trend. However, 
there was no statistically significant difference between data sets for peaks 2 and 3. Upon 
analyzing the Fisher’s LSD by adjacent mean differences for peak 1 in Table 2.37, it   
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Table 2.36: Corrected area (mAU) ANOVA for peak 1 capillary 2 CZE. 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 40.40 10.10 1.30 x 10
-3
 
  Day 1 Set 2 4 39.59 9.90 1.81 x 10
-2
 
  Day 2 Set 1 3 30.28 10.09 1.68 x 10
-3
 
  Day 2 Set 2 4 38.27 9.57 4.81 x 10
-3
 
  Day 2 Set 3 4 37.38 9.34 2.51 x 10
-2
 
  Day 3 Set 1 3 28.94 9.65 5.68 x 10
-2
 
  Day 3 Set 2 4 38.57 9.64 6.02 x 10
-2
 
  Day 3 Set 3 4 38.45 9.61 1.16 x 10
-1
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 1.86 7 0.27 7.39 1.31 x 10
-4
 2.46 
Within Groups 0.79 22 0.04 
   
       Total 2.66 29         
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Table 2.37: Corrected area adjacent mean differences (mAU) for peak 1 capillary 2 CZE. 
 
 
 
  
Mean
Day 1 
Set 1
Day 2 
Set 1
Day 1 
Set 2
Day 3 
Set 1
Day 3 
Set 2
Day 3 
Set 3
Day 2 
Set 2
Day 2 
Set 3
Day 1 Set 1 10.10 -
Day 2 Set 1 10.09 0.01 -
Day 1 Set 2 9.90 0.20 0.20 -
Day 3 Set 1 9.65 0.46 0.45 0.25 -
Day 3 Set 2 9.64 0.46 0.45 0.25 0.00 -
Day 3 Set 3 9.61 0.49 0.48 0.28 0.03 0.03 -
Day 2 Set 2 9.57 0.53 0.52 0.33 0.08 0.07 0.04 -
Day 2 Set 3 9.34 0.76 0.75 0.55 0.30 0.30 0.27 0.22 -
LSD 0.25
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appears that day 1 yielded some of the higher corrected area values. In general, the large 
spread in data did not correlate to a particular day.   
 
Finally, a comparison between the variance of capillary 1 to capillary 2 was performed 
using an F-test. The F-test for peak 1 is shown in Table 2.38. Since Fcalc (1.22) is less 
than the Ftable value (1.69), the null hypothesis is appropriate for this analysis. This 
indicates that there are no significant differences in the variances between capillaries 1 
and 2. Similarly, the variances in corrected area for peak 2 between capillaries were not 
statistically different. The statistical data for peaks 3 and 4 indicated a significant 
difference in the variance observed between capillaries 1 and 2.  
 
Next, the average area for each capillary was compared using a t-test with equal 
variances. The results of the analysis for peak 1 are shown in Table 2.39. The tcalc value of 
1.88 exceeds the ttable value of 1.67. Therefore, the mean values of corrected area between 
capillaries 1 (9.61 mAU) and 2 (9.74 mAU) are statistically different. The means were 
also statistically different for peaks 2-4. 
 
To determine whether ions injected from the same side of the capillary experience similar 
response with respect to corrected area, the internal standard approach described in 
Section 2.7.3.1 was employed. As all ions were introduced at the anode, only peak 1 
(ephedrine) was employed as the internal standard. 
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Table 2.38: Corrected area (mAU) F-test two- sample for variances for peak 1 CZE. 
 
  
Capillary 
1 
Capillary 
2 
Mean 9.61 9.74 
Variance 0.11 0.09 
Observations 49 38 
DF 48 37 
Fcalc 1.22 
 P-value 0.27 
 Ftable 1.69   
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Table 2.39: Corrected area (mAU) t-test: two sample assuming unequal variances peak 1 
CZE. 
 
  
Capillary 
2 
Capillary 
1 
Mean 9.74 9.61 
Variance 0.09 0.11 
Observations 38 49 
Pooled Variance 0.10 
 Hypothesized Mean Difference 0 
 DF 85 
 tcalc 1.88 
 P-value 0.06 
 ttable 1.99   
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When peak 1 was employed as an internal standard, the corrected area RSD for peak 2 is 
2.81% for capillary 1. The RSD improved to 2.22% when peak 1 was not referenced. The 
RSD for peak 4 decreased from 3.46% to 2.95% when peak 1 is referenced. The RSD for 
peak 3 actually increased (worsened) from 3.72% to 4.90% when peak 1 is referenced. 
For capillary 2, the RSD for peak 2 increased from 2.57% to 3.33%, peak 3 increased 
from 2.57% to 3.25% and peak 4 increased from 1.45% to 3.15% when referencing peak 
1.  
 
As shown by the ANOVA analysis (Appendix A), each of the peaks 2-4 responds 
significantly differently with respect to corrected area than peak 1, the peak from which 
the peak width threshold was determined as recommended. Manual integration may 
provide further insight on why peak 1 responds differently to corrected area calculations.   
 
2.7.4.3 Evaluation of Resolution Precision in CZE  
Resolution in CZE was evaluated in the same way as DOI-CZE. The calculations are 
described in Section 2.6.3.3. The data for the resolution of peak 1 (ephedrine) and peak 2 
(disopyramide) are shown in Table 2.40. It is important to note that a complete 
separation, where a resolution of greater than 1.50 is obtained, is not achieved between 
these two analytes. This is related to the peak tailing that is observed for each of the 
cations in addition to their close elution times due to their similar net mobilities. 
However, a steady decrease in resolution, as shown in Figure 2.16A, is observed for these 
analytes. This is related to the decrease in migration time over time for these analytes as 
described above. 
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Table 2.40: Resolution data for peak 1 (ephedrine) and peak 2 (disopyramide) using 
CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.49 1.47 1.47 1.44 1.40 1.39 0.05 3.67 
 
2 1.37 1.36 1.35 1.35 1.39 
   
 
3 1.35 1.36 1.35 1.38 1.35 
   Day 8 1 1.28 1.27 1.23 1.26 1.28 1.26 0.02 1.26 
 
2 1.27 1.24 1.27 1.24 1.25 
   
 
3 1.25 1.26 1.26 1.24 
    Day 9 1 1.21 1.21 1.21 1.19 1.19 1.21 0.01 1.12 
 
2 1.23 1.22 1.20 1.21 1.24 
   
 
3 1.22 1.20 1.22 1.21 1.20 
   Day 10 1 1.16 1.19 1.14 1.16 1.15 1.16 0.02 1.55 
      
Overall 1.27 0.09 7.04 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.31 1.28 1.26 1.26 1.26 1.26 0.03 2.69 
 
2 1.30 1.24 1.24 1.20 1.22 
   Day 2 1 1.27 1.27 1.24 1.20 
 
1.25 0.03 2.68 
 
2 1.30 1.27 1.27 1.25 1.23 
   
 
3 1.29 1.26 1.21 1.19 1.22 
   Day 3 1 1.19 1.20 1.18 1.19 
 
1.23 0.03 2.75 
 
2 1.26 1.21 1.27 1.27 1.26 
   
 
3 1.26 1.23 1.27 1.21 1.24 
   
      
Overall 1.24 0.03 2.77 
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A. 
 
B. 
 
Figure 2.16: Resolution variation for peak 1 over the sample injections completed for A. 
capillary 1 and B. capillary 2. 
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The ANOVA for capillary 1 is shown in Table 2.41. Based on the ANOVA analysis for 
resolution between peaks 1 and 2, there is a statistically significant difference in the data 
between the groups. As anticipated based on the large Fcalc value from the ANOVA data, 
there are many “breaks” in the data sets. The adjacent mean differences used to evaluate 
the Fisher’s least significant difference, shown in Table 2.42, indicate that the resolution 
decreased steadily over each day. This is likely related to the decrease in migration time 
from days 1 to 8 and also to the slight increase in tailing over time for both analytes; as 
the peaks tail, the reported resolution between them decreases. Similar to the migration 
time and peak area data, resolution precision for capillary 1 is improved, from 7.04% to 
3.03%, by the removal of the data sets from day 1.  
 
For capillary 2, there is less of a decrease in resolution values over each day as observed 
in Figure 2.16B. The resolution for all runs on this capillary was 2.77%, indicating good 
precision. However, the ANOVA data, shown in Table 2.43 indicates a statistically 
significantly difference among the data sets. Table 2.44 shows the adjacent mean 
differences for the resolution between peaks 1 and 2 for capillary 2. The small decrease in 
the reported resolution is a result of the slight decrease in time and increase in peak width 
over time; this drift was enough to cause the variances between data sets to be 
statistically different for this capillary.  
 
To evaluate the differences in resolution precision between the two capillaries, an F-test 
was employed; the results are shown in Table 2.45. This table shows that the variances  
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Table 2.41: Resolution ANOVA for peak 1 and peak 2 capillary 1 CZE. 
 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 5.79 1.45 1.14 x 10
-3
 
  Day 1 Set 2 4 5.45 1.36 2.89 x 10-4 
  Day 1 Set 3 4 5.44 1.36 1.45 x 10
-4
 
  Day 8 Set 1 4 5.03 1.26 4.35 x 10
-4
 
  Day 8 Set 2 4 5.01 1.25 1.89 x 10
-4
 
  Day 8 Set 3 3 3.76 1.25 7.24 x 10
-5
 
  Day 9 Set 1 4 4.79 1.20 1.11 x 10
-4
 
  Day 9 Set 2 4 4.86 1.22 2.49 x 10
-4
 
  Day 9 Set 3 4 4.84 1.21 8.47 x 10
-5
 
  Day 10 Set 1 4 4.64 1.16 4.28 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.29 9 0.03 100.43 2.06 x 10
-19
 2.22 
Within Groups 0.01 29 3.22 x 10
-4
 
   
       Total 0.30 38         
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Table 2.42: Resolution between peak 1 and peak 2 adjacent mean differences for 
capillary 1 CZE. 
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 8 
Set 1
Day 8 
Set 3
Day 8 
Set 2
Day 9 
Set 2
Day 9 
Set 3
Day 9 
Set 1
Day 10 
Set 1
Day 1 Set 1 1.45 -
Day 1 Set 2 1.36 0.08 -
Day 1 Set 3 1.36 0.09 0.00 -
Day 8 Set 1 1.26 0.19 0.10 0.00 -
Day 8 Set 3 1.25 0.19 0.11 0.11 0.01 -
Day 8 Set 2 1.25 0.20 0.11 0.11 0.01 0.00 -
Day 9 Set 2 1.22 0.23 0.15 0.14 0.04 0.04 0.04 -
Day 9 Set 3 1.21 0.24 0.15 0.15 0.05 0.04 0.04 0.01 -
Day 9 Set 1 1.20 0.25 0.16 0.16 0.06 0.05 0.05 0.02 0.01 -
Day 10 Set 1 1.16 0.29 0.20 0.20 0.10 0.09 0.09 0.06 0.05 0.04 -
LSD 0.02
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Table 2.43: Resolution ANOVA for peak 1 and peak 2 capillary 2 CZE. 
 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 5.06 1.26 6.21 x 10
-5
 
  Day 1 Set 2 4 4.90 1.22 3.45 x 10
-4
 
  Day 2 Set 1 3 3.71 1.24 1.08 x 10
-3
 
  Day 2 Set 2 4 5.03 1.26 3.86 x 10
-4
 
  Day 2 Set 3 4 4.87 1.22 8.10 x 10
-4
 
  Day 3 Set 1 3 3.56 1.19 1.56 x 10
-4
 
  Day 3 Set 2 4 5.01 1.25 8.77 x 10
-4
 
  Day 3 Set 3 4 4.95 1.24 4.99 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.01 7 2.09 x 10
-3
 4.03 5.57 x 10
-3
 2.46 
Within Groups 0.01 22 5.19 x 10
-4
 
   
       Total 0.03 29         
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Table 2.44: Resolution between peak 1 and peak 2 adjacent mean differences for 
capillary 2 CZE. 
 
 
 
  
Mean
Day 1 
Set 1
Day 2 
Set 2
Day 3 
Set 2
Day 3 
Set 3
Day 2 
Set 1
Day 1 
Set 2
Day 2 
Set 3
Day 3 
Set 1
Day 1 Set 1 1.26 -
Day 2 Set 2 1.26 0.008 -
Day 3 Set 2 1.25 0.013 0.004 -
Day 3 Set 3 1.24 0.026 0.018 0.014 -
Day 2 Set 1 1.24 0.028 0.020 0.015 0.002 -
Day 1 Set 2 1.22 0.041 0.032 0.028 0.014 0.013 -
Day 2 Set 3 1.22 0.046 0.038 0.033 0.020 0.018 0.005 -
Day 3 Set 1 1.19 0.077 0.068 0.064 0.050 0.048 0.036 0.030 -
LSD 0.030
162 
 
between data sets are statistically different. As expected, the variance of capillary 1 
(0.008) is greater than that of capillary 2 (0.001). This is related to the results from day 1 
on capillary 1. Removal of the data sets from day 1 reduces the variance in resolution for 
capillary 1 to 0.001, making the results from days 8-10 comparable to those from 
capillary 2.  
 
Based on the results from the F-test analysis, a t-test assuming unequal variances was 
used to evaluate the similarity of the average resolution between the two capillaries. The 
results of the t-test are shown in Table 2.46. As evidenced by the fact that  
the tcalc value exceeds the ttable value, there is a statistically significant difference in the 
average resolution values between peaks 1 and 2 for capillaries 1 and 2.  
 
Peaks 3 (p-toluenesulfonic acid) and 4 (benzenesulfonic acid), the two anions studied, 
experienced a similar trend to peaks 1 and 2 with respect to resolution. The RSD was  
3.69% and 2.40% for capillaries 1 and 2, respectively. The ANOVA (see Appendix A) 
for capillary 1 showed a statistically significantly difference in the resolution between 
data sets; day 1 yielded the largest resolution values. The sharp decrease in elution time 
for each of the anions studied contributed to the lower resolution values observed on days 
8-10. The ANOVA for capillary 2, whose overall precision with respect to migration time 
and peak area were very good, showed no statistically significant difference between the 
average resolution values of each data set.  
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Table 2.45: Resolution F-test two- sample for variances of peak 1 and peak 2 CZE. 
 
  Capillary 1 Capillary 2 
Mean 1.27 1.24 
Variance 8.04 x 10
-3
 1.18 x 10
-3
 
Observations 49 38 
DF 48 37 
Fcalc 6.80 
 P-value 1.30 x 10
-8
 
 Ftable 1.69   
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Table 2.46: Resolution t-Test: Two sample assuming unequal variances peak 1 and peak 
2 CZE.  
 
  
Capillary 
1 
Capillary 
2 
Mean 1.27 1.24 
Variance 8.04 x 10
-3
 1.18 x 10
-3
 
Observations 49 38 
Hypothesized Mean Difference 0 
 DF 65 
 tcalc 2.21 
 P-value 0.03 
 ttable 2.00   
 
 
 
  
165 
 
To evaluate the difference in the variances of the resolution between capillaries, an F-test 
was performed. Results indicated that the variances between capillaries 1 (0.03) and 2 
(0.01) are different from one another. As the migration time and corrected areas of each 
analyte varied much less in capillary 2 than capillary 1, it is anticipated that capillary 2 is 
more precise overall. The t-test indicates that the mean resolutions for capillaries 1 and 2 
are also different from one another; the average resolution for capillary 2 was slightly 
higher (4.75) than capillary 1 (4.67).  
 
The oppositely charged peaks disopyramide (peak 2) and p-toluenesulfonic acid (peak 3) 
displayed a different response to resolution precision than the ions of like-charge 
described above. The average resolution between peaks 2 and 3 decreased from 39.82 on 
day 1 to 36.25 on day 8, a decrease of approximately 8.96%. From day 8 to day 9, there 
was another large decrease (5.55%) in resolution, which is reflective of the faster elution 
observed for peak 3 compared to peak 2. The average resolution decreased further to 
33.75 on day 10. The result of these changes yielded an RSD of 4.97%, a much larger 
degree of imprecision compared to the ions of like-charge. A more reproducible 
resolution between peaks 2 and 3 was observed in capillary 2 where an RSD of 2.97% 
was reported.  
 
2.7.4.4 Conclusions Regarding Precision in CZE 
With the exception of all runs completed on day 1 for capillary 1, the overall variation in 
migration time was minimal for all analytes, even though statistical analysis indicates a 
statistically significant difference between days. A larger variation in time for anions 
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compared to cations was observed for capillary 1. However, due to what appears to be an 
irreproducible capillary surface, the migration times of all ions were decreased from day 
1 to day 8. Capillary 2 yielded a more reproducible EOF and migrations times were more 
reproducible as a result. 
 
There was a small decrease in corrected area for all ions over time in both capillaries 
studied. However, given the algorithms employed by the software, there may have been 
resulting inaccurate measurements of area. Exporting the electrophoretic data into 
another data processing program would allow a comparison of the calculated area values. 
While software validation parameters are demonstrated by the developer, an in-depth 
validation of several data processing software programs may provide valuable insight on 
the criteria used for peak area determination.   
 
The resolution between like-charge ions was more reproducible than oppositely-charged 
ions. This is because like-charged analytes experience a more similar change to one 
another with respect to migration time compared to the ions of opposite charge. As a 
result of the significant reduction in migration time for the anions compared to the 
cations, resolution between the oppositely-charged ions changed over time to a greater 
extent than like-charged ions.  
 
2.7.5 Comparison of Separation Techniques 
One of the primary differences between CZE and DOI-CZE is the mandatory suppression 
of EOF for the latter, which allows ions to migrate from both ends of the capillary toward 
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the detector in DOI-CZE. The DOI-CZE experiments presented in this paper utilized a 
combination of low pH and high buffer concentration for EOF suppression. Modifying 
the pH is effective in changing both the magnitude of EOF and the overall charge of the 
ions; a low pH minimizes the zeta potential, which in turn minimizes the magnitude of 
EOF. The use of pH to aid in the suppression of EOF does limit the samples that can be 
analyzed. To maintain a reproducible suppressed EOF in DOI-CZE, the conditioning 
steps described in the experimental section were used between runs. This significantly 
increased the total analysis time compared to CZE.  
 
A buffer that has pKa values in the desired experimental pH ranges, 2.5 ± 1 and 7.0 ± 1 
for DOI-CZE and CZE, respectively, was chosen in order to minimize the number of 
different variables between separation techniques. Sodium phosphate buffer was an ideal 
choice of buffer given that the first two of its three dissociation constants are at 2.15 
(pKa1) and at 7.20 (pKa2), so all analyte ions are fully ionized over the pH ranges studied.  
 
With respect to the concentration of buffer, Kuban [3] notes that a lower concentration 
will be less conductive; this means that higher voltages can be used and higher resolution 
obtained. For our experiments, we found that a buffer concentration of 25 mM was 
unable to maintain a reproducible EOF under DOI-CZE conditions (results not shown). It 
was determined that a 50 mM phosphate buffer at pH 2.5 resulted in a sufficiently stable 
EOF and the applied voltage was suitable for fast analysis. Under CZE conditions, the 
EOF obtained with a 25 mM phosphate buffer was not of high enough magnitude to push 
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the anions to the detector in a consistent manner; therefore, a 15 mM concentration was 
employed.  
 
One difference in the separation conditions between CZE and DOI-CZE results from the 
buffer concentrations employed. The voltage for CZE was maintained at +30 kV and for 
DOI-CZE +16 kV was maintained. These values were the maximum voltages that could 
be employed without causing overheating of the capillary. For a better comparison of 
data, the electric field (V/cm) should be the same between experiments. However, if the 
exact same electric field values were employed, the CZE separation would have to be 
decreased to 16 kV. The migration time and peak broadening for all analytes would have 
increased significantly. Alternative methods of EOF suppression can allow the exact 
same buffer to be used in each experiment for a better comparison.  
 
As first described by Padarauskas and co-workers, the position of the detector window in 
DOI-CZE can be an additional way to adjust the migration time of analytes from opposite 
ends of the capillary and avoid co-detection [4,5]. Although it is advantageous to arrange 
the migration distances travelled by the analytes to avoid co-elution, there are limits. The 
commercially available capillary cartridge design constrains, to a certain degree, the 
given lengths possible for ions to travel on either side of the detector window. The 
optimum detector window position allows ions from both ends to migrate toward the 
detector quickly and without co-detection. To keep the same total capillary length 
between separation techniques, a 55 cm capillary was used. In the CZE experiment, a 
migration distance of 46.6 cm was used for all analytes. The distances employed in the 
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DOI-CZE experiment were 25 cm for anions and 30 cm for cations in order to fit the 
capillary cartridge design.  
 
2.7.5.1 Comparison of Migration Time Precision between CZE and DOI-CZE 
The voltage ramp corrected average migration time reproducibility in DOI-CZE is similar 
to that observed in CZE in that the longer the migration time of an ion, the higher the 
RSD. However, this observation is much less pronounced in DOI-CZE. This is likely a 
result of the lower EOF and correspondingly lower run-to-run variations in EOF. 
 
For an EOF of 5.50 x 10
-4
 cm
2
/Vs and 2.50 x 10
-5
 cm
2
/Vs for CZE and DOI-CZE, 
respectively, a 5% variation in EOF affects the analyte migration time of an ion in CZE 
to a much greater extent than the same variation in DOI-CZE. 
 
2.7.5.2 Comparison of Corrected Area Precision between CZE and DOI-CZE 
With respect to the corrected area, both CZE and DOI-CZE yielded precise results as the 
%RSDs were below 2%. There was a noted systematic error in DOI-CZE when anions 
are injected at the outlet. This error may only be specific to the capillary cartridge 
employed; reversal of the polarity can further investigate this error. 
 
Tailing of the cations was problematic under both CZE and DOI-CZE conditions. The 
degree of tailing may be reduced by the use of a competing base, such as triethanolamine.  
It is unclear exactly how the integration parameters employed by the Agilent 
ChemStation software determine the area of a given peak. Further investigation of these 
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parameters may aid in the improvement of precision with respect to the reported peak 
area and subsequent corrected area results.  
 
2.7.5.3 Comparison of Resolution Precision between CZE and DOI-CZE 
Resolution comparisons between CZE and DOI-CZE results are not easily evaluated 
since the order of the analytes is not the same between experiments. Although parameters 
for DOI-CZE could be changed to get a similar elution order to CZE, it would not be 
practical since the DOI-CZE separation is faster using the current method.   
 
It was observed that in CZE the faster migration time of the anion decreased the 
resolution between the slowest eluting cation and fasting eluting anion. However, the 
large distance between these two peaks makes the analysis of precision in resolution less 
meaningful. The DOI-CZE separation lengths were in part chosen to allow oppositely 
charged analytes to migrate more closely to one another to more adequately study 
precision and the reported resolution values. It was determined that under both CZE and 
DOI-CZE conditions, proper control of the EOF is the most important factor to ensure 
precise values.  
 
2.8 Conclusion 
Although conditions were kept as similar as possible to allow for the best comparison, the 
necessarily different elution orders of the analytes make it difficult to compare the two 
separation modes closely in terms of the precision of resolution. Nonetheless, DOI-CZE 
presents an excellent alternative to conventional CZE experiments given its ability to 
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simultaneously analyze cations and anions with no inherent bias in analysis time or 
resolution.   
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Chapter 3: Analysis of Advil® Allergy & Congestion Relief using Dual-Opposite 
Injection Capillary Zone Electrophoresis and Comparison to Conventional 
Capillary Zone Electrophoresis 
 
 
3.1 Drug Analysis 
A drug is classified as a chemical substance used to diagnosis, treat, cure, or prevent a 
disease [1]. The United States Food and Drug Administration (FDA) [2], United States 
Pharmacopoeia (USP) [3,4] and International Conference on Harmonization of Technical 
Requirements for Registration of Pharmaceuticals for Human Use (ICH) [5] have each 
developed method validation criteria to support new drug applications (NDA). Data 
acquired from a method validation are used to establish that a particular method is 
suitable for its intended purpose [2,6-8]. A method may be developed to study a raw 
material, excipient, degradation and/or drug product for characteristics, such as identity, 
stability, strength, quality, and/or purity [9-16]. 
 
Method validation for CE has been included in both the USP [17] and ICH [18] 
guidelines since 2009 for the qualitative and quantitative analysis of raw materials, 
excipients, degradation products, impurities, drug products and compounds in biological 
fluids. 
 
3.2 Validation of Electrophoretic Methods  
 
The validation parameters for a particular electrophoretic method may vary based on such 
factors as the type of sample, available time for analysis, and cost [6,8,18-22]. To 
confirm that a method in development is capable of performing routine analysis for a 
specific application, parameters such as specificity, limit of detection (LOD), limit of 
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quantitation (LOQ), linearity, range, accuracy, and precision are commonly evaluated. 
Each of these parameters will be described in further detail below.  
 
3.2.1 Specificity (Selectivity)  
In pharmaceutical analysis, specificity is defined as the ability of an analytical method to 
identify a particular analyte in the presence of all potential sample components, which 
may include, but are not limited to, excipients, degradation products, synthesis 
intermediates, and impurities [3,8,18,19,22]. Specificity is studied in order to confirm 
that the measured property of an given analyte is caused solely by the analyte [21]. The 
term selectivity is also sometimes used to describe the general separation of the 
components of a sample [7,23].  
 
One way to determine specificity using electrophoretic separations is to analyze the 
retention of individual standards of the compounds of interest and compare them with the 
sample components studied [3,7,18,19,21,22,24,25]. However, identification based solely 
on retention time is unreliable [21]. A particular peak can be evaluated for purity by the 
use of a spectrophotometric detector, such as a UV-visible diode-array detector (DAD), 
or by using mass spectrometry [22]. Based on available instrumentation, peak purity 
using a DAD will be described.  
 
The optical system of an Agilent 8453 UV-visible spectroscopy system is shown in 
Figure 3.1. This system uses a deuterium lamp to emit light from approximately 190-800 
nm and a tungsten lamp to emit light from 370-1100 nm [26]. Light from each lamp is 
collimated by the source lens and passed through a stray-light filter before reaching the  
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Figure 3.1: Optical system of the Agilent 8453 UV-visible spectroscopy system [27]. 
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sample. After passing through the sample, the transmitted light is focused onto a grating 
to disperse wavelengths of light onto a linear array of photodiodes. Photodiodes generate 
a signal of the complete UV-visible spectrum as a function of time.  
 
When using a CE instrument with DAD, multiple wavelength ranges can be selectively 
monitored. For each wavelength range, a signal of absorbance over time will be 
produced. However, it is difficult to determine whether a given peak consists of one or 
more compounds from a visual analysis. One way to assess peak purity is to analyze a 
given compound at each wavelength measured. If absorbance is observed at a wavelength 
where an analyte of interest has no absorbance, the observed signal could be caused by an 
impurity of a co-eluting peak. Additionally, spectra from reference standards can be 
collected and stored in a database called a spectral library. The spectrum of a reference 
standard can be overlaid with the spectrum of a peak from an unknown sample for visual 
comparison. 
 
For a more in-depth determination of specificity, peak purity applications are available 
for most instrument operating software [3,7,19,21,28]. As instructed by the user, the 
software can record the entire UV-visible spectrum for an eluting peak that produces a 
signal above a predetermined absorbance threshold. All spectra within a given peak can 
be collected; however, to save hard drive storage space, spectra are commonly collected 
at the apex, baseline, upslope, and downslope of a peak [26].  
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To determine peak purity, collected spectra are compared with recorded spectra from a 
reference standard that are stored in a spectral library. If the spectra are identical, as 
shown on the left side of Figure 3.2, the peak is likely pure. If the spectra are not 
identical, shown on the right side of Figure 3.2, the peak consists of at least two 
compounds [22]. From these data, a match factor is determined for each peak based on 
the calculated ratio of signals; this determination is completed automatically by the data 
analysis software.  
 
For the Agilent ChemStation software, a match factor (MF) is determined by 
 
𝑀𝐹 =  
103∗[∑ 𝑥∗𝑦−(
∑ 𝑥 ∑ 𝑦 
𝑛
)]
2
[∑ 𝑥2−(
∑ 𝑥 ∑ 𝑦 
𝑛
)][∑ 𝑦2−(
∑ 𝑥 ∑ 𝑦 
𝑛
)]
                  (3.1) 
 
where x and y are measured absorbances, at the same wavelength, in the first and second 
spectra respectively, and n is the number of data points. The match factor is determined at 
the apex, upslope, downslope and baseline and an average match factor value is presented 
[26]. 
 
It is important to note that a peak with a “perfect” match factor can still be impure. This 
can occur if an impurity is present in lower concentration than the main component of the 
peak. Therefore, peak purity is an analysis technique that can aid in the confirmation of 
the presence of impurities but cannot confirm with absolute certainty that a given peak is 
entirely pure [22].  
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Figure 3.2: Depiction of peak purity determination in chromatographic and 
electrophoretic separations.  
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3.2.2 Limit of Detection 
The limit of detection (LOD) is defined as the smallest amount of analyte that can be 
distinguished from a blank sample [3,6-8,18,19,21-23,29]. The simplest, although least 
accurate, approach to determine the limit of detection is based on visual estimation by the 
user. Signals from known amounts of analyte are studied to establish the minimum 
amount of analyte at which signal can be detected [7,8,18,22]. 
 
One of the most widely used limit of detection determinations is based on the following 
equation [8,18,21,22,28,30-32]: 
 
    𝐿𝑂𝐷 =
3∗𝑠𝑏
𝑆
            (3.2) 
 
where sb is standard deviation of analytical blank signal, and S is the slope of a signal 
response versus concentration calibration curve. Calibration curves will be described in 
detail in Section 3.2.4 [6-8,18,29,33]. The numerical value of 3 is based on obtaining 
both false positive and false negative results at the 95% confidence level. A value of 1.65 
is the one-tailed student t-value for an infinite number of degrees of freedom at the 95% 
confidence level; since false positive and false negative results are analyzed, the t-value 
must be multiplied by 2 for a value of 3.30. Depending on the number of significant 
figures reported, this value is sometimes rounded to 3. For a more statistically accurate 
estimate of the LOD, the multiplication factor used should take into account the number 
of degrees of freedom used in the experimental determination [34,35]. 
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One way to determine sb is to estimate the vertical distance between the top and bottom 
of the baseline signal and calculate the standard deviation based on at least 20 replicate 
injections [18,29]. However, a more practical approach was proposed by Foley and 
Dorsey [29] using the equation:  
 
  𝑠𝑏 =
𝑁𝑝−𝑝
5
                          (3.3) 
 
where Np-p is the peak-to-peak noise. It is important to note that np-p should be measured 
in a representative section of the baseline equal to 20 times the peak width of the analyte 
of interest. The numerical value of 5 is based on the assumption that the noise is random 
and normally distributed [29]. 
 
3.2.3 Limit of Quantitation 
The limit of quantitation (LOQ) is defined as the smallest amount of analyte that can be 
measured with a given level of accuracy and precision [3,6-8,18,19,21,22,33,35]. 
Accuracy and precision values of ±10% each are commonly employed as threshold levels 
for LOQ [21].  
 
The calculations to determine the limit of quantitation are very similar to the calculations 
presented above for limit of detection. The difference between the calculations for these 
two validation parameters is the multiplication factor used in each calculation. In the 
calculation for LOD, a multiplication factor of 3 was used. The LOQ can be determined 
by 
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𝐿𝑂𝑄 =
10∗𝑠𝑏
𝑆
         (3.4) 
 
where sb is the standard deviation of the blank signal and S is the slope of the signal vs. 
amount of analyte calibration curve. The numerical value 10 is a predetermined value 
selected by the IUPAC [34,35]. The methods for determining sb presented in Section 
3.2.2 are also applicable for sb determinations for LOQ. 
 
3.2.4 Linearity and Range 
Linearity is defined as the ability of a method to generate a signal response that is directly 
proportional to the analyte concentration or amount of a sample. Linearity is determined 
experimentally by preparing a set of standards for each analyte of interest in a range of 
80-120% of the final concentration of analyte in the unknown sample [3,6-
8,18,21,22,33]. Replicates of each standard are run in order to determine the experimental 
uncertainty for a given set of data using a particular method.  
 
To assess linearity, a calibration curve of signal response versus amount of analyte is 
made. The method of least squares is commonly employed to analyze the data 
[6,8,21,36]. First, a straight line is drawn through the data points using the equation, 
 
y = mx + b            (3.5) 
 
where y is the signal response in terms of peak area, m is the slope of the calibration 
curve, x is the concentration or amount of analyte and b is the y-intercept value. The 
slope can be determined by  
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     𝑚 =
𝑛∗[∑ 𝑥𝑖𝑦𝑖−(∑ 𝑥𝑖 ∑ 𝑦𝑖)]
𝑛∗∑ 𝑥𝑖
2−(∑ 𝑥𝑖)
2           (3.6) 
 
where n is the total number of total number of data points. The y-intercept value can be 
determined by  
 
𝑏 =
(∑ 𝑥𝑖
2) ∑ 𝑦𝑖−(∑ 𝑥𝑖 ∑ 𝑦𝑖)∗∑ 𝑥𝑖
𝑛∗∑ 𝑥𝑖
2−(∑ 𝑥𝑖)
2         (3.7) 
 
The “best” line for a given data set minimizes the vertical deviations of each data point so 
that some data points like above and some lie below the line.  
 
The correlation coefficient (r) is an additional parameter that can be used to evaluate the 
linear relationship between signal response and concentration or amount of analyte. The r 
value can be determined [36] by 
 
𝑟 =   √
[∑(𝑥𝑖−?̅?)(𝑦𝑖−?̅?)]
2
∑(𝑥𝑖−?̅?)
2 ∑(𝑦𝑖−?̅?)
2      (3.8) 
 
An r value of 0 refers to a completely non-linear relationship whereas r
 
values of +1 or -1 
refer to a positive or negative linear relationship, respectively. While the correlation 
coefficient does report on linearity, this parameter does not guarantee that the linear 
model fits the data well [6,8]. 
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As the correlation coefficient is insensitive to problems in the data set, the analysis of 
residuals should be completed to determine the data fit to the regression line [3,6,8,33-
35]. A residual is defined as the deviation of the data point from the best fit line through 
the data set, 
 
𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙 = 𝑦𝑖 − (𝑚𝑥𝑖 + 𝑏)        (3.9) 
 
Once the residuals are determined, a plot of residuals versus concentration (or amount) of 
analyte should be constructed. The points in a residual plot should vary randomly around 
zero. If a linear regression model is appropriate for the data, no systematic patterns will 
be observed. If a non-random pattern is observed in the residual plot, the model fits the 
data poorly and a new model should be chosen and evaluated [36]. 
 
The regression statistic analyzes the relationship among variables. Data is evaluated 
based on the mean squares (MS) of the slope (MSregression) and the residuals (MSresiduals). 
The MSresiduals is the sum of the MSlack of fit (LOF) and the MSerror (ANOVA). The Fcalc 
value is determined by dividing the MSLOF by the MSerror. If the Fcalc exceeds the Ftable, 
the selected regression model is not appropriate and another model should be tested.   
 
The range is determined based on linearity studies and is the interval between the upper 
and lower concentration (or amount) of analyte that provides an appropriate level of 
precision and accuracy for an analysis [3,8,18,22,34]. The lower end of the range is 
limited by the LOQ [34]. 
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3.2.5 Accuracy 
Accuracy is the closeness of agreement between the average concentration of the 
experimental results and the accepted or true concentration [3,6,8,18,19,21,22,33-35]. Six 
replicates at the intended concentration of the unknown sample may be used to determine 
accuracy [7]. Accuracy can be analyzed by comparing the measured value to the value of 
a standard compound or certified reference material [3,8,22,33,34].  
 
3.2.6 Precision 
Precision is the measure of the amount of scatter of replicate measurements of the same 
sample using the intended method of analysis [3,8,18,21,22,33-35]. The levels of 
precision that are commonly evaluated are repeatability, intermediate precision and 
reproducibility [3,7,8,18,21,22,33,34]. 
 
Repeatability is defined as the scatter of replicate measurements over a short time interval 
under the same experimental conditions, such as sample preparation, analyst, instrument, 
and day. Repeatability can be evaluated using a minimum of six measurements at a value 
of 100% of the test concentration [3,7,8,18,21,22,33,34].  
 
Repeatability is commonly expressed in terms of standard deviation (SD) 
[3,7,8,18,21,22,33,34], which is determined by 
 
𝑆𝐷 = √
∑(𝑥𝑖−?̅?)
2
𝑛−2
      (3.10) 
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where x is the measured value, ?̅? is the average x-value and n is the number of 
measurements. Precision is also expressed as the percent relative standard deviation,  
 
     %𝑅𝑆𝐷 =  
𝑆𝐷
?̅?
∗ 100      (3.11) 
 
Values for repeatability are expected to give the smallest variation compared with the 
variations obtained for intermediate precision and reproducibility [34]. 
The objective of intermediate precision is to verify that the proposed method will provide 
the same results on multiple days of analysis. Therefore, intermediate precision is 
obtained from within-lab variations in factors such as the day of analysis, capillary, 
analyst, and/or equipment [3,7,8,18,21,22,33]. An ANOVA can be performed as 
described in Chapter 2 to evaluate large groups of data sets. 
 
Reproducibility is the precision obtained from multiple laboratories [3,8,18,21,22,33]. 
The objective of reproducibility is to verify that the proposed method will provide the 
same results in different laboratories. The same calculations to evaluate precision for 
intermediate precision can be applied for reproducibility. This type of precision is 
expected to yield the largest amount of error [33]. 
 
3.3 New Drug Application 
In the new drug application for Advil® Allergy and Congestion Relief tablets, high-
performance liquid chromatography was employed for validation. This work presents the 
method validation of Advil® Allergy and Congestion Relief Tablets using capillary zone 
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electrophoresis and dual-opposite injection capillary zone electrophoresis to test the 
suitability of the proposed methods as complementary method of analysis. 
 
3.4 Advil® Allergy & Congestion Relief Tablets 
Advil® Allergy & Congestion Relief tablets were developed by Pfizer Consumer 
Healthcare, formerly Wyeth Consumer Healthcare, to aid in the relief of upper respiratory 
ailments, such as runny nose, itchy, watery eyes, nasal congestion, sinus pressure, 
headache, aches, pains, and fever. A new drug application was submitted to the FDA in 
September 2007. This application was evaluated and returned unapproved on July 25, 
2008. After resubmission, FDA approval for this NDA occurred on December 21, 2011 
[37]. 
 
3.4.1 Active Ingredients in Advil® Allergy & Congestion Relief Tablets 
According to the label, one Advil® Allergy & Congestion Relief tablet contains 200 mg 
ibuprofen, 4 mg chlorpheniramine maleate, and 10 mg phenylephrine. The structures for 
these compounds are shown in Figure 3.3. 
 
Ibuprofen, (RS)-2-(4-(2-methylpropyl)phenyl)propanoic acid, is a nonsteroidal anti-
inflammatory drug (NSAID) used for pain relief and fever and inflammatory reduction. 
Ibuprofen was approved as an over-the-counter (OTC) product in 1984 with 200 mg 
maximum dosage per tablet and 1200 mg per day. In drug formulations, ibuprofen is 
present as a racemic mixture of S-[+] and R-[-] isomers [38]. 
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              Ibuprofen                                              Phenylephrine hydrochloride 
 
 
 
 
                        Chlorpheniramine maleate 
 
Figure 3.3: Molecular structures of the active ingredients in an Advil® Allergy and 
Congestion Relief.  
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Ibuprofen has limited solubility in water; at room temperature (25˚C) reported 
experimental values for solubility in water range from 0.021- 0.08 mg/mL. However, 
solubility can be increased by dissolving ibuprofen in an organic solvent, such as 
methanol [39-42]. 
 
As a weak acid, ibuprofen is present in solution in an equilibrium between its protonated 
(neutral charge) and deprotonated (-1 charge) forms. Ibuprofen undergoes deprotonation 
of the hydrogen on the hydroxyl group of the carboxylic acid above its pKa. Reported pKa  
values of ibuprofen range from 4.14 to 4.76 [40,43-46]; a pKa value 4.4 is the most 
widely reported value [43,44]. 
 
Phenylephrine, (R)-3-[-1-hydroxy-2-(methylamino)ethyl]phenol, is used in drug products 
as a nasal decongestant. It is a common replacement for pseudoephedrine, whose sales 
became restricted as a result of the Combat Methamphetamine Epidemic Act of 2005. 
This act was designed to deter the manufacture of illegal drugs [47]. Phenylephrine is 
available in OTC formulations as 10 mg maximum dosage per tablet and 40 mg 
maximum per day.  
 
Phenylephrine also has limited solubility in water [48]. To increase the solubility of 
phenylephrine, the hydrochloride salt form of phenylephrine is used in drug formulations 
[49]. Solubility values of 10-12 mg/mL for phenylephrine hydrochloride have been 
reported [48,50].  
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As a weak base, phenylephrine is a molecule that exists at equilibrium as a neutral 
molecule and a positively charged cation upon the addition of a proton to the nitrogen 
atom. When the pH is higher than the pKa, phenylephrine exists primarily in its 
deprotonated (neutral) form. Phenylephrine is primarily a cation with +1 charge when the 
pH is below the pKa; experimentally determined pKa values a range from 8.77 to 8.97 
[50-52].  
 
Chlorpheniramine, 3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine, is a 
weak base found in OTC drug formulations in its salt form, chlorpheniramine maleate. 
Chlorpheniramine maleate is an antihistamine that is used to prevent the symptoms of 
allergic responses, such as red, itchy, and/or watery eyes, sneezing, itchy nose or throat, 
and runny nose. The amount of chlorpheniramine in one OTC tablet is 4 mg with a 
maximum daily dosage of 24 mg [53].  
 
Chlorpheniramine maleate is a polar molecule; therefore, polar solvents, such as water, 
methanol and ethanol, can easily dissolve this molecule [54-56]. In solution, 
chlorpheniramine exists at equilibrium as a neutral molecule and a positively charged 
cation. When the pH is higher than the pKa, chlorpheniramine exists primarily in its 
deprotonated (neutral) form. Chlorpheniramine is primarily a cation with +1 charge when 
the pH is below the pKa; experimentally determined pKa values of chlorpheniramine are 
reported from 9.13- 9.20 [57-62]. 
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3.4.2 Inactive Ingredients in Advil® Allergy and Congestion Relief Tablets 
According to the label, inactive ingredients in an Advil® Allergy and Congestion Relief 
tablet include acesulfame potassium, artificial flavors, carnauba wax, colloidal silicon 
dioxide, corn starch, croscarmellose sodium, glycerin, glyceryl behenate, hypromellose, 
lactic acid, lecithin, maltodextrin, medium-chain triglycerides, microcrystalline cellulose,  
pharmaceutical ink, polydextrose, polyvinyl alcohol, pregelatinized starch, propyl gallate, 
silicon dioxide, sucralose, synthetic iron oxide, talc, titanium dioxide, triacetin, and 
xanthan gum. 
 
Table 3.1 lists several properties of the inactive ingredients listed above including 
solubility in water, wavelength of UV-visible absorbance, and pKa. If a compound was 
determined to be partially soluble or insoluble in water, no UV-visible absorbance or pKa 
data were recorded as analysis via CZE requires compounds in solution. If the compound 
has no absorbance in the UV-visible region, the pKa value, if any, was still recorded since 
indirect UV-visible can be utilized in commercial instruments. 
 
Based on Table 3.1, acesulfame potassium, lactic acid, and propyl gallate are notable 
compounds that may be present in a CZE experiment based on the absorbance and pKa 
values provided. 
 
3.5 Purpose of Study 
Quantitation of a small peak in the presence of another peak that is much greater in 
concentration is difficult. A benefit of DOI-CZE is the ability to vary the amount of 
anions and cations injected individually. One tablet contains 200 mg ibuprofen, an anion,   
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Table 3.1: Selected properties of the inactive ingredients in Advil® Allergy and 
Congestion Relief, which include solubility in water, UV-visible absorbance wavelength 
(if any), and pKa (if any). 
 
Analyte Soluble in 
water [Ref.] 
UV-Visible Absorbance 
[Ref.] 
pKa[Ref.] 
Acesulfame potassium Yes [63] 227 nm [63] 5.67 [63] 
Carnauba wax No [64] - - 
Colloidal silicon dioxide No [65] - - 
corn starch No [66] - - 
croscarmellose sodium No [67] - - 
glycerin Yes [68] *below 200 nm [26]  14.05 [69] 
glyceryl behenate No [68] - - 
hypromellose Yes [70] None [71]  - 
lactic acid Yes [65] 200 nm [72] 3.69 [73] 
lecithin Partially [74] - - 
maltodextrin Yes [75] None [76] - 
medium-chain 
triglycerides 
Partially [77] - - 
microcrystalline cellulose No - - 
polydextrose Yes [78] - - 
polyvinyl alcohol Yes [79] 280 nm [80] 10.64 [81] 
pregelatinized starch Yes [82] - - 
propyl gallate Yes [83] 230 nm [84] 4.4 [84] 
silicon dioxide No [74] - - 
synthetic iron oxide  No [85] - - 
talc Partially [86] - - 
titanium dioxide No [87] - - 
triacetin Yes [70] None [70] None [70] 
xanthan gum Yes [88] - - 
* The UV cutoff wavelength below which the solvent absorbs light. 
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10 mg phenylephrine hydrochloride and 4 mg chlorpheniramine maleate, which are 
cations. Because there is 10 times more ibuprofen than phenylephrine and 50 times more 
ibuprofen than chlorpheniramine in each tablet, it becomes very difficult to detect all 
analytes in one run in a CZE experiment. If ibuprofen is diluted to an appropriate 
concentration for detection, phenylephrine and especially chlorpheniramine are extremely 
difficult to detect because they are present in such low quantity. If the cations are diluted 
at a detectable concentration, ibuprofen is too concentrated and is eluted as a very broad 
peak. In order to solve this problem, we have utilized DOI-CZE with sequential sample 
introduction in order to modify the quantity of each analyte injected. 
 
3.6 Experimental 
3.6.1 Reagents and Materials 
 
Distilled deionized water was obtained from a Barnstead E-Pure Water System 
(Dubuque, IA) with a resistance of at least 18 MΩ. Disodium hydrogen phosphate 
(Na2HPO4) and sodium dihydrogen phosphate (NaH2PO4) were purchased from J.T. 
Baker (Phillipsburg, NJ). Sodium hydroxide, ibuprofen, ketoprofen, ephedrine 
hydrochloride and chlorpheniramine maleate were purchased from Sigma-Aldrich (St. 
Louis, MO) and phenylephrine hydrochloride was purchased from Spectrum Chemical 
(Gardena, CA). Advil® Allergy & Congestion Relief tablets were purchased from a local 
pharmacy. 
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3.6.2 Standard Solutions 
 
The aqueous buffer solution was prepared by dissolving the appropriate amounts of 
disodium hydrogen phosphate (Na2HPO4) and sodium dihydrogen phosphate (NaH2PO4) 
in distilled deionized water equivalent to approximately three-quarters of the final 
volume. The total phosphate concentration was 15 mM. Sodium hydroxide was added 
until the pH reached 7. Water was added to bring the solution to volume. The same buffer 
solution was used for all experiments. 
 
3.6.3 Sample Solutions 
One Advil® Allergy & Congestion Relief tablet was placed in a solution of 50:50 
buffer:methanol. Methanol was used in order to dissolve the large quantity of ibuprofen. 
Approximately 0.5 mg/mL of ephedrine hydrochloride and ketoprofen were added to the 
solution as cationic and anionic internal standards, respectively. The final concentration 
was 2.5 mg/mL ibuprofen, 0.5 mg/mL ketoprofen, 0.5 mg/mL ephedrine hydrochloride, 
0.125 mg/mL phenylephrine hydrochloride and 0.05 mg/mL chlorpheniramine maleate, 
which could then be diluted as desired. Figure 3.4 shows the appearance of the tablet as it 
is initially placed in the buffer and methanol solution, after 30 minutes, and after 3 hours. 
Ibuprofen, phenylephrine hydrochloride and chlorpheniramine maleate standards were 
made to verify which component from the mixture corresponds to which analyte based on 
both migration time and UV spectral library matching. 
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3.6.4 Electrophoretic Conditions 
All experiments were performed on a 
3D
HP CE instrument, model G1600AX (Agilent 
Technologies, Waldbronn, Germany) equipped with a diode array detector. The primary 
wavelength monitored was 210 nm; other wavelengths included 200, 215, 254, and 300 
nm. ChemStation software, version B.03.02, was used for data acquisition (at 10 Hz) and 
analysis. Fused silica capillaries (50 m I.D., 365 m O.D., 32 cm total length, 23.6 cm 
migration length) from Polymicro Technologies (Phoenix, AZ) were used for the CZE 
experiments and Guarant™-coated capillaries (50 m I.D., 365 m O.D., 32 cm total 
length, 23.6 cm migration distance for cations, 8.4 cm migration distance for anions from 
Alcor BioSeparations LLC (Palo Alto, CA) were used for the DOI-CZE experiments. The 
capillary cartridge temperature was maintained at 25°C for all experiments.  
 
The conditioning of new capillaries for CZE was a series of injections as follows: 
distilled deionized water for 10 min, 1 M NaOH for 10 min, 0.1 M NaOH for 5 min, 
distilled deionized water for 3 min and 15 mM phosphate buffer solution (pH 7) for 15 
min. To reduce EMD effects, NaOH was used instead of LiOH. This conditioning was 
also carried out at the start of each day. CZE injections were performed 
hydrodynamically at +15 mbar for 2 sec. New capillaries for DOI-CZE were conditioned 
with only 15 mM phosphate buffer solution (pH 7) for 30 min as recommended by the 
manufacturer. This conditioning was also carried out at the start of each day. Both CZE 
and DOI-CZE capillaries were flushed with buffer for 2 min between runs.  
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Figure 3.4: One Advil® Allergy & Congestion Relief tablet A. Immediately upon 
placing in the solution of 80 mL total of 50:50 methanol: 15 mM phosphate buffer pH 7. 
B. After 30 minutes. C. After 3 hours.   
A. 
B. 
C. 
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Injections in DOI-CZE were performed via sequential hydrodynamic injection (SeqHI). 
Most injections consisted of an initial injection of sample at the cathode of -15 mbar for 2 
sec, followed by an injection of buffer behind the sample at -25 mbar for 5 sec. Sample 
was then introduced to the opposite side of the capillary at +25 mbar for 4 sec. 
 
Following the completion of sample introduction and preliminary transport where 
applicable (DOI-CZE only), a constant applied voltage of +16 kV was used for all 
experiments after a 0.3 minute voltage ramp from 0 to 16 kV.  
 
3.6.5 UV-Visible Spectrophotometer Conditions 
UV-visible absorbance spectra were obtained for each analyte on an Agilent 8453 UV-
visible Spectroscopy System. A quartz sample cell with a 1-cm pathlength was used to 
contain all measured samples. The instrument was run in spectrum/peaks mode where the 
full wavelength range of the instrument (190-1100 nm) was obtained. The spectral slit 
width on this instrument is fixed at 1 nm. The blank (reference) sample was 15 mM 
phosphate pH 7.0. Data were recorded every 1 nm. 
 
3.7 Results 
3.7.1 Determination of Appropriate Wavelengths for Electrophoretic Analysis  
To determine the appropriate wavelength(s) to monitor in CE with a diode array detector 
(DAD), UV-visible absorbance spectra were analyzed for each analyte of interest. The 
individual spectra obtained for each of the active ingredients are shown in Figure 3.5. The 
maximum UV-absorbances were determined to be 211 nm for chlorpheniramine, 
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phenylephrine, and ibuprofen.The wavelengths chosen for all CE and DOI-CZE 
experiments were 200 nm, 210 nm, 215 nm, 254 nm, and 300 nm. At the final 
wavelength, 300 nm, no absorbance should occur for any of the analytes studied. A 
bandwidth of 10 nm was chosen for each wavelength studied. 
 
3.7.2 Capillary Zone Electrophoresis 
When employing a background electrolyte for both CZE and DOI-CZE conditions with a 
pH of 7 as described above, sample analyte ionization [36] is approximately 99.6%, 
93.1%, and 86.5% for ibuprofen, chlorpheniramine, and phenylephrine, respectively. For 
the internal standards employed, ionization values of approximately 97.5% and 99.6% for 
ephedrine (pKa 9.6 [89,90]) and ketoprofen (pKa 4.45 [91]), respectively, were calculated. 
The experiment was first run under CZE conditions and the resulting electropherogram is 
shown in Figure 3.6. In this experiment, the elution order is ephedrine (0.05 mg/mL), 
phenylephrine (0.0125 mg/mL), chlorpheniramine (0.005 mg/mL), ketoprofen (0.05 
mg/mL), and ibuprofen (0.25 mg/mL).  
 
3.7.2.1 Specificity 
A lack of specificity was one reason that contributed to the rejection of the first NDA for 
this OTC drug. To identify each analyte, the migration times of the tablet components 
(plus internal standards) were compared to individually prepared standards. Peak purity 
was evaluated to show that a given peak is only attributable to one component. A spectral 
library was created by analyzing individually prepared standards and storing the UV 
spectra for a given peak. In addition to the analytes studied and the internal standards,  
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Figure 3.5: UV-visible spectrum of A. chlorpheniramine maleate (maxima at 211 nm and 
261 nm), B. phenylephrine hydrochloride (maxima at 211 and 274 nm) and C. ibuprofen 
(maxima at 211 nm and 271 nm) using an Agilent 8453 UV-visible Spectrometer. A 
quartz sample cell with a 1-cm pathlength was used for all samples. The range 200-400 
nm is shown in the figure. The spectral slit width is 1 nm. The 15 mM phosphate buffer 
was used as the blank (reference) sample. Absorbance data were recorded every 1 nm. 
  
A. 
B. 
C. 
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Figure 3.6: Capillary zone electrophoresis separation of one Advil® Allergy & 
Congestion Relief tablet. Conditions: 50 m i.d. fused silica capillary, 32 cm Lt, 23.6 cm 
Ld; +16 kV voltage; 210 nm detection wavelength; 25°C; 15 mM phosphate buffer, pH 7. 
Peak identification: (1) ephedrine (0.05 mg/mL); (2) phenylephrine (0.0125 mg/mL); (3) 
chlorpheniramine (0.005 mg/mL); (4) ketoprofen (0.05 mg/mL); and (5) ibuprofen (0.25 
mg/mL). Not detected: maleic acid.  
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one additional cation (pseudoephedrine) and one additional anion (flurbiprofen) were 
added to the library to compare purity against a larger pool of ions. The peak purity 
values (out of 1000) for ephedrine, phenylephrine, ketoprofen and ibuprofen are 973, 
767, 916, and 996, respectively. The ChemStation software notes that a purity value of 
over 900 generally indicates a pure peak. Unfortunately, at the concentration of 0.005 
mg/mL, peak purity information could not be obtained for chlorpheniramine due to the 
small peak size. The small peak area of phenylephrine contributed to its less than ideal 
purity value. By increasing the amount injected or using a higher concentration sample, 
purity values for all analytes are more easily determined and larger purity values are 
obtained (data not shown).   
 
3.7.2.2 Limit of Detection and Limit of Quantitation 
The minimum concentrations at which the analytes can be reliably detected (LOD) and 
quantified (LOQ) were calculated. As minimal baseline noise was observed for the CZE 
electropherogram, the LOD and LOQ were determined based on the signal-to-noise ratio 
described in Section 3.2.2. To establish these values, equations 3.2- 3.4 were used. The 
migration time, peak width, time window studied, and peak-to-peak noise were 
determined to measure the LOD and LOQ in a representative section of the baseline for 
each analyte of interest. Results are shown in Table 3.2. The slope values were 
determined by calibration curves that will be described further in Section 3.7.2.3. 
 
The concentration of the analytes corresponding to signal-to-noise ratios of 3 and 10, for 
the LOD and LOQ, respectively, were determined. LOD values of 0.7 g/mL, 0.8 g/mL,  
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Table 3.2: Parameters determined for limit of detection and limit of quantitation 
calculations. 
 
Analyte Migration 
Time (min) 
Peak Width 
(min) 
Time Window 
Studied (min) 
Np-p 
Phenylephrine 1.29 0.017 0.95-1.63 0.19 
Chlorpheniramine 1.41 0.025 0.91-1.91 0.19 
Ibuprofen 5.64 0.132 3.00-8.28 0.19 
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and 0.7 g/mL were calculated for phenylephrine, chlorpheniramine, and ibuprofen, 
respectively. LOQ values of 2.6 g/mL, 2.6 g/mL, and 2.5 g/mL were determined for 
phenylephrine, chlorpheniramine, and ibuprofen, respectively. 
 
3.7.2.3 Linearity 
To assess linearity, a calibration curve of signal response versus amount of analyte 
injected was made for each analyte of interest. The amount of analyte of injected was 
determined by, 
𝑉𝑖𝑛𝑗 = 𝜋 ∗ 𝑟
2 ∗ 𝐿𝑖𝑛𝑗       (3.12) 
 
where r is the capillary radius and Linj is the length of sample plug introduced. Linj can be 
determined by 
 
𝐿𝑖𝑛𝑗 = (
𝑟2∗∆𝑃
8∗𝑛∗𝐿𝑡
) ∗ 𝑡𝑖𝑛𝑗        (3.13) 
 
where P is the pressure drop (in mbar) across the capillary during sample injection,  is 
the viscosity of the background electrolyte at the temperature of the analysis (25ºC in this 
study), Lt is the total capillary length, and tinj is the time of pressure injection. Under CZE 
conditions, a 15 mbar, 2-second injection of sample on a 32 cm x 50 m i.d. capillary 
yields a volume of 1.6 nL. To determine the amount of analyte injected, the volume 
injected was multiplied by the concentration of analyte prepared.  
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The method of least squares was employed to analyze the plot of corrected area versus 
amount of analyte injected for each active ingredient [3,5]. To determine how well the 
data fit to the regression line, an analysis of residuals was also performed. 
 
The calibration curves for chlorpheniramine, phenylephrine, and ibuprofen under CZE 
conditions are shown in Figure 3.7. Chlorpheniramine, shown in Figure 3.7A, has an r-
squared value of 0.9936; these data are based on triplicate measurements of the following 
concentrations: 0.005 mg/mL, 0.01 mg/mL, 0.025 mg/mL, 0.05 mg/mL, 0.075 mg/mL, 
0.1 mg/mL, and 0.5 mg/mL. This range was selected by choosing an upper concentration 
whose value exceeded the concentration (0.05 mg/mL) of the initial tablet dissolved in 80 
mL 50:50 methanol:15 mM phosphate buffer by at least a factor of 10 and using a 
concentration close to the LOQ as the lower limit. Regression analysis, shown in Table 
3.3, indicated that a 1
st
 order zero-intercept model is appropriate for these data.  
 
The calibration curve for phenylephrine is shown in Figure 3.7B. The upper 
concentration value exceeded the concentration (0.125 mg/mL) of the initial tablet 
dissolved in 80 mL 50:50 methanol:15 mM phosphate buffer by a factor of at least 10. A 
value of 0.005 mg/mL was chosen as the lowest concentration due to its proximity to the 
LOQ. Data points within the range of concentrations studied include 0.01 mg/mL, 0.025 
mg/mL, 0.05 mg/mL, 0.075 mg/mL, 0.1 mg/mL, 0.5 mg/mL and 1 mg/mL. The r-squared 
value of 0.9913 indicates a linear response between corrected peak area and amount 
injected. Regression analysis, shown in Table 3.4, indicated that a 1
st
 order zero-intercept 
model is appropriate for these data.  
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An extended concentration range was studied for ibuprofen, shown in Figure 3.7C, due to 
its higher concentration. An upper concentration limit of 2.5 mg/mL was selected as a 
result of the poor solubility of ibuprofen, approximately 1 mg/mL in aqueous buffer. A 
ratio of 50:50 methanol:15 mM phosphate buffer was found to dissolve ibuprofen to a 
concentration no more than 3 mg/mL. A value of 0.005 mg/mL was chosen as the lowest 
concentration range due to its proximity to the LOQ. Data points within this 
concentration range included 0.01 mg/mL, 0.05 mg/mL, 0.17 mg/mL, 0.4 mg/mL, 1 
mg/mL, 1.5 mg/mL, 2.25 mg/mL and 2.55 mg/mL. The r-squared value of 0.9938 
indicates a linear response between corrected peak area and amount injected. The 
regression analysis, shown in Table 3.5, indicated a 1
st
 order zero-intercept model was 
appropriate for these data. 
 
The residual plots based on the 1
st
 order zero-intercept model for each of the three active 
ingredients studied is shown in Figure 3.8. Based on the residual plots, it appears that the 
chlorpheniramine concentrations of 0.05 and 0.075 mg/mL were all lower than expected. 
For phenylephrine, the response of the 1.5 mg/mL standard was generally higher than 
anticipated while the concentrations 0.25 and 0.5 mg/mL were low. For ibuprofen, 0.4 
mg/mL was lower than excepted and 0.05 mg/mL was higher than expected. While some 
of the standards appear to have minimal spread in the residual values, there is no 
statistically significant lack of fit in these data.   
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Figure 3.7. CE calibration curve data for (a) chlorpheniramine, (b) phenylephrine, and 
(c) ibuprofen. Conditions described in Figure 3.6. 
   
A. 
B. 
C. 
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Table 3.3: 1
st
 order zero intercept regression analysis for chlorpheniramine in CZE. 
 
Regression Statistics 
    Correlation 
Coefficient 0.998 
    Standard 
Error 1.690 
    Observations 20 
    
    
Ftable 2.92 
ANOVA 
     
  DF SS MS Fcalc P-Value 
Regression 1 11483.18 11483.18 4019.77 1.29 x 10
-22
 
LOF 6 29.73 4.96 2.62 
 Error 13 24.54 1.89 
  Residual 19 54.28 2.86 
  Total 20 11537.45       
 
  
Coefficients 
Standard 
Error 
t Stat P-value Lower 95% 
Upper 
95% 
Amount 
Injected 
(mg) 
8.89 x 10
7
 1.40 x 10
6
 63.40 1.40 x 10
-23
 8.60 x 10
7
 9.18 x 10
7
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Table 3.4: 1
st
 order zero intercept regression analysis for phenylephrine in CZE. 
       Regression Statistics 
     Correlation 
Coefficient 0.998 
     Standard Error 6.798 
     Observations 28 
     
    
Ftable 2.46 
 ANOVA 
        DF SS MS Fcalc P-value 
 Regression 1 251965.34 251965.34 5451.78 9.64 x 10
-32
 
 LOF 9 562.32 62.48 1.64 
  Error 18 685.54 38.09 
   Residual 27 1247.86 46.22 
   Total 28 253213.20 
    
              
 
  
Coefficients 
Standard 
Error 
t Stat P-value Lower 95% 
Upper 
95% 
Amount 
Injected 
(mg) 
8.89 x 10
7
 1.19 x 10
6
 73.84 1.08 x 10
-23
 8.57 x 10
7
 9.06 x 10
7
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Table 3.5: 1
st
 order zero intercept regression analysis for ibuprofen in CZE. 
       Regression Statistics 
     Correlation 
Coefficient 0.998 
     Standard Error 11.950 
     Observations 25 
     
    
Ftable 2.59 
 ANOVA 
        DF SS MS Fcalc P-value 
 Regression 1 984778.31 984778.31 6896.54 5.20 x 10
-30
 
 LOF 8 1704.54 213.07 1.98 
  Error 16 1722.49 107.66 
   Residual 24 3427.03 142.79 
   Total 25 988205.35 
     
 
  
Coefficients 
Standard 
Error 
t Stat P-value Lower 95% 
Upper 
95% 
Amount 
Injected 
(mg) 
9.27 x 10
7
 1.12 x 10
6
 83.05 4.88 x 10
-31
 9.04 x 10
7
 9.50 x 10
7
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A. 
 
B. 
 
C. 
 
Figure 3.8: Residual plots for the CZE analysis of A. chlorpheniramine, B. 
phenylephrine, and C. ibuprofen.  
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3.7.2.4 Accuracy 
Six replicates at the intended concentration of the unknown sample were used to 
determine accuracy and compare to a standard mixture [3,5]. The method of external 
standardization evaluates the response factor (RF) is a ratio that accounts for differences 
in the detector response as the detector sensitivity varies from one compound to another. 
The response of a given analyte is proportional to the amount of this analyte that is 
introduced into the capillary. The RF value for each analyte was calculated by 
  
𝑅𝐹 =
𝐴𝑐𝑜𝑟𝑟
𝑞𝑖𝑛𝑗
        (3.14) 
 
where Acorr is the corrected peak area and qinj is the amount of analyte injected.  
The method of internal standards evaluates the relative response factor (RRF) for the 
determination of the quantity of the analytes present in pharmaceutical products. 
 
The response factor of each analyte can be calculated and compared to the response of an 
internal standard. This approach is appropriate for this analysis as it accounts for minor 
variations in the injection volume. As large relative variations in the injection volume are 
commonly observed in CZE, the injection volume when employing DOI-CZE may also 
vary. Therefore, two internal standards were employed, ephedrine for cations and 
ketoprofen for anions.  
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The relative response factor can be determined as  
 
𝑅𝑅𝐹 =
𝑅𝐹𝑎𝑛𝑎𝑙𝑦𝑡𝑒
𝑅𝐹𝐼𝑆
      (3.15) 
 
where RFanalyte is the analyte response factor and RFIS is the internal standard response 
factor. 
 
The relative response factor for each analyte of interest can be determined in a mixture 
with known concentrations of each standard, and then the concentration of each of the 
analytes in the Advil® tablet can be determined individually by, 
 
𝑐𝑎𝑛𝑎𝑙𝑦𝑡𝑒 = (
𝐴𝑎𝑛𝑎𝑙𝑦𝑡𝑒
𝐴𝐼𝑆
) ∙ (
𝑐𝐼𝑆
𝑅𝑅𝐹𝑎𝑛𝑎𝑙𝑦𝑡𝑒
)       (3.16) 
 
where Aanalyte and AIS are the peak areas of the analyte and the internal standard, 
respectively, from the tablet sample, CIS is the known concentration of internal standard 
added to the tablet sample, and RRFanalyte is the relative response factor of the analyte. 
 
When a tablet with concentrations of 0.125, 0.05, and 2.5 mg/mL for phenylephrine, 
chlorpheniramine, and ibuprofen, respectively is analyzed, co-elution of ketoprofen and 
ibuprofen occurs due to the very broad peaks observed at this concentration. Therefore, 
the tablet was analyzed with a 1:10 dilution. 
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Table 3.6: Measured concentration (reported in mg/mL) of each active ingredient in one 
Advil® Allergy & Congestion Relief tablet using CZE.  
 
Sample Phenylephrine Chlorpheniramine Ibuprofen 
1 0.124 0.068 2.420 
2 0.131 0.060 2.339 
3 0.123 0.051 2.395 
4 0.126 0.059 2.566 
5 0.123 0.052 2.316 
6 0.127 0.062 2.417 
Average 0.126 0.059 2.382 
%RSD 2.4% 10.7% 1.8% 
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Table 3.6 shows the concentration calculated for each analyte in the 1:10 diluted Advil ® 
tablet for CZE using the relative response factor approach. The average concentration for 
chlorpheniramine was determined to be 0.06 mg/mL, which is 0.009 mg/mL higher than 
expected. One possible contribution to the 117% recovery for this analyte is the slight 
overestimation of the peak start and peak stop time in order for the software to record an 
area for integration. The concentration measured for phenylephrine was 0.13 mg/mL, 
equivalent to a 100% recovery. A concentration of 2.38 mg/mL, a 95% recovery, was 
determined for ibuprofen. The low recovery may be related to the poor solubility of 
original diluted tablet as ibuprofen at 2.5 mg/mL approaches the solubility limit. 
 
3.7.2.5 Precision  
Using CZE, the relative standard deviation (RSD) for the concentrations of 
phenylephrine, chlorpheniramine, and ibuprofen were 2.4, 10.3, and 1.8%, respectively. 
The poor repeatability for chlorpheniramine probably stems from the small size of the 
peak in the 1:10 dilution of the tablet, which is too small to properly integrate in the 
software. 
 
3.7.3 Dual Opposite Injection Capillary Zone Electrophoresis Separation 
A DOI-CZE separation was performed using the same analytes as in the previously 
described CZE experiments. A representative DOI-CZE electropherogram is shown in 
Figure 3.9. For best comparison, DOI-CZE separation parameters were kept as similar as 
possible to the CZE experiment. However, there were two changes made to the DOI-CZE 
experiment. First, a sequential hydrodynamic sample introduction was employed and the  
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Figure 3.9: Dual-opposite injection capillary zone electrophoresis separation of one 
Advil® Allergy & Congestion Relief tablet. Conditions: 50 m i.d. Guarant® coated 
capillary, 32 cm Lt, 23.6 cm Lc, 8.4 cm La; +16 kV voltage; 210 nm detection 
wavelength; 25 °C; 15 mM phosphate buffer, pH 7. Peak identification: (1) maleate anion 
(2) ephedrine (0.05 mg/mL); (3) phenylephrine (0.0125 mg/mL); (4) chlorpheniramine 
(0.005 mg/mL); (6) ibuprofen (0.25 mg/mL); and (6) ketoprofen (0.05 mg/mL). 
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sample volume for the cations was increased as described in the experimental section. 
Second, it is essential that in DOI-CZE analytes injected from each end of the capillary 
can reach the detection window. Therefore, the electroosmotic flow was suppressed. A 
coated capillary was employed for this separation in order to keep all aspects of the 
buffer (composition, concentration, pH, etc.) constant between separation techniques.  
 
In the DOI-CZE electropherogram, 6 peaks were observed; this was unexpected as there 
were 3 active ingredients and 2 internal standard components in the sample mixture. 
Determination of the identity of this extra peak is described further below.The eluted 
peaks under DOI-CZE conditions are much broader compared to the same peaks run 
under CZE conditions, particularly for ibuprofen and ketoprofen. As the sample 
introduction parameters for the anions were not modified between CZE and DOI-CZE, it 
is suspected that these ions are interacting with the capillary in some way. As the coated 
capillary from Alcor BioSeparations is proprietary, further comments on analyte-wall 
interactions are unable to be made. However, it is possible that the capillary coating was 
damaged when the outer coating was removed. While a window burner was used to 
create a window for detection, the manufacturer recommended fuming sulfuric acid to 
remove of the outer capillary coating. Correspondence with the manufacturer, indicated 
that no other products were recommended for the coating removal. As fuming sulfuric 
acid was unavailable, a window burner was used instead. The potential degradation of 
wall coating may have affected the separation. Further studies of the capillary coating 
surface upon various coating removal methods may provide more information. 
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In addition to the noticeably broader peaks in the DOI-CZE separation, the total analysis 
exceeds 10 minutes compared to less than 6 minutes when CZE conditions are employed. 
The increase in migration time for the anions is related to the EOF. For the coated 
capillary studied, an EOF of approximately 1.85 x 10
-4
 cm
2
/Vs (RSD of 4.42% based on 
10 successive measurements) was determined using the Williams and Vigh method that 
was described in Chapter 2. The electrophoretic mobilities, determined under CZE 
conditions, of the anions were determined to be approximately -2.14 x 10
-4
 cm
2
/Vs and  
-2.27 x 10
-4
 cm
2
/Vs for ketoprofen and ibuprofen, respectively. Since the same buffer 
(pH, ionic strength) was employed for both CZE and DOI-CZE conditions, the 
electrophoretic mobilities of the ions under DOI-CZE conditions will be the same as in 
CZE. Thus, because of the suppressed EOF under DOI-CZE conditions, an increase in 
the migration time of the anions from CZE to DOI-CZE is expected. 
 
3.7.3.1 Specificity in DOI-CZE 
In order to identify each peak by means of UV spectral library matching, the signal for 
the cations must be increased. The ability of DOI-CZE to independently vary the amount 
of cationic and anionic analytes introduced via separate sample introduction conditions 
(injection time, pressure, and/or voltage) allows for an increased signal for the cations via 
an increase in the amount of cations introduced. An increase in the peak area is needed to 
obtain more accurate peak purity values for the cations phenylephrine and 
chlorpheniramine. It is of particular interest to increase the signal for chlorpheniramine, 
whose purity values were unable to be determined in CZE. As adequate signals were 
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obtained for the anions under CZE conditions, the sample introduction parameters for 
ibuprofen and ketoprofen were unchanged in the DOI-CZE experiments.   
 
The unidentified peak (#1 in figure 3.9) in the DOI-CZE electropherograms, suspected to 
be the maleate anion from the chlorpheniramine salt, was further investigated to 
determine its identity. This ion travels in the opposite direction of the EOF. Confirmation 
of the direction of migration was confirmed by introducing the tablet sample at the anode 
and buffer only at the cathode. A separate analysis where buffer was introduced at the 
anode and tablet sample at the cathode was completed for comparison.  
The method described above indicated that the unknown peak was an anion based on its 
migration direction. Based on the properties of the active and inactive ingredients in the 
table, it was suspected that the unknown peak was the maleate anion from the 
chlorpheniramine maleate salt. In order to confirm this hypothesis, chlorpheniramine 
maleate standards were run under DOI-CZE conditions. An injection of buffer only at the 
anode and the chlorpheniramine maleate sample at the cathode, resulted in a peak eluting 
with a closely matching time to that of the unknown peak from the electropherogram of 
the table. The UV spectrum of this peak was retained and added to the spectral library. A 
peak purity of 988 was obtained. Because of magnitude of the electrophoretic mobility of 
this ion exceeds that of the EOF, this peak is not eluted under CZE conditions.  
 
The peak purity values of all analytes could be determined and values of 994, 876, 774, 
935, and 976, were found for ephedrine, phenylephrine, chlorpheniramine, ketoprofen 
and ibuprofen, respectively. For ephedrine, phenylephrine, and ketoprofen, an increase in 
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peak purity value was observed under DOI-CZE conditions, likely a result of the increase 
in signal. Chlorpheniramine was identified by comparing UV spectra under DOI-CZE 
conditions only. 
 
3.7.3.2 Limit of Detection and Limit of Quantitation in DOI-CZE 
The use of DOI-CZE allows for the separate modification of sample introduction 
procedures for cations and anions. Therefore, the sample introduction procedure for 
cations was increased from +15 mbar for 2 sec to +25 mbar for 4 sec. The sample 
introduction parameters for ibuprofen and ketoprofen were not modified. Increasing the 
amount of pressure and also the amount of time that pressure is employed for the cations 
improved (reduced) the LOD for phenylephrine and chlorpheniramine from a 
concentration of 0.7 g/mL in CZE to 0.3 g/mL in DOI-CZE. The LOQ for 
phenylephrine and chlorpheniramine each improved (were reduced) from 2.6 g/mL in 
CZE to 1.0 g/mL in DOI-CZE.  
 
3.7.3.3 Linearity in DOI-CZE 
The method of least squares was employed to analyze the plot of corrected area versus 
amount of analyte injected for each active ingredient. To determine the amount of analyte 
injected, the volume injected was multiplied by the concentration of analyte prepared. A 
+25 mbar, 4-second injection of sample on a 50-m i.d. capillary yields a volume of 5.4 
nL; this was the injection volume for cations. For anions, the same injection volume as 
CZE (1.6 nL) was introduced into the capillary from the cathode as a result of a +15 
mbar, 2-second injection.  
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Figure 3.10: DOI-CZE calibration curve data for (a) chlorpheniramine, (b) 
phenylephrine, and (c) ibuprofen. Conditions described in Figure 3.9. 
 
  
A. 
B. 
C. 
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The DOI-CZE chlorpheniramine calibration curve is shown in Figure 3.10A. These data 
were generated using the same standard concentrations described above for the CZE 
separation, with one modification. An additional concentration, 0.25 mg/mL, was added 
to this analysis to decrease the large gap between the concentrations of 0.1 mg/mL and 
0.5 mg/mL. As also observed in the CZE calibration curve, these data displayed a linear 
response between the corrected area and amount of sample injected, with an  
r-squared value of 0.9950. Regression analysis, shown in Table 3.7, indicated a 1
st
 order 
zero intercept model is appropriate for these data.  
 
The phenylephrine standard solutions described above for the CZE separation were also 
used in the DOI-CZE separations. The calibration curve generated is shown in Figure 
3.10B. These data display a linear response between corrected area and amount of analyte 
injected, with an r-squared value of 0.9962. Regression analysis, shown in Table 3.8, 
indicated a 1
st 
order zero intercept model for these data. 
 
The ibuprofen standard solutions described above for the CZE separation were also used 
under DOI-CZE conditions. The calibration curve generated is shown in Figure 3.10C. 
These data display a linear response between corrected area and amount of analyte 
injected, with an r-squared value of 0.9962. A slightly larger slope is observed in DOI-
CZE compared to CZE. This may be related to the exceptionally broad peaks obtained at 
higher concentrations of ibuprofen for this capillary, which yield larger than anticipated 
peak areas, particularly for the analytes of higher concentration. Regression analysis, 
shown in Table 3.9, indicated a 1
st
 order zero intercept model for this data.  
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Table 3.7: 1
st
 order zero intercept regression analysis for chlorpheniramine in DOI-CZE. 
       Regression Statistics 
     Correlation 
Coefficient 0.998 
     Standard Error 5.572 
     Observations 24 
     
    
Ftable 2.66 
 ANOVA 
        DF SS MS Fcalc P-value 
 Regression 1 231154.20 231154.20 7444.00 2.45 x 10
-29
 
 LOF 7 95.24 13.61 0.35 
  Error 16 618.96 38.69 
   Residual 23 714.21 31.05 
   Total 24 231868.41       
  
  
Coefficients 
Standard 
Error 
t Stat P-value Lower 95% 
Upper 
95% 
Amount 
Injected 
(mg) 
8.95 x 10
7
 1.04 x 10
6
 82.28 2.17 x 10
-30
 8.74 x 10
7
 9.17 x 10
7
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Table 3.8: 1
st
 order zero intercept regression analysis for phenylephrine in DOI-CZE. 
       Regression Statistics 
     Correlation 
Coefficient 0.999 
     Standard Error 15.112 
     Observations 28 
     
       ANOVA 
        DF SS MS Fcalc P-value 
 Regression 1 2926350 2926350 12813.46 1.49 x 10
-36
 
 LOF 9 1937.52 215.28 0.92 
  Error 18 4228.76 234.93 
   Residual 27 6166.28 228.38 
   Total 28 2932516 
    
        
  
Coefficients 
Standard 
Error 
t Stat P-value Lower 95% 
Upper 
95% 
Amount 
Injected 
(mg) 
9.01 x 10
7
 7.96 x 10
5
 113.20 1.10 x 10
-37
 8.85 x 10
7
 9.18 x 10
7
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Table 3.9: 1
st 
order zero intercept regression analysis for ibuprofen in DOI-CZE. 
       Regression Statistics 
     Correlation 
Coefficient 
0.999 
     Standard Error 9.852 
     Observations 24 
     
    
Ftable 2.66 
 ANOVA 
        DF SS MS Fcalc P-value 
 Regression 1 1050943 1050943 10826.46 4.02 x 10
-31
 
 LOF 7 1018.79 145.54 1.92 
 
 Error 16 1213.86 75.87 
  
 Residual 23 2232.65 97.07 
  
 Total 24 1053175 
   
 
        
  
Coefficients 
Standard 
Error 
t Stat P-value Lower 95% 
Upper 
95% 
Amount 
Injected 
(mg) 
9.79 x 10
7
 9.41 x 10
5
 104.05 2.95 x 10
-32
 9.59 x 10
7
 9.98 x 10
7
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The residual plots for the active ingredients using DOI-CZE are shown in Figure 3.11. 
For chlorpheniramine, the response of the 0.1 mg/mL standard was low. For 
phenylephrine, 0.5 mg/mL was lower than excepted and the 0.005 mg/mL was higher 
than expected. The 0.4 mg/mL ibuprofen standard was lower than expected while the 
0.005, 0.01, and 0.05 mg/mL standards were all higher than anticipated. While some of 
the standards appear to have minimal spread in the residual values, there is no statistically 
significant lack of fit in these data.      
 
3.7.3.4 Accuracy in DOI-CZE 
The relative response factor (RRF) values for the 1:10 diluted Advil ® tablet using DOI-
CZE are shown in Table 3.10. The average concentration for chlorpheniramine was 
determined to be 0.05 mg/mL, a 98% recovery. The larger peak height and area due to 
the increased amount of sample introduced allowed for easier integration. Phenylephrine 
yielded a similar recovery to CZE (100%) with a determined concentration of 0.125 
mg/mL. Ibuprofen yielded lower than anticipated recovery with a recovery of 96%. It is 
again proposed that due to solubility issues, not all of the ibuprofen may have been 
solubilized in the undiluted solution.  
 
3.7.3.5 Precision 
RSD values of 1.3, 5.3, and 2.5% were determined for phenylephrine, chlorpheniramine, 
and ibuprofen, respectively, under DOI-CZE conditions. 
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A. 
  
B. 
 
C. 
 
 
Figure 3.11: Residual plots for the DOI-CZE analysis of A. chlorpheniramine, B. 
phenylephrine, and C. ibuprofen.  
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Table 3.10: Measured concentration (reported in mg/mL) of each active ingredient in one 
Advil® Allergy & Congestion Relief tablet using DOI-CZE.  
 
Sample Chlorpheniramine Phenylephrine Ibuprofen 
1 0.127 0.046 2.454 
2 0.127 0.046 2.397 
3 0.125 0.052 2.400 
4 0.124 0.051 2.472 
5 0.126 0.049 2.389 
6 0.123 0.047 2.443 
Average 0.125 0.0485 2.41 
%RSD 1.3% 5.3% 2.5% 
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3.8 Conclusion 
DOI-CZE is an effective approach for the elimination of the unavoidable and significant 
biases in the resolution and analysis time of anionic and cationic species that occur in 
CZE when oppositely-charged analytes are determined simultaneously (in a single run).   
In addition to being generally better-suited for the simultaneous analysis of oppositely 
charged analytes than CZE, DOI-CZE is especially advantageous when one class of 
charged analytes is much more concentrated than the analytes of opposite charge. The 
simple conversion from CZE to DOI-CZE conditions reported here demonstrates the ease 
at which DOI-CZE could potentially replace CZE in many routine experiments where 
concentration mismatches occur.  
 
While the values for limit of detection and limit of quantitation were not investigated for 
more dilute samples of cations, the sample introduction procedures could be increased 
with respect to both pressure and time of injection to allow lower concentrations to be 
detected. A study of sample dilution with respect to sample introduction should be 
conducted in the future. Such a study would help to determine how much a given sample 
could be diluted and still yield a detectable signal for analyte, given an increase in the 
sample introduction parameters. It is important to note that these studies are limited by 
the wide analyte zones that result from increased sample introduction volume unless 
sample stacking is employed.  
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Chapter 4: A Systematic Approach to Avoid Co-Detection Between Oppositely 
Charged Analytes In Dual-Opposite Injection Capillary Zone Electrophoresis  
 
4.1 Elution Order in Dual-Opposite Injection Capillary Zone Electrophoresis 
In dual-opposite injection capillary zone electrophoresis (DOI-CZE), the elution order of 
analytes in a given separation can vary widely due to the individual electrophoretic 
mobilities of the analytes of interest and the total migration distance that each analyte 
travels to the detector window. Unterholzner et al. [1] introduced the term “apparent 
separation selectivity” to describe this phenomenon. To illustrate the concept of apparent 
separation selectivity in a DOI-CZE separation, Microsoft Excel was used to provide 
appropriate calculations for the construction and display of simulated electropherograms. 
An in-depth explanation on how the simulated electropherograms were generated will be 
provided later in this chapter. 
 
A random number generator (restricted to a range of ±1.50 - 4.00 x 10
-4
 cm
2
/Vs) was 
used to generate twelve electrophoretic mobilities, µep, for six cations and six anions. 
These twelve values are shown in Table 4.1 and are listed in order of elution, with the 
fastest mobilities of each charge eluting first under DOI-CZE conditions. Using values of 
55.00 cm for the total capillary length (Lt), +24 kV for the applied voltage (V),  
1.75 x 10
-5
 cm
2
/Vs for the electroosmotic flow, and 30.00 cm and 25.00 cm for the 
migration distance of cations (Lc) and anions (La), respectively, the simulated 
electropherogram shown in Figure 4.1 was generated.  
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Table 4.1: Randomly selected electrophoretic mobilities for six cations and six anions. 
 
Electrophoretic mobility, ep (cm
2/Vs) 
Cations Anions 
C1 3.03 x 10-4 A1 -3.75 x 10-4 
C2 2.78 x 10-4 A2 -3.05 x 10-4 
C3 2.40 x 10-4 A3 -2.78 x 10-4 
C4 2.21 x 10-4 A4 -2.29 x 10-4 
C5 1.99 x 10-4 A5 -2.12 x 10-4 
C6 1.59 x 10-4 A6 -2.00 x 10-4 
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Figure 4.1: Simulated electropherogram of six cations and six anions (whose 
electrophoretic mobilities are provided in Table 4.1) using DOI-CZE under positive 
polarity (+24 kV) with EOF of 1.75 x 10
-5
 cm
2
/Vs, and capillary lengths of Lt= 55.00 cm, 
Lc= 25.00 cm, La= 30.00 cm. Co-detection is evident between the second eluting cation 
(C2) and first eluting anion (A1), the fourth eluting cation (C4) and second eluting anion 
(A2), the fifth eluting cation (C5) and third eluting anion (A3), and also between the sixth 
eluting cation (C6) and fourth eluting anion (A4). 
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C1 A1, C2 
C3 
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As observed in Figure 4.1, one potential disadvantage of sample introduction from 
opposite ends of the capillary is that an analyte of a given charge migrating from one end 
of the capillary may reach the detector at approximately the same time as an analyte of 
opposite charge migrating from the opposite end of the capillary, resulting in co-
detection. In Figure 4.1, co-detection between oppositely charged analytes is evident 
between the second eluting cation (C2) and first eluting anion (A1), the fourth eluting 
cation (C4) and second eluting anion (A2), the fifth eluting cation (C5) and third eluting 
anion (A3), and also between the sixth eluting cation (C6) and fourth eluting anion (A4). 
 
4.2 Approaches to Avoid Co-Detection in Dual-Opposite Injection Capillary 
Electrophoresis 
When co-detection occurs, there are several approaches that can be used to improve the 
separation. First, the polarity can be reversed so that all analytes migrate toward the 
detector under a different migration distance than the original separation [2]. It is 
important to note that this approach is only effective if unequal migration lengths were 
selected for the original DOI-CZE separation.  
 
If the electropherogram shown in Figure 4.1 is designated as the original separation, 
reversal of the polarity from +24 kV to -24 kV changes Lc from 25.00 cm to 30.00 cm 
and La from 30.00 cm to 25.00 cm. Figure 4.2 shows the simulated electropherogram 
generated using reversed polarity. In this figure, the co-detection between analytes C2 
and A1, C4 and A2, C5 and A3, and also between C6 and A4 is eliminated; however, co- 
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Figure 4.2: Simulated electropherogram of six cations and six anions (whose 
electrophoretic mobilities are provided in Table 4.1) using DOI-CZE under negative 
polarity (-24 kV) with EOF of 1.75 x 10
-5
 cm
2
/Vs, and capillary lengths of Lt= 55.00 cm, 
Lc= 30.00 cm, La= 25.00 cm. Co-detection is observed between the third eluting cation 
(C3) and fourth eluting anion (A4) and the fifth eluting cation (C5) and sixth eluting 
anion (A6). 
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detection between the third eluting cation (C3) and A4 and between C5 and the sixth 
eluting anion (A6) is now observed. 
 
If reversing the polarity provides an unsatisfactory separation, a second approach to avoid 
co-detection is to modify the migration distances by making a new capillary with 
repositioned lengths to the detector [3-5]. As shown in Figure 4.3A, when the migration 
distances are modified from 25.00 to 35.00 cm for cations and from 30.00 to 20.00 cm for 
anions, co-detection occurs between the first eluting cation (C1) and A6.  
 
By reversing the polarity of the capillary whose lengths are described in Figure 4.3A, a 
fully resolved separation is achieved. Under these optimum conditions to avoid co-
detection, anions travel 35.00 cm and cations travel 20.00 cm toward the detector. The 
simulated electropherogram of these conditions is shown in Figure 4.3B. 
 
Unfortunately, optimizing the position of the detection window can be both time 
consuming and costly. If using UV-absorbance detection, one of the most common 
detection methods in CE, a new capillary with a newly burned detection window must be 
made each time the migration distances are modified. New capillaries must also be 
thoroughly preconditioned before first use. This is required no matter what the method of 
detection. 
 
Third, a small amount of external pressure (for example, 5 mbar) can be applied to either 
end of the capillary during the analysis to generate just enough forward or reverse  
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Figure 4.3: Simulated electropherogram of six cations and six anions (whose 
electrophoretic mobilities are provided in Table 4.1) using DOI-CZE under (A) positive 
polarity (+24 kV) with EOF of 1.75 x 10
-5
 cm
2
/Vs, and capillary lengths of Lt= 55.00 cm, 
Lc= 35.00 cm, La= 20.00 cm. Co-detection is evident between the first eluting cation (C1) 
and sixth eluting anion (A6) and (B) negative polarity (-24 kV) with capillary lengths of 
Lt= 55.00 cm, Lc= 20.00 cm, La= 35.00 cm. No co-detection is observed in this 
electropherogram.  
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hydrodynamic flow to change the migration times of the previously co-detected ions 
[2,6,7]. The use of external pressure does, however, increase zone broadening due to the 
parabolic flow profile of the additional hydrodynamic flow generated [7]. While this 
problem can be minimized by using only small external pressures and/or capillaries with 
a small inner diameter [8], use of the latter can result in a significant loss in sensitivity 
when using optical detection methods [7]. Conductivity detection is a viable alternative 
detection method that can be used but is less common in commercial instrumentation [8]. 
 
In a similar approach, the EOF can be modified through the use of a buffer additive that 
alters the charge density and thickness of the surface of the fused silica capillary to 
accelerate the movement of one set of charged analytes and retard the movement of the 
other set of analytes [3,4,9]. Caution should be taken to avoid increasing the magnitude 
of EOF to the point that analytes migrating against the EOF cannot reach the detector [7].  
 
Fourth, a delay can be incorporated into the injection sequence during which time an 
applied pressure or voltage is used [2,9]. This allows analytes of one charge to migrate 
toward the detector for a specified amount of time before the second sample is injected 
and the separation voltage is applied.  
 
It is obvious that using any of the above-mentioned techniques for the avoidance of co-
detection for a specific combination of oppositely charged analytes may result in co-
detection problems for another combination of analytes, especially when the number of 
analytes is large relative to the peak capacity.  
250 
 
Figure 4.4 represents a scatter plot of the predicted migration time for each of the twelve 
analytes in Table 4.1 versus the ratio of migration distance between Lc and La (Lc/La).  
 
Maintaining a total capillary length (Lt) of 55.00 cm, Lc was varied from 9.00 to 46.00 
cm; the migration distance for anions (La) can be determined by subtracting the selected 
migration distance for cations from the total capillary length. This plot shows that when 
Lc/La ranges from 0.53-1.75, the elution order of cations and anions overlap. Co-detection 
is observed in 82.35% of migration length combinations within this range. Therefore, the 
use of central [2,10-12] or approximately central detection [1,4,9,13,14], where Lc/La is 
close or equal to 1.00, is undesirable with respect to achieving a fully resolved separation 
of a large number of oppositely charged analytes.  
 
Haumann et al. [7] was the first to recognize that the simplest way to avoid co-detection 
is to ensure that one group of charged analytes migrates past the detector window before 
any of the analytes of the opposite charge reach the same window. They proposed that at 
least 30 seconds should separate the EOF and the first eluting analyte after the EOF to 
avoid any problems with small shifts in migration times due to variation in the magnitude 
of EOF. In their experiment, the migration distances used were 15.50 cm and 60.00 cm 
for cations and anions, respectively. The EOF was only slightly suppressed and thus 
easily measured with a neutral marker. Separation was achieved in less than 7 minutes 
under these conditions, although it appears that a faster separation could be achieved with 
reduced capillary lengths as described in this chapter.  
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Although not described by Haumann et al., it would be highly desirable to take out the 
“guess work” needed to determine the appropriate lengths required for a fast separation 
that avoids co-detection and ensures adequate resolution is achieved between analytes of 
like charge when using DOI-CZE. The purpose of this study was to derive relationships 
that would determine migration distances under which co-detection is impossible under 
any desired method of sample introduction, detection and type of EOF suppression. 
 
4.3 Theory  
4.3.1 Calculations 
When unequal migration distances are utilized in DOI-CZE, it becomes apparent that as 
the ratio of the larger to smaller distance increases, at some point co-detection becomes 
impossible. Co-detection cannot occur if the fastest ion of a given charge arrives at the 
detector window later than the slowest ion of opposite charge. In order to calculate the 
appropriate capillary lengths necessary to avoid co-detection, the length in which those 
pairs of ions will reach the detector window at the same time (and thus be co-detected) 
must first be determined.  
 
Given that the net mobility, μnet, can be expressed as 
 
            μnet = μeo + μep           (4.1) 
 
where μeo is the electroosmotic mobility and μep is the electrophoretic mobility, both of 
which can be determined experimentally, we can use the well-known relation, 
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     tm =
LdLt
μnetV
        (4.2) 
 
where tm is the migration time, Lt is the total capillary length, Ld is the migration distance 
from the capillary inlet to the detector, and V is the applied voltage, to derive expressions 
for the migration times of the slowest ion of a given charge and the fastest ion of opposite 
charge under DOI-CZE conditions,  
 
tslowest ion of a given charge =  
L1Lt
|(μeo,DOI+ μep,slowest ion of a given charge)V|
     (4.3a) 
 
tfastest ion of opposite charge =
L2Lt
|(μeo,DOI+μep, fastest ion of opposite charge)V|
     (4.3b) 
 
where μeo,DOI is the electrophoretic mobility under DOI-CZE conditions and L1 and L2 
refer to the migration distances (which may be the same or different values) for the 
slowest ion of a given charge and the fastest ion of opposite charge, respectively.   
 
Under DOI-CZE conditions, the electroosmotic mobility is smaller than the 
electrophoretic mobilities of all ions; since the direction of EOF determines which 
direction is positive, the net mobilities of co-electroosmotic ions will be positive and the 
net mobilities of the counter-electroosmotic ions will be negative. Given that time 
quantities should always be positive, the absolute values of the expressions of equations 
4.3a and 4.3b must be taken.   
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If equations 4.3a and 4.3b are set equal to each other, it is possible to calculate the 
migration distances (L1 and L2) for which the slowest ion of a given charge and the 
fastest ion of opposite charge will be co-detected, 
 
tfastest ion of opposite charge =
L2Lt
|(μeo,DOI+μep, fastest ion of opposite charge)V| 
=
 
L1Lt
|(μeo,DOI+ μep,slowest ion of a given charge)V|
= tslowest ion of a given charge          (4.4) 
 
As all analytes migrate in the same capillary with the same total length and same applied 
voltage, these terms can be canceled out, 
 
       
L2
|(μeo,DOI+μep, fastest ion of opposite charge)|
=  
L1
|(μeo,DOI+ μep, slowest ion of a given charge)|
    (4.5) 
 
If  
 
    L2 = rL1          (4.6) 
 
is substituted into equation 4.5, where r represents the factor by which the migration 
distance differs for ions of opposite charge, the equation becomes 
 
        
rL1
|(μeo,DOI+μep, fastest ion of opposite charge)|
=  
L1
|(μeo,DOI+ μep, slowest ion of a given charge)|
    (4.7) 
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Solving for r yields 
 
       r =  
|(μeo, DOI+ μep, fastest ion of opposite charge)|
|(μeo, DOI+ μep, slowest ion of a given charge)|
      (4.8) 
 
Once the r-factor is known, a value for L1 can be chosen and L2 can be calculated using 
equation 4.6.  
 
4.3.2 Terminology 
In equation 4.8, when the fastest ion (determined by the absolute value of the 
electrophoretic mobility) of one charge is in the numerator and the slowest ion of 
opposite charge is in the denominator, an r-factor greater than 1 will be obtained. This 
ratio will be referred to as rlonger. When applying the rlonger approach to a sample, the 
analytes in the denominator of equation 4.8 will migrate a shorter distance (L1). As a 
result, these analytes will reach the detector first. By definition, the analytes in the 
numerator will migrate a longer distance (L2) to the detector based on equation 4.6 and 
will thus be detected last. For example, rlonger, cation/anion will refer to calculations in which 
the cations have a sufficiently longer migration distance than the anions and the slowest 
anion will reach the detector before the fastest cation. 
 
It is also possible to determine an r-factor where the slowest analyte of one charge is in 
the numerator and the fastest analyte of opposite charge is in the denominator. Under 
these conditions, a value of r-factor of less than 1 is calculated and is referred to as rshorter; 
when using either form of rshorter (rshorter,anion/cation or rshorter,cation/anion), L2 will be less than L1. 
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The charge of analytes in the denominator will therefore travel the longer migration 
distance. In any of the r-factor designations, the class of like-charge ions with the shorter 
migration distance will reach the detector first.  
 
4.4 Avoidance of Co-Detection Using the r-factor 
In equation 4.8, the r-factor determines the exact ratio of migration lengths that will result 
in the co-detection of the fastest anion and slowest cation (or vice versa). Since in 
actuality the goal is to completely eliminate co-detection by having the slowest cation be 
detected prior to the fastest anion (or vice versa), a slight adjustment of an experimental 
condition is required. The two approaches to address this problem depend on the desired 
method of sample introduction as described below.  
 
4.4.1 Sample-introduction-dependent Methods of Avoiding Co-Detection  
 
In DOI-CZE, the sample can be introduced at the opposite ends of the capillary in three 
ways [2,6,13]. The simplest approach is simultaneous electrokinetic injection (SimEI). As 
described in Chapter 2, two identical sample vials are placed at opposite ends of the 
capillary and a voltage is applied for a specific amount of time. The two other methods of 
sample introduction are based on the sequential injection of sample. In sequential 
electrokinetic injection (SeqEI), a sample is introduced via an applied voltage, first at one 
end of the capillary, then the other; sequential hydrodynamic injection (SeqHI) uses 
pressure rather than voltage to introduce sample into the capillary.  
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As described in Section 2.4.1, the analytes injected on the first side of the capillary will 
be expelled by the second injection on the opposite side of the capillary when using 
sequential injection (SeqEI or SeqHI) unless a preliminary transport (PT) step is 
performed prior to the second injection. Preliminary transport is achieved by introducing 
a buffer zone behind the first injected sample via a voltage, pressure, or both for an 
appropriate length of time after the first sample in order to move the sample plug far 
enough into the capillary to avoid expulsion from the second injection of sample. 
 
When using SimEI or SeqEI with a hydrodynamic preliminary transport step, a small 
increase to the migration distance L2 (e.g., 1.0- 2.0 cm) is sufficient to delay the arrival of 
the second group of ions at the detector so that the slowest ion in the first group of ions is 
detected first. A larger increase in the migration distance L2 is recommended for less 
accurately determined mobilities, see Appendix B.  
 
Under any conditions where preliminary transport is applied to the first eluting group of 
ions, the migration distance of these analytes will be reduced; this effect is illustrated in 
Figure 4.5. In the top frame of the figure, the first group of ions (e.g., cations), shown in 
blue, is injected via pressure or voltage a distance of 1 cm into the capillary (measured 
from the front). The middle frame shows the use of a preliminary transport of buffer 
(white with black stripes) to move the first group of ions (cations) an additional 2 cm (3 
cm total) into the capillary. The bottom frame shows a second group of ions (e.g., 
anions), in red, whose sample front is injected a distance of 1 cm into the opposite end of  
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Figure 4.5: Representation of a preliminary transport step via an injection of a buffer 
plug (white with black diagonal lines) after the injection of the sample plug of cations 
(blue) to avoid expulsion due to the injection of the sample plug of anions (red) from the 
opposite end of the capillary. 
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the capillary. As a result of the final injection, a 1-cm portion of the buffer plug is 
expelled from the capillary and the first group of ions will have migrated toward the 
detector about 2 cm before the separation voltage is applied. In summary, when using the 
r-factor to select migration distances and a PT step is applied in either SeqHI or SeqEI to 
the first eluting group of ions, the resulting shortened migration distance can be designed 
so that the slowest ion in the first group will arrive at the detection window before the 
fastest ion of the second group.  
 
4.5 How Electropherograms were Simulated 
Simulated electropherograms were generated to show how the proposed relationship 
shown in equation 4.8 works using SimEI and SeqEI or SeqHI conditions. A random 
number generator (restricted to a range of ±1.50 - 4.00 x 10
-4
 cm
2
/Vs) was used to 
generate twelve electrophoretic mobilities, µep, for six cations and six anions. These 
values are shown in Table 4.1 and are listed in order of elution, with the fastest mobilities 
of each charge eluting first under DOI-CZE conditions.  
 
Table 4.2 shows the chosen experimental conditions used for the simulated 
electropherograms under positive polarity mode where V is the applied voltage, Lt is the 
total length, Lc is the migration distance for cations, La is the migration distance for 
anions, E is the electric field, D is the diffusion coefficient, and µeo,DOI is the 
electroosmotic flow under DOI-CZE conditions. The applied voltages employed in 
separations 4.1 and 4.2 were selected based on the Joule heating characteristics of the 
buffers we have typically employed for DOI-CZE (see Chapters 2 and 3). In separations  
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Table 4.2: Chosen experimental conditions used to generate simulated electropherograms 
assuming a positive polarity is applied. Note that when negative polarity is applied, the 
migration distance that each set of analytes travels toward the detector is reversed. Key: 
V is the applied voltage, Lt is the total length, Lc is the migration distance for cations, La 
is the migration distance for anions, E is the electric field, D is the diffusion coefficient, 
and µeo,DOI is the electroosmotic flow under DOI-CZE conditions 
 
Separation 4.1 4.2 4.3A 4.3B 4.6A 4.6B 4.8 4.10 4.11 
V (volts) +24000 -24000 +24000 -24000 +11090 +11526 +11090 +13963 +6189 
Lt (cm) 55.00 55.00 55.00 55.00 25.41 26.41 25.41 32.00 14.18 
Lc (cm) 25.00 30.00 35.00 20.00 17.01 18.01 16.91 24.60 9.40 
La (cm) 30.00 25.00 20.00 35.00 8.40 8.40 8.07 8.40 4.78 
 
 
Shared Experimental 
Conditions 
E (V/cm) 436 
D (cm2/s) 1.00 x 10-5 
µeo,DOI (cm
2/Vs) 1.75 x 10-5 
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4.3-4.10, the applied voltage was chosen so as to maintain the same electric field in all 
experiments, in order to allow a more accurate comparison. An average diffusion 
coefficient was chosen and applied to all analytes. 
 
A spreadsheet and graphing program (Microsoft Excel) was used for all calculations and 
construction of the electropherograms.  First, equations 4.3a and 4.3b were used to 
calculate the migration time (in seconds) of all analytes. The migration time data was 
then corrected for any applied voltage ramp, tVRC, using the following equation, 
  
                 tVRC = tm −
tVR
2
           (4.9) 
 
where tm is the migration time and tVR is the time the voltage ramp is applied. 
 
Simulated electropherograms were generated by plotting the calculated signal response 
(y-axis) at any given time (x-axis) based on the following equation. The signal response 
over the time interval of the electropherogram was obtained by summing the detector 
signals of the individual ions (zones assumed to be Gaussian) by 
 
y =  ∑ (hi ∗ e
−0.5( 
t−t,VRC
σi
)
2
)ni       (4.10) 
 
where 
 
       hi =
Ai
𝜎𝑖√2π
        (4.11) 
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and 
  
                                        σi =  
√2∗D∗tm,VRC
Ld
tm,VRC
                   (4.12) 
 
where hi is the peak height of analyte i, Ai is the peak area of analyte i, t is the migration 
time (in seconds) on the x-axis of the electropherogram, tVRC is the voltage ramp 
corrected migration time, σi is the standard deviation (square root of the variance or 
second central moment) in time units of the zone of analyte i, D is the diffusion 
coefficient, and Ld is the migration distance. Using equations 4.9-4.12 and the conditions 
defined for separation 4.1 and 4.2 in Table 4.2, the simulated electropherograms shown in 
Figures 4.1-4.2 were generated.  
 
As previously mentioned, co-detection between C2 and A1, C4 and A2, C5 and A3, and 
also C6 and A4 is evident in the original separation shown in Figure 4.1. Since the 
reversal of the polarity (reversal of migration distances) shown in Figure 4.2 did not 
alleviate co-detection, simulations were tried using the conditions described for 
separation 4.2 in Table 4.2 under positive (Figure 4.3A) and negative (Figure 4.3B) 
polarities until all peaks were fully separated from one another in Figure 4.3B.  
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4.6 Determination of Appropriate Migration Distances to Achieve Baseline 
Resolution of All Analytes  
 
Before the r-factor is applied to a given set of data, the minimum migration distance 
needed to obtain a desired resolution between analytes of like charge should be 
determined.  
 
Using the well-known equation [15],  
 
      𝑅𝑠 =  
1
4√2
∆μ
√μ̅ep+μeo
√
VLd
DLt
      (4.13) 
 
where for two adjacent analyte zones, Rs is the resolution, Δµ is the difference in 
electrophoretic mobility, μ̅ep is the mean electrophoretic mobility, µeo is the 
electroosmotic mobility, V is the applied voltage, Ld is the migration distance, D is the 
diffusion coefficient, and Lt is the total capillary length, we can substitute E, the electric 
field, for V/Lt and rearrange equation 4.13 to solve for Ld 
 
    Ld =
𝐷
𝐸
(
Rs∗ 4√2∗ √μ̅ep+μeo
∆μ
)
2
    (4.14) 
 
Using a resolution of 1.5 and the values of D and E given in Table 4.2, equation 4.14 was 
applied separately to the cations and anions with the smallest difference in electrophoretic 
mobility in order to determine the minimum migration distance required for each type of 
analyte ion. The minimum migration distance required to separate anions A5 and A6, 
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whose electrophoretic mobilities are -2.12 x 10
-4
 and -2.00 x 10
-4
 cm
2
/Vs, respectively, is 
2.56 cm. Similarly, the minimum migration distance required to separate cations C3 and 
C4 is 1.15 cm, given the respective electrophoretic mobilities of 2.40 x 10
-4
 cm
2
/Vs and 
2.21 x 10
-4
 cm
2
/Vs.  
 
4.7 Simulations using the rlonger Approach  
The rlonger approach can be utilized in both the presence or absence of instrumental 
restrictions on the migration distances. The functional migration distance on one or both 
ends of the capillary may be restricted dependent upon the instrument used.  
 
4.7.1 Rlonger,anion/cation with Simultaneous Electrokinetic Injection (SimEI)  
 
For the simulations below, a value of 8.40 cm was chosen as the migration distance that 
cations will migrate toward the detector to conform to length restrictions based on the use 
of the Agilent
 3D
CE. This distance is referred to as L1 but could also be referred to as Lc 
to emphasize that it is the migration distance for cations. 
 
When using the electrophoretic mobilities in Table 4.1 and rlonger,anion/cation, an r-factor of 
2.03 is calculated. Therefore, the migration distance that anions migrate toward the 
detector, L2 or La, is calculated by using equation 4.6 and a value of 17.01 cm was 
determined. The total capillary length, Lt, is then calculated by adding Lc and La, which 
gives a value of 25.41 cm. Using the electrophoretic mobilities in Table 4.1, the 
migration and total capillary lengths described above, and equations 4.9-4.12, a simulated 
electropherogram was generated and is shown in Figure 4.6A. As expected, the cations  
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A. 
 
B.  
 
Figure 4.6: Simulated electropherograms for the simultaneous electrokinetic injection 
(SimEI) of six cations and six anions using DOI-CZE generated using (a) rlonger,anion/cation 
where Lt= 25.41 cm, Lc= 8.40 cm, and La= 17.01 cm; and (b) rlonger,anion/cation, where Lt= 
26.41 cm, Lc= 8.40 cm, and La= 18.01 cm. The elution order when using rlonger,anion/cation is 
cations followed by anions. 
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reach the detector window before the anions. However, since this electropherogram was 
generated without a migration distance offset, the slowest cation and fastest anion are co-
detected at approximately 100 seconds.  
 
4.7.1.1 Simulations Using rlonger,anion/cation with SimEI and a Small Migration  
Offset 
 
To avoid co-detection when using rlonger,anion/cation, SimEI can be utilized by adding at least 
1-cm length to the distance that the anions travel to yield a new La value of 18.01 cm and  
a total capillary length of 26.41 cm. A simulated electropherogram was generated using 
these conditions (defined by separation 4.6B in Table 4.2) and is shown in Figure 4.6B.  
 
The combination of the rlonger,anion/cation with SimEI and a 1-cm increase in migration 
distance for anions allows all cations to elute before any anion has reached the detector. 
Therefore, this approach successfully eliminates co-detection between the slowest eluting 
cation (C6) and the fastest eluting anion (A1). All twelve analytes are separated from one 
another and detected in less than four minutes, which, compared to the original separation 
in Figure 4.3B, reduces the total capillary length and analysis time by half. While the 
overall migration time of cations was only reduced by a factor of approximately 1.5, 
anions elute about 3.5 times faster under these conditions compared to the original 
separation.  
 
As the elution order of analytes differs slightly between the original separation and the r-
factor approach, it is impossible to compare resolution directly for some combinations of 
analytes. However, it is important to note that shorter capillary lengths will result in 
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reduced resolution between analytes of like charge. This is why the minimum length 
required for a desired resolution must be completed prior to calculation and application of 
the r-factor.  
 
Compared to the original separation (Figure 4.3B), the total peak capacity will be reduced 
when using rlonger,anion/cation due to the reduced total capillary length (55.00 cm to 26.41 
cm). As described in Chapter 2, the potential peak capacity represents the separation 
space from the first eluting analyte to the last eluting analyte, including regions of gaps. 
In DOI-CZE, both cations and anions can elute in this space. This means that the more 
overlap between the migrating cations and anions, the less potential peak capacity. 
Therefore, the r-factor approach allows a unique opportunity to expand the potential peak 
capacity under certain experimental conditions where a conventional DOI-CZE may 
result in the overlap of opposite charged analytes. 
 
In the conventional DOI-CZE separation shown in Figure 4.3B, co-detection is avoided. 
The sample separation space is shown again for convenience in the top portion of Figure 
4.7. In this particular separation, the elution order varies between cations and anions (C5, 
A1, C6, A2) in a segment of the separation space. The sample peak capacities are 33 and 
51 for cations and anions, respectively. However, since overlap in the elution order of 
oppositely charged analytes occurs, the total sample peak capacity of 84 is overestimated. 
Therefore, a more appropriate estimate of peak capacity is obtained using the potential 
peak capacity of 72, which uses the geometric mean of migration distances and the first 
and last eluting analytes to determine the peak capacity.  
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Figure 4.7: Pictorial representation of separation space (in time) for six cations and six 
anions whose electrophoretic mobilities are provided in Table 4.1. Top separation: DOI-
CZE with SimEI; positive polarity (+11.5 kV); EOF of 1.75 x 10-5 cm
2
/Vs; capillary 
lengths of Lt= 26.41 cm, Lc= 18.01 cm, La= 8.40 cm. Bottom separation conditions as in 
Figure 4.3b. 
 
Key: cations (blue diamond); anions (green triangles).  
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Using rlonger,anion/cation and SimEI with a 1-cm increase in the migration distance of cations, 
the sample separation space shown in the top portion of Figure 4.7B is obtained. There 
are several factors that may influence the resulting sample peak capacity of 58. First, the 
inherent design of the rlonger,anion/cation and SimEI approach means that cations will elute 
before anions with no possibility of co-detection; avoiding overlap between the elution of 
oppositely charged analytes. This can slightly increase the potential peak capacity. 
Second, the use of the shortest migration distances possible for a fully resolved separation 
can decrease the sample peak capacity compared to conventional DOI-CZE, which 
commonly employs total capillary lengths of 50 cm or longer. Therefore, the reduction in 
sample peak capacity by the use of shorter capillary lengths can be somewhat offset by 
utilizing the r-factor approach to expand the total elution time by fully separating ions by 
like-charge. It is also important to note that as long as the r-factor remains constant, the 
migration distance on each side of the capillary could be proportionally increased to 
provide a longer analysis time and increased peak capacity while still avoiding co-
detection. 
 
4.7.1.2 Simulations Using rlonger,anion/cation with Sequential Hydrodynamic Injection  
(SeqHI)  
 
SeqHI can also be used in combination with the r-factor approach to avoid co-detection 
of oppositely charged analytes as shown in Figure 4.8. When using hydrodynamic 
injection (HI), the width of a sample zone that is introduced into the capillary, Linj, can be 
calculated by 
 
                       Linj =   
∆Pr2tp
8Lt
       (4.15) 
270 
 
where ∆P is the applied pressure, r is the inner radius of the capillary, tp is the time that 
the pressure is applied,  is the viscosity of the electrolyte, and Lt is the total capillary 
length. The net movement of the first sample zone, LFI, can be determined by 
 
LFI = LPT − L2I         (4.16) 
 
where LPT is the distance the first sample zone (of width Linj,1) is moved by the previously 
discussed preliminary transport (PT) step, and L2I is the total width of fluid introduced 
afterwards on the opposite side of the capillary. As previously described, the PT step 
should be applied to the side from which the slowest analyte migrates to push it further 
into the capillary so that it will have sufficient time to be detected before the fastest 
analyte of opposite charge reaches the detector. The value L2I will be the sum of the 
widths of the second sample zone (Linj,2) and any optional fluid zone introduced behind it 
(e.g., to minimize sample loss due to diffusion out of the capillary).  
 
For this simulation, rlonger,anion/cation and SeqHI were employed for a 25.41 cm x 50-µm i.d. 
capillary, with migration distances of 17.01 and 8.40 cm for La and Lc, respectively. If an 
initial injection of sample is applied on the anodic end of the capillary for 2 sec at 25 
mbar, a value of 0.17 cm is determined for Linj,1. A 25 mbar, 3 sec injection of buffer 
pushes these analytes another 0.26 cm into the capillary; the total movement of sample 
into the capillary is 0.43 cm when measuring from the front of the sample plug. The 
injection of a second sample plug on the cathodic end of the capillary for 2 sec at 15 mbar 
produces a sample plug width (Linj,2) of 0.10 cm. As no optional fluid is used behind this 
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sample plug, the value of L2I is 0.00 cm. To determine LFI, equation 4.16 was used and 
the overall length of the first sample plug was 0.33 cm when measured from the end of 
the capillary to the front of the sample plug after all sample and preliminary transport 
steps are complete. 
 
The calculated values for LFI and the combination of Linj,2 and L2I were subtracted from 
La and Lc, respectively, to obtain new migration distances of 16.91 cm for anions and 
8.07 cm for cations to migrate toward the detector. The new migration distances 
(summarized in separation 4.8 in Table 4.2) were used in conjunction with the 
electrophoretic mobilities in Table 4.1 and equations 4.9-4.12 to generate the simulated 
electropherogram shown in Figure 4.8.  
 
The combination of sequential hydrodynamic injection and hydrodynamic preliminary 
transport pushes the first sample zone a given distance into the capillary before the 
separation voltage is applied. This distance is designed to offset the starting position of 
each charge of analytes so that once the separation voltage is applied, cations will migrate 
toward the detector from a position along their pre-determined migration distance that is 
actually closer to the detector than the point of injection at the start of the capillary; 
therefore, when determining the migration times for these analytes, the modified 
“migration distances” employed must be taken into account.  
 
When comparing the migration distances determined under SeqHI conditions to the 
SimEI simulations described in Section 4.7.1.1, the migration times observed under both  
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Figure 4.8: Simulated electropherograms for sequential hydrodynamic injection (SeqHI) 
of six cations and six anions using DOI-CZE generated using rlonger,anion/cation, where Lt= 
25.41 cm, Lc= 8.07 cm, La= 16.91 cm.  
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sets of conditions will be similar for the charge of ions that was moved a smaller distance 
into the capillary before the applied voltage. For example, C1 reaches the detector 
window in 60.06 seconds when using SimEI with a 1-cm increase to the migration 
distance for anions and 57.72 seconds when using SeqHI. In comparison, A1 elutes 
109.07 seconds in SimEI and 108.40 second in SeqHI; it is expected that the migration 
time for anions will decrease more when SeqHI is employed due to their movement into 
the capillary, which can be a considerable distance depending on the preliminary 
transport conditions utilized, before the separation voltage is applied.   
 
4.7.2 Simulations Using the rlonger,cation/anion Approach  
If it is desirable to have all of the anions reach the detector before any cation in order to 
reduce the total migration time of all analytes, the r-factor approach can be applied to the 
fastest cation and slowest anion. Simulated electropherograms for rlonger,cation/anion using 
SimEI and SeqHI are provided in Appendix C. 
 
For the electrophoretic mobility values studied, there is little difference in the total 
separation time as shown in Table 4.3. In SimEI rlonger,anion/cation, the fastest cation elutes in 
60.06 seconds and the slowest anion elutes in 226.21 seconds, yielding a separation range 
of 166.15 seconds. When rlonger,cation/anion is employed, the elution range is 150.67 seconds 
with the fastest  anion eluting in 53.85 seconds and the slowest cation eluting in 204.52 
seconds.  
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Table 4.3: Comparison between rlonger,cation/anion and rlonger,anion/cation with SimEI 
 rlonger,anion/cation rlonger,cation/anion 
r-factor value 2.03 1.76 
Migration distances Lc – 8.40 cm  
La – 18.01 cm 
Lc – 15.75 cm 
La – 8.40 cm 
First eluting analyte 60.06 seconds (cation) 53.85 seconds (anion) 
Last eluting analyte 226.21 seconds (anion) 204.52 seconds (cation) 
Total elution window 166.15 seconds 150.67 seconds 
Potential Peak 
capacity 
58 58 
Sample Peak Capacity Cations – 22  
Anions – 37  
Cations – 30  
Anions – 25  
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The total peak capacity for rlonger,cation/anion will be slightly less than for rlonger,anion/cation due 
to the decrease in capillary length for the former (24.15 cm for rlonger,cation/anion vs. 26.41 
cm for rlonger,anion/cation). However, based on the overall migration times shown in Figure 
4.9, the sample peak capacity for each rlonger calculation should be similar, although 
rlonger,cation/anion will be slightly less based on a purely visual evaluation. To confirm this 
evaluation, values of approximately 57 were calculated for the sample peak capacities of 
both rlonger,cation/anion and rlonger,anion/cation.   
 
4.8 Selecting Experimental Capillary Lengths that Exceed the Calculated Capillary  
      Length  
 
As described above for separation of the six cations and six anions of interest, the 
minimum capillary length from the outlet to the detection window for the Agilent 
3D
CE 
instrument is 8.40 cm. Although not mentioned previously, the minimum capillary length 
from the inlet to the detection window for this instrument is 23.60 cm. It is apparent that 
for the selected electrophoretic mobilities and a fixed L1 value of 8.40 cm, the current 
values of neither rlonger,cation/anion  nor rlonger,anion/cation provide calculated lengths of L2 that 
are experimentally feasible to run on this instrument. One way to solve this problem is to 
increase L1 beyond its minimum value while increasing L2 proportionally. However, this 
would involve modifying the cassette cartridge that holds the capillary as described by 
Weekley and Foley [2]. A simpler approach for a given value of rlonger, as shown below, is 
to choose an experimental L2 value (L2,exp) that exceeds the L2 value determined using 
equation 4.6 (L2,calc).  
 
 
276 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Pictorial representation of separation space (in time) for DOI-CZE 
separations. Upper separation: SimEI and rlonger,cation/anion. Lower separation: SimEI and 
rlonger,anion/cation. 
  
Key: cations (blue diamond); anions (green triangles).  
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4.8.1 Simulations Using Experimental Capillary Lengths that Exceed the Calculated  
         Capillary Lengths  
 
In Figure 4.6B, the combination of rlonger,anion/cation with SimEI utilized migration distances 
for cations and anions of 8.40 and 18.01 cm, respectively. Figure 4.10, whose conditions 
are provided in separation 4.10 in Table 4.2, represents a simulated electropherogram 
using the minimum capillary lengths for the Agilent 
3D
CE, 8.40 cm for cations and 23.60 
cm for anions.  
 
The migration time observed using rlonger,anion/cation is 60.06-109.07 seconds for C1-C6 and 
115.48-226.21 seconds for A1-A6. The resolution between C6 and A1 is 3.50. One 
consequence of extending the effective capillary length to the minimum allowable on the 
Agilent 
3D
CE is that the migration time of the second class of analytes will increase, 
although resolution between these ions will increase slightly. In Figure 4.10, C1-C6 
experience the same migration time (60.06-109.07 seconds) as Figure 4.6B due to the 
same electric field and migration distance employed in each separation. It is observed that 
increasing the effective capillary length of anions, from 18.01 cm in Figure 4.6B to 23.60 
cm in Figure 4.10, increases the migration time for A1-A6 from 115.48-226.21 to 151.28-
296.35 seconds, respectively. In addition, the resolution between the slowest cation and 
the fastest anion increases from 3.50 to 22.01 and the potential peak capacity increases 
from 58 to approximately 75. While the sample peak capacity for cations remains 
constant (with a value of 22), the sample peak capacity for anions increases from 37 to 42 
with the increase in migration distance. Therefore, as L2,exp exceeds L2,calc, the use of 
sample-introduction-dependent methods to avoid co-detection becomes unnecessary.    
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Figure 4.10: Simulated electropherograms of six cations and six anions introduced via 
SimEI, using conditions in which the slowest cation elutes before the fastest anion, and 
where Lt= 32.00 cm, Lc= 8.40 cm, La= 23.60 cm. 
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4.9 The rshorter Approach 
As described in Section 4.3, rshorter is calculated by inserting the electrophoretic mobility 
of the slowest ion of one charge in the numerator and the electrophoretic mobility of the 
fastest ion of opposite charge in the denominator of equation 4.8. By definition, rshorter 
will be less than 1. Therefore, when using either form of rshorter (rshorter,anion/cation or 
rshorter,cation/anion), the migration distance for the second group of ions (L2) will be less than 
the migration distance for the first group of ions (L1). 
 
The rshorter approach is less desirable than the rlonger approach to avoiding co-detection in 
DOI-CZE, since the former is feasible only when there are essentially no instrumental 
restrictions on the migration distances of the anions and cations. As simulated 
electropherograms for rlonger,anion/cation were described above, rshorter,anion/cation will be 
described below for comparative purposes. The simulated electropherograms for 
rshorter,cation/anion can be found in Appendix D. 
 
When applying rshorter,anion/cation to the set of randomly selected electrophoretic mobilities 
shown in Table 4.1, a value of 0.57 is calculated. The migration distance for the first 
group of ions (L1) was chosen to be 8.40 cm, the same L1 distance used in the rlonger 
approach; the same L1 value was utilized to emphasize the differences between the two r-
factor approaches. This distance will be referred to as Lc to emphasize that this is the 
migration length for cations. The migration length that the anions travel towards the 
detector, L2 or La, is calculated by using equation 4.6; a migration length of 4.78 cm was 
determined. As this length is significantly less than the minimum for the Agilent 
3D
CE 
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instrument (23.60 cm), this experiment could not be implemented using this instrument. 
However, there are several DOI-CZE investigators [7,9,14,16] with homemade 
instrumentation where these lengths could be successfully implemented. 
 
If neither method of sample introduction is taken into consideration, the slowest cation 
and fastest anion would experience co-detection at approximately 60 seconds. When 
using SimEI in combination with rshorter,anion/cation, the addition of at least 1.0 cm to the end 
of the capillary from which the cations travel will delay their arrival at the detection 
window enough so that all of the anions can be detected first without interference by the 
cations. The migration distance for the cations (Lc) was therefore increased from 8.40 cm  
to 9.40 cm. This is because the capillary length must be extended for the charge of ions 
eluting last. When using rlonger, the later eluting ions where the charge class of analytes in 
the denominator. However, by definition, the longer capillary length is used for the 
analytes in the numerator in rshorter. 
 
Using the capillary lengths above, the electrophoretic mobilities from Table 4.1, and 
equations 4.9-4.12, a simulated electropherogram was generated and is shown in Figure 
4.11.  A comparison of key differences between rshorter,anion/cation to both the original 
separation and rlonger,anion/cation is given in Table 4.4. It is apparent that rshorter provides the 
fastest separation while easily and efficiently avoiding co-detection. In the original 
separation (Figure 4.3B), the total analysis time is approximately 8 minutes. In the 
proposed method of using rshorter,anion/cation in combination with SimEI, the separation is  
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Figure 4.11: Simulated electropherograms of six cations and six anions using DOI-CZE 
generated using rshorter,anion/cation with SimEI and a 1-cm increase in migration distance for 
cations, where Lt= 14.18 cm, Lc= 9.40 cm, La= 4.78 cm. 
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Table 4.4: Comparison between the original separation, rlonger,anion/cation and rlonger,anion/cation  
 Original 
separation 
rshorter,anion/cation rlonger,anion/cation 
r-factor value - 0.57 2.03 
Migration Distance 
Lc – 20.00 cm 
La – 35.00 cm 
Lc – 9.40 cm 
La – 4.78 cm 
Lc – 8.40 cm 
La – 18.01 cm 
First eluting analyte 
143.01 seconds 
(cation) 
30.66 seconds 
(anion) 
60.06 seconds 
(cation) 
Last eluting analyte 
439.50 seconds 
(anion) 
122.05 seconds 
(cation) 
226.21 seconds 
(anion) 
Total elution 
window 
296.49 seconds 91.39 seconds 166.14 seconds 
Potential Peak 
Capacity 
72 46 58 
Sample Peak 
Capacity 
Cations – 33 
Anions – 51 
Cations – 23 
Anions – 20 
Cations – 22 
Anions – 37 
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completed in less than 2 minutes as a result of the very short total capillary lengths 
utilized. When using rlonger,anion/cation in combination with SimEI, the separation is 
completed in 4 minutes. 
 
Based on the design of the r-factor approach, a complete set of like-charged ions will be 
detected prior to the detection of any ion of opposite charge. As the charge of ions that 
migrate the shorter migration length are detected first, opposite elution orders are 
observed between rlonger,anion/cation and rshorter,anion/cation. The resolution of like-charge 
analytes will be considerably less in rshorter,anion/cation compared to both rlonger,anion/cation and 
the original separation due to the decrease in migration distances and total capillary 
lengths in the former. It is important to note that the use of rshorter may not be applicable to 
mixtures where the electrophoretic mobilities of like-charge ions are too similar to one 
another. As described in Section 4.6, determination of appropriate migration distances to 
achieve baseline resolution of all analytes must be determined prior to experimentation. 
 
The rshorter approach will severely limit the total and sample peak capacities as shown in 
Figure 4.12. The upper, middle and lower separation space of analytes represents 
rshorter,anion/cation, rlonger,anion/cation and the original separation, respectively. For the conditions 
shown, total and sample peak capacities increase with increasing total capillary length. 
Therefore, the probability of a successful separation of a mixture with a large 
 
 
 
284 
 
 
 
 
 
 
Figure 4.12: Pictorial representation of separation space (in time) for DOI-CZE 
separations. Upper separation: rshorter,anion/cation. Middle separation: rlonger,anion/cation and 
Lower separation: original separation. 
 
Key: cations (blue diamonds); anions (green triangles).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Lt: 26.41 cm; Lc: 8.40 cm; La: 18.01 cm 
Lt: 55.00 cm; Lc: 20.00 cm; La: 35.00 cm 
Lt: 14.18 cm; Lc: 9.40 cm; La: 4.78 cm 
Potential Peak Capacity - 46 
Potential Peak Capacity - 58 
Potential Peak Capacity - 72 
C1 
C2 
C3 
C4 
C5 C6 
A1 A2 
A3 
A4 A5 A6 
A4  A6 
A5 
A2   
A3 A1 
C6 C1 C3 
C2 C5 
C4 
A1-A6 C1-C5 C6 
285 
 
number of components using the rshorter approach will be significantly lower than either 
rlonger or the original separation.  The values for sample peak capacity for the original 
separation and rlonger,anion/cation were calculated as 72 and 58, respectively. In comparison, 
the sample peak capacity for rshorter,anion/cation was determined to be 46, a significant 
decrease from the original. 
 
 
4.10 Effectiveness of Simulated Electropherograms to Replicate Experimental  
        Data  
 
4.10.1 Selection of Literature Data to Replicate 
To test our systematic approach to avoid co-detection on experimental data, we decided 
to try to replicate DOI-CZE separations from the literature to demonstrate the potential 
improvements to the separation. Unfortunately, since a numerical value of the 
electroosmotic mobility is needed for our simulations, only a limited number of DOI-
CZE articles were available to choose from. This is because very few DOI-CZE papers 
report electroosmotic mobility when it is highly suppressed due to the difficulty in its 
measurement [7,17-19]. Under the condition of a highly suppressed EOF, a neutral 
marker would elute after several hours or days, depending on the magnitude of EOF 
generated. However, it is important to note that in DOI-CZE experiments, the EOF only 
needs to be suppressed enough so that all analytes migrating from the direction opposite 
the EOF can reach the detector in a reasonable amount of time.  
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4.10.2 Obtaining Information from Previously Published Electropherograms for  
           Replication 
  
The electropherogram chosen for replication was published by Macka et al. [19] and is 
shown in Figure 4.13a. In this study, low-molecular weight anions and cations were 
analyzed using DOI-CZE with a background electrolyte comprised of 50 mM 2-(N-
morpholino)ethanesulfonic acid (MES) and histidine (His) pH 6.0 with 1% w/v 
poly(diallydimethylammonium chloride) (PDDAC) to reverse EOF. 
 
The net mobilities (µnet), electroosmotic mobility (µeo), and electrophoretic mobilities 
(µep) were determined via the following equations,   
 
μnet= 
Lt*Ld
V*tr
       (4.17) 
 
 
μeo= 
Lt*Ld
V*t0
           (4.18) 
 
 
μep =  μnet − μeo         (4.19) 
 
 
where Lt is the total capillary length, Ld is the effective length, V is the applied voltage, 
and t0 and tr are the migration times for the neutral marker and analyte, respectively. 
Values of 72.2 cm, 53.28 cm, 18.92 cm, and -30 kV were provided in the manuscript for 
Lt, Lc, La and V, respectively.  
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The migration time for all analytes were estimated from the original electropherogram 
and equations 4.17-4.19 were used to determine the mobility values. The EOF was 
estimated to be 8.67 x 10
-5
 cm
2
/Vs. Electrophoretic mobility values of 1.17 x 10
-3
, 5.24 x 
10
-4
, and 4.35 x 10
-4
 cm
2
/Vs were determined for K
+
, Na
+
, and Mg
2+
, respectively, and 
3.37 x 10
-4
, 3.04 x 10
-4
 and 2.62 x 10
-4
 cm
2
/Vs for anions Br
-
, NO3
-
, and BrO3
-
, 
respectively.  
  
4.10.3 Comparison of Simulated Electropherogram to the Original  
           Electropherogram  
 
Using equations 4.9-4.12 and the mobility information provided in Section 4.10.3, the 
simulated electropherogram shown in Figure 4.13B was generated. In the original  
electropherogram (Figure 4.13A), three cations and three anions are separated in less than 
five minutes; the simulated electropherogram is able to replicate the migration times of 
these analytes. The simulated data do not account for factors such as the concentration of 
each analyte injected, peak fronting or tailing caused by electromigration dispersion or 
analyte interaction with the capillary wall; the simulation is currently designed so that 
corrected peak area is conserved, meaning that the signal response (peak height) will 
decrease as a function of time due to diffusional zone broadening that is assumed to be 
the only major source of zone dispersion. 
 
4.10.4 Simulation of Literature Data using the rlonger Approach 
With the understanding that the simulated electropherograms provide a general 
representation of experimental data, simulated electropherograms using the minimum 
capillary lengths for an Agilent instrument (23.60 cm and 8.40 cm) were chosen. Based  
288 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: Electropherograms of three cations and three anions using DOI-CZE (a) as 
determined experimentally by Macka et al. and (b) simulated electropherogram based on 
Macka figure data. Reprinted from [19] with permission from Wiley.  
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on these migration distances, an rlonger,cation/anion value of 2.81 was utilized. An La value of 
8.40 cm was chosen for the anions to migrate toward the detector. Therefore, Lc, the 
length that the cations migrate toward the detector is 23.60 cm. The total capillary length, 
Lt, is then calculated by adding Lc and La for a total of 32.00 cm. The rlonger,cation/anion value 
for this system is calculated to be 4.80. However, the ratio of migration distances utilized 
(23.60/8.40) provides a value of 2.81. Therefore, the elution order of analytes will not be 
separated by charge class. In order to ensure that all anions would elute before any cation, 
a migration distance of over 40 cm must be employed for cations. 
 
Using the standard capillary lengths for an Agilent CE separation, the electrophoretic 
mobilities provided above and equations 4.9-4.12, and the same electric field as in Macka 
et al., the simulated electropherogram shown in Figure 4.14A was generated. When 
comparing the simulated electropherogram in Figure 4.14A to the original 
electropherogram by Macka et al., the overall separation time when using shorter 
capillary lengths is improved by over a factor of approximately 2 for both cations and 
anions; all 6 analytes are separated in Figure 4.14A in approximately two minutes with 
the chosen experimental conditions compared to 4.5 minutes in the original separation. 
When using SimEI and the r-factor of 4.80, the electropherogram shown in Figure 4.14B 
was generated. In this separation, analytes are separated by charge, with anions eluting 
first. This separation takes over a minute longer (approximately 3.5 minutes total) than 
the separation in Figure 4.14A. This is due to the relatively fast migration of potassium 
compared to the other two cations of interest.  
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A. 
 
B.  
 
Figure 4.14: Simulated electropherograms of three cations and three anions using SimEI 
DOI-CZE generated using (A) Lt= 32.00 cm, Lc= 23.6 cm, La= 8.40 cm and (B) Lt= 
49.72 cm, Lc= 41.32 cm, La= 8.40 cm. 
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4.11 Evaluation of the Migration Distance-based Approach to the Universal 
Avoidance of Co-Detection  
 
While one of the compelling reasons for DOI-CZE is a great reduction if not complete 
elimination of the well-known biases in conventional CE in the resolving power and 
analysis times for oppositely charged ionic species, there is a tradeoff in DOI-CZE 
between the elimination of co-detection via unequal migration distances for oppositely-
charged ions and the modest bias in resolving power that is introduced. For a given 
electric field and a given difference in the mobility of two analyte ions, the resolution 
achieved in CZE is proportional to the square root of the migration distance to the 
detector for those ions. Since the method described here is based on the systematic 
exploitation of different migration distances for cations and anions, there will necessarily 
be a bias in the resolving power that favors the ions that have the longer effective 
migration distance. Given the square root dependence of resolution on migration 
distance, however, the bias will be moderate rather than excessive under most 
circumstances. For example, assuming for simplicity an EOF of exactly zero and a four-
fold difference in the migration distance for cations and anions (typical for what might be 
needed to avoid co-detection), the bias in resolving power would only be two-fold, and 
any concerns about achieving less than complete resolution for the ions traveling the 
shorter distance can be addressed by using the minimum migration distance needed for 
baseline resolution calculated via equation 4.14.  A more detailed analysis of this tradeoff 
is planned in a future paper along with a detailed comparison of predicted versus 
experimental results for a wide variety of samples.   
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4.12 Conclusion 
When employing DOI-CZE, co-detection of all combinations of anionic and cationic 
species can easily and efficiently be avoided by adjusting the migration distances for the 
anions and cations so that the slowest anion is detected before the fastest cation or vice-
versa. Such an adjustment is facilitated by using equation 4.8 to calculate the factor 
difference (r) in the migration distances of cations and anions needed to avoid co-
detection. 
 
A relatively simple, quantitative approach to completely avoiding co-detection of 
oppositely charged ionic species in DOI-CZE while simultaneously achieving baseline 
resolution of all ions in a sample is summarized below:   
 
1. The electrophoretic mobilities of the fastest and slowest anions and cations and the 
EOF under DOI-CZE conditions must be determined.  
 
2. The value of rlonger for each set of conditions, rlonger,anion/cation and rlonger,cation/anion, should 
be calculated using equation 4.8.  
 
3. The minimum effective migration distance needed for baseline resolution of all 
adjacent pairs of anions should be calculated using equation 4.14, and then repeated 
for all adjacent pairs of cations.  
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a. If the minimum effective length calculated for anions or cations (whichever 
one is selected) is greater than the standard minimum (short-end) migration 
distance dictated by the cartridge design of the instrument, the capillary 
cartridge should be modified to accommodate the greater length as described 
by Weekley and Foley for one type of commercial cartridge [2].  
 
b. If the minimum effective length calculated is less than the standard short-end 
migration distance, the latter is then used. 
 
4. L2, the migration distance for the complementary ions (L2 for cations if L1 was 
determined for anions and vice-versa), is then determined using equation 4.6; as long 
as the capillary length chosen for L2 exceeds the value determined with equation 4.6 
and the effects of preliminary transport and/or sequential injection (if either is 
employed) are accounted for via equations 4.15 and 4.16, co-detection is not possible.  
 
5. Both combinations of anion/cation migration distances, (L1,anions, L2,cations) and 
(L1,cations, L2,anions), should be evaluated, and the one that provides better results (i.e., a 
shorter analysis time and/or better overall resolution) can be adopted.   
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Chapter 5: Recommendations for the Future Direction of Dual-Opposite Injection 
Capillary Zone Electrophoresis 
 
5.1 Recommendations for Chapter 2 
In Chapter 2, the migration time, corrected area and resolution precision of CZE and 
DOI-CZE were compared. Based on the results presented, EOF and integration 
parameters appear to have a large influence on the reported precision values. In this work, 
EOF was suppressed for DOI-CZE by using a combination of low pH and high buffer 
concentration (50 mM phosphate at pH 2.5). This buffer system severely limited the 
number of analytes available to study as many pharmaceuticals anions are neutral at this 
pH. Therefore, other approaches to EOF suppression should be explored to expand the 
range of analytes that can be studied. Collaboration with groups who have expertise in 
preparing various types of capillary coatings such as the Lucy group at the University of 
Alberta [1] and the Belder group [2] at the University of Leipsig would be beneficial to 
our research as generating and maintaining a suppressed and reproducible EOF via 
dynamic coatings has proven to be quite difficult. 
 
The studies reported here indicated that the resolution precision between oppositely-
charged analytes was poorer than between like-charged analytes. Since the EOF is 
suppressed but not fully eliminated, there is still some amount of electroosmotic flow 
from anode to cathode. Variations in this remaining flow will move adjacent oppositely-
charged analytes closer to or farther from one another depending on their elution order. 
Due to the experimental design, each of the analytes of interest were well-resolved from 
adjacent ions (Rs >> 1.5), and small changes in EOF generally have less significant 
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effects on results under such circumstances. Separation conditions that result in a lower 
resolution between adjacent oppositely-charged analytes, i.e., Rs ≈ 1.5 may provide more 
insightful results.  
 
In this study, the capillaries showed statistically significantly different responses with 
respect to the reported values of migration time, corrected area, and resolution using the 
same buffer and sample. It is possible that different responses were observed due to the 
way in which each capillary was utilized in the experiment. The two capillaries were each 
used for a different total number of injections before and after storage. To better 
determine if there any apparent differences between capillaries, more capillaries from the 
same batch should be studied. At least two capillaries should be run in one day using the 
same buffer, sample, conditioning, amount of injections and instrument for the best 
comparison. The total number of injections completed in one day will be limited by the 
45 min capillary precondition required at the beginning of each day and the time to 
complete each run. Under the conditions described in Chapter 2, a single DOI-CZE run 
requires 9 minutes of preconditioning, 10 seconds of sample introduction, 7 minutes for 
the separation itself, and a 5 minute post conditioning. Therefore, in a 10 hour day, 
approximately 10 injections could be run with each capillary. While this approach will 
limit the total number of injections studied each day, it could provide a more clear 
understanding on how the capillary surface is modified over the course of each 
separation.   
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As the study in Chapter 2 was completed before the simulation work described in Chapter 
4 was developed, only long capillary lengths (55 cm) were employed. However, the 
simulations in Chapter 4 suggest that good separations using short-end capillaries (8.40 
cm from outlet to detector) may be achievable. A study of the migration time, corrected 
area, and resolution precision between CZE and DOI-CZE should be completed using the 
shortest total capillary length (32 cm). In these studies, exactly the same migration 
distances should be employed (23.6 cm for cations and 8.4 cm for anions under the 
standard positive polarity mode). Assuming the same buffer could be employed for each 
experiment, pending the determination of alternate methods of EOF suppression, the 
same electric field could be applied. Each of these modifications from the experimental 
procedure described in Chapter 2 will provide a better comparison between separation 
techniques.  
 
As explained in Chapter 2, it is hypothesized that there is systematic error with respect to 
the corrected area of the anions in the DOI-CZE study. Under conventional conditions, 
the anode is at the inlet and the cathode is at the outlet. To test for systematic error, the 
voltage is reversed. This means that the cathode is at the inlet and the anode is at the 
outlet. These conditions allow for the cations to be injected at the outlet. If outliers are 
observed for the first injection of each set of runs, systematic error is observed. If 
systematic error is confirmed, the capillary cartridge design will need to be improved to 
restrict movement of the capillary from the outlet to the detector or shorter capillary 
lengths can be employed. A study on the effect of capillary length on migration time, 
corrected area, and resolution precision should also be conducted in the future. The use of 
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a shorter capillary length can potentially eliminating systematic error due to a more stable 
capillary design.  
 
It was discovered during data processing that peak integration has a very large impact on 
the reported values of migration time, peak area, and resolution. Figure 5.1 highlights the 
large difference in reported area values depending on the peak integration parameters. In 
Figure 5.1A, auto integration using the classical baseline correction was applied. The 
slope sensitivity determined by the ChemStation software integration events was 11.52 
and the peak width was 0.025. For the peak shown, values of 2.758 min, 14.7 mAU·s, 
11.8, 0.019, 0.488 were determined for the migration time, area, height, width, and 
symmetry. From a visual perspective, it appears as though the stop point of this peak was 
premature.  
 
In order to better optimize the start and end of a peak, advanced baseline correction is 
used, although it is unclear how the software accomplishes this. Using the same slope 
sensitivity and peak width, the integration in Figure 5.1B was generated. For the peak 
shown, values of 2.758 min, 15.1 mAU·s, 11.5, 0.0194, 0.478 were determined for the 
migration time, area, height, width, and symmetry. A larger area and peak width but 
lower height and symmetry values were reported compared to the classical baseline 
approach. 
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Figure 5.1: Peak integration using: A. classical baseline correction and auto integration, 
B. advanced baseline correction while maintaining the same slope sensitivity and peak 
width integration events as A., and C. advanced baseline correction and auto integration.  
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Auto integration by means of the advanced baseline correction was applied and is shown 
in Figure 5.1C. The slope sensitivity determined by the ChemStation software integration 
events was 10.65 and the peak width was 0.027. For the peak shown, values of 2.759 
min, 17.2 mAU·s, 11.5, 0.0219, 0.406 were determined for the migration time, area, 
height, width, and symmetry.  
 
There were many resulting concerns regarding the ability of the software to accurately 
and precisely determine the starting and ending points of a given peak. Other researchers 
have noted similar problems with peak integration [3,4]. By analyzing the migration time, 
peak area, and resolution values based on changes to the starting and ending points of a 
peak, it may be possible to suggestion modifications to the current auto-integration 
parameters used to evaluate peaks. Data could be exported and analyzed in a separate 
program to compare calculations with the ChemStation software for additional 
confirmation. The development of open source software that eliminates common data 
processing issues could place pressure on instrument companies to address concerns 
within their software. 
 
5.1 Recommendations for Chapter 3 
 
In Chapter 3, the validation of a method to analyze of an over-the-counter pharmaceutical 
drug using DOI-CZE was reported. One critical finding was that another method of EOF 
suppression is clearly needed, as extremely broad peak shapes were observed for all ions, 
but especially for anions, using the proprietary capillary from Alcor BioSeparations. A 
method of EOF suppression that is also able to reduce the magnitude of EOF from the 
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value of 1.85  x 10
-4
 cm
2
/Vs measured for the capillary employed in Chapter 3 is desired. 
By reducing the magnitude of the EOF, anions will migrate faster, thus reducing the total 
analysis time. Currently, the total analysis time for the DOI-CZE separation is 
approximately 10 minutes compared to approximately 6 minutes for the CZE separation.  
 
It was suggested in Chapter 3 that a study of the injection volume and sample dilution be 
conducted to determine the lowest concentration and largest injection volume possible for 
a sample. A limitation to this study is that increased injection volume will introduce an 
excessively-wide sample plug, resulting in broad peaks. One way in which to introduce a 
large volume of sample without a significant increase in peak broadening is to utilize 
sample stacking. Field-amplified sample stacking has been used previously in 
combination with dual-opposite injection capillary electrophoresis for model acidic and 
basic compounds [5]. In this technique, sample ions are prepared with a lower 
conductivity buffer than the running buffer. The sample will therefore have a higher field 
strength than the running buffer. When a voltage is applied, the ions in the sample zone 
will migrate forward until they reach the boundary of the running buffer. This results in a 
reduction of the sample zone width. 
   
Based on the successful analysis of the Advil® Allergy & Congestion Relief tablet, other 
OTC products should be considered for DOI-CZE analysis. Suggested samples include 
products from the Advil, Aleve, or Tylenol brands of OTC drugs and comparable generic 
drugs. Many of these formulations include several charged active ingredients. Reagent 
grade standards for each of the active ingredients studied will need to be purchased. 
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Besides the simultaneous analysis of oppositely charged analytes and the ability to 
optimize sample introduction parameters based on charge class of ion, DOI-CZE can be 
used for chiral analysis. The addition of a pseudostationary phase to DOI-CZE provides a 
chromatographic mechanism for the separation of charged analytes. While a few phases 
have been studied [6], the area of dual-opposite injection electrokinetic chromatography 
(DOI-EKC) is relatively unexplored.  
 
Given the poor solubility of ibuprofen in water, DOI-CZE with non-aqueous solvents 
(DOI-NACE) may be a viable solution for an improved separation of ibuprofen and 
related NSAIDs. Methanol, acetonitrile, and ammonium acetate are common background 
electrolytes in NACE [7]. Low currents are typically observed in NACE. Therefore, 
higher electric fields can be used which can reduce the total analysis time. The 
optimization of a DOI-NACE separation may be difficult as pH is only defined in 
aqueous solutions but acidic or basic conditions influence separation parameters [8]. 
 
5.2 Recommendations for Chapter 4 
In Chapter 4, a calculation method referred to as the r-factor approach was developed as a 
systematic approach to avoid co-detection between oppositely-charged analytes in DOI-
CZE. The r-factor approach analyzes the net mobility of ions, which is a sum of the 
electrophoretic and electroosmotic mobilities, to determine the appropriate experimental 
ratio of migration distances to be employed for separation. A random number generator 
was used to create a test sample of analytes with suitable electrophoretic mobilities. The 
experiments completed in Chapters 2 and 3 showed that EOF varies over time for a given 
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capillary by at least 5-10%. Variation in the EOF may result in co-detection if the elution 
of the oppositely-charged analytes are as close as designed by the r-factor approach. As 
the electrophoretic mobility values will be determined experimentally, the approximate 
error in these measurements should also be taken into account. It was suggested for 
highly inaccurate and imprecise measurements that at least 2-cm capillary length be 
added to the second charge class of eluting ions. However, one of the most important 
aspects in the continuation of this work will be to compare the simulated results to 
experimental data. Comparison of simulated results to experimental data will help to 
refine calculations for more accurate predictions.   
 
Several simulation programs have been developed to aid in the optimization of separation 
parameters for capillary electrophoresis experiments. One of the most popular programs 
is PeakMaster by the Gas group from Charles University in Prague [9]. Unfortunately, 
this program was very difficult to use even after correspondence with the group for 
support and does not support introduction of sample from both ends of the capillary. 
However, PeakMaster factors the ionic strength, buffering capacity and pH of a selected 
buffer into their simulation electropherogram. Therefore, electromigration dispersion can 
be predicted and simulated for each peak. As our current model assumes Gaussian peaks 
for all analytes, the addition of ionic strength, buffering capacity and pH to our 
simulation may better model peak shape and more accurately predict peak width and 
resolution between adjacent ions. As research continues in the area of DOI-CZE, more 
complex mixtures and real-life samples will undoubtedly create challenging analyses.  
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Appendix A: Statistical Data for CZE and DOI-CZE Experiments from Chapter 2 
Table A.1: Migration time (minutes) for peak 2 (chlorpheniramine) using DOI-CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 3.641 3.628 3.621 3.617 3.619 3.622 0.008 0.217 
 
2 3.616 3.611 3.615 3.614 3.617 
   
 
3 3.629 3.623 3.621 3.626 3.631 
   Day 2 1 3.625 3.608 3.599 3.594 3.592 3.575 0.024 0.664 
 
2 3.579 3.568 3.566 3.568 3.566 
   
 
3 3.563 3.553 3.549 3.544 3.553 
   Day 3 1 3.583 3.575 3.579 3.587 3.578 3.581 0.005 0.131 
Day 12 1 3.556 3.546 3.550 3.548 3.548 3.559 0.009 0.260 
 
2 3.567 3.556 3.553 3.553 3.556 
   
 
3 3.573 3.565 3.566 3.569 3.571 
   
 
     
Overall 3.585 0.029 0.822 
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 3.642 3.637 3.637 3.637 3.638 3.638 0.002 0.054 
Day 10 1 3.665 3.649 3.648 3.646 3.643 3.654 0.008 0.208 
 
2 3.660 3.653 3.654 3.659 3.663 
   Day 11 1 3.666 3.658 3.658 3.658 3.657 3.658 0.007 0.201 
 
2 3.659 3.652 3.650 3.649 3.649 
   
 
3 3.675 3.654 3.658 3.664 3.669 
   Day 12 1 3.646 3.636 3.635 3.634 3.638 3.640 0.005 0.126 
 
2 3.648 3.640 3.638 3.639 3.642 
   Day 13 1 3.650 3.637 3.627 3.621 3.619 3.620 0.030 0.841 
 
2 3.611 3.605 3.605 3.604 3.609 
   
 
3 3.632 3.620 3.618 3.622 3.622 
   Day 14 1 3.681 3.668 3.668 3.664 3.669 3.668 0.006 0.166 
 
2 3.677 3.668 3.666 3.663 3.661 
   Day 15 1 3.629 3.624 3.620 3.619 3.622 3.633 0.010 0.273 
 
2 3.638 3.630 3.630 3.631 3.632 
   
 
3 3.652 3.640 3.640 3.642 3.646    
Day 16 1 3.673 3.659 3.654 3.651 3.647 3.639 0.014 0.394 
 
2 3.635 3.627 3.630 3.631 3.633 
   
 
3 3.637 3.629 3.626 3.626 3.628 
   
      
Overall 3.643 0.018 0.485 
       
3.623 0.036 0.982 
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A. 
 
B. 
 
 
Figure A.1: Migration time variation (minutes) for peak 2 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.2: Migration time (minutes) ANOVA for peak 2 capillary 1.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 18.125 3.625 9.818 x 10
-5
 
Day 1 Set 2 5 18.073 3.615 5.213 x 10
-6
 
Day 1 Set 3 5 18.130 3.626 1.528 x 10
-5
 
Day 2 Set 1 5 18.018 3.604 1.864 x 10
-4
 
Day 2 Set 2 5 17.848 3.570 3.060 x 10
-5
 
Day 2 Set 3 5 17.761 3.552 4.789 x 10
-5
 
Day 9 Set 1 5 17.903 3.581 2.191 x 10
-5
 
Day 12 Set 1 5 17.748 3.550 1.567 x 10
-5
 
Day 12 Set 2 5 17.785 3.557 3.198 x 10
-5
 
Day 12 Set 3 5 17.845 3.569 1.170 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 4.064 x 10
-2
 9 4.515 x 10
-3
 97.135 
Within Groups 1.859 x 10
-3
 40 4.649 x 10
-5
 
 
     Total 4.250 x 10
-2
 49     
   
P-value Ftable 
   
2.536 x 10
-24
 2.124 
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Table A.3: Migration time adjacent mean differences (minutes) for peak 2 capillary 1.  
 
  
Mean
Day 1 
Set 3
Day 1 
Set 1
Day 1 
Set 2
Day 2 
Set 1
Day 9 
Set 1
Day 2 
Set 2
Day 12 
Set 3
Day 12 
Set 2
Day 2 
Set 3
Day 12 
Set 1
Day 1 Set 3 3.626 -
Day 1 Set 1 3.625 0.001 -
Day 1 Set 2 3.615 0.011 0.010 -
Day 2 Set 1 3.604 0.022 0.021 0.000 -
Day 9 Set 1 3.581 0.045 0.044 0.034 0.023 -
Day 2 Set 2 3.570 0.056 0.055 0.045 0.034 0.011 -
Day 12 Set 3 3.569 0.057 0.056 0.046 0.035 0.012 0.001 -
Day 12 Set 2 3.557 0.069 0.068 0.058 0.047 0.024 0.013 0.012 -
Day 2 Set 3 3.552 0.074 0.073 0.062 0.051 0.028 0.017 0.017 0.005 -
Day 12 Set 1 3.550 0.076 0.075 0.065 0.054 0.031 0.020 0.019 0.008 0.003 -
LSD 0.009
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Table A.4: Migration time (minutes) ANOVA for peak 2 capillary 2.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 18.191 3.638 3.832 x 10
-6
 
Day 10 Set 1 5 18.251 3.650 7.770 x 10
-5
 
Day 10 Set 2 5 18.289 3.658 1.601 x 10
-5
 
Day 11 Set 1 5 18.296 3.659 1.450 x 10
-5
 
Day 11 Set 2 5 18.260 3.652 1.740 x 10
-5
 
Day 11 Set 3 5 18.319 3.664 6.952 x 10
-5
 
Day 12 Set 1 5 18.188 3.638 2.398 x 10
-5
 
Day 12 Set 2 5 18.207 3.641 1.506 x 10
-5
 
Day 13 Set 1 5 18.154 3.631 1.689 x 10
-4
 
Day 13 Set 2 5 18.034 3.607 9.219 x 10
-6
 
Day 13 Set 3 5 18.114 3.623 2.693 x 10
-5
 
Day 14 Set 1 5 18.348 3.670 4.134 x 10
-5
 
Day 14 Set 2 5 18.335 3.667 3.808 x 10
-5
 
Day 15 Set 1 5 18.114 3.623 1.830 x 10
-5
 
Day 15 Set 2 5 18.162 3.632 1.262 x 10
-5
 
Day 15 Set 3 5 18.221 3.644 2.629 x 10
-5
 
Day 16 Set 1 5 18.284 3.657 9.893 x 10
-5
 
Day 16 Set 2 5 18.155 3.631 7.772 x 10
-6
 
Day 16 Set 3 5 18.146 3.629 1.911 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 2.652 x 10
-2
 18 1.473 x 10
-3
 39.674 
Within Groups 2.822 x 10
-3
 76 3.713 x 10
-5
 
 
     Total 2.934 x 10
-2
 94     
   
P-value Ftable 
   
2.710 x 10
-31
 1.741 
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Table A.6: Migration time (minutes) F-test two- sample for variances for peak 2.  
 
 
  Capillary 1 Capillary 2 
Mean 3.585 3.643 
Variance 8.673 x 10
-4
 3.121 x 10
-4
 
Observations 50 95 
DF 49 94 
Fcalc 2.779 
 P-value 1.064 x 10
-5
 
 
Ftable 1.488   
 
 
  
313 
 
Table A.7: Migration time (minutes) t-test: two sample assuming unequal variances peak 
2.  
 
  Capillary 2 Capillary 1 
Mean 3.643 3.585 
Variance 3.121 x 10
-4
 8.673 x 10
-4
 
Observations 95 50 
Hypothesized Mean 
Difference 
0 
 DF 68 
 tcalc 12.787 
 P-value 9.272 x 10
-20
 
 
ttable 1.995 
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Table A.8: Migration time (minutes) for peak 3 (benzenesulfonic acid) using DOI-CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 4.129 4.122 4.110 4.103 4.089 4.073 0.030 0.730 
 
2 4.064 4.065 4.060 4.055 4.047 
   
 
3 4.054 4.056 4.055 4.047 4.037 
   Day 2 1 4.019 4.017 4.012 4.003 3.993 3.994 0.013 0.332 
 
2 3.991 3.992 3.989 3.984 3.975 
   
 
3 3.993 3.996 3.990 3.987 3.976 
   Day 3 1 3.937 3.938 3.931 3.914 3.918 3.928 0.011 0.284 
Day 12 1 3.948 3.945 3.940 3.931 3.921 3.949 0.013 0.319 
 
2 3.962 3.964 3.958 3.948 3.941 
   
 
3 3.962 3.962 3.957 3.951 3.941 
   
 
     
Overall 3.998 0.058 1.443 
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 4.057 4.057 4.053 4.050 4.043 4.052 0.005 0.134 
Day 10 1 4.016 4.017 4.006 3.999 3.992 4.006 0.008 0.205 
 
2 4.008 4.012 4.008 4.002 3.997 
   Day 11 1 4.043 4.043 4.037 4.029 4.019 4.035 0.014 0.358 
 
2 4.030 4.029 4.024 4.018 4.007 
   
 
3 4.041 4.048 4.054 4.055 4.053 
   Day 12 1 4.018 4.028 4.028 4.027 4.023 4.034 0.011 0.266 
 
2 4.047 4.047 4.045 4.041 4.033 
   Day 13 1 4.041 4.045 4.040 4.031 4.026 4.037 0.053 1.325 
 
2 4.017 4.023 4.027 4.030 4.028 
   
 
3 4.035 4.052 4.055 4.052 4.051 
   Day 14 1 4.013 4.021 4.016 4.007 3.999 4.015 0.009 0.225 
 
2 4.024 4.029 4.021 4.014 4.006 
   Day 15 1 4.003 4.007 4.002 3.994 3.988 4.008 0.009 0.234 
 
2 4.009 4.014 4.011 4.006 4.001    
 
3 4.018 4.023 4.019 4.014 4.007 
   Day 16 1 4.038 4.042 4.036 4.029 4.022 4.028 0.007 0.180 
 
2 4.025 4.034 4.029 4.025 4.019    
 
3 4.025 4.028 4.026 4.021 4.016 
   
      
Overall 4.026 0.017 0.418 
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A. 
 
B. 
 
Figure A.2: Migration time variation (minutes) for peak 3 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.9: Migration time (minutes) ANOVA for peak 3 capillary 1.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 20.554 4.111 2.552 x 10
-4
 
Day 1 Set 2 5 20.291 4.058 5.065 x 10
-5
 
Day 1 Set 3 5 20.249 4.050 6.153 x 10
-5
 
Day 2 Set 1 5 20.044 4.009 1.199 x 10
-4
 
Day 2 Set 2 5 19.932 3.986 4.781 x 10
-5
 
Day 2 Set 3 5 19.941 3.988 6.101 x 10
-5
 
Day 9 Set 1 5 19.638 3.928 1.241 x 10
-4
 
Day 12 Set 1 5 19.686 3.937 1.279 x 10
-4
 
Day 12 Set 2 5 19.774 3.955 9.386 x 10
-5
 
Day 12 Set 3 5 19.772 3.954 7.826 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 1.590 x 10
-1
 9 1.767 x 10
-2
 173.194 
Within Groups 4.081 x 10
-3
 40 1.020 x 10
-4
 
 
     Total 1.631 x 10
-1
 49     
   
P-value Ftable 
   
3.780 x 10
-29
 2.124 
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Table A.10: Migration time adjacent mean differences (minutes) for peak 3 capillary 1. 
  
 
 
 
 
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 2 
Set 1
Day 2 
Set 3
Day 2 
Set 2
Day 12 
Set 2
Day 12 
Set 3
Day 12 
Set 1
Day 9 
Set 1
Day 1 Set 1 4.111 -
Day 1 Set 2 4.058 0.053 -
Day 1 Set 3 4.050 0.061 0.008 -
Day 2 Set 1 4.009 0.102 0.049 0.000 -
Day 2 Set 3 3.988 0.123 0.070 0.062 0.021 -
Day 2 Set 2 3.986 0.124 0.072 0.064 0.022 0.002 -
Day 12 Set 2 3.955 0.156 0.103 0.095 0.054 0.033 0.032 -
Day 12 Set 3 3.954 0.156 0.104 0.095 0.054 0.034 0.032 0.000 -
Day 12 Set 1 3.937 0.174 0.121 0.113 0.072 0.051 0.049 0.018 0.017 -
Day 9 Set 1 3.928 0.183 0.131 0.122 0.081 0.061 0.059 0.027 0.027 0.010 -
LSD 0.013
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Table A.11: Migration time (minutes) ANOVA for peak 3 capillary 2. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 20.260 4.052 2.934 x 10
-5
 
Day 10 Set 1 5 20.031 4.006 1.179 x 10
-4
 
Day 10 Set 2 5 20.027 4.005 3.386 x 10
-5
 
Day 11 Set 1 5 20.170 4.034 1.066 x 10
-4
 
Day 11 Set 2 5 20.108 4.022 8.939 x 10
-5
 
Day 11 Set 3 5 20.250 4.050 3.052 x 10
-5
 
Day 12 Set 1 5 20.123 4.025 1.976 x 10
-5
 
Day 12 Set 2 5 20.214 4.043 3.589 x 10
-5
 
Day 13 Set 1 5 20.184 4.037 5.868 x 10
-5
 
Day 13 Set 2 5 20.125 4.025 2.855 x 10
-5
 
Day 13 Set 3 5 20.246 4.049 6.025 x 10
-5
 
Day 14 Set 1 5 20.058 4.012 7.153 x 10
-5
 
Day 14 Set 2 5 20.094 4.019 7.874 x 10
-5
 
Day 15 Set 1 5 19.995 3.999 5.529 x 10
-5
 
Day 15 Set 2 5 20.042 4.008 2.635 x 10
-5
 
Day 15 Set 3 5 20.081 4.016 3.913 x 10
-5
 
Day 16 Set 1 5 20.167 4.033 6.542 x 10
-5
 
Day 16 Set 2 5 20.132 4.026 2.952 x 10
-5
 
Day 16 Set 3 5 20.117 4.023 2.276 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 2.267 x 10
-2
 18 1.259 x 10
-3
 23.940 
Within Groups 3.998 x 10
-3
 76 5.261 x 10
-5
 
 
     Total 2.667 x 10
-2
 94     
   
P-value Ftable 
   
3.559 x 10
-24
 1.741 
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Table A.13: Migration time (minutes) F-test two- sample for variances for peak 3.  
 
 
  Capillary 1 Capillary 2 
Mean 3.9976 4.026 
Variance 3.329 x10
-3
 2.837 x 10
-4
 
Observations 50 95 
DF 49 94 
Fcalc 11.733 
 P-value 8.422 x 10
-24
 
 
Ftable 1.488 
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Table A.14: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 3.  
 
 
  Capillary 2 Capillary 1 
Mean 4.026 3.998 
Variance 2.837 x 10
-4
 3.329 x 10
-3
 
Observations 95 50 
Hypothesized Mean 
Difference 
0 
 DF 53 
 tcalc 3.347 
 P-value 1.508 x 10
-3
 
 
ttable 2.006 
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Table A.15: Migration time (minutes) for peak 4 (p-toluenesulfonic acid) using DOI-
CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 4.605 4.599 4.585 4.578 4.564 4.541 0.035 0.765 
 
2 4.527 4.530 4.526 4.522 4.513 
   
 
3 4.517 4.520 4.520 4.511 4.501 
   Day 2 1 4.477 4.475 4.470 4.461 4.451 4.451 0.014 0.314 
 
2 4.444 4.447 4.445 4.440 4.432 
   
 
3 4.447 4.452 4.447 4.444 4.432 
   Day 3 1 4.381 4.383 4.375 4.356 4.362 4.371 0.012 0.269 
Day 12 1 4.396 4.394 4.389 4.381 4.371 4.399 0.012 0.284 
 
2 4.412 4.415 4.410 4.401 4.393 
   
 
3 4.409 4.411 4.407 4.401 4.391 
   
 
     
Overall 4.454 0.066 1.492 
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 4.518 4.516 4.512 4.511 4.504 4.512 0.005 0.120 
Day 10 1 4.472 4.473 4.461 4.454 4.447 4.460 0.008 0.184 
 
2 4.460 4.465 4.462 4.458 4.452 
   Day 11 1 4.502 4.501 4.495 4.486 4.476 4.494 0.016 0.365 
 
2 4.487 4.485 4.481 4.474 4.464 
   
 
3 4.501 4.510 4.515 4.516 4.515 
   Day 12 1 4.474 4.483 4.486 4.484 4.481 4.492 0.012 0.273 
 
2 4.508 4.506 4.505 4.502 4.493 
   Day 13 1 4.500 4.502 4.499 4.489 4.484 4.495 0.061 1.356 
 
2 4.470 4.479 4.485 4.488 4.486 
   
 
3 4.493 4.509 4.513 4.511 4.511 
   Day 14 1 4.465 4.474 4.469 4.461 4.453 4.469 0.009 0.200 
 
2 4.476 4.483 4.475 4.469 4.461 
   Day 15 1 4.454 4.460 4.455 4.447 4.441 4.461 0.010 0.221 
 
2 4.460 4.467 4.465 4.460 4.455 
   
 
3 4.473 4.477 4.474 4.469 4.461 
   Day 16 1 4.495 4.497 4.493 4.486 4.478 4.484 0.007 0.157 
 
2 4.482 4.489 4.485 4.481 4.476 
   
 
3 4.479 4.483 4.482 4.478 4.474 
   
      
Overall 4.482 0.019 0.426 
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A. 
 
B. 
 
 
 
Figure A.3: Migration time variation (minutes) for peak 4 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.16: Migration time (minutes) ANOVA for peak 4 capillary 1.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 22.931 4.586 2.663 x 10
-4
 
Day 1 Set 2 5 22.619 4.524 4.495 x 10
-5
 
Day 1 Set 3 5 22.569 4.514 6.130 x 10
-5
 
Day 2 Set 1 5 22.334 4.467 1.188 x 10
-4
 
Day 2 Set 2 5 22.208 4.442 3.402 x 10
-5
 
Day 2 Set 3 5 22.222 4.444 5.661 x 10
-5
 
Day 9 Set 1 5 21.856 4.371 1.380 x 10
-4
 
Day 12 Set 1 5 21.931 4.386 1.040 x 10
-4
 
Day 12 Set 2 5 22.031 4.406 7.590 x 10
-5
 
Day 12 Set 3 5 22.021 4.404 6.583 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 2.127 x 10
-1
 9 2.363 x 10
-2
 244.670 
Within Groups 3.863 x 10
-3
 40 9.657 x 10
-5
 
 
     Total 2.165 x 10
-1
 49     
   
P-value Ftable 
   
4.476 x 10
-32
 2.124 
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Table A.17: Migration time adjacent mean differences (minutes) for peak 4 capillary 1.  
 
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 2 
Set 1
Day 2 
Set 3
Day 2 
Set 2
Day 12 
Set 2
Day 12 
Set 3
Day 12 
Set 1
Day 9 
Set 1
Day 1 Set 1 4.586 -
Day 1 Set 2 4.524 0.062 -
Day 1 Set 3 4.514 0.072 0.010 -
Day 2 Set 1 4.467 0.119 0.057 0.000 -
Day 2 Set 3 4.444 0.142 0.079 0.069 0.022 -
Day 2 Set 2 4.442 0.144 0.082 0.072 0.025 0.003 -
Day 12 Set 2 4.406 0.180 0.118 0.108 0.061 0.038 0.036 -
Day 12 Set 3 4.404 0.182 0.120 0.110 0.063 0.040 0.038 0.002 -
Day 12 Set 1 4.386 0.200 0.137 0.127 0.081 0.058 0.055 0.020 0.018 -
Day 9 Set 1 4.371 0.215 0.153 0.143 0.096 0.073 0.071 0.035 0.033 0.015 -
LSD 0.013
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Table A.18: Migration time (minutes) ANOVA for peak 4 capillary 2.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 22.562 4.512 2.953 x 10
-5
 
Day 10 Set 1 5 22.306 4.461 1.252 x 10
-4
 
Day 10 Set 2 5 22.297 4.459 2.417 x 10
-5
 
Day 11 Set 1 5 22.461 4.492 1.154 x 10
-4
 
Day 11 Set 2 5 22.390 4.478 8.801 x 10
-5
 
Day 11 Set 3 5 22.556 4.511 4.130 x 10
-5
 
Day 12 Set 1 5 22.408 4.482 2.110 x 10
-5
 
Day 12 Set 2 5 22.514 4.503 3.589 x 10
-5
 
Day 13 Set 1 5 22.474 4.495 5.816 x 10
-5
 
Day 13 Set 2 5 22.408 4.482 5.614 x 10
-5
 
Day 13 Set 3 5 22.538 4.508 6.565 x 10
-5
 
Day 14 Set 1 5 22.322 4.464 6.785 x 10
-5
 
Day 14 Set 2 5 22.364 4.473 6.922 x 10
-5
 
Day 15 Set 1 5 22.257 4.451 5.191 x 10
-5
 
Day 15 Set 2 5 22.306 4.461 2.002 x 10
-5
 
Day 15 Set 3 5 22.353 4.471 3.645 x 10
-5
 
Day 16 Set 1 5 22.449 4.490 6.347 x 10
-5
 
Day 16 Set 2 5 22.412 4.482 2.209 x 10
-5
 
Day 16 Set 3 5 22.396 4.479 1.299 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 3.022 x 10
-2
 18 1.679 x 10
-3
 31.751 
Within Groups 4.018 x 10
-3
 76 5.287 x 10
-5
 
 
     Total 3.423 x 10
-2
 94   
 
   
P-value Ftable 
   
4.347 x 10
-28
 1.741 
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Table A.20: Migration time (minutes) F-test two- sample for variances of peak 4.  
 
 
  Capillary 1 Capillary 2 
Mean 4.454 4.482 
Variance 4.419 x 10
-3
 3.642 x 10
-4
 
Observations 50 95 
DF 49 94 
Fcalc 12.133 
 P-value 2.410 x 10
-24
 
 
Ftable 1.488 
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Table A.21: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 4.  
 
 
  Capillary 2 Capillary 2 
Mean 4.482 4.454 
Variance 3.642 x 10
-4
 4.419 x 10
-3
 
Observations 95 50 
Hypothesized Mean 
Difference 
0 
 DF 53 
 tcalc 2.854 
 P-value 6.139 x 10
-3
 
 
ttable 2.006 
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Table A.22: Migration time (minutes) for peak 5 (disopyramide) using DOI-CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 4.716 4.695 4.683 4.676 4.679 4.689 0.012 0.259 
 
2 4.685 4.676 4.680 4.677 4.680 
   
 
3 4.706 4.696 4.690 4.696 4.701 
   Day 2 1 4.706 4.679 4.664 4.656 4.652 4.633 0.034 0.724 
 
2 4.645 4.625 4.621 4.622 4.617 
   
 
3 4.621 4.603 4.595 4.588 4.598 
   Day 3 1 4.661 4.648 4.652 4.664 4.647 4.654 0.008 0.164 
Day 12 1 4.619 4.601 4.605 4.600 4.598 4.615 0.013 0.289 
 
2 4.630 4.611 4.605 4.604 4.607 
   
 
3 4.640 4.625 4.624 4.627 4.629 
   
 
     
Overall 4.646 0.037 0.788 
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 4.726 4.716 4.714 4.711 4.711 4.716 0.006 0.135 
Day 10 1 4.765 4.739 4.735 4.731 4.726 4.745 0.012 0.261 
 
2 4.759 4.747 4.745 4.749 4.754 
   Day 11 1 4.762 4.747 4.745 4.744 4.741 4.747 0.010 0.219 
 
2 4.755 4.742 4.736 4.735 4.733 
   
 
3 4.770 4.742 4.745 4.751 4.757 4.720 0.009 0.184 
Day 12 1 4.737 4.720 4.713 4.712 4.714 
   
 
2 4.735 4.723 4.715 4.715 4.719 4.693 0.039 0.823 
Day 13 1 4.740 4.718 4.701 4.692 4.688 
   
 
2 4.688 4.676 4.671 4.669 4.673 
   
 
3 4.713 4.695 4.689 4.690 4.690 
   Day 14 1 4.789 4.768 4.765 4.759 4.763 4.766 0.012 0.243 
 
2 4.783 4.766 4.762 4.755 4.752 
   Day 15 1 4.716 4.707 4.697 4.695 4.697 4.716 0.015 0.309 
 
2 4.728 4.713 4.711 4.712 4.710 
   
 
3 4.748 4.728 4.725 4.725 4.729 
   Day 16 1 4.773 4.752 4.741 4.734 4.729 4.721 0.021 0.452 
 
2 4.719 4.707 4.706 4.707 4.707 
   
 
3 4.723 4.708 4.704 4.701 4.701 
   
      
Overall 4.727 0.026 0.557 
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A. 
 
B. 
 
Figure A.4: Migration time variation (minutes) for peak 5 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.23: Migration time (minutes) ANOVA for peak 5 capillary 1.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 23.449 4.690 2.615 x 10
-4
 
Day 1 Set 2 5 23.398 4.680 1.221 x 10
-5
 
Day 1 Set 3 5 23.488 4.698 3.594 x 10
-5
 
Day 2 Set 1 5 23.357 4.671 4.835 x 10
-4
 
Day 2 Set 2 5 23.130 4.626 1.215 x 10
-4
 
Day 2 Set 3 5 23.005 4.601 1.541 x 10
-4
 
Day 9 Set 1 5 23.271 4.654 5.844 x 10
-5
 
Day 12 Set 1 5 23.024 4.605 6.952 x 10
-5
 
Day 12 Set 2 5 23.057 4.611 1.182 x 10
-4
 
Day 12 Set 3 5 23.145 4.629 4.290 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 6.023 x 10
-2
 9 6.693 x 10
-3
 49.293 
Within Groups 5.431 x 10
-3
 40 1.358 x 10
-4
 
 
     Total 6.567 x 10
-2
 49     
   
P-value Ftable 
   
7.494 x 10
-19
 2.124 
 
 
  
333 
 
Table A.24: Migration time adjacent mean differences (minutes) for peak 5 capillary 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Mean
Day 1 
Set 3
Day 1 
Set 1
Day 1 
Set 2
Day 2 
Set 1
Day 9 
Set 1
Day 12 
Set 3
Day 2 
Set 2
Day 12 
Set 2
Day 12 
Set 1
Day 2 
Set 3
Day 1 Set 3 4.698 -
Day 1 Set 1 4.690 0.008 -
Day 1 Set 2 4.680 0.018 0.010 -
Day 2 Set 1 4.671 0.026 0.018 0.000 -
Day 9 Set 1 4.654 0.044 0.036 0.026 0.017 -
Day 12 Set 3 4.629 0.069 0.061 0.051 0.042 0.025 -
Day 2 Set 2 4.626 0.072 0.064 0.054 0.045 0.028 0.003 -
Day 12 Set 2 4.611 0.086 0.078 0.068 0.060 0.043 0.018 0.015 -
Day 12 Set 1 4.605 0.093 0.085 0.075 0.067 0.049 0.024 0.021 0.007 -
Day 2 Set 3 4.601 0.097 0.089 0.079 0.070 0.053 0.028 0.025 0.010 0.004 -
LSD 0.015
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Table A.25: Migration time (minutes) ANOVA for peak 5 capillary 2.  
 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 23.578 4.716 4.024 x 10
-5
 
Day 10 Set 1 5 23.696 4.739 2.294 x 10
-4
 
Day 10 Set 2 5 23.754 4.751 3.123 x 10
-5
 
Day 11 Set 1 5 23.739 4.748 6.847 x 10
-5
 
Day 11 Set 2 5 23.701 4.740 7.716 x 10
-5
 
Day 11 Set 3 5 23.765 4.753 1.253 x 10
-4
 
Day 12 Set 1 5 23.596 4.719 1.028 x 10
-4
 
Day 12 Set 2 5 23.607 4.721 6.408 x 10
-5
 
Day 13 Set 1 5 23.538 4.708 4.654 x 10
-4
 
Day 13 Set 2 5 23.377 4.675 5.657 x 10
-5
 
Day 13 Set 3 5 23.477 4.695 1.060 x 10
-4
 
Day 14 Set 1 5 23.844 4.769 1.384 x 10
-4
 
Day 14 Set 2 5 23.817 4.763 1.449 x 10
-4
 
Day 15 Set 1 5 23.512 4.702 8.287 x 10
-5
 
Day 15 Set 2 5 23.575 4.715 5.806 x 10
-5
 
Day 15 Set 3 5 23.654 4.731 9.373 x 10
-5
 
Day 16 Set 1 5 23.729 4.746 2.981 x 10
-4
 
Day 16 Set 2 5 23.546 4.709 3.254 x 10
-5
 
Day 16 Set 3 5 23.537 4.707 8.403 x 10
-5
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 5.585 x 10
-2
 18 3.103 x 10
-3
 25.641 
Within Groups 9.197 x 10
-3
 76 1.210 x 10
-4
 
 
     Total 6.505 x 10
-2
 94     
   
P-value Ftable 
   
4.140 x 10
-25
 1.741 
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Table A.27: Migration time (minutes) F-test two- sample for variances of peak 5.  
 
 
  Capillary 1 Capillary 2 
Mean 4.646 4.727 
Variance 1.340 x10
-3
 6.920 x 10
-4
 
Observations 50 95 
DF 49 94 
Fcalc 1.936 
 P-value 3.079 x 10
-3
 
 
Ftable 1.488 
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Table A.28: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 5.  
 
  Capillary 2 Capillary 1 
Mean 4.727 4.646 
Variance 6.920 x 10
-4
 1.340 x 10
-3
 
Observations 95 50 
Hypothesized Mean 
Difference 
0 
 DF 76 
 tcalc 13.752 
 P-value 2.583 x 10
-22
 
 
ttable 1.992 
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Table A.29: Migration time (minutes) ratio for peak 2 in reference to peak 1. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.365 1.365 1.365 1.365 1.365 1.364 0.001 0.052 
 
2 1.364 1.363 1.363 1.363 1.363 
   
 
3 1.364 1.363 1.363 1.364 1.364    
Day 2 1 1.365 1.364 1.363 1.363 1.363 1.363 0.001 0.066 
 
2 1.363 1.363 1.363 1.363 1.363 
   
 
3 1.363 1.362 1.362 1.361 1.362    
Day 3 1 1.366 1.365 1.366 1.367 1.366 1.366 0.001 0.046 
Day 12 1 1.363 1.363 1.363 1.363 1.364 
1.364 
4.982  
x 10
-4
 0.037 
 
2 1.364 1.363 1.363 1.363 1.363 
   
 
3 1.364 1.364 1.364 1.364 1.364    
 
     
Overall 1.364 0.001 0.081 
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
1.364 1.363 1.364 1.363 1.363 1.363 
2.397  
x 10
-4
 0.018 
Day 10 1 
1.367 1.366 1.366 1.366 1.366 1.366 
4.300  
x 10
-4
 0.031 
 
2 1.367 1.366 1.366 1.367 1.367    
Day 11 1 1.365 1.365 1.365 1.365 1.365 1.365 0.001 0.056 
 
2 1.366 1.365 1.365 1.365 1.365 
   
 
3 1.367 1.364 1.364 1.364 1.364    
Day 12 1 
1.365 1.364 1.364 1.364 1.364 1.364 
4.554  
x 10
-4
 0.033 
 
2 1.364 1.363 1.364 1.364 1.363    
Day 13 1 1.364 1.364 1.363 1.363 1.363 1.363 0.001 0.082 
 
2 1.364 1.363 1.362 1.362 1.362 
   
 
3 1.364 1.362 1.362 1.362 1.362    
Day 14 1 1.367 1.366 1.366 1.366 1.367 1.366 0.001 0.037 
 
2 1.367 1.366 1.366 1.366 1.366    
Day 15 1 
1.365 1.364 1.364 1.364 1.365 1.364 
4.132  
x 10
-4
 0.030 
 
2 1.365 1.365 1.364 1.365 1.365 
   
 
3 1.365 1.364 1.364 1.364 1.365    
Day 16 1 1.365 1.364 1.364 1.364 1.364 1.363 0.001 0.055 
 
2 1.363 1.362 1.363 1.363 1.363    
 
3 1.364 1.363 1.363 1.363 1.363    
      
Overall 1.364 0.001 0.101 
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Table A.30: Migration time (minutes) ANOVA for peak 2 in reference to peak 1 for 
capillary 1. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 6.824 1.365 5.769 x 10
-8
 
Day 1 Set 2 5 6.817 1.363 6.554 x 10
-8
 
Day 1 Set 3 5 6.818 1.364 8.529 x 10
-8
 
Day 2 Set 1 5 6.819 1.364 4.449 x 10
-7
 
Day 2 Set 2 5 6.815 1.363 1.041 x 10
-7
 
Day 2 Set 3 5 6.810 1.362 2.332 x 10
-7
 
Day 9 Set 1 5 6.830 1.366 3.872 x 10
-7
 
Day 12 Set 1 5 6.817 1.363 1.426 x 10
-7
 
Day 12 Set 2 5 6.816 1.363 1.044 x 10
-7
 
Day 12 Set 3 5 6.820 1.364 1.030 x 10
-7
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 5.341 x 10
-5
 9 5.934 x 10
-6
 34.344 
Within Groups 6.911 x 10
-6
 40 1.728 x 10
-7
 
 
     Total 6.032 x 10
-5
 49     
   
P-value Ftable 
   
4.522 x 10
-16
 2.124 
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Table A.31: Migration time adjacent mean differences (minutes) for peak 2 in reference 
to peak 1 for capillary 1.  
 
 
 
 
  
Mean
Day 9 
Set 1
Day 1 
Set 1
Day 12 
Set 3
Day 2 
Set 1
Day 1 Set 3
Day 12 
Set 1
Day 1 Set 
2
Day 12 
Set 2
Day 2 
Set 2
Day 2 
Set 3
Day 9 Set 1 1.366 -
Day 1 Set 1 1.365 0.0012 -
Day 12 Set 3 1.364 0.0019 0.0008 -
Day 2 Set 1 1.364 0.0022 0.0011 0.0003 -
Day 1 Set 3 1.364 0.0024 0.0013 0.0005 0.0002 -
Day 12 Set 1 1.363 0.0025 0.0013 0.0006 0.0002 0.0000 -
Day 1 Set 2 1.363 0.0026 0.0015 0.0007 0.0004 0.0002 0.0002 -
Day 12 Set 2 1.363 0.0028 0.0017 0.0009 0.0006 0.0004 0.0004 0.0002 -
Day 2 Set 2 1.363 0.0030 0.0019 0.0011 0.0008 0.0006 0.0006 0.0004 0.0002 -
Day 2 Set 3 1.362 0.0040 0.0029 0.0021 0.0018 0.0016 0.0016 0.0014 0.0012 0.001 -
LSD 0.0005
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Table A.32: Migration time (minutes) ANOVA for peak 2 in reference to peak 1 for 
capillary 2. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 6.817 1.363 5.745 x 10
-8
 
Day 10 Set 1 5 6.830 1.366 2.102 x 10
-7
 
Day 10 Set 2 5 6.832 1.366 1.114 x 10
-7
 
Day 11 Set 1 5 6.826 1.365 4.470 x 10
-8
 
Day 11 Set 2 5 6.826 1.365 2.751 x 10
-8
 
Day 11 Set 3 5 6.824 1.365 1.759 x 10
-6
 
Day 12 Set 1 5 6.820 1.364 2.370 x 10
-7
 
Day 12 Set 2 5 6.819 1.364 1.869 x 10
-7
 
Day 13 Set 1 5 6.817 1.363 4.542 x 10
-7
 
Day 13 Set 2 5 6.812 1.362 5.025 x 10
-7
 
Day 13 Set 3 5 6.812 1.362 6.339 x 10
-7
 
Day 14 Set 1 5 6.832 1.366 3.245 x 10
-7
 
Day 14 Set 2 5 6.831 1.366 1.970 x 10
-7
 
Day 15 Set 1 5 6.821 1.364 2.488 x 10
-7
 
Day 15 Set 2 5 6.823 1.365 9.364 x 10
-8
 
Day 15 Set 3 5 6.822 1.364 1.660 x 10
-7
 
Day 16 Set 1 5 6.821 1.364 4.085 x 10
-7
 
Day 16 Set 2 5 6.814 1.363 7.863 x 10
-8
 
Day 16 Set 3 5 6.816 1.363 2.250 x 10
-7
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 1.550 x 10
-4
 18 8.613 x 10
-6
 27.426 
Within Groups 2.387 x 10
-5
 76 3.140 x 10
-7
 
 
     
Total 1.789 x 10
-4
 94     
   
P-value Ftable 
   
4.900 x 10
-26
 1.741 
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Table A.34: Migration time (minutes) ratio for peak 5 in reference to peak 1. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.768 1.766 1.765 1.764 1.765 1.766 0.001 0.076 
 
2 1.767 1.765 1.764 1.764 1.764 
   
 
3 1.768 1.767 1.766 1.766 1.766    
Day 2 1 1.772 1.768 1.767 1.766 1.766 1.766 0.003 0.143 
 
2 1.769 1.767 1.765 1.765 1.765 
   
 
3 1.767 1.764 1.763 1.762 1.763    
Day 3 1 1.776 1.775 1.775 1.777 1.774 1.775 0.001 0.068 
Day 12 1 1.771 1.769 1.769 1.768 1.768 1.768 0.002 0.089 
 
2 1.770 1.767 1.766 1.766 1.766 
   
 
3 1.771 1.769 1.768 1.769 1.768    
 
     
Overall 1.768 0.003 0.192 
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.770 1.768 1.767 1.766 1.766 1.767 0.002 0.101 
Day 10 1 1.777 1.774 1.773 1.772 1.772 1.774 0.002 0.098 
 
2 1.777 1.775 1.774 1.774 1.773    
Day 11 1 1.773 1.771 1.771 1.771 1.770 1.771 0.002 0.103 
 
2 1.774 1.773 1.771 1.771 1.771 
   
 
3 1.775 1.771 1.769 1.769 1.769    
Day 12 1 1.773 1.771 1.769 1.768 1.767 1.769 0.002 0.115 
 
2 1.771 1.769 1.768 1.767 1.767    
Day 13 1 1.772 1.769 1.767 1.766 1.765 1.767 0.003 0.184 
 
2 1.770 1.767 1.765 1.764 1.764 
   
 
3 1.770 1.766 1.765 1.764 1.763    
Day 14 1 1.779 1.776 1.775 1.774 1.775 1.775 0.002 0.107 
 
2 1.778 1.775 1.775 1.774 1.773    
Day 15 1 1.774 1.772 1.770 1.769 1.770 1.771 0.002 0.095 
 
2 1.774 1.772 1.771 1.771 1.770 
   
 
3 1.774 1.772 1.771 1.770 1.770    
Day 16 1 1.774 1.772 1.770 1.769 1.768 1.769 0.002 0.131 
 
2 1.770 1.768 1.767 1.767 1.766 
   
 
3 1.771 1.769 1.768 1.766 1.766    
      
Overall 1.770 0.003 0.194 
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Table A.35: Migration time (minutes) ANOVA for peak 5 in reference to peak 1 for 
capillary 1. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 8.828 1.766 2.193 x 10
-6
 
Day 1 Set 2 5 8.825 1.765 1.459 x 10
-6
 
Day 1 Set 3 5 8.833 1.767 1.187 x 10
-6
 
Day 2 Set 1 5 8.839 1.768 6.128 x 10
-6
 
Day 2 Set 2 5 8.831 1.766 3.363 x 10
-6
 
Day 2 Set 3 5 8.820 1.764 3.696 x 10
-6
 
Day 9 Set 1 5 8.877 1.775 1.471 x 10
-6
 
Day 12 Set 1 5 8.844 1.769 1.402 x 10
-6
 
Day 12 Set 2 5 8.836 1.767 2.899 x 10
-6
 
Day 12 Set 3 5 8.846 1.769 1.450 x 10
-6
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 4.614 x 10
-4
 9 5.126 x 10
-5
 20.305 
Within Groups 1.010 x 10
-4
 40 2.525 x 10
-6
 
 
     
Total 5.624 x 10
-4
 49     
   
P-value Ftable 
   
2.810 x 10
-12
 2.124 
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Table A.36: Migration time adjacent mean differences (minutes) for peak 5 in reference 
to peak 1 for capillary 1.  
 
 
 
 
 
  
Mean
Day 9 
Set 1
Day 12 
Set 3
Day 12 
Set 1
Day 2 
Set 1
Day 12 
Set 2
Day 1 
Set 3
Day 2 
Set 2
Day 1 
Set 1
Day 1 
Set 2
Day 2 
Set 3
Day 9 Set 1 1.775 -
Day 12 Set 3 1.769 0.006 -
Day 12 Set 1 1.769 0.007 0.000 -
Day 2 Set 1 1.768 0.008 0.001 0.001 -
Day 12 Set 2 1.767 0.008 0.002 0.002 0.001 -
Day 1 Set 3 1.767 0.009 0.003 0.002 0.001 0.001 -
Day 2 Set 2 1.766 0.009 0.003 0.003 0.001 0.001 0.000 -
Day 1 Set 1 1.766 0.010 0.003 0.003 0.002 0.001 0.001 0.001 -
Day 1 Set 2 1.765 0.010 0.004 0.004 0.003 0.002 0.002 0.001 0.001 -
Day 2 Set 3 1.764 0.011 0.005 0.005 0.004 0.003 0.003 0.002 0.002 0.001 -
LSD 0.0020
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Table A.37: Migration time (minutes) ANOVA for peak 5 in reference to peak 1 for 
capillary 2. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 8.836 1.767 3.160 x 10
-6
 
Day 10 Set 1 5 8.868 1.774 3.736 x 10
-6
 
Day 10 Set 2 5 8.874 1.775 2.174 x 10
-6
 
Day 11 Set 1 5 8.856 1.771 1.215 x 10
-6
 
Day 11 Set 2 5 8.860 1.772 2.207 x 10
-6
 
Day 11 Set 3 5 8.852 1.770 6.528 x 10
-6
 
Day 12 Set 1 5 8.848 1.770 5.233 x 10
-6
 
Day 12 Set 2 5 8.841 1.768 2.964 x 10
-6
 
Day 13 Set 1 5 8.839 1.768 7.048 x 10
-6
 
Day 13 Set 2 5 8.831 1.766 7.814 x 10
-6
 
Day 13 Set 3 5 8.828 1.766 6.647 x 10
-6
 
Day 14 Set 1 5 8.879 1.776 3.500 x 10
-6
 
Day 14 Set 2 5 8.874 1.775 3.919 x 10
-6
 
Day 15 Set 1 5 8.854 1.771 3.191 x 10
-6
 
Day 15 Set 2 5 8.857 1.771 2.899 x 10
-6
 
Day 15 Set 3 5 8.856 1.771 3.540 x 10
-6
 
Day 16 Set 1 5 8.852 1.770 5.955 x 10
-6
 
Day 16 Set 2 5 8.837 1.767 2.706 x 10
-6
 
Day 16 Set 3 5 8.840 1.768 3.951 x 10
-6
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 7.982 x 10
-4
 18 4.434 x 10
-5
 10.748 
Within Groups 3.135 x 10
-4
 76 4.126 x 10
-6
 
 
     
Total 1.112 x 10
-3
 94     
   
P-value Ftable 
   
2.589 x 10
-14
 1.741 
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Table A.39: Migration time (minutes) ratio for peak 4 in reference to peak 3. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.115 1.116 1.116 1.116 1.116 1.115 0.001 0.055 
 
2 1.114 1.115 1.115 1.115 1.115 
   
 
3 1.114 1.114 1.115 1.115 1.115 
   
Day 2 1 1.114 1.114 1.114 1.114 1.115 1.114 
4.413 x 
10
-4
 
0.040 
 
2 1.113 1.114 1.114 1.115 1.115 
   
 
3 1.114 1.114 1.114 1.115 1.115 
   
Day 3 1 1.113 1.113 1.113 1.113 1.113 1.113 
2.960 x 
10
-4
 
0.027 
Day 12 1 1.113 1.114 1.114 1.115 1.115 1.114 0.001 0.051 
 
2 1.113 1.114 1.114 1.115 1.115 
   
 
3 1.113 1.113 1.114 1.114 1.114 
   
 
     
Overall 1.114 0.001 0.070 
 
      
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.114 1.113 1.113 1.114 1.114 1.114 
2.513 x 
10
-4
 
0.023 
Day 10 1 1.113 1.113 1.114 1.114 1.114 1.113 
3.947 x 
10
-4
 
0.035 
 
2 1.113 1.113 1.113 1.114 1.114 
   
Day 11 1 1.114 1.113 1.114 1.114 1.114 1.114 
2.967 x 
10
-4
 
0.027 
 
2 1.113 1.113 1.113 1.114 1.114 
   
 
3 1.114 1.114 1.114 1.114 1.114 
   
Day 12 1 1.114 1.113 1.114 1.114 1.114 1.114 
3.118 x 
10
-4
 
0.028 
 
2 1.114 1.113 1.114 1.114 1.114 
   Day 13 1 1.113 1.113 1.113 1.114 1.114 1.113 0.001 0.072 
 
2 1.113 1.113 1.114 1.114 1.114 
   
 
3 1.113 1.113 1.113 1.113 1.114 
   
Day 14 1 1.113 1.113 1.113 1.113 1.113 1.113 
3.872 x 
10
-4
 
0.035 
 
2 1.112 1.113 1.113 1.113 1.114 
   
Day 15 1 1.113 1.113 1.113 1.113 1.114 1.113 
3.671 x 
10
-4
 
0.033 
 
2 1.112 1.113 1.113 1.113 1.114 
   
 
3 1.113 1.113 1.113 1.113 1.113 
   
Day 16 1 
1.113 1.113 1.113 1.113 1.113 1.113 
3.868 x 
10
-4
 0.035 
 
2 1.114 1.113 1.113 1.113 1.114 
   
 
3 1.113 1.113 1.113 1.114 1.114 
   
      
Overall 1.113 
4.161 x 
10
-4
 0.037 
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Table A.40: Migration time (minutes) ANOVA for peak 4 in reference to peak 3 for 
capillary 1. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 5.578 1.116 1.489 x 10
-7
 
Day 1 Set 2 5 5.574 1.115 1.442 x 10
-7
 
Day 1 Set 3 5 5.573 1.115 1.193 x 10
-7
 
Day 2 Set 1 5 5.571 1.114 1.073 x 10
-7
 
Day 2 Set 2 5 5.571 1.114 3.607 x 10
-7
 
Day 2 Set 3 5 5.572 1.114 1.963 x 10
-7
 
Day 9 Set 1 5 5.565 1.113 8.764 x 10
-8
 
Day 12 Set 1 5 5.570 1.114 3.935 x 10
-7
 
Day 12 Set 2 5 5.571 1.114 3.170 x 10
-7
 
Day 12 Set 3 5 5.569 1.114 2.825 x 10
-7
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 2.155 x 10
-5
 9 2.394 x 10
-6
 11.097 
Within Groups 8.630 x 10
-6
 40 2.157 x 10
-7
 
 
     
Total 3.018 x 10
-5
 49     
   
P-value Ftable 
   
1.960 x 10
-8
 2.124 
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Table A.41: Migration time adjacent mean differences (minutes) for peak 4 in reference 
to peak 3 for capillary 1.  
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 2 
Set 3
Day 2 
Set 1
Day 2 
Set 2
Day 12 
Set 2
Day 12 
Set 1
Day 12 
Set 3
Day 9 
Set 1
Day 1 Set 1 1.116 -
Day 1 Set 2 1.115 0.0009 -
Day 1 Set 3 1.115 0.0011 0.0002 -
Day 2 Set 3 1.114 0.0013 0.0003 0.0002 -
Day 2 Set 1 1.114 0.0014 0.0005 0.0003 0.0001 -
Day 2 Set 2 1.114 0.0014 0.0005 0.0003 0.0002 0.0000 -
Day 12 Set 2 1.114 0.0015 0.0006 0.0004 0.0003 0.0001 0.0001 -
Day 12 Set 1 1.114 0.0016 0.0006 0.0005 0.0003 0.0002 0.0001 0.0000 -
Day 12 Set 3 1.114 0.0019 0.0010 0.0008 0.0007 0.0005 0.0005 0.0004 0.0004 -
Day 9 Set 1 1.113 0.0027 0.0018 0.0016 0.0014 0.0013 0.0013 0.0012 0.0011 0.0008 -
LSD 0.0006
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Table A.42: Migration time (minutes) ANOVA for peak 4 in reference to peak 3 for 
capillary 2. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 5.568 1.114 6.314 x 10
-8
 
Day 10 Set 1 5 5.568 1.114 5.346 x 10
-8
 
Day 10 Set 2 5 5.567 1.113 2.596 x 10
-7
 
Day 11 Set 1 5 5.568 1.114 4.660 x 10
-8
 
Day 11 Set 2 5 5.567 1.113 8.648 x 10
-8
 
Day 11 Set 3 5 5.570 1.114 4.823 x 10
-8
 
Day 12 Set 1 5 5.568 1.114 1.186 x 10
-7
 
Day 12 Set 2 5 5.569 1.114 5.668 x 10
-8
 
Day 13 Set 1 5 5.567 1.113 6.259 x 10
-8
 
Day 13 Set 2 5 5.567 1.113 1.663 x 10
-7
 
Day 13 Set 3 5 5.566 1.113 7.622 x 10
-8
 
Day 14 Set 1 5 5.565 1.113 9.692 x 10
-8
 
Day 14 Set 2 5 5.565 1.113 2.390 x 10
-7
 
Day 15 Set 1 5 5.566 1.113 1.495 x 10
-7
 
Day 15 Set 2 5 5.565 1.113 2.189 x 10
-7
 
Day 15 Set 3 5 5.566 1.113 7.349 x 10
-8
 
Day 16 Set 1 5 5.566 1.113 8.369 x 10
-8
 
Day 16 Set 2 5 5.566 1.113 1.232 x 10
-7
 
Day 16 Set 3 5 5.566 1.113 3.033 x 10
-7
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 6.968 x 10
-6
 18 3.871 x 10
-7
 3.162 
Within Groups 9.306 x 10
-6
 76 1.224 x 10
-7
 
 
     
Total 1.627 x 10
-5
 94     
   
P-value Ftable 
   
2.374 x 10
-4
 1.741 
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Table A.44: Corrected area (mAU) for peak 2 (chlorpheniramine) using DOI-CZE. 
 
       
Day 
Capillary 
1 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 5.43 5.25 5.37 5.52 5.20 5.35 0.13 2.50 
 
2 5.30 5.41 5.11 5.45 5.21 
   
 
3 5.30 5.44 5.60 5.25 5.34    
Day 2 1 5.46 5.48 5.25 5.22 5.29 5.32 0.15 2.87 
 
2 5.49 5.29 5.12 5.12 5.22    
 
3 5.56 5.37 5.40 5.42 5.05    
Day 3 1 5.25 5.20 4.95 4.97 5.24 5.12 0.15 2.90 
Day 12 1 5.27 5.53 5.59 5.13 5.56 5.47 0.14 2.48 
 
2 
 
5.47 5.48 5.39 5.41 
   
 
3 5.60 5.50 5.63 5.49 5.52    
      
Overall 5.35 0.17 3.18 
       
Day 
Capillary
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 5.80 5.96 5.77 5.72 5.53 5.76 0.16 2.73 
Day 10 1 5.86 5.89 5.54 5.79 5.68 5.72 0.23 4.01 
 
2 5.52 5.73 5.70 5.30 5.98    
Day 11 1 5.68 5.88 5.58 5.60 5.60 5.64 0.22 3.96 
 
2 
 
5.67 6.03 6.15 5.90    
 
3 5.59 5.61 5.35 5.95 5.45 
   Day 12 1 5.29 5.75 5.41 5.66 5.55 5.85 0.23 3.93 
 
2 6.07 5.78 5.65 5.76 5.47    
Day 13 1 6.10 5.82 5.76 6.01 5.46 5.75 0.26 4.61 
 
2 5.78 6.15 6.17 5.51 6.02    
 
3 5.96 5.96 5.86 5.56 5.65 
   Day 14 1 6.08 6.05 5.48 5.43 5.57 5.80 0.22 3.85 
 
2 5.76 5.46 6.02 5.98 5.65    
Day 15 1 5.98 6.05 6.09 6.04 5.45 5.66 0.14 2.53 
 
2 5.98 5.81 5.98 5.70 5.83 
   
 
3 5.33 5.69 5.73 5.68 5.68    
Day 16 1 5.83 5.62 5.81 5.72 5.56 5.74 0.22 3.80 
 
2 5.56 5.75 5.53 5.36 5.61    
 
3 5.88 5.56 5.80 5.59 5.76    
      
Overall 5.61 0.27 4.90 
 
354 
 
A. 
 
B. 
 
Figure A.5: Corrected area (mAU) for peak 2 over the sample injections completed for 
A. capillary 1 and B. capillary 2. 
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Table A.45: Corrected area (mAU) ANOVA for peak 2 capillary 1.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 26.78 5.36 0.02 
Day 1 Set 2 5 26.47 5.29 0.02 
Day 1 Set 3 5 26.94 5.39 0.02 
Day 2 Set 1 5 26.70 5.34 0.01 
Day 2 Set 2 5 26.24 5.25 0.02 
Day 2 Set 3 5 26.79 5.36 0.04 
Day 3 Set 1 5 25.60 5.12 0.02 
Day 12 Set 1 5 27.08 5.42 0.04 
Day 12 Set 2 4 21.747 5.437 0.002 
Day 12 Set 3 5 27.738 5.548 0.004 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.59 9 0.07 3.19 
Within Groups 0.80 39 0.02 
 
     Total 1.38 48     
   
P-value Ftable 
   
5.57 x 10
-3
 2.13 
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Table A.46: Corrected area (mAU) adjacent mean differences for peak 2 capillary 1.  
 
  
  
Mean
Day 12 
Set 3
Day 12 
Set 2
Day 12 
Set 1
Day 1 
Set 3
Day 2 
Set 3
Day 1 
Set 1
Day 2 
Set 1
Day 1 
Set 2
Day 2 
Set 2
Day 3 
Set 1
Day 12 Set 3 5.548 -
Day 12 Set 2 5.437 0.111 -
Day 12 Set 1 5.42 0.13 0.02 -
Day 1 Set 3 5.39 0.16 0.05 0.03 -
Day 2 Set 3 5.36 0.19 0.08 0.06 0.03 -
Day 1 Set 1 5.36 0.19 0.08 0.06 0.03 0.00 -
Day 2 Set 1 5.34 0.21 0.10 0.08 0.05 0.02 0.01 -
Day 1 Set 2 5.29 0.25 0.14 0.12 0.09 0.06 0.06 0.05 -
Day 2 Set 2 5.25 0.30 0.19 0.17 0.14 0.11 0.11 0.09 0.05 -
Day 3 Set 1 5.12 0.43 0.32 0.30 0.27 0.24 0.23 0.22 0.17 0.13 -
LSD 0.18
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Table A.47: Corrected area (mAU) ANOVA for peak 2 capillary 2.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 28.78 5.76 0.02 
Day 10 Set 1 5 28.75 5.75 0.02 
Day 10 Set 2 5 28.22 5.64 0.06 
Day 11 Set 1 5 28.35 5.67 0.02 
Day 11 Set 2 4 23.75 5.94 0.04 
Day 11 Set 3 5 27.96 5.59 0.05 
Day 12 Set 1 5 27.66 5.53 0.04 
Day 12 Set 2 5 28.73 5.75 0.05 
Day 13 Set 1 5 29.16 5.83 0.06 
Day 13 Set 2 5 29.64 5.93 0.08 
Day 13 Set 3 5 29.00 5.80 0.03 
Day 14 Set 1 5 28.6 5.7 0.1 
Day 14 Set 2 5 28.87 5.77 0.05 
Day 15 Set 1 5 29.61 5.92 0.07 
Day 15 Set 2 5 29.31 5.86 0.01 
Day 15 Set 3 5 28.12 5.62 0.03 
Day 16 Set 1 5 28.54 5.71 0.01 
Day 16 Set 2 5 27.81 5.56 0.02 
Day 16 Set 3 5 28.59 5.72 0.02 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 1.27 18 7.06 x 10
-2
 1.68 
Within Groups 3.16 75 4.21 x 10
-2
 
 
     Total 4.43 93     
   
P-value Ftable 
   
6.31 x 10
-2
 1.74 
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Table A.48: Corrected area (mAU) F-test two- sample for variances for peak 2.  
 
  
Capillary 
2 
Capillary 
1 
Mean 5.74 5.35 
Variance 0.05 0.03 
Observations 94 49 
DF 93 48 
Fcalc 1.65 
 P-value 0.03 
 Ftable 1.54   
 
 
  
359 
 
Table A.49: Corrected area (mAU) t-test: two sample assuming unequal variances peak 
2. 
 
  Capillary 2 Capillary 1 
Mean 5.74 5.35 
Variance 0.05 0.03 
Observations 94 49 
Hypothesized mean 
Difference 
0 
 DF 120 
 tcalc 11.79 
 P-value 8.95 x 10
-22
 
 ttable 1.98 
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Table A.50: Corrected area (mAU) for peak 3 (benzenesulfonic acid) using DOI-CZE. 
 
       
Day 
Capillary 
1 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
5.17 5.21 5.16 5.30 5.18 0.11 2.12 
 
2 5.12 5.01 5.27 5.19 5.23 
   
 
3 5.21 5.13 5.41 5.09 5.00 5.24 0.07 1.32 
Day 2 1 
 
5.34 5.29 5.24 5.17 
   
 
2 5.31 5.19 5.17 5.20 5.11 
   
 
3 5.30 5.24 5.34 5.23 5.24    
Day 3 1 5.02 4.99 4.94 5.32 5.19 5.09 0.16 3.13 
Day 12 1 5.36 
 
5.36 5.41 5.28 5.36 0.10 1.88 
 
2 5.31 5.51 5.40 5.50 5.46 
   
 
3 5.43 5.38 5.31 5.22 5.15    
      
Overall 5.24 0.13 2.56 
       
Day 
Capillary 
2 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
6.65 6.40 6.39 6.31 6.44 0.15 2.29 
Day 10 1 6.34 6.64 6.34 6.39 6.36 6.53 0.19 2.84 
 
2 
 
6.79 6.80 6.59 6.53    
Day 11 1 
 
6.46 6.26 6.68 6.36 6.43 0.24 3.75 
 
2 
 
6.26 6.32 6.32 6.00 
   
 
3 
 
6.90 6.70 6.52 6.40    
Day 12 1 
 
6.85 6.56 6.52 6.36 6.56 0.16 2.38 
 
2 
 
6.62 6.61 6.56 6.37    
Day 13 1 
 
6.79 6.80 6.59 6.53 6.77 0.15 2.27 
 
2 6.85 6.86 6.70 6.66 6.56 
   
 
3 
 
7.03 6.90 6.88 6.90    
Day 14 1 
 
7.20 7.30 7.12 7.15 7.23 0.11 1.46 
 
2 7.30 7.44 7.26 7.12 7.17    
Day 15 1 7.46 7.67 7.62 7.59 7.47 7.64 0.16 2.08 
 
2 7.87 7.67 7.81 7.39 7.62 
   
 
3 
 
7.54 7.92 7.78 7.53    
Day 16 1 
 
7.31 7.27 7.24 7.11 7.22 0.17 2.35 
 
2 
 
7.51 7.46 7.24 7.04    
 
3 7.29 7.28 7.12 7.07 6.90    
      
Overall 6.93 0.47 6.79 
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A. 
 
B. 
 
Figure A.6: Corrected area (mAU) for peak 3 over the sample injections completed for 
A. capillary 1 and B. capillary 2. 
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Table A.51: Corrected area (mAU) ANOVA for peak 3 capillary 1.  
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 20.8 5.21 4.07  x 10
-3
 
  Day 1 Set 2 5 25.8 5.16 1.06  x 10
-2
 
  Day 1 Set 3 5 25.8 5.17 2.40  x 10
-2
 
  Day 2 Set 1 4 21.0 5.26 5.07  x 10
-3
 
  Day 2 Set 2 5 26.0 5.20 5.55  x 10
-3
 
  Day 2 Set 3 5 26.3 5.27 2.34  x 10
-3
 
  Day 3 Set 1 5 25.5 5.09 2.54  x 10
-2
 
  Day 12 Set 1 4 21.4 5.35 2.95  x 10
-3
 
  Day 12 Set 2 5 27.2 5.43 6.30  x 10
-3
 
  Day 12 Set 3 5 26.5 5.30 1.31  x 10
-2
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.44 9 0.05 4.74 3.18 x 10
-4
 2.14 
Within Groups 0.39 37 0.01 
   
       Total 0.83 46         
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Table A.52: Corrected area (mAU) adjacent mean differences for peak 3 capillary 1.  
 
 
 
 
 
 
  
Mean
Day 12 
Set 2
Day 12 
Set 1
Day 12 
Set 3
Day 2 
Set 3
Day 2 
Set 1
Day 1 
Set 1
Day 2 
Set 2
Day 1 
Set 3
Day 1 
Set 2
Day 3 
Set 1
Day 12 Set 2 5.43 -
Day 12 Set 1 5.35 0.08 -
Day 12 Set 3 5.30 0.13 0.05 -
Day 2 Set 3 5.27 0.17 0.09 0.03 -
Day 2 Set 1 5.26 0.17 0.09 0.04 0.01 -
Day 1 Set 1 5.21 0.22 0.14 0.09 0.06 0.05 -
Day 2 Set 2 5.20 0.24 0.16 0.10 0.07 0.07 0.02 -
Day 1 Set 3 5.17 0.27 0.19 0.13 0.10 0.09 0.04 0.03 -
Day 1 Set 2 5.16 0.27 0.19 0.14 0.10 0.10 0.05 0.03 0.00 -
Day 3 Set 1 5.09 0.34 0.26 0.21 0.18 0.17 0.12 0.11 0.08 0.07 -
LSD 0.13
364 
 
Table A.53: Corrected area (mAU) ANOVA for peak 3 capillary 2.  
 
Groups Count Sum Average Variance 
Day 1 Set 1 4 24.66 6.16 3.70 x 10
-3
 
Day 10 Set 1 5 30.42 6.08 1.03 x 10
-3
 
Day 10 Set 2 4 24.55 6.14 1.41 x 10
-3
 
Day 11 Set 1 4 25.14 6.28 4.16 x 10
-3
 
Day 11 Set 2 4 24.55 6.14 6.25 x 10
-3
 
Day 11 Set 3 4 25.67 6.42 2.20 x 10
-2
 
Day 12 Set 1 4 25.17 6.29 3.06 x 10
-3
 
Day 12 Set 2 4 25.65 6.41 7.28 x 10
-3
 
Day 13 Set 1 4 26.06 6.52 5.74 x 10
-3
 
Day 13 Set 2 5 32.90 6.58 6.10 x 10
-3
 
Day 13 Set 3 4 26.86 6.71 3.84 x 10
-3
 
Day 14 Set 1 4 27.22 6.80 1.24 x 10
-4
 
Day 14 Set 2 4 28.31 7.08 6.66 x 10
-3
 
Day 15 Set 1 5 35.78 7.16 6.09 x 10
-3
 
Day 15 Set 2 5 35.92 7.18 7.05 x 10
-3
 
Day 15 Set 3 4 28.71 7.18 1.08 x 10
-2
 
Day 16 Set 1 4 27.75 6.94 1.03 x 10
-2
 
Day 16 Set 2 4 28.61 7.15 7.87 x 10
-3
 
Day 16 Set 3 5 34.48 6.90 1.13 x 10
-2
 
     
     ANOVA 
    
Source of Variation SS DF MS Fcalc 
Between Groups 12.53 18 0.70 106.30 
Within Groups 0.41 62 0.01 
 
     Total 12.94 80     
   
P-value Ftable 
   
1.21 x 10
-39
 1.77 
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Table A.55: Corrected area (mAU) F-test two- sample for variances for peak 3.  
 
  
Capillary 
2 
Capillary 
1 
Mean 6.7 5.27 
Variance 0.2 0.030 
Observations 77 48 
DF 76 47 
Fcalc 5.5 
 P-value 3.7 x 10
-9
 
 Ftable 1.6   
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Table A.56: Corrected area (mAU) t-test: two sample assuming unequal variances peak 
3.  
 
  Capillary 2 Capillary 1 
Mean 6.7 5.27 
Variance 0.2 0.03 
Observations 77 48 
Hypothesized mean 
Difference 
0 
 DF 112 
 tcalc 26.6 
 P-value 2.8 x 10
-50
 
 ttable 2.0   
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Table A.57: Corrected area (mAU) for peak 4 (p-toluenesulfonic acid) using DOI-CZE. 
 
       
Day 
Capillary 
1 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
6.50 6.51 6.38 6.33 6.44 0.10 1.61 
 
2 6.47 6.62 6.47 6.37 6.29 
   
 
3 6.59 6.55 6.41 6.40 6.32 
   Day 2 1 
 
6.58 6.54 6.48 6.59 6.57 0.16 2.47 
 
2 6.77 6.60 6.31 6.47 6.30 
   
 
3 6.79 6.81 6.72 6.55 6.47 
   Day 3 1 6.49 6.19 6.28 6.63 6.45 6.41 0.17 2.73 
Day 12 1 6.80 6.82 6.56 6.70 6.69 6.75 0.08 1.15 
 
2 6.68 6.87 6.74 6.71 6.80 
   
 
3 6.71 6.81 6.80 6.74 6.81 
   
      
Overall 6.57 0.18 2.74 
       
Day 
Capillary 
2 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
7.51 7.52 7.62 7.67 7.58 0.08 1.06 
Day 10 1 7.52 7.45 7.66 7.52 7.60 7.56 0.06 0.76 
 
2 
 
7.55 7.57 7.59 7.54 
   Day 11 1 
 
7.66 7.66 7.52 7.45 7.78 0.23 2.98 
 
2 7.64 7.66 7.68 7.87 7.76 
   
 
3 
 
8.13 8.04 7.92 8.20 
   Day 12 1 
 
8.66 8.35 8.34 8.36 8.37 0.16 1.93 
 
2 
 
8.45 8.44 8.28 8.09 
   Day 13 1 
 
8.80 8.69 8.51 8.31 8.67 0.18 2.07 
 
2 8.74 8.81 8.70 8.67 8.40 
   
 
3 
 
8.93 8.85 8.72 8.56 
   Day 14 1 
 
8.95 9.02 8.91 8.97 8.94 0.10 1.14 
 
2 8.89 9.06 8.87 8.74 9.05 
   Day 15 1 8.74 8.91 8.89 8.44 8.58 8.86 0.24 2.67 
 
2 8.87 8.80 9.01 8.69 8.81 
   
 
3 
 
9.42 8.91 9.15 8.83 
   Day 16 1 
 
8.90 8.70 8.61 9.46 9.02 0.25 2.80 
 
2 
 
9.05 8.97 8.75 9.04 
   
 
3 9.29 9.14 9.31 9.15 8.87 
   
      
Overall 8.45 0.59 6.95 
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A. 
 
B. 
 
 
Figure A.7: Corrected area (mAU) for peak 4 over the sample injections completed for 
A. capillary 1 and B. capillary 2. 
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Table A.58: Corrected area (mAU) ANOVA for peak 4 capillary 1.  
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 25.72 6.43 8.19 x 10
-3
 
  Day 1 Set 2 5 32.22 6.44 1.53 x 10
-2
 
  Day 1 Set 3 5 32.28 6.46 1.32 x 10
-2
 
  Day 2 Set 1 4 26.18 6.55 2.52 x 10
-3
 
  Day 2 Set 2 5 32.45 6.49 4.01 x 10
-2
 
  Day 2 Set 3 5 33.35 6.67 2.25 x 10
-2
 
  Day 3 Set 1 5 32.03 6.41 3.06 x 10
-2
 
  Day 12 Set 1 5 33.56 6.71 1.11 x 10
-2
 
  Day 12 Set 2 5 33.79 6.76 5.68 x 10
-3
 
  
Day 12 Set 3 5 33.87 6.77 1.83 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.93 9 0.10 6.62 1.26 x 10
-5
 2.14 
Within Groups 0.59 38 0.02 
   
       Total 1.52 47         
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Table A.59: Corrected area (mAU) adjacent mean differences for peak 4 capillary 1. 
 
  
Mean
Day 12 
Set 3
Day 12 
Set 2
Day 12 
Set 1
Day 2 
Set 3
Day 2 
Set 1
Day 2 
Set 2
Day 1 
Set 3
Day 1 
Set 2
Day 1 
Set 1
Day 3 
Set 1
Day 12 Set 3 6.77 -
Day 12 Set 2 6.76 0.01 -
Day 12 Set 1 6.71 0.06 0.05 -
Day 2 Set 3 6.67 0.10 0.09 0.04 -
Day 2 Set 1 6.55 0.23 0.21 0.17 0.12 -
Day 2 Set 2 6.49 0.28 0.27 0.22 0.18 0.06 -
Day 1 Set 3 6.46 0.32 0.30 0.26 0.21 0.09 0.03 -
Day 1 Set 2 6.44 0.33 0.31 0.27 0.22 0.10 0.04 0.01 -
Day 1 Set 1 6.43 0.34 0.33 0.28 0.24 0.12 0.06 0.03 0.02 -
Day 3 Set 1 6.41 0.37 0.35 0.31 0.26 0.14 0.08 0.05 0.04 0.02 -
LSD 0.16
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Table A.60: Corrected area (mAU) ANOVA for peak 4 capillary 2.  
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 31.39 7.85 0.03 
  Day 10 Set 1 5 38.93 7.79 0.03 
  Day 10 Set 2 4 31.66 7.91 0.01 
  Day 11 Set 1 4 31.13 7.78 0.03 
  Day 11 Set 2 4 31.39 7.85 0.01 
  Day 11 Set 3 4 33.03 8.26 0.01 
  Day 12 Set 1 4 33.85 8.46 0.03 
  Day 12 Set 2 4 33.07 8.27 0.04 
  Day 13 Set 1 4 34.66 8.66 0.05 
  Day 13 Set 2 5 43.17 8.63 0.03 
  Day 13 Set 3 4 35.3 8.8 0.1 
  Day 14 Set 1 4 36.01 9.00 0.02 
  Day 14 Set 2 5 46.56 9.31 0.02 
  Day 15 Set 1 5 48.70 9.74 0.03 
  Day 15 Set 2 5 47.57 9.51 0.03 
  Day 15 Set 3 4 38.45 9.61 0.05 
  Day 16 Set 1 4 39.09 9.77 0.01 
  Day 16 Set 2 4 39.43 9.86 0.01 
  Day 16 Set 3 5 45.9 9.2 0.1 
  
       
       ANOVA 
      Source of 
Variation SS DF MS Fcalc P-value Ftable 
Between Groups 42.6 18 2.37 84.02 4.59 x 10
-37
 1.77 
Within Groups 1.78 63 0.03 
   
       Total 44.43 81 
     
 
 
  
373 
 
               
 
                
M
ea
n
D
ay
 1
6
 
S
et
 2
D
ay
 1
6
 
S
et
 1
D
ay
 1
5
 
S
et
 1
D
ay
 1
5
 
S
et
 3
D
ay
 1
5
 
S
et
 2
D
ay
 1
4
 
S
et
 2
D
ay
 1
6
 
S
et
 3
D
ay
 1
4
 
S
et
 1
D
ay
 1
3
 
S
et
 3
D
ay
 1
3
 
S
et
 1
D
ay
 1
3
 
S
et
 2
D
ay
 1
2
 
S
et
 1
D
ay
 1
2
 
S
et
 2
D
ay
 1
1
 
S
et
 3
D
ay
 1
0
 
S
et
 2
D
ay
 1
1
 
S
et
 2
D
ay
 1
 
S
et
 1
D
ay
 1
0
 
S
et
 1
D
ay
 1
1
 
S
et
 1
D
ay
 1
6
 S
et
 2
9
.8
6
-
D
ay
 1
6
 S
et
 1
9
.7
7
0
.0
9
-
D
ay
 1
5
 S
et
 1
9
.7
4
0
.1
2
0
.0
3
-
D
ay
 1
5
 S
et
 3
9
.6
1
0
.2
5
0
.1
6
0
.1
3
-
D
ay
 1
5
 S
et
 2
9
.5
1
0
.3
4
0
.2
6
0
.2
2
0
.1
0
-
D
ay
 1
4
 S
et
 2
9
.3
1
0
.5
5
0
.4
6
0
.4
3
0
.3
0
0
.2
0
-
D
ay
 1
6
 S
et
 3
9
.1
8
0
.6
8
0
.5
9
0
.5
6
0
.4
3
0
.3
3
0
.1
3
-
D
ay
 1
4
 S
et
 1
9
.0
0
0
.8
6
0
.7
7
0
.7
4
0
.6
1
0
.5
1
0
.3
1
0
.1
8
-
D
ay
 1
3
 S
et
 3
8
.8
2
1
.0
4
0
.9
5
0
.9
2
0
.7
9
0
.7
0
0
.4
9
0
.3
6
0
.1
8
-
D
ay
 1
3
 S
et
 1
8
.6
6
1
.1
9
1
.1
1
1
.0
7
0
.9
5
0
.8
5
0
.6
5
0
.5
2
0
.3
4
0
.1
5
-
D
ay
 1
3
 S
et
 2
8
.6
3
1
.2
2
1
.1
4
1
.1
1
0
.9
8
0
.8
8
0
.6
8
0
.5
5
0
.3
7
0
.1
8
0
.0
3
-
D
ay
 1
2
 S
et
 1
8
.4
6
1
.4
0
1
.3
1
1
.2
8
1
.1
5
1
.0
5
0
.8
5
0
.7
2
0
.5
4
0
.3
6
0
.2
0
0
.1
7
-
D
ay
 1
2
 S
et
 2
8
.2
7
1
.5
9
1
.5
0
1
.4
7
1
.3
4
1
.2
5
1
.0
4
0
.9
1
0
.7
4
0
.5
5
0
.4
0
0
.3
7
0
.1
9
-
D
ay
 1
1
 S
et
 3
8
.2
6
1
.6
0
1
.5
1
1
.4
8
1
.3
5
1
.2
6
1
.0
5
0
.9
2
0
.7
4
0
.5
6
0
.4
1
0
.3
8
0
.2
0
0
.0
1
-
D
ay
 1
0
 S
et
 2
7
.9
1
1
.9
4
1
.8
6
1
.8
2
1
.7
0
1
.6
0
1
.4
0
1
.2
7
1
.0
9
0
.9
0
0
.7
5
0
.7
2
0
.5
5
0
.3
5
0
.3
4
-
D
ay
 1
1
 S
et
 2
7
.8
5
2
.0
1
1
.9
2
1
.8
9
1
.7
6
1
.6
7
1
.4
6
1
.3
3
1
.1
5
0
.9
7
0
.8
2
0
.7
9
0
.6
1
0
.4
2
0
.4
1
0
.0
7
-
D
ay
 1
 S
et
 1
7
.8
5
2
.0
1
1
.9
3
1
.8
9
1
.7
7
1
.6
7
1
.4
6
1
.3
4
1
.1
6
0
.9
7
0
.8
2
0
.7
9
0
.6
2
0
.4
2
0
.4
1
0
.0
7
0
.0
0
-
D
ay
 1
0
 S
et
 1
7
.7
9
2
.0
7
1
.9
9
1
.9
5
1
.8
3
1
.7
3
1
.5
3
1
.4
0
1
.2
2
1
.0
3
0
.8
8
0
.8
5
0
.6
8
0
.4
8
0
.4
7
0
.1
3
0
.0
6
0
.0
6
-
D
ay
 1
1
 S
et
 1
7
.7
8
2
.0
7
1
.9
9
1
.9
6
1
.8
3
1
.7
3
1
.5
3
1
.4
0
1
.2
2
1
.0
3
0
.8
8
0
.8
5
0
.6
8
0
.4
8
0
.4
8
0
.1
3
0
.0
6
0
.0
6
0
.0
0
-
L
S
D
0
.2
1
T
a
b
le
 A
.6
1
: 
C
o
rr
ec
te
d
 a
re
a 
(m
A
U
) 
ad
ja
ce
n
t 
m
ea
n
 d
if
fe
re
n
ce
s 
fo
r 
p
ea
k
 4
 c
ap
il
la
ry
 2
. 
374 
 
Table A.62: Corrected area (mAU) F-test two- sample for variances of peak 4.  
 
  
Capillary 
2 
Capillary 
1 
Mean 8.8 6.63 
Variance 0.5 0.05 
Observations 82 48 
DF 81 47 
Fcalc 11.2 
 P-value 3.7 x 10
-15
 
 Ftable 1.6   
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Table A.63: Corrected area (mAU) t-test: two sample assuming unequal variances peak 
4.  
 
  
Capillary 
2 
Capillary 
1 
Mean 8.8 6.63 
Variance 0.5 0.05 
Observations 82 48 
Hypothesized mean 
Difference 
0 
 DF 104 
 tcalc 24.3 
 P-value 9.5 x 10
-45
 
 ttable 2.0   
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Table A.64: Corrected area (mAU) data for peak 5 (disopyramide) using DOI-CZE. 
 
       
Day 
Capillary 
1 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 - 7.54 7.18 7.31 6.73 7.24 0.21 2.97 
 
2 7.32 7.36 7.11 7.42 7.17 
   
 
3 7.44 7.36 7.39 7.08 7.00 
   Day 2 1 7.12 7.47 7.09 7.09 7.14 7.14 0.20 2.82 
 
2 7.49 7.23 7.01 7.01 6.80 
   
 
3 7.19 7.08 7.42 6.85 7.07 
   Day 3 1 6.77 6.79 6.68 6.44 6.58 6.65 0.15 2.20 
Day 12 1 7.05 7.34 7.16 7.18 7.07 7.43 0.25 3.42 
 
2 7.65 7.52 7.72 7.68 7.33 
   
 
3 - 7.82 7.43 7.68 7.44 
   
      
Overall 7.20 0.31 4.27 
       
Day 
Capillary
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 8.47 8.61 8.60 8.45 8.16 8.46 0.18 2.15 
Day 10 1 8.47 8.61 8.60 8.45 8.16 8.56 0.18 2.12 
 
2 8.80 8.69 8.70 8.68 8.46 
   Day 11 1 8.79 8.75 8.90 8.84 8.50 8.69 0.20 2.34 
 
2 
 
8.48 8.72 8.77 8.15 
   
 
3 8.61 8.68 8.94 8.74 8.78 
   Day 12 1 8.60 8.90 8.24 8.36 8.49 8.64 0.22 2.58 
 
2 8.64 8.71 8.90 8.78 8.80 
   Day 13 1 8.83 8.93 8.27 8.64 8.68 8.74 0.24 2.78 
 
2 8.97 8.87 8.98 8.68 8.50 
   
 
3 8.97 8.87 9.01 8.46 8.36 8.64 0.32 3.67 
Day 14 1 8.85 8.82 8.34 8.88 8.42 
   
 
2 9.04 8.01 8.69 8.86 8.48 
   Day 15 1 8.18 8.96 8.25 8.26 8.98 8.55 0.29 3.43 
 
2 8.47 8.37 8.46 8.26 8.33 
   
 
3 8.67 8.59 8.93 8.99 8.50 
   Day 16 1 8.76 8.77 8.88 8.82 8.40 8.63 0.23 2.71 
 
2 8.17 8.38 8.77 8.44 8.34 
   
 
3 8.98 8.64 8.85 8.60 8.62 
   
      
Overall 8.63 0.25 2.85 
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A. 
 
B. 
 
 
Figure A.8: Corrected area (mAU) for peak 5 over the sample injections completed for 
A. capillary 1 and B. capillary 2. 
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Table A.65: Corrected area (mAU) ANOVA for peak 5 capillary 1.  
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 28.8 7.2 0.1 
  Day 1 Set 2 5 35.95 7.19 0.02 
  Day 1 Set 3 5 36.27 7.25 0.04 
  Day 2 Set 1 5 35.91 7.18 0.03 
  Day 2 Set 2 5 36.40 7.28 0.03 
  Day 2 Set 3 5 37.04 7.41 0.04 
  Day 3 Set 1 5 33.26 6.65 0.02 
  Day 12 Set 1 5 36.46 7.29 0.05 
  Day 12 Set 2 5 38.05 7.61 0.04 
  Day 12 Set 3 4 30.58 7.65 0.06 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 3.24 9 0.36 8.53 7.63 x 10
-7
 2.14 
Within Groups 1.60 38 0.04 
   
       Total 4.85 47         
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Table A.66: Corrected area (mAU) adjacent mean differences for peak 5 capillary 1.  
 
 
 
  
Mean
Day 12 
Set 3
Day 12 
Set 2
Day 2 
Set 3
Day 12 
Set 1
Day 2 
Set 2
Day 1 
Set 3
Day 1 
Set 2
Day 1 
Set 1
Day 2 
Set 1
Day 3 
Set 1
Day 12 Set 3 7.65 -
Day 12 Set 2 7.61 0.04 -
Day 2 Set 3 7.41 0.24 0.20 -
Day 12 Set 1 7.29 0.35 0.32 0.12 -
Day 2 Set 2 7.28 0.37 0.33 0.13 0.01 -
Day 1 Set 3 7.25 0.39 0.36 0.15 0.04 0.03 -
Day 1 Set 2 7.19 0.46 0.42 0.22 0.10 0.09 0.06 -
Day 1 Set 1 7.19 0.46 0.42 0.22 0.10 0.09 0.06 0.00 -
Day 2 Set 1 7.18 0.46 0.43 0.22 0.11 0.10 0.07 0.01 0.01 -
Day 3 Set 1 6.65 0.99 0.96 0.75 0.64 0.63 0.60 0.54 0.54 0.53 -
LSD 0.26
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Table A.67: Corrected area (mAU) ANOVA for peak 5 capillary 2.  
       Groups Count Sum Average Variance 
  Day 1 Set 1 5 42.30 8.46 0.03 
  Day 10 Set 1 5 42.30 8.46 0.03 
  Day 10 Set 2 5 43.32 8.66 0.02 
  Day 11 Set 1 5 43.78 8.76 0.02 
  Day 11 Set 2 4 34.13 8.53 0.08 
  Day 11 Set 3 5 43.75 8.75 0.02 
  Day 12 Set 1 5 42.60 8.52 0.06 
  Day 12 Set 2 5 43.83 8.77 0.01 
  Day 13 Set 1 5 43.35 8.67 0.06 
  Day 13 Set 2 5 44.01 8.80 0.04 
  Day 13 Set 3 5 43.67 8.73 0.09 
  Day 14 Set 1 5 43.31 8.66 0.07 
  Day 14 Set 2 5 43.08 8.62 0.2 
  Day 15 Set 1 5 42.63 8.53 0.2 
  Day 15 Set 2 5 41.89 8.38 0.01 
  Day 15 Set 3 5 43.68 8.74 0.05 
  Day 16 Set 1 5 43.64 8.73 0.04 
  Day 16 Set 2 5 42.11 8.42 0.05 
  Day 16 Set 3 5 43.69 8.74 0.03 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 1.61 18 0.09 1.67 0.07 1.74 
Within Groups 4.03 75 0.05 
   
       Total 5.63 93         
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Table A.68: Corrected area (mAU) F-test two- sample for variances of peak 5.  
 
  
Capillary 
1 
Capillary 
2 
Mean 7.20 8.63 
Variance 0.09 0.06 
Observations 48 94 
DF 47 93 
Fcalc 1.56 
 P-value 0.03 
 Ftable 1.50   
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Table A.69: Corrected area (mAU) t-test: two sample assuming unequal variances peak 
5. 
 
  Capillary 2 Capillary 1 
Mean 8.63 7.20 
Variance 0.06 0.09 
Observations 94 48 
Hypothesized mean 
Difference 
0 
 DF 79 
 tcalc 27.87 
 P-value 1.25 x 10
-42
 
 ttable 1.99   
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Table A.70: Corrected area (mAU) for peak 2 in reference to peak 1. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.03 0.94 1.02 1.01 0.95 0.99 0.04 4.00 
 
2 0.94 0.98 0.97 0.98 0.92 
   
 
3 0.98 0.97 1.07 1.00 1.02    
Day 2 1 1.03 1.01 0.95 0.97 1.00 1.00 0.03 3.42 
 
2 1.06 0.98 0.98 0.97 1.06 
   
 
3 1.01 0.97 1.01 1.03 0.95    
Day 3 1 1.02 0.98 0.92 0.94 1.01 0.98 0.04 4.43 
Day 12 1 1.03 0.99 1.01 0.97 1.03 1.03 0.04 3.94 
 
2 
 
1.05 1.07 1.00 0.98 
   
 
3 1.08 
 
1.09 1.05 1.08    
      
Overall 1.00 0.04 4.25 
       
Day 
Capillary
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 0.99 0.98 0.97 0.99 1.01 0.99 0.02 1.58 
Day 10 1 0.90 1.01 0.96 0.90 0.95 0.95 0.04 3.79 
 
2 0.95 0.99 0.96 0.94 0.96    
Day 11 1 
 
0.95 1.03 1.08 0.98 0.94 0.06 6.42 
 
2 
 
0.95 0.88 0.97 0.89 
   
 
3 0.88 0.95 0.89 0.92 0.90    
Day 12 1 0.98 0.94 0.96 1.00 0.92 0.96 0.03 2.87 
 
2 0.94 0.95 0.99 0.98 0.92    
Day 13 1 0.98 1.02 1.05 0.87 1.03 0.96 0.05 5.19 
 
2 0.98 0.95 0.94 0.94 0.94 
   
 
3 0.95 0.97 0.89 0.93 0.98    
Day 14 1 0.88 0.88 0.93 0.99 0.95 0.95 0.05 5.42 
 
2 0.95 0.97 0.98 1.05 0.98    
Day 15 1 0.92 0.89 0.94 0.88 0.92 0.90 0.03 3.24 
 
2 0.85 0.88 0.90 0.96 0.91 
   
 
3 0.89 0.86 0.90 0.91 0.90    
Day 16 1 0.86 0.92 0.90 0.81 0.88 0.89 0.03 3.54 
 
2 0.93 0.91 0.92 0.88 0.90    
 
3 0.90 0.89 0.93 0.85 0.87    
      
Overall 0.94 0.05 5.38 
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Table A.71: Corrected area (mAU) ANOVA for peak 2 in reference to peak 1 for 
capillary 1. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 5 4.94 0.99 1.69 x 10
-3
 
Day 1 Set 2 5 4.80 0.96 7.12 x 10
-4
 
Day 1 Set 3 5 5.04 1.01 1.62 x 10
-3
 
Day 2 Set 1 5 4.96 0.99 8.49 x 10
-4
 
Day 2 Set 2 5 5.04 1.01 1.97 x 10
-3
 
Day 2 Set 3 5 4.96 0.99 1.03 x 10
-3
 
Day 3 Set 1 5 4.88 0.98 1.86 x 10
-3
 
Day 12 Set 1 5 5.02 1.00 7.18 x 10
-4
 
Day 12 Set 2 4 4.11 1.03 1.58 x 10
-3
 
Day 12 Set 3 4 4.29 1.07 4.07 x 10
-4
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.04 9 4.15 x 10
-3
 3.30 
Within Groups 0.05 38 1.26 x 10
-3
 
 
     Total 0.09 47     
   
P-value Ftable 
   
4.62 x 10
-3
 2.14 
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Table A.72: Corrected area (mAU) adjacent mean differences for peak 2 in reference to 
peak 1 for capillary 1. 
 
 
 
  
Mean
Day 3 
Set 1
Day 2 
Set 3
Day 12 
Set 2
Day 1 
Set 3
Day 2 
Set 2
Day 12 
Set 3
Day 12 
Set 1
Day 1 
Set 1
Day 2 
Set 1
Day 1 
Set 2
Day 3 Set 1 1.07 -
Day 2 Set 3 1.03 0.05 -
Day 12 Set 2 1.01 0.07 0.02 -
Day 1 Set 3 1.01 0.07 0.02 0.00 -
Day 2 Set 2 1.00 0.07 0.02 0.00 0.00 -
Day 12 Set 3 0.99 0.08 0.03 0.02 0.01 0.01 -
Day 12 Set 1 0.99 0.08 0.03 0.02 0.02 0.01 0.00 -
Day 1 Set 1 0.99 0.08 0.04 0.02 0.02 0.01 0.00 0.00 -
Day 2 Set 1 0.98 0.10 0.05 0.03 0.03 0.03 0.02 0.02 0.01 -
Day 1 Set 2 0.96 0.11 0.07 0.05 0.05 0.04 0.03 0.03 0.03 0.01 -
LSD 0.05
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Table A.73: Corrected area (mAU) ANOVA for peak 2 in reference to peak 1 for 
capillary 2. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 5 4.94 0.99 2.43 x 10
-4
 
  Day 10 Set 1 5 4.70 0.94 2.19 x 10
-3
 
  Day 10 Set 2 5 4.80 0.96 4.71 x 10
-4
 
  Day 11 Set 1 4 4.04 1.01 3.20 x 10
-3
 
  Day 11 Set 2 4 3.68 0.92 2.16 x 10
-3
 
  Day 11 Set 3 5 4.54 0.91 6.82 x 10
-4
 
  Day 12 Set 1 5 4.80 0.96 8.25 x 10
-4
 
  Day 12 Set 2 5 4.79 0.96 8.83 x 10
-4
 
  Day 13 Set 1 5 4.95 0.99 5.49 x 10
-3
 
  Day 13 Set 2 5 4.75 0.95 3.33 x 10
-4
 
  Day 13 Set 3 5 4.71 0.94 1.19 x 10
-3
 
  Day 14 Set 1 5 4.62 0.92 2.20 x 10
-3
 
  Day 14 Set 2 5 4.93 0.99 1.53 x 10
-3
 
  Day 15 Set 1 5 4.55 0.91 6.61 x 10
-4
 
  Day 15 Set 2 5 4.51 0.90 1.72 x 10
-3
 
  Day 15 Set 3 5 4.45 0.89 3.47 x 10
-4
 
  Day 16 Set 1 5 4.36 0.87 1.55 x 10
-3
 
  Day 16 Set 2 5 4.54 0.91 4.03 x 10
-4
 
  Day 16 Set 3 5 4.45 0.89 7.68 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.13 18 7.32 x 10
-3
 5.31 1.23 x 10
-7
 1.74 
Within Groups 0.10 74 1.38 x 10
-3
 
   
       Total 0.23 92         
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Table A.75: Corrected area (mAU) ratio for peak 5 in reference to peak 1. 
 
       
Day 
Capillary 
1 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
1.35 1.37 1.33 1.23 1.33 0.05 3.39 
 
2 1.30 1.34 1.35 1.34 1.27 
   
 
3 1.38 1.31 1.41 1.34 1.34 
   Day 2 1 1.34 1.38 1.29 1.32 1.35 1.34 0.04 3.23 
 
2 1.44 1.34 1.34 1.33 1.38 
   
 
3 1.31 1.27 1.39 1.30 1.34 
   Day 3 1 1.31 1.28 1.24 1.22 1.27 1.27 0.04 2.97 
Day 12 1 1.38 1.31 1.29 1.35 1.31 1.39 0.07 5.20 
 
2 
 
1.44 1.51 1.43 1.33 
   
 
3 
  
1.44 1.46 1.45 
   
      
Overall 1.34 0.06 4.66 
       
Day 
Capillary 
2 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.43 1.43 1.51 1.45 1.45 1.45 0.03 2.17 
Day 10 1 1.38 1.52 1.44 1.43 1.29 1.44 0.06 4.48 
 
2 1.47 1.47 1.49 1.45 1.45 
   Day 11 1 1.48 1.46 1.52 1.55 1.42 1.45 0.05 3.59 
 
2 
 
1.44 1.43 1.43 1.33 
   
 
3 1.44 1.43 1.47 1.42 1.42 
   Day 12 1 1.39 1.45 1.40 1.44 1.43 1.43 0.05 3.82 
 
2 1.33 1.42 1.54 1.44 1.49 
   Day 13 1 1.50 1.48 1.41 1.36 1.48 1.44 0.04 2.76 
 
2 1.48 1.41 1.44 1.47 1.41 
   
 
3 1.40 1.41 1.46 1.44 1.46 
   Day 14 1 1.35 1.42 1.29 1.47 1.41 1.41 0.09 6.20 
 
2 1.44 1.28 1.40 1.54 1.52 
   Day 15 1 1.26 1.37 1.30 1.28 1.41 1.34 0.05 3.66 
 
2 1.35 1.30 1.34 1.40 1.34 
   
 
3 1.32 1.31 1.38 1.43 1.37 
   Day 16 1 1.36 1.40 1.44 1.34 1.31 1.36 0.05 3.44 
 
2 1.29 1.37 1.39 1.32 1.30 
   
 
3 1.39 1.37 1.41 1.28 1.35 
   
      
Overall 1.41 0.07 4.81 
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Table A.76: Corrected area (mAU) ANOVA for peak 5 in reference to peak 1 for 
capillary 1. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 5.28 1.32 3.87 x 10
-3
 
  Day 1 Set 2 5 6.60 1.32 1.12 x 10
-3
 
  Day 1 Set 3 5 6.78 1.36 1.55 x 10
-3
 
  Day 2 Set 1 5 6.67 1.33 1.07 x 10
-3
 
  Day 2 Set 2 5 6.82 1.36 2.19 x 10
-3
 
  Day 2 Set 3 5 6.60 1.32 1.96 x 10
-3
 
  Day 3 Set 1 5 6.33 1.27 1.41 x 10
-3
 
  Day 12 Set 1 5 6.64 1.33 1.38 x 10
-3
 
  Day 12 Set 2 4 5.71 1.43 5.10 x 10
-3
 
  Day 12 Set 3 3 4.36 1.45 8.74 x 10
-5
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.11 9 0.01 6.09 3.63 x 10
-5
 2.15 
Within Groups 0.07 36 1.94 x 10
-3
 
   
       Total 0.18 45         
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Table A.77: Corrected area (mAU) adjacent mean differences for peak 5 in reference to 
peak 1 for capillary 1. 
 
 
 
 
  
Mean
Day 12 
Set 3
Day 12 
Set 2
Day 2 
Set 2
Day 1 
Set 3
Day 2 
Set 1
Day 12 
Set 1
Day 2 
Set 3
Day 1 
Set 1
Day 1 
Set 2
Day 3 
Set 1
Day 12 Set 3 1.45 -
Day 12 Set 2 1.43 0.03 -
Day 2 Set 2 1.36 0.09 0.06 -
Day 1 Set 3 1.36 0.10 0.07 0.01 -
Day 2 Set 1 1.33 0.12 0.09 0.03 0.02 -
Day 12 Set 1 1.33 0.12 0.10 0.04 0.03 0.01 -
Day 2 Set 3 1.32 0.13 0.11 0.04 0.04 0.01 0.01 -
Day 1 Set 1 1.32 0.13 0.11 0.05 0.04 0.01 0.01 0.00 -
Day 1 Set 2 1.32 0.13 0.11 0.05 0.04 0.01 0.01 0.00 0.00 -
Day 3 Set 1 1.27 0.19 0.16 0.10 0.09 0.07 0.06 0.05 0.05 0.05 -
LSD 0.06
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Table A.78: Corrected area (mAU) ANOVA for peak 5 in reference to peak 1 for 
capillary 2. 
 
       Groups Count Sum Average Variance 
  Day 1 Set 1 5 115.97 23.19 0.04 
  Day 10 Set 1 5 114.79 22.96 0.01 
  Day 10 Set 2 5 115.26 23.05 0.02 
  Day 11 Set 1 5 114.98 23.00 0.02 
  Day 11 Set 2 4 91.73 22.93 0.01 
  Day 11 Set 3 5 112.93 22.59 0.02 
  Day 12 Set 1 5 112.68 22.54 0.01 
  Day 12 Set 2 5 111.46 22.29 0.05 
  Day 13 Set 1 5 111.32 22.26 0.01 
  Day 13 Set 2 5 110.51 22.10 0.02 
  Day 13 Set 3 5 109.90 21.98 0.02 
  Day 14 Set 1 5 109.047 21.809 0.005 
  Day 14 Set 2 5 111.14 22.23 0.07 
  Day 15 Set 1 5 107.09 21.42 0.03 
  Day 15 Set 2 5 108.67 21.73 0.01 
  Day 15 Set 3 5 108.24 21.65 0.02 
  Day 16 Set 1 5 106.60 21.32 0.05 
  Day 16 Set 2 5 105.70 21.14 0.08 
  Day 16 Set 3 5 111.08 22.22 0.04 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 34.29 18 1.91 65.98 1.74 x 10
-5
 1.74 
Within Groups 2.17 75 0.03 
   
       Total 36.46 93         
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Table A.80: Corrected area (mAU) ratio for peak 4 in reference to peak 3. 
 
       
Day 
Capillary 
1 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
1.26 1.25 1.24 1.19 1.24 0.04 2.91 
 
2 1.26 1.32 1.23 1.23 1.20 
   
 
3 1.27 1.28 1.18 1.26 1.26 
   Day 2 1 
 
1.23 1.24 1.24 1.27 1.25 0.02 1.88 
 
2 1.27 1.27 1.22 1.24 1.23 
   
 
3 1.28 1.30 1.26 1.25 1.24 
   Day 3 1 1.29 1.24 1.27 1.25 1.24 1.26 0.02 1.87 
Day 12 1 1.27 
 
1.22 1.24 1.27 1.26 0.03 2.17 
 
2 1.26 1.25 1.25 1.22 1.25 
   
 
3 1.24 1.26 1.28 1.29 1.32 
   
      
Overall 1.25 0.03 2.28 
       
Day 
Capillary 
2 
Set Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
1.13 1.17 1.19 1.22 1.12 0.04 3.28 
Day 10 1 1.19 1.12 1.21 1.18 1.20 1.16 0.04 3.13 
 
2 
 
1.11 1.11 1.15 1.15 
   Day 11 1 
 
1.18 1.22 1.13 1.17 1.21 0.05 3.85 
 
2 
 
1.22 1.21 1.24 1.29 
   
 
3 
 
1.18 1.20 1.21 1.28 
   Day 12 1 
 
1.26 1.27 1.28 1.32 1.28 0.02 1.30 
 
2 
 
1.28 1.28 1.26 1.27 
   Day 13 1 
 
1.30 1.28 1.29 1.27 1.28 0.02 1.26 
 
2 1.28 1.28 1.30 1.30 1.28 
   
 
3 
 
1.27 1.28 1.27 1.24 
   Day 14 1 
 
1.24 1.24 1.25 1.25 1.24 0.02 1.37 
 
2 1.22 1.22 1.22 1.23 1.26 
   Day 15 1 1.17 1.16 1.17 1.11 1.15 1.16 0.03 2.80 
 
2 1.13 1.15 1.15 1.18 1.15 
   
 
3 
 
1.25 1.13 1.18 1.17 
   Day 16 1 
 
1.22 1.20 1.19 1.33 1.25 0.05 3.91 
 
2 
 
1.21 1.20 1.21 1.28 
   
 
3 1.27 1.26 1.31 1.29 1.29 
   
      
Overall 1.22 0.06 4.71 
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Table A.81: Corrected area (mAU) ANOVA for peak 4 in reference to peak 3 for 
capillary 1. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 4.94 1.23 7.89 x 10
-4
 
  Day 1 Set 2 5 6.24 1.25 2.13 x 10
-3
 
  Day 1 Set 3 5 6.25 1.25 1.38 x 10
-3
 
  Day 2 Set 1 4 4.98 1.24 3.87 x 10
-4
 
  Day 2 Set 2 5 6.24 1.25 5.82 x 10
-4
 
  Day 2 Set 3 5 6.33 1.27 6.23 x 10
-4
 
  Day 3 Set 1 5 6.29 1.26 5.52 x 10
-4
 
  Day 12 Set 1 4 4.99 1.25 4.84 x 10
-4
 
  Day 12 Set 2 5 6.22 1.24 1.93 x 10
-4
 
  Day 12 Set 3 5 6.39 1.28 1.01 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 6.79 x 10
-3
 9 7.54 x 10
-4
 0.90 0.53 2.14 
Within Groups 3.09 x 10
-2
 37 8.34 x 10
-4
 
   
       Total 0.04 46         
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Table A.82: Corrected area (mAU) ANOVA for peak 4 in reference to peak 3 for 
capillary 2. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 4.71 1.18 1.36 x 10
-3
 
  Day 10 Set 1 5 5.89 1.18 1.10 x 10
-3
 
  Day 10 Set 2 4 4.53 1.13 5.48 x 10
-4
 
  Day 11 Set 1 4 4.70 1.18 1.65 x 10
-3
 
  Day 11 Set 2 4 4.97 1.24 1.24 x 10
-3
 
  Day 11 Set 3 4 4.87 1.22 2.04 x 10
-3
 
  Day 12 Set 1 4 5.13 1.28 5.14 x 10
-4
 
  Day 12 Set 2 4 5.08 1.27 3.62 x 10
-5
 
  Day 13 Set 1 4 5.14 1.29 1.17 x 10
-4
 
  Day 13 Set 2 5 6.44 1.29 1.20 x 10
-4
 
  Day 13 Set 3 4 5.06 1.27 3.52 x 10
-4
 
  Day 14 Set 1 4 4.99 1.25 8.08 x 10
-5
 
  Day 14 Set 2 5 6.15 1.23 3.50 x 10
-4
 
  Day 15 Set 1 5 5.76 1.15 5.84 x 10
-4
 
  Day 15 Set 2 5 5.76 1.15 2.89 x 10
-4
 
  Day 15 Set 3 4 4.72 1.18 2.60 x 10
-3
 
  Day 16 Set 1 4 4.93 1.23 4.35 x 10
-3
 
  Day 16 Set 2 4 4.90 1.22 1.54 x 10
-3
 
  Day 16 Set 3 5 6.42 1.28 3.90 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.21 18 1.15 x 10
-2
 11.97 4.45 x 10
-14
 1.77 
Within Groups 0.06 63 9.62 x 10
-4
 
   
       Total 0.27 81         
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Table A.84: Resolution data for peak 2 (chlorpheniramine) and peak 3 (benzenesulfonic 
acid) using DOI-CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
8.33 8.23 8.30 7.95 8.43 0.31 3.65 
 
2 8.86 8.93 8.80 8.52 8.41 
   
 
3 8.56 8.51 8.56 8.17 7.93 
   Day 2 1 
 
8.21 8.02 7.97 7.86 8.29 0.26 3.13 
 
2 8.51 8.29 8.26 8.19 8.03 
   
 
3 8.35 8.66 8.63 8.60 8.43 
   Day 3 1 8.97 8.56 8.78 8.76 8.95 8.80 0.17 1.88 
Day 12 1 7.87 
 
7.79 7.92 7.64 7.80 0.12 1.54 
 
2 
 
7.77 7.67 7.55 7.87 
   
 
3 7.75 7.84 7.96 7.86 7.87 
   
      
Overall 8.25 0.40 4.81 
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 6.78 6.94 6.62 6.56 6.60 6.70 0.16 2.34 
Day 10 1 
 
6.63 6.58 6.42 6.55 6.78 0.27 3.97 
 
2 
 
7.14 7.12 6.90 6.84 
   Day 11 1 
 
7.32 7.41 7.25 7.36 7.20 0.30 4.20 
 
2 
 
6.55 6.70 7.24 6.96 
   
 
3 
 
7.46 7.49 7.36 7.28 
   Day 12 1 
 
6.85 7.28 6.25 6.83 6.81 0.28 4.17 
 
2 
 
6.87 6.84 6.87 6.67 
   Day 13 1 6.62 6.59 6.97 6.81 6.68 6.60 0.17 2.52 
 
2 
 
6.54 6.48 6.50 6.49 
   
 
3 
 
6.69 6.62 6.52 6.29 
   Day 14 1 6.41 6.46 6.43 6.39 6.28 6.32 0.13 2.10 
 
2 6.13 6.49 6.31 6.24 6.12 
   Day 15 1 
 
6.16 6.20 6.25 5.99 6.21 0.14 2.20 
 
2 
 
6.44 6.37 6.13 6.15 
   
 
3 
 
6.16 6.23 6.02 6.37 
   Day 16 1 
 
6.42 6.37 6.32 6.13 6.68 0.35 5.29 
 
2 6.67 6.64 6.58 6.54 6.38 
   
 
3 6.99 7.18 7.19 7.05 7.07 
   
      
Overall 6.65 0.38 5.76 
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A. 
 
B. 
 
 
Figure A.9: Resolution between peak 2 and peak 3 over the sample injections completed 
for A. capillary 1 and B. capillary 2. 
 
7.400
7.600
7.800
8.000
8.200
8.400
8.600
8.800
9.000
9.200
0 10 20 30 40 50
R
e
so
lu
ti
o
n
 
Injection Number 
Resolution DOI-CZE Capillary 1 Peak 2 
and Peak 3 
5.50
6.00
6.50
7.00
7.50
8.00
0 20 40 60 80 100
R
e
so
lu
ti
o
n
 
Injection Number 
Resolution DOI-CZE Capillary 2 Peak 2 
and Peak 3 
399 
 
Table A.85: Resolution ANOVA for peak 2 and peak 3 capillary 1. 
      Groups Count Sum Average Variance 
  Day 1 Set 1 4 32.81 8.20 0.03 
  Day 1 Set 2 5 43.52 8.70 0.05 
  Day 1 Set 3 5 41.73 8.35 0.08 
  Day 2 Set 1 4 32.05 8.01 0.02 
  Day 2 Set 2 5 41.28 8.26 0.03 
  Day 2 Set 3 5 42.67 8.53 0.02 
  Day 3 Set 1 5 44.02 8.80 0.03 
  Day 12 Set 1 4 31.23 7.81 0.02 
  Day 12 Set 2 4 30.84 7.71 0.02 
  Day 12 Set 3 5 39.289 7.858 0.006 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between 
Groups 5.97 9 0.66 21.41 6.41 x 10
-21
 2.15 
Within 
Groups 1.11 36 0.03 
   
       Total 7.08 45         
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Table A.86: Resolution adjacent mean differences for peak 2 and peak 3 capillary 1. 
 
 
  
Mean
Day 3 
Set 1
Day 1 
Set 2
Day 2 
Set 3
Day 1 
Set 3
Day 2 
Set 2
Day 1 
Set 1
Day 2 
Set 1
Day 12 
Set 3
Day 12 
Set 1
Day 12 
Set 2
Day 3 Set 1 8.80 -
Day 1 Set 2 8.70 0.10 -
Day 2 Set 3 8.53 0.27 0.17 -
Day 1 Set 3 8.35 0.46 0.36 0.19 -
Day 2 Set 2 8.26 0.55 0.45 0.28 0.09 -
Day 1 Set 1 8.20 0.60 0.50 0.33 0.14 0.05 -
Day 2 Set 1 8.01 0.79 0.69 0.52 0.33 0.24 0.19 -
Day 12 Set 3 7.86 0.95 0.85 0.68 0.49 0.40 0.35 0.16 -
Day 12 Set 1 7.81 1.00 0.90 0.73 0.54 0.45 0.40 0.21 0.05 -
Day 12 Set 2 7.71 1.09 0.99 0.82 0.63 0.54 0.49 0.30 0.15 0.10 -
LSD 0.23
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Table A.87: Resolution ANOVA for peak 2 and peak 3 capillary 2. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 5 33.50 6.70 2.45 x 10
-2
 
  Day 10 Set 1 4 26.19 6.55 8.01 x 10
-3
 
  Day 10 Set 2 4 28.01 7.00 2.34 x 10
-2
 
  Day 11 Set 1 4 29.33 7.33 4.36 x 10
-3
 
  Day 11 Set 2 4 27.45 6.86 9.32 x 10
-2
 
  Day 11 Set 3 4 29.59 7.40 9.12 x 10
-3
 
  Day 12 Set 1 4 27.21 6.80 1.78 x 10
-1
 
  Day 12 Set 2 4 27.25 6.81 9.95 x 10
-3
 
  Day 13 Set 1 5 33.66 6.73 2.41 x 10
-2
 
  Day 13 Set 2 4 26.02 6.50 6.43 x 10
-4
 
  Day 13 Set 3 4 26.13 6.53 2.97 x 10
-2
 
  Day 14 Set 1 5 31.97 6.39 4.81 x 10
-3
 
  Day 14 Set 2 5 31.28 6.26 2.33 x 10
-2
 
  Day 15 Set 1 4 24.60 6.15 1.27 x 10
-2
 
  Day 15 Set 2 4 25.08 6.27 2.46 x 10
-2
 
  Day 15 Set 3 4 24.78 6.20 2.09 x 10
-2
 
  Day 16 Set 1 4 25.23 6.31 1.58 x 10
-2
 
  Day 16 Set 2 5 32.80 6.56 1.29 x 10
-2
 
  Day 16 Set 3 5 35.49 7.10 7.69 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 10.22 18 0.57 21.29 3.50 x 10
-20
 1.77 
Within Groups 1.68 63 0.03 
   
       Total 11.90 81         
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Table A.89: Resolution F-test two- sample for variances of peak 2 and peak 3. 
 
  
Capillary 
1 
Capillary 
2 
Mean 8.02 6.62 
Variance 0.10 0.09 
Observations 50 94 
DF 49 93 
Fcalc 1.13 
 P-value 0.30 
 Ftable  1.49   
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Table A.90: Resolution t-Test: two sample assuming equal variances peak 2 and peak 3. 
  
  Capillary 2 Capillary 1 
Mean 8.02 6.62 
Variance 0.10 0.09 
Observations 50 94 
Pooled Variance 0.09 
 Hypothesized mean Difference 0 
 DF 142 
 tcalc  26.05 
 P-value 5.89 x 10
-56
 
 ttable  1.98 
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Table A.91: Resolution data for peak 3 (benzenesulfonic acid) and peak 4  
(p-toluenesulfonic acid) using DOI-CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
8.36 8.30 8.36 8.34 8.41 0.08 4.00 
 
2 8.44 8.46 8.53 8.33 8.38 
   
 
3 8.57 8.44 8.48 8.33 8.39 
   Day 2 1 
 
8.54 8.52 8.21 8.32 8.25 0.13 1.54 
 
2 8.19 8.22 8.25 8.24 8.21 
   
 
3 8.15 8.13 8.15 8.20 8.19 
   Day 3 1 8.19 8.30 8.18 8.32 8.56 8.31 0.16 1.87 
Day 12 1 8.24 8.24 8.28 8.05 8.30 8.07 0.14 1.71 
 
2 7.97 7.93 7.96 7.99 8.20 
   
 
3 8.10 7.99 7.94 8.00 7.94 
   
      
Overall 8.25 0.18 2.16 
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 7.96 7.99 8.01 8.07 8.02 8.01 0.04 0.53 
Day 10 1 8.51 8.02 7.92 8.01 8.11 8.08 0.17 2.09 
 
2 8.17 7.97 8.05 8.02 7.97 
   Day 11 1 8.03 7.98 7.95 7.94 8.01 7.95 0.16 2.04 
 
2 8.20 8.38 7.83 7.89 7.91 
   
 
3 7.86 7.77 7.82 7.89 7.79 
   Day 12 1 7.98 7.72 7.76 7.77 7.82 7.79 0.08 1.05 
 
2 
 
7.71 7.72 7.79 7.82 
   Day 13 1 
 
7.68 7.74 7.78 7.73 7.69 0.05 0.70 
 
2 7.65 7.73 7.69 7.68 7.74 
   
 
3 
 
7.60 7.60 7.70 7.68 
   Day 14 1 
 
7.51 7.60 7.66 7.65 7.58 0.06 0.79 
 
2 7.55 7.63 7.53 7.49 7.59 
   Day 15 1 7.61 7.42 7.51 7.47 7.70 7.49 0.13 1.72 
 
2 7.36 7.45 7.35 7.46 7.46 
   
 
3 7.82 7.40 7.42 7.45 7.41 
   Day 16 1 7.30 7.22 7.23 7.29 7.35 7.40 0.19 2.54 
 
2 
 
7.14 7.27 7.35 7.36 
   
 
3 7.57 7.59 7.63 7.64 7.73 
   
      
Overall 7.71 0.27 3.46 
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A. 
 
B. 
 
 
Figure A.10: Resolution between peak 3 and peak 4 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.92: Resolution ANOVA for peak 3 and peak 4 capillary 1.  
      Groups Count Sum Average Variance 
  Day 1 Set 1 5 42.44 8.49 0.07 
  Day 1 Set 2 5 42.122 8.424 0.006 
  Day 1 Set 3 5 42.19 8.44 0.01 
  Day 2 Set 1 5 41.75 8.35 0.03 
  Day 2 Set 2 5 41.069 8.214 0.001 
  Day 2 Set 3 5 40.824 8.165 0.001 
  Day 3 Set 1 5 41.55 8.31 0.02 
  Day 12 Set 1 5 41.11 8.22 0.01 
  Day 12 Set 2 5 40.05 8.01 0.01 
  Day 12 Set 3 5 39.965 7.993 0.004 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 1.34 9 0.15 9.25 2.07 x 10
-7
 2.12 
Within Groups 0.64 40 0.02 
   
       Total 1.99 49         
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Table A.93: Resolution adjacent mean differences for peak 3 and peak 4 capillary 1.  
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 3
Day 1 
Set 2
Day 2 
Set 1
Day 3 
Set 1
Day 12 
Set 1
Day 2 
Set 2
Day 2 
Set 3
Day 12 
Set 2
Day 12 
Set 3
Day 1 Set 1 8.49 -
Day 1 Set 3 8.44 0.05 -
Day 1 Set 2 8.424 0.06 0.01 -
Day 2 Set 1 8.35 0.14 0.09 0.07 -
Day 3 Set 1 8.31 0.18 0.13 0.11 0.04 -
Day 12 Set 1 8.22 0.27 0.22 0.20 0.13 0.09 -
Day 2 Set 2 8.214 0.27 0.22 0.21 0.14 0.10 0.01 -
Day 2 Set 3 8.165 0.32 0.27 0.26 0.19 0.14 0.06 0.05 -
Day 12 Set 2 8.01 0.48 0.43 0.42 0.34 0.30 0.21 0.20 0.16 -
Day 12 Set 3 7.993 0.49 0.45 0.43 0.36 0.32 0.23 0.22 0.17 0.02 -
LSD 0.16
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Table A.94: Resolution ANOVA for peak 3 and peak 4 capillary 2.  
      Groups Count Sum Average Variance 
  Day 1 Set 1 5 40.051 8.010 0.002 
  Day 10 Set 1 5 40.58 8.12 0.05 
  Day 10 Set 2 5 40.175 8.035 0.007 
  Day 11 Set 1 5 39.911 7.982 0.001 
  Day 11 Set 2 5 40.21 8.04 0.06 
  Day 11 Set 3 5 39.125 7.825 0.003 
  Day 12 Set 1 5 39.04 7.81 0.01 
  Day 12 Set 2 4 31.047 7.762 0.003 
  Day 13 Set 1 4 30.939 7.735 0.002 
  Day 13 Set 2 5 38.495 7.699 0.001 
  Day 13 Set 3 4 30.582 7.645 0.003 
  Day 14 Set 1 4 30.422 7.606 0.004 
  Day 14 Set 2 5 37.799 7.560 0.003 
  Day 15 Set 1 5 37.71 7.54 0.01 
  Day 15 Set 2 5 37.086 7.417 0.003 
  Day 15 Set 3 5 37.50 7.50 0.03 
  Day 16 Set 1 5 36.384 7.277 0.003 
  Day 16 Set 2 4 29.12 7.28 0.01 
  Day 16 Set 3 5 38.161 7.632 0.004 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 5.52 18 0.31 26.18 2.43 x 10
-24
 1.75 
Within Groups 0.83 71 0.01 
   
       Total 6.35 89         
 
  
410 
 
                
M
ea
n
D
ay
 1
0
 
S
et
 1
D
ay
 1
1
 
S
et
 2
D
ay
 1
0
 
S
et
 2
D
ay
 1
 
S
et
 1
D
ay
 1
1
 
S
et
 1
D
ay
 1
1
 
S
et
 3
D
ay
 1
2
 
S
et
 1
D
ay
 1
2
 
S
et
 2
D
ay
 1
3
 
S
et
 1
D
ay
 1
3
 
S
et
 2
D
ay
 1
3
 
S
et
 3
D
ay
 1
6
 
S
et
 3
D
ay
 1
4
 
S
et
 1
D
ay
 1
4
 
S
et
 2
D
ay
 1
5
 
S
et
 1
D
ay
 1
5
 
S
et
 3
D
ay
 1
5
 
S
et
 2
D
ay
 1
6
 
S
et
 2
D
ay
 1
6
 
S
et
 1
D
ay
 1
0
 S
et
 1
8
.1
2
-
D
ay
 1
1
 S
et
 2
8
.0
4
0
.0
7
-
D
ay
 1
0
 S
et
 2
8
.0
3
0
.0
8
0
.0
1
-
D
ay
 1
 S
et
 1
8
.0
1
0
.1
0
0
.0
3
0
.0
2
-
D
ay
 1
1
 S
et
 1
7
.9
8
0
.1
3
0
.0
6
0
.0
5
0
.0
3
-
D
ay
 1
1
 S
et
 3
7
.8
3
0
.2
9
0
.2
2
0
.2
1
0
.1
9
0
.1
6
-
D
ay
 1
2
 S
et
 1
7
.8
1
0
.3
1
0
.2
3
0
.2
3
0
.2
0
0
.1
7
0
.0
2
-
D
ay
 1
2
 S
et
 2
7
.7
6
0
.3
5
0
.2
8
0
.2
7
0
.2
5
0
.2
2
0
.0
6
0
.0
5
-
D
ay
 1
3
 S
et
 1
7
.7
3
0
.3
8
0
.3
1
0
.3
0
0
.2
8
0
.2
5
0
.0
9
0
.0
7
0
.0
3
-
D
ay
 1
3
 S
et
 2
7
.7
0
0
.4
2
0
.3
4
0
.3
4
0
.3
1
0
.2
8
0
.1
3
0
.1
1
0
.0
6
0
.0
4
-
D
ay
 1
3
 S
et
 3
7
.6
5
0
.4
7
0
.4
0
0
.3
9
0
.3
6
0
.3
4
0
.1
8
0
.1
6
0
.1
2
0
.0
9
0
.0
5
-
D
ay
 1
6
 S
et
 3
7
.6
3
0
.4
8
0
.4
1
0
.4
0
0
.3
8
0
.3
5
0
.1
9
0
.1
8
0
.1
3
0
.1
0
0
.0
7
0
.0
1
-
D
ay
 1
4
 S
et
 1
7
.6
1
0
.5
1
0
.4
4
0
.4
3
0
.4
0
0
.3
8
0
.2
2
0
.2
0
0
.1
6
0
.1
3
0
.0
9
0
.0
4
0
.0
3
-
D
ay
 1
4
 S
et
 2
7
.5
6
0
.5
6
0
.4
8
0
.4
8
0
.4
5
0
.4
2
0
.2
7
0
.2
5
0
.2
0
0
.1
8
0
.1
4
0
.0
9
0
.0
7
0
.0
5
-
D
ay
 1
5
 S
et
 1
7
.5
4
0
.5
7
0
.5
0
0
.4
9
0
.4
7
0
.4
4
0
.2
8
0
.2
7
0
.2
2
0
.1
9
0
.1
6
0
.1
0
0
.0
9
0
.0
6
0
.0
2
-
D
ay
 1
5
 S
et
 3
7
.5
0
0
.6
1
0
.5
4
0
.5
3
0
.5
1
0
.4
8
0
.3
2
0
.3
1
0
.2
6
0
.2
3
0
.2
0
0
.1
4
0
.1
3
0
.1
0
0
.0
6
0
.0
4
-
D
ay
 1
5
 S
et
 2
7
.4
2
0
.7
0
0
.6
2
0
.6
2
0
.5
9
0
.5
6
0
.4
1
0
.3
9
0
.3
4
0
.3
2
0
.2
8
0
.2
3
0
.2
2
0
.1
9
0
.1
4
0
.1
2
0
.0
8
-
D
ay
 1
6
 S
et
 2
7
.2
8
0
.8
4
0
.7
6
0
.7
6
0
.7
3
0
.7
0
0
.5
5
0
.5
3
0
.4
8
0
.4
5
0
.4
2
0
.3
7
0
.3
5
0
.3
3
0
.2
8
0
.2
6
0
.2
2
0
.1
4
-
D
ay
 1
6
 S
et
 1
7
.2
8
0
.8
4
0
.7
6
0
.7
6
0
.7
3
0
.7
1
0
.5
5
0
.5
3
0
.4
8
0
.4
6
0
.4
2
0
.3
7
0
.3
6
0
.3
3
0
.2
8
0
.2
6
0
.2
2
0
.1
4
0
.0
0
-
L
S
D
0
.1
4
T
a
b
le
 A
.9
5
: 
R
es
o
lu
ti
o
n
 a
d
ja
ce
n
t 
m
ea
n
 d
if
fe
re
n
ce
s 
fo
r 
p
ea
k
 3
 a
n
d
 p
ea
k
 4
 c
ap
il
la
ry
 2
. 
411 
 
Table A.96: Resolution F-test two- sample for variances of peak 3 and peak 4.  
 
 
  
Capillary 
2 
Capillary 
1 
Mean 7.71 8.25 
Variance 0.07 0.03 
Observations 90 48 
DF 89 47 
Fcalc 2.26 
 P-value 1.39 x 10
-3
 
 Ftable 1.55   
 
 
  
412 
 
Table A.97: Resolution t-test: two sample assuming unequal variances peak 3 and peak 
4.  
 
  Capillary 2 Capillary 1 
Mean 8.25 7.71 
Variance 0.03 0.07 
Observations 48 90 
Hypothesized mean Difference 0 
 DF 129 
 tcalc  13.99 
 P-value 1.26 x 10
-27
 
 ttable  1.98   
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Table A.98: Resolution data for peak 4 (p-toluenesulfonic acid) and peak 5 
(disopyramide) using DOI-CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
3.55 3.58 3.58 3.74 3.63 0.07 4.00 
 
2 3.69 3.56 3.57 3.64 3.56 
   
 
3 3.71 3.70 3.60 3.70 3.59 
   Day 2 1 
 
3.34 3.38 3.20 3.37 3.31 0.07 2.09 
 
2 3.32 3.29 3.29 3.31 3.31 
   
 
3 3.21 3.28 3.27 3.34 3.47 
   Day 3 1 3.64 3.84 3.84 3.79 3.90 3.80 0.10 2.56 
Day 12 1 3.75 3.51 3.61 3.59 3.81 3.54 0.14 4.09 
 
2 3.55 3.41 3.49 3.59 3.24 
   
 
3 
 
3.40 3.45 3.60 3.58 
   
      
Overall 3.53 0.19 5.28 
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 
 
3.81 3.90 4.03 4.11 3.96 0.13 3.32 
Day 10 1 3.84 3.66 3.69 3.75 3.88 3.73 0.09 2.37 
 
2 
 
3.64 3.63 3.71 3.75 
   Day 11 1 
 
3.66 3.69 3.67 3.79 3.63 0.09 2.41 
 
2 
 
3.66 3.56 3.59 3.70 
   
 
3 
 
3.49 3.50 3.61 3.58 
   Day 12 1 
 
3.31 3.24 3.33 3.42 3.40 0.10 2.94 
 
2 
 
3.41 3.41 3.54 3.50 
   Day 13 1 
 
3.27 3.07 3.09 3.09 3.28 0.14 4.33 
 
2 3.41 3.36 3.36 3.43 3.46 
   
 
3 
 
3.28 3.40 3.12 3.34 
   Day 14 1 
 
3.30 3.29 3.29 3.17 3.26 0.04 1.34 
 
2 3.26 3.25 3.24 3.24 3.31 
   Day 15 1 3.30 3.28 3.21 3.26 3.43 3.17 0.13 4.11 
 
2 
 
3.02 3.04 3.07 3.17 
   
 
3 
 
3.01 3.17 3.03 3.21 
   Day 16 1 
 
3.37 3.33 3.33 3.41 3.44 0.15 4.31 
 
2 
 
3.48 3.22 3.28 3.39 
   
 
3 
 
3.65 3.57 3.58 3.67 
   
      
Overall 3.43 0.25 7.19 
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A. 
 
B. 
 
Figure A.11: Resolution between peak 4 and peak 5 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
 
  
3.000
3.100
3.200
3.300
3.400
3.500
3.600
3.700
3.800
3.900
4.000
0 10 20 30 40 50
R
e
so
lu
ti
o
n
 
Injection Number 
Resolution DOI-CZE Capillary 1 Peak 4 
and Peak 5 
2.500
3.000
3.500
4.000
4.500
0 20 40 60 80
R
e
so
lu
ti
o
n
 
Injection Number 
Resolution DOI-CZE Capillary 2 Peak 4 
and Peak 5 
415 
 
Table A.99: Resolution ANOVA for peak 4 and peak 5 capillary 1.  
      Groups Count Sum Average Variance 
  Day 1 Set 1 4 14.451 3.613 0.008 
  Day 1 Set 2 5 18.030 3.606 0.004 
  Day 1 Set 3 5 18.302 3.660 0.003 
  Day 2 Set 1 4 13.291 3.323 0.007 
  Day 2 Set 2 5 16.5223 3.3045 0.0002 
  Day 2 Set 3 5 16.578 3.316 0.010 
  Day 3 Set 1 5 19.021 3.804 0.010 
  Day 12 Set 1 5 18.27 3.65 0.01 
  Day 12 Set 2 5 17.28 3.46 0.02 
  Day 12 Set 3 4 14.028 3.507 0.010 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 1.28 9 0.14 16.57 1.76 x 10
-10
 2.14 
Within Groups 0.32 37 0.01 
   
       Total 1.60 46         
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Table A.100: Resolution adjacent mean differences for peak 4 and peak 5 capillary 1.  
 
 
 
  
Mean
Day 3 
Set 1
Day 1 
Set 3
Day 12 
Set 1
Day 1 
Set 1
Day 1 
Set 2
Day 12 
Set 3
Day 12 
Set 2
Day 2 
Set 1
Day 2 
Set 3
Day 2 
Set 2
Day 3 Set 1 3.80 -
Day 1 Set 3 3.66 0.14 -
Day 12 Set 1 3.65 0.15 0.01 -
Day 1 Set 1 3.61 0.19 0.05 0.04 -
Day 1 Set 2 3.61 0.20 0.05 0.05 0.01 -
Day 12 Set 3 3.51 0.30 0.15 0.15 0.11 0.10 -
Day 12 Set 2 3.46 0.35 0.20 0.20 0.16 0.15 0.05 -
Day 2 Set 1 3.32 0.48 0.34 0.33 0.29 0.28 0.18 0.13 -
Day 2 Set 3 3.32 0.49 0.34 0.34 0.30 0.29 0.19 0.14 0.01 -
Day 2 Set 2 3.30 0.50 0.36 0.35 0.31 0.30 0.20 0.15 0.02 0.01 -
LSD 0.12
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Table A.101: Resolution ANOVA for peak 4 and peak 5 capillary 2. 
      Groups Count Sum Average Variance 
  Day 1 Set 1 4 15.85 3.96 0.02 
  Day 10 Set 1 5 18.830 3.766 0.009 
  Day 10 Set 2 4 14.734 3.683 0.003 
  Day 11 Set 1 4 14.816 3.704 0.004 
  Day 11 Set 2 4 14.516 3.629 0.004 
  Day 11 Set 3 4 14.181 3.545 0.003 
  Day 12 Set 1 4 13.305 3.326 0.006 
  Day 12 Set 2 4 13.860 3.465 0.005 
  Day 13 Set 1 4 12.521 3.130 0.009 
  Day 13 Set 2 5 17.013 3.403 0.002 
  Day 13 Set 3 4 13.14 3.29 0.01 
  Day 14 Set 1 4 13.052 3.263 0.004 
  Day 14 Set 2 5 16.298 3.260 0.001 
  Day 15 Set 1 5 16.476 3.295 0.007 
  Day 15 Set 2 4 12.286 3.071 0.005 
  Day 15 Set 3 4 12.43 3.11 0.01 
  Day 16 Set 1 4 13.449 3.362 0.002 
  Day 16 Set 2 4 13.37 3.34 0.01 
  Day 16 Set 3 4 14.475 3.619 0.002 
  
       
       ANOVA 
      Source of 
Variation SS DF MS Fcalc P-value Ftable 
Between Groups 4.43 18 0.25 39.47 7.11 x 10
-27
 1.78 
Within Groups 0.38 61 0.01 
   
       Total 4.81 79         
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Table A.103: Resolution F-test two- sample for variances of peak 4 and peak 5.  
 
  
Capillary 
2 
Capillary 
1 
Mean 3.43 3.53 
Variance 0.06 0.03 
Observations 80 47 
DF 79 46 
Fcalc 1.75 
 P-value 0.02 
 Ftable 1.57   
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Table A.104: Resolution t-test: two sample assuming unequal variances peak 4 and peak 
5.  
 
  
Capillary 
1 
Capillary 
2 
Mean 3.53 3.43 
Variance 0.03 0.06 
Observations 47 80 
Hypothesized mean Difference 0 
 DF 117 
 tcalc 2.44 
 P-value 0.02 
 ttable 1.98   
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Table A.105: Migration time (minutes) for peak 2 (disopyramide) using CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 2.263 2.263 2.256 2.253 2.246 2.219 0.029 1.299 
 
2 2.210 2.211 2.207 2.208 2.205 
   
 
3 2.207 2.199 2.192 2.183 2.182 
   Day 8 1 2.003 2.011 2.025 2.071 2.088 2.031 0.024 1.165 
 
2 2.048 2.037 2.031 2.027 2.025 
   
 
3 2.025 2.011 2.011 2.024 
    Day 9 1 2.063 2.041 2.047 2.040 2.051 2.052 0.031 1.503 
 
2 2.097 2.088 2.088 2.088 2.088 
   
 
3 2.025 2.011 2.011 2.025 2.022 
   Day 10 1 2.046 2.043 2.030 2.026 2.030 2.035 0.009 0.430 
      
Overall 2.096 0.087 4.163 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 2.23 2.23 2.22 2.22 2.20 2.211 0.014 0.655 
 
2 2.20 2.21 2.20 2.20 2.19 
   Day 2 1 2.20 2.19 2.18 2.18 
 
2.188 0.009 0.405 
 
2 2.20 2.20 2.19 2.19 2.18 
   
 
3 2.20 2.19 2.18 2.18 2.18 
   Day 3 1 2.20 2.20 2.19 2.19 
 
2.171 0.019 0.856 
 
2 2.17 2.16 2.16 2.18 2.15 
   
 
3 2.15 2.16 2.15 2.15 2.16 
   
      
Overall 2.188 0.022 0.984 
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A. 
 
B. 
 
 
Figure A.12: Migration time variation (minutes) for peak 2 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.106: Migration time (minutes) ANOVA for peak 2 capillary 1 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 9.017 2.254 5.198 x 10
-5
 
  Day 1 Set 2 4 8.830 2.208 6.847 x 10
-6
 
  Day 1 Set 3 4 8.756 2.189 5.974 x 10
-5
 
  Day 8 Set 1 4 8.353 2.088 9.328 x 10
-8
 
  Day 8 Set 2 4 8.120 2.030 2.780 x 10
-5
 
  Day 8 Set 3 3 6.046 2.015 5.238 x 10
-5
 
  Day 9 Set 1 4 8.179 2.045 2.485 x 10
-5
 
  Day 9 Set 2 4 8.194 2.049 1.334 x 10
-3
 
  Day 9 Set 3 4 8.069 2.017 5.044 x 10
-5
 
  Day 10 Set 1 4 8.130 2.032 5.623 x 10
-5
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.282 9 0.031 184.046 4.062 x 10
-23
 2.223 
Within Groups 0.005 29 1.704 x 10
-4
 
   
       Total 0.287 38         
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Table A.107: Migration time (minutes) adjacent mean differences for peak 2 capillary 1 
CZE. 
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 8 
Set 1
Day 9 
Set 2
Day 9 
Set 1
Day 10 
Set 1
Day 8 
Set 2
Day 9 
Set 3
Day 8 
Set 3
Day 1 Set 1 2.254 -
Day 1 Set 2 2.208 0.047 -
Day 1 Set 3 2.189 0.065 0.019 -
Day 8 Set 1 2.088 0.166 0.119 0.101 -
Day 9 Set 2 2.049 0.206 0.159 0.140 0.040 -
Day 9 Set 1 2.045 0.209 0.163 0.144 0.043 0.004 -
Day 10 Set 1 2.032 0.222 0.175 0.157 0.056 0.016 0.012 -
Day 8 Set 2 2.030 0.224 0.178 0.159 0.058 0.019 0.015 0.002 -
Day 9 Set 3 2.017 0.237 0.190 0.172 0.071 0.031 0.028 0.015 0.013 -
Day 8 Set 3 2.015 0.239 0.192 0.174 0.073 0.033 0.030 0.017 0.015 0.002 -
LSD 0.009
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Table A.108: Migration time (minutes) ANOVA for peak 2 capillary 2 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 8.881 2.220 1.430 x 10
-4
 
  Day 1 Set 2 4 8.802 2.200 5.229 x 10
-5
 
  Day 2 Set 1 3 6.549 2.183 8.175 x 10
-5
 
  Day 2 Set 2 4 8.766 2.191 5.690 x 10
-5
 
  Day 2 Set 3 4 8.730 2.182 5.623 x 10
-5
 
  Day 3 Set 1 3 6.586 2.195 4.015 x 10
-6
 
  Day 3 Set 2 4 8.657 2.164 9.456 x 10
-5
 
  Day 3 Set 3 4 8.622 2.155 2.032 x 10
-5
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.012 7 0.002 25.346 3.928 x 10
-9
 2.464 
Within Groups 0.001 22 6.552 x 10
-5
 
   
       Total 0.013 29         
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Table A.109: Migration time (minutes) adjacent mean differences for peak 2 capillary 2 
CZE. 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 3 
Set 1
Day 2 
Set 2
Day 2 
Set 1
Day 2 
Set 3
Day 3 
Set 2
Day 3 
Set 3
Day 1 Set 1 2.220 -
Day 1 Set 2 2.200 0.020 -
Day 3 Set 1 2.195 0.025 0.005 -
Day 2 Set 2 2.191 0.029 0.009 0.004 -
Day 2 Set 1 2.183 0.037 0.017 0.012 0.008 -
Day 2 Set 3 2.182 0.038 0.018 0.013 0.009 0.001 -
Day 3 Set 2 2.164 0.056 0.036 0.031 0.027 0.019 0.018 -
Day 3 Set 3 2.155 0.065 0.045 0.040 0.036 0.028 0.027 0.009 -
LSD 0.011
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Table A.110: Migration time (minutes) F-test two- sample for variances for peak 2 CZE. 
  Capillary 1 Capillary 2 
Mean 2.096 2.188 
Variance 7.609 x 10
-3
 4.630 x 10
-4
 
Observations 49 38 
DF 48 37 
Fcalc 16.433 
 P-value 1.247 x 10
-14
 
 
Ftable 1.690   
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Table A.111: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 2 CZE. 
 
  Capillary 2 Capillary 1 
Mean 2.188 2.096 
Variance 4.630 x 10
-4
 7.609 x 10
-3
 
Observations 38 49 
Hypothesized Mean 
Difference 
0 
 DF 55 
 tcalc 7.132 
 P-value 2.293 x 10
-9
 
 
ttable 2.004   
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Table A.112: Migration time (minutes) for peak 3 (p-toluenesulfonic acid) using CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 7.15 7.12 7.09 7.06 7.03 6.937 0.135 1.944 
 
2 7.03 6.96 6.91 6.86 6.82 
   
 
3 6.88 6.84 6.81 6.77 6.74 
   Day 8 1 6.31 6.26 6.21 6.26 6.15 6.276 0.111 1.776 
 
2 6.27 6.24 6.24 6.22 6.20 
   
 
3 6.20 6.28 6.43 6.59 
    Day 9 1 6.27 6.26 6.23 6.23 6.22 6.235 0.058 0.934 
 
2 6.22 6.20 6.21 6.18 6.15 
   
 
3 6.37 6.32 6.28 6.22 6.16 
   Day 10 1 6.37 6.35 6.36 6.33 6.30 6.344 0.030 0.473 
      
Overall 6.268 0.089 1.412 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 6.64 6.59 6.55 6.50 6.46 6.556 0.087 1.327 
 
2 6.58 6.59 6.71 6.53 6.41 
   Day 2 1 6.55 6.29 6.39 6.56 
 
6.419 0.103 1.609 
 
2 6.44 6.47 6.40 6.42 6.42 
   
 
3 6.21 6.32 6.35 6.54 6.52 
   Day 3 1 6.35 6.34 6.32 6.31 
 
6.366 0.053 0.835 
 
2 6.42 6.40 6.38 6.37 6.26 
   
 
3 6.47 6.42 6.40 6.36 6.32 
   
      
Overall 6.436 0.112 1.734 
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A. 
 
B. 
 
 
Figure A.13: Migration time variation (minutes) for peak 3 over the sample injections 
completed for A. capillary 1 and B. capillary 2 
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Table A.113: Migration time (minutes) ANOVA for peak 3 capillary 1 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 28.303 7.076 1.748 x 10
-3
 
  Day 1 Set 2 4 27.540 6.885 3.667 x 10
-3
 
  Day 1 Set 3 4 27.157 6.789 1.891 x 10
-3
 
  Day 8 Set 1 4 24.877 6.219 2.580 x 10
-3
 
  Day 8 Set 2 4 24.908 6.227 3.260 x 10
-4
 
  Day 8 Set 3 3 19.301 6.434 2.455 x 10
-2
 
  Day 9 Set 1 4 24.939 6.235 2.717 x 10
-4
 
  Day 9 Set 2 4 24.745 6.186 8.070 x 10
-4
 
  Day 9 Set 3 4 24.975 6.244 5.006 x 10
-3
 
  Day 10 Set 1 4 25.345 6.336 8.070 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between 
Groups 3.873 9 0.430 124.292 1.040 x 10
-20
 2.223 
Within 
Groups 0.100 29 3.463 x 10
-3
 
   
       Total 3.974 38         
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Table A.114: Migration time (minutes) adjacent mean differences for peak 3 capillary 1 
CZE. 
 
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 8 
Set 3
Day 10 
Set 1
Day 9 
Set 3
Day 9 
Set 1
Day 8 
Set 2
Day 8 
Set 1
Day 9 
Set 2
Day 1 Set 1 7.076 -
Day 1 Set 2 6.885 0.191 -
Day 1 Set 3 6.789 0.286 0.096 -
Day 8 Set 3 6.434 0.642 0.451 0.356 -
Day 10 Set 1 6.336 0.739 0.549 0.453 0.097 -
Day 9 Set 3 6.244 0.832 0.641 0.545 0.190 0.092 -
Day 9 Set 1 6.235 0.841 0.650 0.554 0.199 0.101 0.009 -
Day 8 Set 2 6.227 0.849 0.658 0.562 0.206 0.109 0.017 0.008 -
Day 8 Set 1 6.219 0.856 0.666 0.570 0.214 0.117 0.025 0.016 0.008 -
Day 9 Set 2 6.186 0.889 0.699 0.603 0.247 0.150 0.058 0.049 0.041 0.033 -
LSD 0.076
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Table A.115: Migration time (minutes) ANOVA for peak 3 capillary 2 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 26.099 6.525 3.190 x 10
-3
 
  Day 1 Set 2 4 26.244 6.561 1.571 x 10
-2
 
  Day 2 Set 1 3 19.234 6.411 1.896 x 10
-2
 
  Day 2 Set 2 4 25.711 6.428 9.245 x 10
-4
 
  Day 2 Set 3 4 25.725 6.431 1.288 x 10
-2
 
  Day 3 Set 1 3 18.979 6.326 2.123 x 10
-4
 
  Day 3 Set 2 4 25.409 6.352 3.639 x 10
-3
 
  Day 3 Set 3 4 25.503 6.376 2.045 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between 
Groups 0.174 7 0.025 3.558 1.040 x 10
-2
 2.464 
Within 
Groups 0.153 22 6.977 x 10
-3
 
   
       Total 0.327 29         
 
 
 
  
434 
 
Table A.116: Migration time (minutes) adjacent mean differences for peak 3 capillary 2 
CZE. 
 
 
  
Mean
Day 1 
Set 2
Day 1 
Set 1
Day 2 
Set 3
Day 2 
Set 2
Day 2 
Set 1
Day 3 
Set 3
Day 3 
Set 2
Day 3 
Set 1
Day 1 Set 2 6.561 -
Day 1 Set 1 6.525 0.036 -
Day 2 Set 3 6.431 0.130 0.094 -
Day 2 Set 2 6.428 0.133 0.097 0.004 -
Day 2 Set 1 6.411 0.149 0.113 0.020 0.016 -
Day 3 Set 3 6.376 0.185 0.149 0.055 0.052 0.036 -
Day 3 Set 2 6.352 0.209 0.173 0.079 0.075 0.059 0.024 -
Day 3 Set 1 6.326 0.235 0.198 0.105 0.101 0.085 0.049 0.026 -
LSD 0.110
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Table A.117: Migration time (minutes) F-test two- sample for variances for peak 3 CZE. 
  Capillary 1 Capillary 2 
Mean 6.473 6.436 
Variance 0.108 0.012 
Observations 49 38 
DF 48 37 
Fcalc 8.662 
 P-value 3.578 x 10
-10
 
 
Ftable 1.690   
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Table A.118: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 3 CZE. 
  
Capillary 
1 
Capillary 
2 
Mean 6.473 6.436 
Variance 0.108 0.012 
Observations 49 38 
Hypothesized Mean 
Difference 
0 
 DF 62 
 tcalc 0.735 
 P-value 0.465 
 
ttable 1.999   
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Table A.119: Migration time (minutes) for peak 4 (benzenesulfonic acid) using CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 7.975 7.827 7.723 7.628 7.517 7.716 0.144 1.871 
 
2 7.931 7.842 7.775 7.717 7.655 
   
 
3 7.772 7.713 7.640 7.555 7.469 
   Day 8 1 6.914 6.994 7.198 7.386 7.435 7.089 0.153 2.162 
 
2 7.050 7.040 7.005 6.966 6.962 
   
 
3 7.106 7.085 7.070 7.029 
    Day 9 1 7.109 7.064 7.001 6.921 6.846 7.012 0.073 1.046 
 
2 7.048 7.007 7.008 6.973 6.922 
   
 
3 7.096 7.085 7.070 7.029 7.008 
   Day 10 1 7.034 7.012 7.003 6.980 6.951 6.996 0.032 0.458 
      
Overall 7.248 0.337 4.656 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 7.739 7.578 7.438 7.348 7.554 7.563 0.113 1.500 
 
2 7.672 7.634 7.612 7.553 7.506 
   Day 2 1 7.598 7.510 7.451 7.431 
 
7.508 0.070 0.933 
 
2 7.612 7.588 7.549 7.504 7.458 
   
 
3 7.556 7.525 7.490 7.484 7.362 
   Day 3 1 7.456 7.410 7.362 7.397 
 
7.352 0.083 1.129 
 
2 7.465 7.420 7.391 7.364 7.323 
   
 
3 7.360 7.305 7.253 7.240 7.182 
   
      
Overall 7.465 0.124 1.664 
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A. 
 
B. 
 
Figure A.14: Migration time variation (minutes) for peak 4 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.120: Migration time (minutes) ANOVA for peak 4 capillary 1 CZE. 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 30.694 7.674 1.744 x 10
-2
 
  Day 1 Set 2 4 30.989 7.747 6.377 x 10
-3
 
  Day 1 Set 3 4 30.376 7.594 1.113 x 10
-2
 
  Day 8 Set 1 4 29.013 7.253 4.021 x 10
-2
 
  Day 8 Set 2 4 27.974 6.994 1.345 x 10
-3
 
  Day 8 Set 3 3 21.184 7.061 8.293 x 10
-4
 
  Day 9 Set 1 4 27.831 6.958 9.016 x 10
-3
 
  Day 9 Set 2 4 27.910 6.977 1.655 x 10
-3
 
  Day 9 Set 3 4 28.193 7.048 1.252 x 10
-3
 
  Day 10 Set 1 4 27.946 6.987 7.543 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 3.619 9 0.402 43.324 1.987 x 10
-14
 2.223 
Within Groups 0.269 29 0.009 
   
       Total 3.888 38         
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Table A.121: Migration time adjacent mean differences (minutes) for peak 4 capillary 1 
CZE. 
 
 
 
  
Mean
Day 1 
Set 2
Day 1 
Set 1
Day 1 
Set 3
Day 8 
Set 1
Day 8 
Set 3
Day 9 
Set 3
Day 8 
Set 2
Day 10 
Set 1
Day 9 
Set 2
Day 9 
Set 1
Day 1 Set 2 7.747 -
Day 1 Set 1 7.674 0.074 -
Day 1 Set 3 7.594 0.153 0.080 -
Day 8 Set 1 7.253 0.494 0.420 0.341 -
Day 8 Set 3 7.061 0.686 0.612 0.533 0.192 -
Day 9 Set 3 7.048 0.699 0.625 0.546 0.205 0.013 -
Day 8 Set 2 6.994 0.754 0.680 0.600 0.260 0.068 0.055 -
Day 10 Set 1 6.987 0.761 0.687 0.608 0.267 0.075 0.062 0.007 -
Day 9 Set 2 6.977 0.770 0.696 0.617 0.276 0.084 0.071 0.016 0.009 -
Day 9 Set 1 6.958 0.790 0.716 0.636 0.296 0.104 0.090 0.036 0.029 0.020 -
LSD 0.125
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Table A.122: Migration time (minutes) ANOVA for peak 4 capillary 2 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 29.918 7.479 1.148 x 10
-2
 
  Day 1 Set 2 4 30.306 7.576 3.379 x 10
-3
 
  Day 2 Set 1 3 22.392 7.464 1.694 x 10
-3
 
  Day 2 Set 2 4 30.099 7.525 3.190 x 10
-3
 
  Day 2 Set 3 4 29.861 7.465 5.076 x 10
-3
 
  Day 3 Set 1 3 22.168 7.389 6.244 x 10
-4
 
  Day 3 Set 2 4 29.498 7.375 1.699 x 10
-3
 
  Day 3 Set 3 4 28.980 7.245 2.558 x 10
-2
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.290 7 0.041 10.521 9.191 x 10
-6
 2.464 
Within Groups 0.087 22 0.004 
   
       Total 0.377 29         
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Table A.123: Migration time adjacent mean differences (minutes) for peak 4 capillary 2 
CZE. 
 
  
Mean
Day 1 
Set 2
Day 2 
Set 2
Day 1 
Set 1
Day 2 
Set 3
Day 2 
Set 1
Day 3 
Set 1
Day 3 
Set 2
Day 3 
Set 3
Day 1 Set 2 7.576 -
Day 2 Set 2 7.525 0.052 -
Day 1 Set 1 7.479 0.097 0.045 -
Day 2 Set 3 7.465 0.111 0.060 0.014 -
Day 2 Set 1 7.464 0.113 0.061 0.016 0.001 -
Day 3 Set 1 7.389 0.187 0.135 0.090 0.076 0.074 -
Day 3 Set 2 7.375 0.202 0.150 0.105 0.091 0.089 0.015 -
Day 3 Set 3 7.245 0.331 0.280 0.234 0.220 0.219 0.144 0.129 -
LSD 0.082
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Table A.124: Migration time (minutes) F-test two- sample for variances for peak 4 CZE. 
 
  Capillary 1 Capillary 2 
Mean 7.25 7.47 
Variance 0.11 0.02 
Observations 49 38 
DF 48 37 
Fcalc 7.38 
 P-value 3.97 x 10
-9
 
 Ftable 1.69   
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Table A.125: Migration time (minutes) t-test: two sample assuming unequal variances 
peak 4 CZE. 
  
Capillary 
2 
Capillary 
1 
Mean 7.47 7.25 
Variance 0.02 0.11 
Observations 38 49 
Hypothesized mean 
Difference 
0 
 DF 64 
 tcalc 4.16 
 P-value 9.70 x 10
-5
 
 ttable 2.00   
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Table A.126: Migration time (minutes) for peak 2 in reference to peak 1 CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.098 1.098 1.098 1.098 1.097 1.095 0.003 0.289 
 
2 1.092 1.092 1.092 1.092 1.091 
   
 
3 1.096 1.095 1.095 1.095 1.094 
   Day 8 1 1.098 1.098 1.098 1.100 1.100 1.089 0.010 0.903 
 
2 1.094 1.090 1.085 1.088 1.082 
   
 
3 1.075 1.074 1.075 1.083 
    Day 9 1 1.100 1.091 1.096 1.092 1.097 1.096 0.016 1.417 
 
2 1.123 1.112 1.111 1.111 1.111 
   
 
3 1.084 1.074 1.072 1.087 1.076 
   Day 10 1 1.091 1.096 1.092 1.092 1.095 1.093 0.002 0.203 
      
Overall 1.093 0.010 0.950 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.097 1.098 1.096 1.097 1.091 1.097 0.002 0.206 
 
2 1.099 1.098 1.099 1.098 1.098 
   Day 2 1 1.102 1.102 1.095 1.095 
 
1.108 0.009 0.813 
 
2 1.108 1.106 1.100 1.123 1.118 
   
 
3 1.107 1.115 1.112 1.115 1.119 
   Day 3 1 1.105 1.102 1.104 1.105 
 
1.120 0.012 1.038 
 
2 1.120 1.120 1.123 1.135 1.125 
   
 
3 1.125 1.132 1.127 1.129 1.131 
   
      
Overall 1.110 0.013 1.147 
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Table A.127: Migration time (minutes) ANOVA for peak 2 in reference to peak 1 for 
capillary 1 CZE. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 4 4.391 1.098 2.307 x 10
-7
 
Day 1 Set 2 4 4.367 1.092 1.262 x 10
-7
 
Day 1 Set 3 4 4.380 1.095 1.809 x 10
-7
 
Day 8 Set 1 4 4.397 1.099 1.241 x 10
-6
 
Day 8 Set 2 4 4.344 1.086 1.268 x 10
-5
 
Day 8 Set 3 3 3.232 1.077 2.399 x 10
-5
 
Day 9 Set 1 4 4.375 1.094 1.006 x 10
-5
 
Day 9 Set 2 4 4.445 1.111 6.625 x 10
-7
 
Day 9 Set 3 4 4.310 1.077 4.610 x 10
-5
 
Day 10 Set 1 4 4.375 1.094 5.108 x 10
-6
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.004 9 3.899 x 10
-4
 40.802 
Within Groups 2.771 x 10
-4
 29 9.555 x 10
-6
 
 
     Total 0.004 38     
   
P-value Ftable 
   
4.394 x 10
-14
 2.223 
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Table A.128: Migration time adjacent mean differences (minutes) for peak 2 in reference 
to peak 1 capillary 1. 
 
 
 
  
Mean
Day 9 
Set 2
Day 8 
Set 1
Day 1 
Set 1
Day 1 
Set 3
Day 10 
Set 1
Day 9 
Set 1
Day 1 
Set 2
Day 8 
Set 2
Day 8 
Set 3
Day 9 
Set 3
Day 9 Set 2 1.111 -
Day 8 Set 1 1.099 0.012 -
Day 1 Set 1 1.098 0.014 0.002 -
Day 1 Set 3 1.095 0.016 0.004 0.003 -
Day 10 Set 1 1.094 0.018 0.005 0.004 0.001 -
Day 9 Set 1 1.094 0.018 0.005 0.004 0.001 0.000 -
Day 1 Set 2 1.092 0.020 0.007 0.006 0.003 0.002 0.002 -
Day 8 Set 2 1.086 0.025 0.013 0.012 0.009 0.008 0.008 0.006 -
Day 8 Set 3 1.077 0.034 0.022 0.020 0.017 0.016 0.016 0.014 0.009 -
Day 9 Set 3 1.077 0.034 0.022 0.020 0.017 0.016 0.016 0.014 0.009 0.000 -
LSD 0.004
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Table A.129: Migration time (minutes) ANOVA for peak 2 in reference to peak 1 for 
capillary 2 CZE. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 4 4.383 1.096 9.799 x 10
-6
 
Day 1 Set 2 4 4.393 1.098 2.194 x 10
-7
 
Day 2 Set 1 3 3.291 1.097 1.741 x 10
-5
 
Day 2 Set 2 4 4.447 1.112 1.043 x 10
-4
 
Day 2 Set 3 4 4.462 1.115 9.443 x 10
-6
 
Day 3 Set 1 3 3.310 1.103 2.899 x 10
-6
 
Day 3 Set 2 4 4.504 1.126 4.118 x 10
-5
 
Day 3 Set 3 4 4.519 1.130 5.602 x 10
-6
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.005 7 6.711 x 10
-4
 26.741 
Within Groups 5.521 x 10
-4
 22 2.510 x 10
-5
 
 
     Total 0.005 29     
   
P-value Ftable 
   
2.353 x 10
-9
 2.464 
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Table A.130: Migration time adjacent mean differences (minutes) for peak 2 in reference 
to peak 1 capillary 2. 
 
 
 
  
Mean
Day 3 
Set 3
Day 3 
Set 2
Day 2 
Set 3
Day 2 
Set 2
Day 3 
Set 1
Day 1 
Set 2
Day 2 
Set 1
Day 1 
Set 1
Day 3 Set 3 1.130 -
Day 3 Set 2 1.126 0.004 -
Day 2 Set 3 1.115 0.014 0.010 -
Day 2 Set 2 1.112 0.018 0.014 0.004 -
Day 3 Set 1 1.103 0.026 0.022 0.012 0.008 -
Day 1 Set 2 1.098 0.031 0.028 0.017 0.014 0.005 -
Day 2 Set 1 1.097 0.033 0.029 0.018 0.015 0.006 0.001 -
Day 1 Set 1 1.096 0.034 0.030 0.020 0.016 0.008 0.003 0.001 -
LSD 0.007
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Table A.131: Migration time (minutes) for peak 3 in reference to peak 1 CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 3.470 3.457 3.452 3.438 3.434 3.423 0.032 0.931 
 
2 3.474 3.436 3.418 3.394 3.373 
   
 
3 3.416 3.407 3.401 3.397 3.379 
   Day 8 1 3.458 3.416 3.367 3.327 3.242 3.364 0.074 2.186 
 
2 3.350 3.341 3.332 3.339 3.315 
   
 
3 3.291 3.353 3.437 3.527 
    Day 9 1 3.346 3.344 3.334 3.332 3.330 3.329 0.036 1.083 
 
2 3.333 3.304 3.304 3.291 3.271 
   
 
3 3.409 3.376 3.346 3.339 3.279 
   Day 10 1 3.401 3.408 3.422 3.413 3.396 3.408 0.010 0.299 
      
Overall 3.376 0.061 1.796 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 3.264 3.239 3.231 3.214 3.196 3.253 0.045 1.374 
 
2 3.288 3.281 3.347 3.259 3.213 
   Day 2 1 3.285 3.158 3.209 3.300 
 
3.251 0.064 1.968 
 
2 3.241 3.258 3.210 3.284 3.293 
   
 
3 3.133 3.213 3.239 3.350 3.347 
   Day 3 1 3.186 3.179 3.182 3.179 
 
3.286 0.074 2.240 
 
2 3.315 3.317 3.310 3.321 3.271 
   
 
3 3.379 3.366 3.357 3.333 3.312 
   
      
Overall 3.265 0.064 1.963 
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Table A.132: Migration time (minutes) ANOVA for peak 3 in reference to peak 1 for 
capillary 1 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 13.782 3.445 1.246 x 10
-4
 
  Day 1 Set 2 4 13.620 3.405 7.499 x 10
-4
 
  Day 1 Set 3 4 13.584 3.396 1.472 x 10
-4
 
  Day 8 Set 1 4 13.353 3.338 5.428 x 10
-3
 
  Day 8 Set 2 4 13.327 3.332 1.458 x 10
-4
 
  Day 8 Set 3 3 10.318 3.439 7.574 x 10
-3
 
  Day 9 Set 1 4 13.340 3.335 4.278 x 10
-5
 
  Day 9 Set 2 4 13.169 3.292 2.387 x 10
-4
 
  Day 9 Set 3 4 13.339 3.335 1.649 x 10
-3
 
  Day 10 Set 1 4 13.640 3.410 1.192 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.095 9 0.011 7.458 1.469 x 10
-5
 2.223 
Within Groups 0.041 29 0.001 
   
       Total 0.136 38         
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Table A.133: Migration time adjacent mean differences (minutes) for peak 3 in reference 
to peak 1 capillary 1. 
 
 
 
  
Mean
Day 1 
Set 1
Day 8 
Set 3
Day 10 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 8 
Set 1
Day 9 
Set 1
Day 9 
Set 3
Day 8 
Set 2
Day 9 
Set 2
Day 1 Set 1 3.445 -
Day 8 Set 3 3.439 0.006 -
Day 10 Set 1 3.410 0.035 0.029 -
Day 1 Set 2 3.405 0.040 0.034 0.005 -
Day 1 Set 3 3.396 0.050 0.044 0.014 0.009 -
Day 8 Set 1 3.338 0.107 0.101 0.072 0.067 0.058 -
Day 9 Set 1 3.335 0.110 0.104 0.075 0.070 0.061 0.003 -
Day 9 Set 3 3.335 0.111 0.105 0.075 0.070 0.061 0.003 0.000 -
Day 8 Set 2 3.332 0.114 0.108 0.078 0.073 0.064 0.007 0.003 0.003 -
Day 9 Set 2 3.292 0.153 0.147 0.118 0.113 0.104 0.046 0.043 0.043 0.039 -
LSD 0.049
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Table A.134: Migration time (minutes) ANOVA for peak 3 in reference to peak 1 for 
capillary 2 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 12.881 3.220 3.628 x 10
-4
 
  Day 1 Set 2 4 13.099 3.275 3.121 x 10
-3
 
  Day 2 Set 1 3 9.666 3.222 5.178 x 10
-3
 
  Day 2 Set 2 4 13.045 3.261 1.401 x 10
-3
 
  Day 2 Set 3 4 13.149 3.287 5.132 x 10
-3
 
  Day 3 Set 1 3 9.540 3.180 3.268 x 10
-6
 
  Day 3 Set 2 4 13.219 3.305 5.139 x 10
-4
 
  Day 3 Set 3 4 13.369 3.342 6.068 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.068 7 0.010 4.863 1.956 x 10
-3
 2.464 
Within Groups 0.044 22 0.002 
   
       Total 0.112 29         
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Table A.135: Migration time adjacent mean differences (minutes) for peak 3 in reference 
to peak 1 capillary 2. 
 
 
 
 
  
Mean
Day 3 
Set 3
Day 3 
Set 2
Day 2 
Set 3
Day 1 
Set 2
Day 2 
Set 2
Day 2 
Set 1
Day 1 
Set 1
Day 3 
Set 1
Day 3 Set 3 3.342 -
Day 3 Set 2 3.305 0.037 -
Day 2 Set 3 3.287 0.055 0.017 -
Day 1 Set 2 3.275 0.067 0.030 0.012 -
Day 2 Set 2 3.261 0.081 0.043 0.026 0.014 -
Day 2 Set 1 3.222 0.120 0.083 0.065 0.053 0.039 -
Day 1 Set 1 3.220 0.122 0.084 0.067 0.055 0.041 0.002 -
Day 3 Set 1 3.180 0.162 0.125 0.107 0.095 0.081 0.042 0.040 -
LSD 0.059
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Table A.136: Migration time (minutes) for peak 4 in reference to peak 1 CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 3.870 3.798 3.758 3.717 3.673 3.808 0.065 1.716 
 
2 3.919 3.873 3.847 3.817 3.789 
   
 
3 3.859 3.842 3.817 3.789 3.745 
   Day 8 1 3.791 3.819 3.905 3.924 3.918 3.799 0.068 1.784 
 
2 3.767 3.767 3.742 3.738 3.720 
   
 
3 3.771 3.784 3.779 3.762 
    Day 9 1 3.792 3.774 3.747 3.703 3.663 3.744 0.041 1.102 
 
2 3.774 3.733 3.728 3.710 3.683 
   
 
3 3.798 3.782 3.770 3.774 3.731 
   Day 10 1 3.753 3.762 3.768 3.761 3.749 3.759 0.0076 0.2027 
      
Overall 3.781 0.062 1.627 
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 3.805 3.726 3.669 3.631 3.739 3.753 0.063 1.684 
 
2 3.831 3.799 3.797 3.769 3.762 
   Day 2 1 3.812 3.773 3.741 3.739 
 
3.803 0.034 0.881 
 
2 3.831 3.821 3.786 3.839 3.824 
   
 
3 3.809 3.827 3.821 3.835 3.780 
   Day 3 1 3.742 3.714 3.704 3.725 
 
3.794 0.054 1.423 
 
2 3.853 3.846 3.837 3.839 3.824 
   
 
3 3.846 3.831 3.802 3.794 3.764 
   
      
Overall 3.786 0.053 1.402 
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Table A.137: Migration time (minutes) ANOVA for peak 4 in reference to peak 1 for 
capillary 1 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 14.946 3.737 2.921 x 10
-3
 
  Day 1 Set 2 4 15.326 3.832 1.338 x 10
-3
 
  Day 1 Set 3 4 15.193 3.798 1.725 x 10
-3
 
  Day 8 Set 1 4 15.567 3.892 2.388 x 10
-3
 
  Day 8 Set 2 4 14.967 3.742 3.816 x 10
-4
 
  Day 8 Set 3 3 11.325 3.775 1.374 x 10
-4
 
  Day 9 Set 1 4 14.887 3.722 2.408 x 10
-3
 
  Day 9 Set 2 4 14.854 3.713 4.950 x 10
-4
 
  Day 9 Set 3 4 15.058 3.764 5.292 x 10
-4
 
  Day 10 Set 1 4 15.040 3.760 6.602 x 10
-5
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.108 9 0.012 9.361 1.667 x 10
-6
 2.223 
Within Groups 0.037 29 0.001 
   
       Total 0.145 38         
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Table A.138: Migration time adjacent mean differences (minutes) for peak 4 in reference 
to peak 1 capillary 1. 
 
 
  
Mean
Day 8 
Set 1
Day 1 
Set 2
Day 1 
Set 3
Day 8 
Set 3
Day 9 
Set 3
Day 10 
Set 1
Day 8 
Set 2
Day 1 
Set 1
Day 9 
Set 1
Day 9 
Set 2
Day 8 Set 1 3.892 -
Day 1 Set 2 3.832 0.060 -
Day 1 Set 3 3.798 0.093 0.033 -
Day 8 Set 3 3.775 0.117 0.057 0.023 -
Day 9 Set 3 3.764 0.127 0.067 0.034 0.011 -
Day 10 Set 1 3.760 0.132 0.072 0.038 0.015 0.004 -
Day 8 Set 2 3.742 0.150 0.090 0.057 0.033 0.023 0.018 -
Day 1 Set 1 3.737 0.155 0.095 0.062 0.038 0.028 0.023 0.005 -
Day 9 Set 1 3.722 0.170 0.110 0.077 0.053 0.043 0.038 0.020 0.015 -
Day 9 Set 2 3.713 0.178 0.118 0.085 0.062 0.051 0.047 0.028 0.023 0.008 -
LSD 0.046
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Table A.139: Migration time (minutes) ANOVA for peak 4 in reference to peak 1 for 
capillary 2 CZE. 
 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 14.765 3.691 2.522 x 10
-3
 
  Day 1 Set 2 4 15.127 3.782 3.533 x 10
-4
 
  Day 2 Set 1 3 11.253 3.751 3.682 x 10
-4
 
  Day 2 Set 2 4 15.271 3.818 5.054 x 10
-4
 
  Day 2 Set 3 4 15.261 3.815 5.992 x 10
-4
 
  Day 3 Set 1 3 11.143 3.714 1.100 x 10
-4
 
  Day 3 Set 2 4 15.346 3.836 8.080 x 10
-5
 
  Day 3 Set 3 4 15.191 3.798 7.573 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.072 7 0.010 14.597 6.033 x 10
-7
 2.464 
Within Groups 0.015 22 7.005 x 10
-4
 
   
       Total 0.087 29         
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Table A.140: Migration time adjacent mean differences (minutes) for peak 4 in reference 
to peak 1 capillary 2. 
 
 
  
Mean
Day 3 
Set 2
Day 2 
Set 2
Day 2 
Set 3
Day 3 
Set 3
Day 1 
Set 2
Day 2 
Set 1
Day 3 
Set 1
Day 1 
Set 1
Day 3 Set 2 3.836 -
Day 2 Set 2 3.818 0.019 -
Day 2 Set 3 3.815 0.021 0.002 -
Day 3 Set 3 3.798 0.039 0.020 0.018 -
Day 1 Set 2 3.782 0.055 0.036 0.034 0.016 -
Day 2 Set 1 3.751 0.086 0.067 0.065 0.047 0.031 -
Day 3 Set 1 3.714 0.122 0.103 0.101 0.083 0.067 0.036 -
Day 1 Set 1 3.691 0.145 0.126 0.124 0.106 0.090 0.060 0.023 -
LSD 0.035
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Table A.141: Corrected area (mAU) for peak 2 (disopyramide) using CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 9.17 9.15 9.13 9.07 9.02 9.01 0.11 1.24 
 
2 8.97 8.88 8.74 9.07 8.95 
   
 
3 9.10 9.05 8.97 8.96 8.97 
   Day 8 1 8.62 8.37 8.94 8.74 8.72 8.76 0.20 2.33 
 
2 8.84 8.80 8.74 8.54 8.52 
   
 
3 8.77 8.99 8.96 9.12 
    Day 9 1 8.78 8.83 8.64 8.76 8.94 8.83 0.18 2.04 
 
2 9.06 9.01 9.01 9.15 8.86 
   
 
3 8.66 8.50 8.88 8.77 8.66 
   Day 10 1 9.08 8.73 8.44 8.92 8.84 8.80 0.24 2.71 
      
Overall 8.86 0.20 2.25 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 8.95 9.06 8.83 8.92 8.47 8.70 0.22 2.57 
 
2 8.59 8.59 8.60 8.53 8.43 
   Day 2 1 8.94 8.80 8.83 8.89 
    
 
2 8.95 9.06 8.83 8.23 8.95 8.74 0.24 2.78 
 
3 8.86 8.44 8.56 8.55 8.50 
   Day 3 1 8.74 8.95 8.24 8.28 
 
8.70 0.22 2.52 
 
2 8.68 8.68 8.63 8.70 8.70 
   
 
3 8.78 8.88 8.97 8.66 8.95 
   
      
Overall 8.72 0.22 2.57 
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A. 
 
B. 
 
 
 
Figure A.15: Corrected area (mAU) for peak 2 over the sample injections completed for 
A. capillary 1 and B. capillary 2. 
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Table A.142: Corrected area (mAU) ANOVA for peak 2 capillary 1 CZE. 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 36.37 9.09 3.74 x 10
-3
 
  Day 1 Set 2 4 35.64 8.91 1.85 x 10
-2
 
  Day 1 Set 3 4 35.94 8.99 1.96 x 10
-3
 
  Day 8 Set 1 4 34.76 8.69 5.60 x 10
-2
 
  Day 8 Set 2 4 34.59 8.65 1.93 x 10
-2
 
  Day 8 Set 3 3 27.07 9.02 6.81 x 10
-3
 
  Day 9 Set 1 4 35.17 8.79 1.64 x 10
-2
 
  Day 9 Set 2 4 36.03 9.01 1.45 x 10
-2
 
  Day 9 Set 3 4 34.81 8.70 2.62 x 10
-2
 
  Day 10 Set 1 4 34.93 8.73 4.35 x 10
-2
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.93 9 0.10 4.90 4.95 x 10
-4
 2.22 
Within Groups 0.61 29 0.02 
   
       Total 1.55 38         
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Table A.143: Corrected area adjacent mean differences (mAU) for peak 2 capillary 1 
CZE. 
 
 
 
  
Mean
Day 1 
Set 1
Day 8 
Set 3
Day 9 
Set 2
Day 1 
Set 3
Day 1 
Set 2
Day 9 
Set 1
Day 10 
Set 1
Day 9 
Set 3
Day 8 
Set 1
Day 8 
Set 2
Day 1 Set 1 9.09 -
Day 8 Set 3 9.02 0.07 -
Day 9 Set 2 9.01 0.08 0.02 -
Day 1 Set 3 8.99 0.11 0.04 0.02 -
Day 1 Set 2 8.91 0.18 0.11 0.10 0.08 -
Day 9 Set 1 8.79 0.30 0.23 0.22 0.19 0.12 -
Day 10 Set 1 8.73 0.36 0.29 0.28 0.25 0.18 0.06 -
Day 9 Set 3 8.70 0.39 0.32 0.31 0.28 0.21 0.09 0.03 -
Day 8 Set 1 8.69 0.40 0.33 0.32 0.30 0.22 0.10 0.04 0.01 -
Day 8 Set 2 8.65 0.44 0.37 0.36 0.34 0.26 0.14 0.08 0.05 0.04 -
LSD 0.01
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Table A.144: Corrected area (mAU) ANOVA for peak 2 capillary 2 CZE. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 35.29 8.82 6.44 x 10
-2
 
  Day 1 Set 2 4 34.15 8.54 5.75 x 10
-3
 
  Day 2 Set 1 3 26.52 8.84 2.05 x 10
-3
 
  Day 2 Set 2 4 35.07 8.77 1.38 x 10
-1
 
  Day 2 Set 3 4 34.05 8.51 3.01 x 10
-3
 
  Day 3 Set 1 3 25.48 8.49 1.57 x 10
-1
 
  Day 3 Set 2 4 34.71 8.68 9.95 x 10
-4
 
  Day 3 Set 3 4 35.46 8.87 2.01 x 10
-2
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.62 7 0.09 1.92 0.11 2.46 
Within Groups 1.02 22 0.05 
   
       Total 1.64 29         
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Table A.145: Corrected area (mAU) F-test two- sample for variances for peak 2 CZE. 
 
  
Capillary 
2 
Capillary 
1 
Mean 8.72 8.86 
Variance 0.05 0.04 
Observations 38 49 
DF 37 48 
Fcalc 1.26 
 P-value 0.22 
 Ftable 1.66   
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Table A.146: Corrected area t-test: two sample assuming equal variances peak 2 CZE. 
 
 
  Capillary 1 Capillary 2 
Mean 8.86 8.72 
Variance 0.04 0.05 
Observations 49 38 
Pooled Variance 0.04 
 Hypothesized mean 
Difference 
0 
 DF 85 
 tcalc 3.26 
 P-value 1.62 x 10
-3
 
 ttable 1.99   
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Table A.147: Corrected area (mAU) for peak 3 (p-toluenesulfonic acid) using CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 13.19 13.22 13.10 13.24 12.72 13.19 0.36 2.77 
 
2 13.12 13.61 13.24 13.94 13.81 
   
 
3 13.50 12.71 13.10 13.02 12.28 
   Day 8 1 11.83 11.88 12.12 12.31 13.49 12.17 0.60 4.90 
 
2 11.90 12.39 12.46 11.43 12.43 
   
 
3 11.11 12.99 12.15 11.95 
    Day 9 1 12.40 12.46 12.38 12.25 12.09 12.21 0.25 2.01 
 
2 12.08 11.92 12.15 12.20 11.93 
   
 
3 11.96 12.29 12.39 11.89 12.77 
   Day 10 1 12.49 12.35 12.33 12.46 12.11 12.35 0.15 1.20 
      
Overall 12.51 0.61 4.90 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 13.34 12.86 13.22 13.26 12.89 12.94 0.24 1.87 
 
2 12.97 12.78 12.71 12.70 12.72 
   Day 2 1 13.18 12.75 13.04 12.52 
 
12.81 0.34 2.64 
 
2 12.71 12.94 12.36 13.14 12.88 
   
 
3 13.46 12.88 12.61 12.21 12.62 
   Day 3 1 12.79 12.65 12.74 12.89 
 
12.68 0.35 2.77 
 
2 12.66 13.56 12.50 12.70 12.93 
   
 
3 12.62 12.61 11.97 12.28 12.67 
   
      
Overall 12.80 0.33 2.57 
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A. 
 
B. 
 
 
Figure A.16: Corrected area (mAU) for peak 3 over the sample injections completed for 
A. capillary 1 and B. capillary 2. 
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Table A.148: Corrected area (mAU) ANOVA for peak 3 capillary 1 CZE. 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 52.28 13.07 5.95 x 10
-2
 
  Day 1 Set 2 4 54.59 13.65 9.24 x 10
-2
 
  Day 1 Set 3 4 51.11 12.78 1.36 x 10
-1
 
  Day 8 Set 1 4 49.80 12.45 5.11 x 10
-1
 
  Day 8 Set 2 4 48.71 12.18 2.49 x 10
-1
 
  Day 8 Set 3 3 37.09 12.36 3.06 x 10
-1
 
  Day 9 Set 1 4 49.18 12.30 2.50 x 10
-2
 
  Day 9 Set 2 4 48.20 12.05 2.08 x 10
-2
 
  Day 9 Set 3 4 49.35 12.34 1.30 x 10
-1
 
  Day 10 Set 1 4 49.24 12.31 2.10 x 10
-2
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 8.50 9 0.94 6.30 6.51 x 10
-5
 2.22 
Within Groups 4.34 29 0.15 
   
       Total 12.84 38         
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Table A.149: Corrected area adjacent mean differences (mAU) for peak 3 capillary 1 
CZE. 
 
 
 
 
  
Mean
Day 1 
Set 2
Day 1 
Set 1
Day 1 
Set 3
Day 8 
Set 1
Day 8 
Set 3
Day 9 
Set 3
Day 10 
Set 1
Day 9 
Set 1
Day 8 
Set 2
Day 9 
Set 2
Day 1 Set 2 13.65 -
Day 1 Set 1 13.07 0.58 -
Day 1 Set 3 12.78 0.87 0.29 -
Day 8 Set 1 12.45 1.20 0.62 0.33 -
Day 8 Set 3 12.36 1.29 0.71 0.42 0.09 -
Day 9 Set 3 12.34 1.31 0.73 0.44 0.11 0.03 -
Day 10 Set 1 12.31 1.34 0.76 0.47 0.14 0.05 0.03 -
Day 9 Set 1 12.30 1.35 0.77 0.48 0.16 0.07 0.04 0.01 -
Day 8 Set 2 12.18 1.47 0.89 0.60 0.27 0.19 0.16 0.13 0.12 -
Day 9 Set 2 12.05 1.60 1.02 0.73 0.40 0.31 0.29 0.26 0.25 0.13 -
LSD 0.50
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Table A.150: Corrected area (mAU) ANOVA for peak 3 capillary 2 CZE. 
       Groups Count Sum Average Variance 
  Day 1 Set 2 4 52.22 13.05 4.44 x 10
-2
 
  Day 1 Set 1 4 50.91 12.73 1.52 x 10
-3
 
  Day 2 Set 1 3 38.31 12.77 6.90 x 10
-2
 
  Day 2 Set 2 4 51.33 12.83 1.11 x 10
-1
 
  Day 2 Set 3 4 50.33 12.58 7.60 x 10
-2
 
  Day 3 Set 1 3 38.28 12.76 1.37 x 10
-2
 
  Day 3 Set 2 4 51.69 12.92 2.09 x 10
-1
 
  Day 3 Set 3 4 49.52 12.38 1.05 x 10
-1
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 1.18 7 0.17 2.05 0.09 2.46 
Within Groups 1.81 22 0.08 
   
       Total 2.99 29         
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Table A.151: Corrected area (mAU) F-Test two- sample for variances for peak 3 CZE. 
 
  
Capillary 
1 
Capillary 
2 
Mean 12.5 12.8 
Variance 0.4 0.1 
Observations 49 38 
DF 48 37 
Fcalc 3.5 
 P-value 8.2 x 10
-5
 
 Ftable 1.7   
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Table A.152: Corrected area (mAU) t-test: two sample assuming unequal variances peak 
3 CZE. 
 
  
Capillary 
2 
Capillary 
1 
Mean 12.8 12.5 
Variance 0.1 0.4 
Observations 38 49 
Hypothesized mean 
Difference 
0 
 DF 77 
 tcalc 2.8 
 P-value 0.01 
 ttable 2.0   
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Table A.153: Corrected area (mAU) for peak 4 (benzenesulfonic acid) using CZE. 
 
       
Day 
Capillary 
1 Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 15.78 15.63 15.46 15.23 15.15 15.44 0.23 1.49 
 
2 15.66 15.62 15.41 15.71 15.51 
   
 
3 15.51 15.46 15.32 15.20 14.97 
   Day 8 1 13.43 13.49 14.71 14.85 14.92 14.04 0.51 3.67 
 
2 13.69 13.76 13.34 13.91 13.84 
   
 
3 14.19 14.39 14.05 14.02 
    Day 9 1 14.18 14.00 13.86 13.71 13.85 13.94 0.18 1.28 
 
2 13.95 13.89 13.92 13.87 13.91 
   
 
3 14.17 14.23 14.06 13.97 13.55 
   Day 10 1 13.90 14.39 13.14 13.43 13.29 13.63 0.51 3.75 
      
Overall 14.40 0.79 5.48 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 15.25 15.22 14.82 14.50 14.94 14.94 0.26 1.75 
 
2 15.18 15.05 15.05 14.85 14.56 
   Day 2 1 15.18 14.85 14.74 14.85 
 
14.96 0.13 0.87 
 
2 15.04 15.06 15.04 15.08 14.98 
   
 
3 14.99 15.06 14.85 14.93 14.78 
   Day 3 1 15.00 14.90 14.96 14.95 
 
14.78 0.22 1.48 
 
2 14.98 14.98 14.89 14.64 14.78 
   
 
3 14.81 14.74 14.45 14.56 14.30 
   
      
Overall 14.89 0.22 1.45 
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A. 
 
B. 
 
 
Figure A.17: Corrected area (mAU) for peak 4 over the sample injections completed for 
A. capillary 1 and B. capillary 2.  
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Table A.154: Corrected area (mAU) ANOVA for peak 4 capillary 1 CZE. 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 61.47 15.37 4.82 x 10
-2
 
  Day 1 Set 2 4 62.25 15.56 1.68 x 10
-2
 
  Day 1 Set 3 4 60.94 15.24 4.34 x 10
-2
 
  Day 8 Set 1 4 57.96 14.49 4.53 x 10
-1
 
  Day 8 Set 2 4 54.84 13.71 6.50 x 10
-2
 
  Day 8 Set 3 3 42.46 14.15 4.19 x 10
-2
 
  Day 9 Set 1 4 55.41 13.85 1.43 x 10
-2
 
  Day 9 Set 2 4 55.59 13.90 4.90 x 10
-4
 
  Day 9 Set 3 4 55.81 13.95 8.41 x 10
-2
 
  Day 10 Set 1 4 54.25 13.56 3.18 x 10
-1
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 19.87 9 2.21 19.91 3.89 x 10
-10
 2.22 
Within Groups 3.22 29 0.11 
   
       Total 23.09 38         
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Table A.155: Corrected area adjacent mean differences (mAU) for peak 4 capillary 1 
CZE. 
 
 
 
 
  
Mean
Day 1 
Set 2
Day 1 
Set 1
Day 1 
Set 3
Day 8 
Set 1
Day 8 
Set 3
Day 9 
Set 3
Day 9 
Set 2
Day 9 
Set 1
Day 8 
Set 2
Day 10 
Set 1
Day 1 Set 2 15.56 -
Day 1 Set 1 15.37 0.19 -
Day 1 Set 3 15.24 0.33 0.13 -
Day 8 Set 1 14.49 1.07 0.88 0.74 -
Day 8 Set 3 14.15 1.41 1.21 1.08 0.34 -
Day 9 Set 3 13.95 1.61 1.42 1.28 0.54 0.20 -
Day 9 Set 2 13.90 1.66 1.47 1.34 0.59 0.26 0.06 -
Day 9 Set 1 13.85 1.71 1.52 1.38 0.64 0.30 0.10 0.04 -
Day 8 Set 2 13.71 1.85 1.66 1.53 0.78 0.44 0.24 0.19 0.14 -
Day 10 Set 1 13.56 2.00 1.81 1.67 0.93 0.59 0.39 0.33 0.29 0.15 -
LSD 0.43
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Table A.156: Corrected area (mAU) ANOVA for peak 4 capillary 2 CZE. 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 59.48 14.87 8.84 x 10
-2
 
  Day 1 Set 2 4 59.52 14.88 5.40 x 10
-2
 
  Day 2 Set 1 3 44.43 14.81 4.21 x 10
-3
 
  Day 2 Set 2 4 60.16 15.04 2.26 x 10
-3
 
  Day 2 Set 3 4 59.62 14.90 1.35 x 10
-2
 
  Day 3 Set 1 3 44.80 14.93 1.11 x 10
-3
 
  Day 3 Set 2 4 59.29 14.82 2.12 x 10
-2
 
  Day 3 Set 3 4 58.05 14.51 3.37 x 10
-2
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.64 7 0.09 3.12 0.02 2.46 
Within Groups 0.65 22 0.03 
   
       Total 1.29 29         
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Table A.157: Corrected area adjacent mean differences (mAU) for peak 4 capillary 2 
CZE. 
 
 
 
 
  
Mean
Day 2 
Set 2
Day 3 
Set 1
Day 2 
Set 3
Day 1 
Set 2
Day 1 
Set 1
Day 3 
Set 2
Day 2 
Set 1
Day 3 
Set 3
Day 2 Set 2 15.04 -
Day 3 Set 1 14.93 0.11 -
Day 2 Set 3 14.90 0.14 0.03 -
Day 1 Set 2 14.88 0.16 0.05 0.02 -
Day 1 Set 1 14.87 0.17 0.06 0.03 0.01 -
Day 3 Set 2 14.82 0.22 0.11 0.08 0.06 0.05 -
Day 2 Set 1 14.81 0.23 0.12 0.09 0.07 0.06 0.01 -
Day 3 Set 3 14.51 0.53 0.42 0.39 0.37 0.36 0.31 0.30 -
LSD 0.23
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Table A.158: Corrected area (mAU) F-test two- sample for variances of peak 4 CZE. 
 
  Capillary 1 Capillary 2 
Mean 14.4 14.89 
Variance 0.6 0.05 
Observations 49 38 
DF 48 37 
Fcalc 13.4 
 P-value 3.6 x 10
-13
 
 Ftable 1.7   
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Table A.159: Corrected area (mAU) t-test: two sample assuming unequal variances peak 
4 CZE. 
 
  Capillary 2 Capillary 1 
Mean 14.89 14.4 
Variance 0.05 0.6 
Observations 38 49 
Hypothesized mean 
Difference 
0 
 DF 57 
 tcalc 4.2 
 P-value 1.0 x 10
-4
 
 ttable 2.0   
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Table A.160: Corrected area (mAU) for peak 2 in reference to peak 1. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 0.87 0.90 0.90 0.88 0.88 0.90 0.02 2.13 
 
2 0.90 0.89 0.88 0.92 0.90 
   
 
3 0.93 0.93 0.91 0.92 0.92 
   Day 8 1 0.94 0.91 0.96 0.92 0.90 0.93 0.02 2.01 
 
2 0.93 0.93 0.93 0.92 0.92 
   
 
3 0.89 0.94 0.94 0.95 
    Day 9 1 0.93 0.96 0.93 0.94 0.93 0.94 0.02 2.50 
 
2 0.98 0.96 0.93 0.96 0.92 
   
 
3 0.93 0.89 0.92 0.96 0.91 
   Day 10 1 0.96 0.93 0.89 0.95 0.96 0.94 0.03 3.34 
      
Overall 0.92 0.03 2.81 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 0.89 0.89 0.87 0.88 0.84 0.87 0.02 1.75 
 
2 0.87 0.87 0.86 0.86 0.87 
   Day 2 1 0.89 0.87 0.87 0.88 
 
0.91 0.03 2.96 
 
2 0.93 0.94 0.92 0.87 0.94 
   
 
3 0.92 0.88 0.91 0.92 0.92 
   Day 3 1 0.88 0.91 0.86 0.88 
 
0.90 0.03 3.48 
 
2 0.89 0.93 0.90 0.90 0.87 
   
 
3 0.95 0.89 0.97 0.91 0.92 
   
      
Overall 0.90 0.03 3.33 
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Table A.161: Corrected area (mAU) ANOVA for peak 2 in reference to peak 1 for 
capillary 1. 
 
Groups Count Sum Average Variance 
Day 1 Set 1 4 3.56 0.89 1.13 x 10
-4
 
Day 1 Set 2 4 3.59 0.90 3.01 x 10
-4
 
Day 1 Set 3 4 3.68 0.92 5.11 x 10
-5
 
Day 8 Set 1 4 3.69 0.92 7.55 x 10
-4
 
Day 8 Set 2 4 3.70 0.92 2.40 x 10
-5
 
Day 8 Set 3 3 2.83 0.94 4.71 x 10
-5
 
Day 9 Set 1 4 3.76 0.94 1.32 x 10
-4
 
Day 9 Set 2 4 3.77 0.94 2.90 x 10
-4
 
Day 9 Set 3 4 3.68 0.92 1.05 x 10
-3
 
Day 10 Set 1 4 3.72 0.93 1.06 x 10
-3
 
     
     ANOVA 
    Source of 
Variation 
SS DF MS Fcalc 
Between Groups 0.01 9 1.30 x 10
-3
 3.29 
Within Groups 0.01 29 3.94 x 10
-4
 
 
     Total 0.02 38     
   
P-value Ftable 
   
7.04 x 10
-3
 2.22 
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Table A.162: Corrected area adjacent mean differences (mAU) for peak 2 in reference to 
peak 1 capillary 1. 
 
 
 
  
Mean
Day 8 
Set 3
Day 9 
Set 2
Day 9 
Set 1
Day 10 
Set 1
Day 8 
Set 2
Day 8 
Set 1
Day 9 
Set 3
Day 1 
Set 3
Day 1 
Set 2
Day 1 
Set 1
Day 8 Set 3 0.943 -
Day 9 Set 2 0.942 0.001 -
Day 9 Set 1 0.941 0.002 0.001 -
Day 10 Set 1 0.930 0.013 0.012 0.011 -
Day 8 Set 2 0.925 0.018 0.018 0.016 0.005 -
Day 8 Set 1 0.923 0.020 0.020 0.018 0.007 0.002 -
Day 9 Set 3 0.920 0.023 0.022 0.021 0.010 0.005 0.003 -
Day 1 Set 3 0.920 0.023 0.023 0.021 0.010 0.005 0.003 0.000 -
Day 1 Set 2 0.897 0.046 0.046 0.044 0.033 0.028 0.026 0.023 0.023 -
Day 1 Set 1 0.889 0.054 0.053 0.052 0.041 0.036 0.034 0.031 0.031 0.008 -
LSD 0.026
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Table A.163: Corrected area (mAU) ANOVA for peak 2 in reference to peak 1 for 
capillary 2. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 3.49 0.87 4.96 x 10
-4
 
  Day 1 Set 2 4 3.45 0.86 2.48 x 10
-5
 
  Day 2 Set 1 3 2.63 0.88 6.44 x 10
-5
 
  Day 2 Set 2 4 3.67 0.92 1.29 x 10
-3
 
  Day 2 Set 3 4 3.64 0.91 3.66 x 10
-4
 
  Day 3 Set 1 3 2.64 0.88 6.18 x 10
-4
 
  Day 3 Set 2 4 3.60 0.90 4.55 x 10
-4
 
  Day 3 Set 3 4 3.69 0.92 1.32 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation SS DF MS Fcalc P-value Ftable 
Between Groups 0.014 7 1.98 x 10
-3
 3.30 0.01 2.46 
Within Groups 0.013 22 6.00 x 10
-4
 
   
       Total 0.027 29         
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Table A.164: Corrected area adjacent mean differences (mAU) for peak 2 in reference to 
peak 1 capillary 2. 
 
 
 
  
Mean
Day 3 
Set 3
Day 2 
Set 2
Day 2 
Set 3
Day 3 
Set 2
Day 3 
Set 1
Day 2 
Set 1
Day 1 
Set 1
Day 1 
Set 2
Day 3 Set 3 0.92 -
Day 2 Set 2 0.92 0.01 -
Day 2 Set 3 0.91 0.01 0.01 -
Day 3 Set 2 0.90 0.02 0.02 0.01 -
Day 3 Set 1 0.88 0.04 0.04 0.03 0.02 -
Day 2 Set 1 0.88 0.05 0.04 0.04 0.02 0.00 -
Day 1 Set 1 0.87 0.05 0.04 0.04 0.03 0.01 0.00 -
Day 1 Set 2 0.86 0.06 0.05 0.05 0.04 0.02 0.01 0.01 -
LSD 0.03
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Table A.165: Corrected area (mAU) for peak 3 in reference to peak 1. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.25 1.29 1.29 1.28 1.24 1.32 0.05 3.84 
 
2 1.31 1.36 1.33 1.41 1.39 
   
 
3 1.38 1.30 1.33 1.33 1.26 
   Day 8 1 1.29 1.29 1.31 1.29 1.40 1.29 0.06 4.97 
 
2 1.25 1.31 1.33 1.23 1.35 
   
 
3 1.13 1.36 1.27 1.25 
    Day 9 1 1.31 1.35 1.34 1.32 1.26 1.29 0.03 2.48 
 
2 1.30 1.27 1.26 1.28 1.24 
   
 
3 1.28 1.28 1.29 1.31 1.34 
   Day 10 1 1.32 1.31 1.29 1.33 1.31 1.31 0.01 0.95 
      
Overall 1.30 0.05 3.72 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.32 1.27 1.31 1.31 1.28 1.30 0.02 1.64 
 
2 1.32 1.29 1.27 1.28 1.31 
   Day 2 1 1.31 1.26 1.29 1.25 
 
1.33 0.05 3.48 
 
2 1.32 1.35 1.28 1.38 1.35 
   
 
3 1.40 1.35 1.34 1.32 1.37 
   Day 3 1 1.28 1.28 1.32 1.37 
 
1.32 0.05 3.66 
 
2 1.30 1.45 1.31 1.31 1.30 
   
 
3 1.37 1.26 1.30 1.29 1.30 
   
      
Overall 1.32 0.04 3.25 
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Table A.166: Corrected area (mAU) ANOVA for peak 3 in reference to peak 1 for 
capillary 1. 
      Groups Count Sum Average Variance 
  Day 1 Set 1 4 5.11 1.28 5.66 x 10
-4
 
  Day 1 Set 2 4 5.49 1.37 1.26 x 10
-3
 
  Day 1 Set 3 4 5.23 1.31 1.05 x 10
-3
 
  Day 8 Set 1 4 5.29 1.32 2.59 x 10
-3
 
  Day 8 Set 2 4 5.21 1.30 2.64 x 10
-3
 
  Day 8 Set 3 3 3.88 1.29 3.39 x 10
-3
 
  Day 9 Set 1 4 5.27 1.32 1.59 x 10
-3
 
  Day 9 Set 2 4 5.04 1.26 1.74 x 10
-4
 
  Day 9 Set 3 4 5.21 1.30 6.49 x 10
-4
 
  Day 10 Set 1 4 5.24 1.31 1.80 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between 
Groups 0.03 9 3.54 x 10
-3
  2.64 0.02 2.22 
Within Groups 0.04 29 1.34 x 10
-3
 
   
       Total 0.07 38         
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Table A.167: Corrected area adjacent mean differences (mAU) for peak 3 in reference to 
peak 1 capillary 1. 
 
 
 
  
Mean
Day 1 
Set 2
Day 8 
Set 1
Day 9 
Set 1
Day 10 
Set 1
Day 1 
Set 3
Day 9 
Set 3
Day 8 
Set 2
Day 8 
Set 3
Day 1 
Set 1
Day 9 
Set 2
Day 1 Set 2 1.374 -
Day 8 Set 1 1.321 0.052 -
Day 9 Set 1 1.316 0.057 0.005 -
Day 10 Set 1 1.311 0.063 0.010 0.005 -
Day 1 Set 3 1.308 0.066 0.014 0.009 0.003 -
Day 9 Set 3 1.304 0.070 0.018 0.013 0.007 0.004 -
Day 8 Set 2 1.302 0.072 0.019 0.014 0.009 0.006 0.002 -
Day 8 Set 3 1.292 0.082 0.029 0.024 0.019 0.016 0.012 0.010 -
Day 1 Set 1 1.278 0.096 0.043 0.038 0.033 0.030 0.026 0.024 0.014 -
Day 9 Set 2 1.261 0.113 0.061 0.056 0.050 0.047 0.043 0.041 0.031 0.017 -
LSD 0.047
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Table A.168: Corrected area (mAU) ANOVA for peak 3 in reference to peak 1 for 
capillary 2. 
      Groups Count Sum Average Variance 
  Day 1 Set 1 4 5.17 1.29 4.86 x 10
-4
 
  Day 1 Set 2 4 5.15 1.29 3.41 x 10
-4
 
  Day 2 Set 1 3 3.80 1.27 5.78 x 10
-4
 
  Day 2 Set 2 4 5.36 1.34 1.75 x 10
-3
 
  Day 2 Set 3 4 5.39 1.35 4.59 x 10
-4
 
  Day 3 Set 1 3 3.97 1.32 2.00 x 10
-3
 
  Day 3 Set 2 4 5.37 1.34 5.11 x 10
-3
 
  Day 3 Set 3 4 5.15 1.29 3.93 x 10
-4
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between 
Groups 0.03 7 3.58 x 10
-3
 2.56 0.043 2.46 
Within Groups 0.03 22 1.40 x 10
-3
 
   
       Total 0.06 29         
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Table A.169: Corrected area adjacent mean differences (mAU) for peak 3 in reference to 
peak 1 capillary 2. 
 
 
 
 
  
Mean
Day 2 
Set 3
Day 3 
Set 2
Day 2 
Set 2
Day 3 
Set 1
Day 1 
Set 1
Day 3 
Set 3
Day 1 
Set 2
Day 2 
Set 1
Day 2 Set 3 1.346 -
Day 3 Set 2 1.341 0.005 -
Day 2 Set 2 1.341 0.005 0.000 -
Day 3 Set 1 1.324 0.023 0.018 0.017 -
Day 1 Set 1 1.292 0.054 0.049 0.049 0.031 -
Day 3 Set 3 1.288 0.058 0.053 0.053 0.035 0.004 -
Day 1 Set 2 1.286 0.060 0.055 0.055 0.037 0.006 0.002 -
Day 2 Set 1 1.265 0.081 0.076 0.076 0.059 0.027 0.023 0.021 -
LSD 0.049
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Table A.170: Corrected area (mAU) for peak 4 in reference to peak 1. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.50 1.53 1.53 1.48 1.48 1.54 0.04 2.34 
 
2 1.57 1.56 1.55 1.59 1.57 
   
 
3 1.58 1.58 1.56 1.56 1.54 
   Day 8 1 1.47 1.46 1.58 1.56 1.55 1.49 0.05 3.26 
 
2 1.44 1.45 1.42 1.50 1.50 
   
 
3 1.45 1.50 1.47 1.46 
    Day 9 1 1.49 1.52 1.50 1.47 1.44 1.48 0.03 2.28 
 
2 1.51 1.47 1.44 1.45 1.45 
   
 
3 1.52 1.49 1.46 1.53 1.42 
   Day 10 1 1.47 1.53 1.38 1.43 1.44 1.45 0.06 3.85 
      
Overall 1.50 0.05 3.46 
          
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 1.51 1.50 1.47 1.44 1.49 1.50 0.03 1.93 
 
2 1.54 1.52 1.50 1.50 1.50 
   Day 2 1 1.51 1.47 1.46 1.48 
 
1.55 0.05 3.30 
 
2 1.56 1.57 1.56 1.59 1.58 
   
 
3 1.56 1.58 1.58 1.61 1.61 
   Day 3 1 1.51 1.51 1.55 1.59 
 
1.54 0.05 2.96 
 
2 1.54 1.60 1.55 1.51 1.49 
   
 
3 1.61 1.47 1.57 1.53 1.47 
   
      
Overall 1.53 0.05 3.15 
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Table A.171: Corrected area (mAU) ANOVA for peak 4 in reference to peak 1 for 
capillary 1. 
      Groups Count Sum Average Variance 
  Day 1 Set 1 4 6.01 1.50 8.00 x 10
-4
 
  Day 1 Set 2 4 6.26 1.57 2.99 x 10
-4
 
  Day 1 Set 3 4 6.24 1.56 3.32 x 10
-4
 
  Day 8 Set 1 4 6.15 1.54 2.73 x 10
-3
 
  Day 8 Set 2 4 5.87 1.47 1.46 x 10
-3
 
  Day 8 Set 3 3 4.44 1.48 4.71 x 10
-4
 
  Day 9 Set 1 4 5.93 1.48 1.06 x 10
-3
 
  Day 9 Set 2 4 5.82 1.45 2.06 x 10
-4
 
  Day 9 Set 3 4 5.90 1.48 2.29 x 10
-3
 
  Day 10 Set 1 4 5.78 1.44 3.97 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between 
Groups 0.07 9 7.50 x 10
-3
 5.38 2.38 x 10
-4
 2.22 
Within Groups 0.04 29 1.39 x 10
-3
 
   
       Total 0.11 38         
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Table A.172: Corrected area adjacent mean differences (mAU) for peak 4 in reference to 
peak 1 capillary 1. 
 
 
  
Mean
Day 1 
Set 2
Day 1 
Set 3
Day 8 
Set 1
Day 1 
Set 1
Day 9 
Set 1
Day 8 
Set 3
Day 9 
Set 3
Day 8 
Set 2
Day 9 
Set 2
Day 10 
Set 1
Day 1 Set 2 1.57 -
Day 1 Set 3 1.56 0.01 -
Day 8 Set 1 1.54 0.03 0.02 -
Day 1 Set 1 1.50 0.06 0.06 0.04 -
Day 9 Set 1 1.48 0.08 0.08 0.06 0.02 -
Day 8 Set 3 1.48 0.09 0.08 0.06 0.02 0.00 -
Day 9 Set 3 1.48 0.09 0.08 0.06 0.03 0.01 0.00 -
Day 8 Set 2 1.47 0.10 0.09 0.07 0.04 0.02 0.01 0.01 -
Day 9 Set 2 1.45 0.11 0.11 0.08 0.05 0.03 0.03 0.02 0.01 -
Day 10 Set 1 1.44 0.12 0.11 0.09 0.06 0.04 0.03 0.03 0.02 0.01 -
LSD 0.05
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Table A.173: Corrected area (mAU) ANOVA for peak 4 in reference to peak 1 for 
capillary 2. 
      Groups Count Sum Average Variance 
  Day 1 Set 1 4 5.89 1.47 7.53 x 10
-4
 
  Day 1 Set 2 4 6.01 1.50 8.39 x 10
-5
 
  Day 2 Set 1 3 4.40 1.47 7.75 x 10
-5
 
  Day 2 Set 2 4 6.29 1.57 1.27 x 10
-4
 
  Day 2 Set 3 4 6.38 1.60 3.29 x 10
-4
 
  Day 3 Set 1 3 4.65 1.55 1.67 x 10
-3
 
  Day 3 Set 2 4 6.15 1.54 2.51 x 10
-3
 
  Day 3 Set 3 4 6.04 1.51 2.35 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between 
Groups 0.06 7 7.80 x 10
-3
 7.81 8.83 x 10
-5
 2.46 
Within Groups 0.02 22 9.98 x 10
-4
 
   
       Total 0.08 29         
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Table A.174: Corrected area adjacent mean differences (mAU) for peak 4 in reference to 
peak 1 capillary 2. 
 
 
 
 
  
Mean
Day 2 
Set 3
Day 2 
Set 2
Day 3 
Set 1
Day 3 
Set 2
Day 3 
Set 3
Day 1 
Set 2
Day 1 
Set 1
Day 2 
Set 1
Day 2 Set 3 1.60 -
Day 2 Set 2 1.57 0.023 -
Day 3 Set 1 1.55 0.046 0.023 -
Day 3 Set 2 1.54 0.057 0.034 0.011 -
Day 3 Set 3 1.51 0.084 0.061 0.038 0.027 -
Day 1 Set 2 1.50 0.092 0.068 0.046 0.035 0.007 -
Day 1 Set 1 1.47 0.123 0.100 0.077 0.066 0.039 0.031 -
Day 2 Set 1 1.47 0.128 0.105 0.082 0.071 0.044 0.036 0.005 -
LSD 0.041
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Table A.175: Resolution data for peak 2 (disopyramide) and peak 3 (p-toluenesulfonic 
acid) using CZE. 
 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 41.96 39.80 41.86 37.86 39.37 39.81 1.46 3.66 
 
2 38.83 40.78 38.63 40.78 39.79 
   
 
3 38.82 40.22 42.23 37.80 38.50 
   Day 8 1 35.74 34.04 32.57 37.06 38.02 36.25 1.64 4.51 
 
2 36.24 34.77 35.56 37.45 38.09 
   
 
3 37.71 35.62 37.10 37.51 
    Day 9 1 35.27 35.43 34.33 35.07 36.26 34.25 1.34 3.92 
 
2 34.45 33.59 34.07 33.41 33.99 
   
 
3 32.50 32.07 32.02 35.27 35.99 
   Day 10 1 34.67 33.85 33.64 32.76 33.84 33.75 0.68 2.02 
      
Overall 36.47 2.78 7.62 
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 35.18 35.78 35.30 35.24 33.88 35.65 0.83 2.34 
 
2 35.70 36.87 35.92 36.54 36.14 
   Day 2 1 36.01 36.35 36.74 34.69 
    
 
2 34.92 34.96 35.53 35.45 35.37 35.90 0.97 2.71 
 
3 35.16 37.80 37.40 36.81 35.41 
   Day 3 1 34.38 35.98 36.57 33.92 
 
35.57 1.31 3.67 
 
2 37.47 36.53 36.98 34.69 36.70 
   
 
3 32.91 36.12 35.89 34.78 35.11 
   
      
Overall 35.72 1.06 2.97 
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A. 
 
B. 
 
 
Figure A.18: Resolution between peak 2 and peak 3 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.176: Resolution ANOVA for peak 2 and peak 3 capillary 1. 
       Groups Count Sum Average Variance 
  Day 1 Set 1 4 158.89 39.72 2.71 
  Day 1 Set 2 4 159.98 39.99 1.05 
  Day 1 Set 3 4 158.75 39.69 3.90 
  Day 8 Set 1 4 141.68 35.42 6.49 
  Day 8 Set 2 4 145.87 36.47 2.43 
  Day 8 Set 3 3 110.23 36.74 0.99 
  Day 9 Set 1 4 141.09 35.27 0.64 
  Day 9 Set 2 4 135.07 33.77 0.01 
  Day 9 Set 3 4 135.34 33.84 4.37 
  Day 10 Set 1 4 134.10 33.52 0.27 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 235.40 9 26.16 11.17 2.71 x 10
-7
 2.22 
Within Groups 67.89 29 2.34 
   
       Total 303.29 38         
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Table A.177: Resolution adjacent mean differences for peak 2 and peak 3 capillary 1. 
 
 
 
  
Mean
Day 1 
Set 2
Day 1 
Set 1
Day 1 
Set 3
Day 8 
Set 3
Day 8 
Set 2
Day 8 
Set 1
Day 9 
Set 1
Day 9 
Set 3
Day 9 
Set 2
Day 10 
Set 1
Day 1 Set 2 39.99 -
Day 1 Set 1 39.72 0.27 -
Day 1 Set 3 39.69 0.31 0.04 -
Day 8 Set 3 36.74 3.25 2.98 2.94 -
Day 8 Set 2 36.47 3.53 3.26 3.22 0.28 -
Day 8 Set 1 35.42 4.57 4.30 4.27 1.32 1.05 -
Day 9 Set 1 35.27 4.72 4.45 4.42 1.47 1.20 0.15 -
Day 9 Set 3 33.84 6.16 5.89 5.85 2.91 2.63 1.59 1.44 -
Day 9 Set 2 33.77 6.23 5.96 5.92 2.98 2.70 1.65 1.50 0.07 -
Day 10 Set 1 33.52 6.47 6.20 6.16 3.22 2.94 1.90 1.75 0.31 0.24 -
LSD 1.98
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Table A.178: Resolution ANOVA for peak 2 and peak 3 capillary 2. 
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 140.20 35.05 0.67 
  Day 1 Set 2 4 145.47 36.37 0.18 
  Day 2 Set 1 3 107.78 35.93 1.19 
  Day 2 Set 2 4 141.31 35.33 0.06 
  Day 2 Set 3 4 147.41 36.85 1.10 
  Day 3 Set 1 3 106.46 35.49 1.94 
  Day 3 Set 2 4 144.90 36.23 1.08 
  Day 3 Set 3 4 141.90 35.47 0.40 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 10.28 7 1.47 1.94 0.11 2.46 
Within Groups 16.69 22 0.76 
   
       Total 26.98 29         
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Table A.179: Resolution F-test two- sample for variances of peak 2 and peak 3. 
 
  
Capillary 
1 
Capillary 
2 
Mean 36.47 35.72 
Variance 7.73 1.12 
Observations 49 38 
DF 48 37 
Fcalc 6.89 
 P-value 1.08 x 10
-8
   
Ftable 1.69   
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Table A.180: Resolution t-test: two sample assuming unequal variances peak 2 and peak 
3. 
 
  Capillary 1 Capillary 2 
Mean 36.47 35.72 
Variance 7.73 1.12 
Observations 49 38 
Hypothesized mean 
Difference 
0 
 DF 65 
 tcalc 1.75 
 P-value 0.08 
 ttable 2.00   
 
 
  
504 
 
Table A.181: Resolution data for peak 3 (p-toluenesulfonic acid) and peak 4 
(benzenesulfonic acid) using CZE. 
       
Day 
Capillary 
1 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 5.07 5.03 4.91 4.76 4.97 4.85 0.12 2.43 
 
2 4.91 4.73 4.66 4.82 4.89 
   
 
3 4.75 4.74 4.76 4.85 4.90 
   Day 8 1 4.52 4.64 4.59 4.53 4.41 4.57 0.15 3.23 
 
2 4.41 4.48 4.55 4.64 4.42 
   
 
3 4.76 4.43 4.93 4.61 
    Day 9 1 4.65 4.80 4.81 4.55 4.64 4.63 0.11 2.47 
 
2 4.52 4.64 4.59 4.53 4.41 
   
 
3 4.79 4.65 4.52 4.60 4.70 
   Day 10 1 4.47 4.49 4.64 4.60 4.51 4.54 0.07 1.59 
      
Overall 4.67 0.17 3.69 
       
Day 
Capillary 
2 
Set 
Run 
1 
Run 
2 
Run 
3 
Run 
4 
Run  
5 
Average SD %RSD 
Day 1 1 4.99 4.88 4.81 4.73 4.74 4.80 0.12 2.44 
 
2 4.76 4.89 4.93 4.61 4.70 
   Day 2 1 4.89 4.62 4.82 4.76 
    
 
2 4.64 4.80 4.70 4.78 4.52 4.73 0.10 2.17 
 
3 4.73 4.87 4.64 4.79 4.74 
   Day 3 1 4.76 4.46 4.64 4.69 
 
4.72 0.12 2.46 
 
2 4.76 4.89 4.93 4.61 4.70 
   
 
3 4.68 4.65 4.76 4.71 4.79 
   
      
Overall 4.75 0.11 2.40 
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A. 
 
B. 
 
 
Figure A.19: Resolution between peak 3 and peak 4 over the sample injections 
completed for A. capillary 1 and B. capillary 2. 
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Table A.182: Resolution ANOVA for peak 3 and peak 4 capillary 1.  
 
Groups Count Sum Average Variance 
  Day 1 Set 1 4 19.66 4.91 1.33 x 10
-2
 
  Day 1 Set 2 4 19.10 4.77 1.04 x 10
-2
 
  Day 1 Set 3 4 19.26 4.81 5.71 x 10
-3
 
  Day 8 Set 1 4 18.18 4.55 9.80 x 10
-3
 
  Day 8 Set 2 4 18.09 4.52 9.36 x 10
-3
 
  Day 8 Set 3 3 13.97 4.66 6.39 x 10
-2
 
  Day 9 Set 1 4 18.80 4.70 1.54 x 10
-2
 
  Day 9 Set 2 4 18.18 4.55 9.80 x 10
-3
 
  Day 9 Set 3 4 18.46 4.62 6.18 x 10
-3
 
  Day 10 Set 1 4 18.24 4.56 4.96 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation SS DF MS Fcalc P-value Ftable 
Between Groups 0.64 9 0.07 5.40 2.34 x 10
-4
 2.22 
Within Groups 0.38 29 0.01 
   
       Total 1.02 38         
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Table A.183: Resolution adjacent mean differences for peak 3 and peak 4 capillary 1. 
 
 
 
  
Mean
Day 1 
Set 1
Day 1 
Set 3
Day 1 
Set 2
Day 9 
Set 1
Day 8 
Set 3
Day 9 
Set 3
Day 10 
Set 1
Day 8 
Set 1
Day 9 
Set 2
Day 8 
Set 2
Day 1 Set 1 4.91 -
Day 1 Set 3 4.81 0.10 -
Day 1 Set 2 4.77 0.14 0.04 -
Day 9 Set 1 4.70 0.21 0.11 0.07 -
Day 8 Set 3 4.66 0.26 0.16 0.12 0.04 -
Day 9 Set 3 4.62 0.30 0.20 0.16 0.08 0.04 -
Day 10 Set 1 4.56 0.35 0.26 0.22 0.14 0.10 0.06 -
Day 8 Set 1 4.55 0.37 0.27 0.23 0.15 0.11 0.07 0.01 -
Day 9 Set 2 4.55 0.37 0.27 0.23 0.15 0.11 0.07 0.01 0.00 -
Day 8 Set 2 4.52 0.39 0.29 0.25 0.18 0.13 0.09 0.04 0.02 0.02 -
LSD 0.15
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Table A.184: Resolution ANOVA for peak 3 and peak 4 capillary 2. 
       Groups Count Sum Average Variance 
  Day 1 Set 2 4 19.17 4.79 4.67 x 10
-3
 
  Day 1 Set 1 4 19.13 4.78 2.34 x 10
-2
 
  Day 2 Set 1 3 14.20 4.73 1.11 x 10
-2
 
  Day 2 Set 2 4 18.79 4.70 1.59 x 10
-2
 
  Day 2 Set 3 4 19.04 4.76 9.21 x 10
-3
 
  Day 3 Set 1 3 13.79 4.60 1.41 x 10
-2
 
  Day 3 Set 2 4 19.13 4.78 2.34 x 10
-2
 
  Day 3 Set 3 4 18.92 4.73 3.65 x 10
-3
 
  
       
       ANOVA 
      Source of 
Variation 
SS DF MS Fcalc P-value Ftable 
Between Groups 0.10 7 0.01 1.03 0.44 2.46 
Within Groups 0.29 22 0.01 
   
       Total 0.39 29         
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Table A.184: Resolution F-test two- sample for variances of peak 3 and peak 4.  
 
  
Capillary 
1 
Capillary 
2 
Mean 4.67 4.75 
Variance 0.03 0.01 
Observations 49 38 
DF 48 37 
Fcalc 2.3 
 P-value  5.22 x 10
-3
 
 Ftable 1.7   
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Table A.185: Resolution t-test: two sample assuming unequal variances peak 3 and peak 
4. 
 
  
Capillary 
2 
Capillary 
1 
Mean 4.75 4.67 
Variance 0.01 0.03 
Observations 38 49 
Hypothesized mean 
Difference 
0 
 DF 83 
 tcalc 2.5 
 P-value 0.01 
 ttable 1.99   
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Appendix B: Determination of an Appropriate Capillary Length Increase for 
Simulated Electropherograms Using the r-factor and SimEI 
 
The following study was completed to determine the effect of migration time and 
resolution on a separation using the r-factor to determine appropriate capillary lengths if 
the electrophoretic mobilities values were not accurately determined.  
 
The leftmost column of Table B.1 shows the original electrophoretic mobilities studied. 
These are the same values used in Chapter 4, repeated here for convenience. For the 
purpose of this study, it is assumed that the mobility values determined are up to 5% 
inaccurate. Therefore, electrophoretic mobilities values that are 5% higher and 5% lower 
than the original values were calculated and are also shown in Table B.1. 
 
Next, a random number generator was used to determine mobilities restricted to the upper 
and lower limits provided in Table 4.1. Including the original, high, and low 
electrophoretic mobilities, 33 sets of mobility values were collected. The resulting 
mobility values are shown in Table 4.2.  
 
Using rlonger,cation/anion, an r-factor of 1.76 was determined for the original electrophoretic 
mobilities. If the migration distance for anions was chosen to be 8.40 cm, the migration 
distance for cations based on equation 4.6 is determined to be 14.78 cm. However, to 
avoid co-detection, the capillary length must be 1 cm longer. Therefore, a value of 15.78 
cm was used for Lc. These fixed capillary lengths were then used to determine the  
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Table B.1: Original electrophoretic mobility values studied and the resulting ±5% change 
in value. 
 
Electrophoretic Mobility Values (cm
2
/Vs) 
Original Low High 
3.03 x 10
-4
 2.88 x 10
-4
 3.18 x 10
-4
 
2.78 x 10
-4
 2.64 x 10
-4
 2.92 x 10
-4
 
2.40 x 10
-4
 2.28 x 10
-4
 2.52 x 10
-4
 
2.21 x 10
-4
 2.10 x 10
-4
 2.32 x 10
-4
 
1.99 x 10
-4
 1.89 x 10
-4
 2.09 x 10
-4
 
1.59 x 10
-4
 1.51 x 10
-4
 1.67 x 10
-4
 
-3.75 x 10
-4
 -3.94 x 10
-4
 -3.56 x 10
-4
 
-3.05 x 10
-4
 -3.20 x 10
-4
 -2.90 x 10
-4
 
-2.78 x 10
-4
 -2.92 x 10
-4
 -2.64 x 10
-4
 
-2.29 x 10
-4
 -2.40 x 10
-4
 -2.18 x 10
-4
 
-2.12 x 10
-4
 -2.23 x 10
-4
 -2.01 x 10
-4
 
-2.00 x 10
-4
 -2.10 x 10
-4
 -1.90 x 10
-4
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migration times for all twelve electrophoretic mobility values of the 33 sets of data 
collected. The resulting migration times for all data sets are shown in Table B.3. The dark 
black boxes observed in Table B.3 represent a separation where the elution of analytes 
has been modified from the original separation. For example, when the electrophoretic 
mobility values are all 5% high, C1 elutes before A6 and in separation 6, C1 elutes before 
A6 and A5 elutes before A4. 
 
Elution order changes are noted in 10 of the 33 sets of data sets (high, 6, 8, 9, 12, 14, 15, 
16, 24, and 27). Of the 10 separations where the elution order is modified, 6 data sets 
contain elution order changes between oppositely charged analytes C1 and A6 (high, 6, 9, 
14, 15, 27). Data sets 6, 8, 12, 16, and 24 show elution order changes between A4 and 
A5.  
 
The resolution between adjacent pairs of analytes was calculated to determine whether or 
not adequate separation is obtained for all analytes, regardless of elution order. The 
resolution data between adjacent analytes is provided in Table B.4. Black boxes are used 
to indicate adjacent analytes that are not sufficiently resolved (a resolution less than 1.5). 
Resolution between C1 and A6 is inadequate in 9 of 33 sets of data (6, 7, 9, 13, 14, 15, 
16, 21, and 27). Additionally, analytes C1 and C2 experience a resolution of less than 1.5 
in data sets 4, 10, 23, 29, and 30. In data sets 7 and 17, the resolution between C4 and C5 
is below 1.5. In data set 9, the resolution between C3 and C4 is 0.61. For anions, a 
resolution of 0.66 was determined for A2 and A3 in data set 10. In data sets 6, 16, 20, 27,  
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and 28, the resolution between A4 and A5 is less than 1.5. Finally, in data sets 12 and 24, 
inadequate resolution is observed between A5 and A6. 
 
Migration time data was then determined using a 2-cm increase in capillary length for 
cations instead of the 1-cm increase in capillary length that was used for the above 
calculations. This data is shown in Table B.5. As expected, the migration time of anions 
remains constant while the cations increase in time, slightly. Under these conditions, no 
co-detection is observed for oppositely charged analytes as evidenced by the resolution 
calculations provided in Table B.6. However, all like-charge analytes still experience 
resolution problems with the longer capillary length for cations.  
 
These calculations show that when inaccurate electrophoretic mobility data is obtained, 
increasing the migration distance for the second eluting charge of ions can eliminate co-
detection between oppositely charges analytes; the increase from 14.78 cm to 16.78 cm 
was sufficient for the electrophoretic mobility values studied  to avoid co-detection. 
However, if the electrophoretic mobility values of like-charged analytes are inaccurate, 
extending the migration distance for the second charge of ions will not allow proper 
resolution. Instead, longer capillary lengths for each class of ions must be used while 
ensuring that the proper ratio between opposite ends of the capillary are maintained.  
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Appendix C: Evaluation of Simulated Electropherograms Generated By the Use of 
rlonger,cation/anion 
 
As described in Chapter 4, the r-factor determines the minimum ratio of migration 
distances between oppositely charged analytes that must be achieved in order to avoid co-
detection. By definition, rlonger refers to conditions where the charge of analytes in the 
numerator migrate a longer distance to the detector than the oppositely charged analytes 
in the denominator; those analytes that migrate a shorter distance to the detector will be 
detected first. 
 
The general elution order can be modified depending on which charge of ions is in the 
numerator and which is in the denominator. In Chapter 4, experimental conditions were 
described where anions were in the numerator and cations were in the denominator. 
Using rlonger,anion/cation and an appropriate sample-introduction-dependent method to avoid 
co-detection (SimEI or SeqHI), all cations will elute before the first anion reaches the 
detector.  
 
However, based on the electrophoretic mobility values studied, the total analysis time 
may be reduced by designing the experiment so that anions elute before cations. 
Therefore, the use of rlonger,cation/anion for the analysis of the electrophoretic mobility values 
in Table 4.1 will be described below. 
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The rlonger approach can be applied to any capillary electrophoresis instrument. However, 
for the simulated electropherograms shown in this Appendix, a value of 8.40 cm was 
chosen as the migration distance that anions will migrate toward the detector to conform 
to length restrictions based on the use of the Agilent
 3D
CE. This distance is referred to as 
La to emphasize that this is the migration distance for anions.  
 
When using the electrophoretic mobilities in Table 4.1 and rlonger,cation/anion, an r-factor of 
1.76 is calculated. To determine the appropriate migration distance that cations migrate 
toward the detector, Lc, equation 4.6 was employed and a value of 14.75 cm was 
determined. To avoid co-detection when using rlonger,catioffin/anion, SimEI can be utilized by 
adding at least 1-cm length to the distance traveled by the cations. The total capillary 
length, Lt, is then calculated by adding Lc and La, which gives a value of 24.15 cm. By 
using the electrophoretic mobilities in Table 4.1, the migration and total capillary lengths 
described above, and equations 4.9-4.12, a simulated electropherogram was generated 
and is shown in Figure C.1.  
 
The combination of the rlonger,cation/anion with SimEI and a 1-cm increase in migration 
distance for cations allows all anions to elute before any cation has reached the detector. 
Therefore, this approach successfully eliminates co-detection between the slowest eluting 
anion (A6) and the fastest eluting cation (C1). All twelve analytes are separated from one 
another and detected in less than four minutes which, compared to the original separation 
in Figure 4.3B, reduces the total capillary length and analysis time by half. While the  
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Figure C.1: Simulated electropherograms of six cations and six anions using DOI-CZE 
generated using rlonger,cation/anion where Lt= 23.15 cm, Lc= 15.75 cm, La= 8.40 cm. The 
elution order when using rlonger,cation/anion is anions followed by cations. 
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overall migration time of cations was only reduced by a factor of approximately 1.25, 
anions elute about 4.5 times faster under these conditions compared to the original 
separation.  
 
As the elution order of analytes using rlonger,cation/anion with SimEI and a 1-cm increase in 
migration distance for cations significantly differs from the original separation, it is 
impossible to compare resolution directly for combinations of oppositely-charge analytes. 
However, it is important to note that shorter capillary lengths will result in reduced 
resolution between analytes of like charge. This is why the minimum length required for 
a desired resolution must be completed prior to calculation and application of the r-factor.  
 
SeqHI can also be used in combination with rlonger,cation/anion to avoid co-detection of 
oppositely-charged analytes as shown in Figure C.2. A 23.15 cm x 50-µm i.d. capillary, 
with migration distances of 8.40 and 14.75 cm for La and Lc, respectively, was chosen for 
this simulation. Equations 4.15 and 4.16 were used to determine the position of each 
sample zone before the separation voltage is applied. With an initial injection of sample 
on the cathodic end of the capillary for 2 sec at 25 mbar, Linj,1 was calculated to be 0.19 
cm. A 25 mbar, 3 sec injection of buffer pushes these analytes another 0.28 cm into the 
capillary for a total of 0.47 cm at the front of the anion sample plug. The injection of the 
second sample on the anodic end of the capillary for 2 sec at 15 mbar, creates a sample 
zone width (Linj,2 and L2I) of 0.11 cm. To determine the length from end of the capillary  
 
 
522 
 
 
 
 
 
 
 
Figure C.2: Simulated electropherograms of six cations and six anions using DOI-CZE 
generated using rlonger,cation/anion with SeqHI, where Lt= 23.15 cm, La= 8.04 cm, Lc= 14.64 
cm.  
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distances to the front of the sample plug, LFI, equation 4.16 was used and a value of 0.36 
cm was determined. 
 
The calculated values of LFI and L2I were subtracted from La and Lc, respectively, to 
obtain new migration distances of 8.04 cm for anions and 14.64 cm for cations. It is 
important to note that the initial injection of sample and the PT step are applied to the 
anions to ensure that the slowest anion has reached the detector before the fastest cation. 
The new migration distances were used in conjunction with the electrophoretic mobilities 
in Table 4.1 and equations 4.9-4.12 to generate the simulated electropherogram shown in 
Figure C.2.  
 
The combination of sequential hydrodynamic injection and hydrodynamic preliminary 
transport pushes the first sample zone far enough into the capillary before the separation 
voltage is applied so that co-detection is avoided between A6 and C1. Since the migration 
are only slightly different from the distances employed under SimEI conditions, the 
migration times observed under both sets of conditions will be very similar. 
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Appendix D: Evaluation of Simulated Electropherograms Generated by the use of 
rshorter,cation/anion 
 
The r-factor is a calculation that determines the minimum ratio of migration distances 
needed between oppositely charged analytes to avoid co-detection. By definition, the 
charge of analytes in the numerator will migrate a shorter distance to the detector than the 
oppositely charged analytes in the denominator when rshorter is employed; those analytes 
that migrate a shorter distance to the detector will be detected first. When simulating 
rshorter,caton/anion with an appropriate sample-introduction-dependent method to avoid co-
detection (SimEI or SeqHI), all anions will elute before the first cation reaches the 
detector.  
 
The rshorter approach can only be applied when there are no capillary length restrictions on 
a given capillary electrophoresis instrument; therefore, this technique is limited to users 
with homemade instruments. However, a value of 8.40 cm was chosen as the migration 
distance that anions will migrate toward the detector to conform to length restrictions 
based on the use of the Agilent
 3D
CE. This distance is referred to as La to emphasize that 
this is the migration distance for anions.  
 
When using the electrophoretic mobilities in Table 4.1 and rshorter,cation/anion, an r-factor of 
0.49 is calculated. To determine the appropriate migration distance that cations migrate 
toward the detector, Lc, equation 4.6 was employed and a value of 4.15 cm was 
determined. To avoid co-detection when using rshorter,cation/anion, SimEI can be utilized by 
adding at least 1-cm length to the distance traveled by the anions. The total capillary 
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length, Lt, is then calculated by adding Lc and La, which gives a value of 13.55 cm. By 
using the electrophoretic mobilities in Table 4.1, the migration and total capillary lengths 
described above, and equations 4.9-4.12, a simulated electropherogram was generated 
and is shown in Figure D.1.  
 
The combination of the rshorter,cation/anion with SimEI and a 1-cm increase in migration 
distance for anions allows all cations to elute before any anion has reached the detector. 
Therefore, this approach successfully eliminates co-detection between the slowest eluting 
cation (C6) and the fastest eluting anion (A1). All twelve analytes are separated from one 
another and detected in less than two minutes which, compared to the original separation 
in Figure 4.3B, is a reduction of over 5 minutes minutes; the overall migration time of 
cations was reduced by a factor of approximately 6 and anions eluted about 4 times faster 
under these conditions compared to the original separation. 
 
It is important to note that shorter capillary lengths will result in reduced resolution 
between analytes of like charge. This is why the minimum length required for a desired 
resolution must be completed prior to calculation and application of the r-factor. 
Therefore, the use of either form of rshorter may not be applicable for like-charge analytes 
with similar electrophoretic mobilities.  
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Figure D.1: Simulated electropherograms of six cations and six anions using DOI-CZE 
generated using rshorter,cation/anion where Lt= 13.55 cm, Lc= 4.15 cm, La= 9.40 cm. The 
elution order when using rshorter,cation/anion is cations followed by anions. 
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SeqHI can also be used in combination with rshorter,cation/anion to avoid co-detection of 
oppositely-charged analytes as shown in Figure D2. A 12.55 cm x 50-µm i.d. capillary, 
with migration distances of 8.40 and 4.15 cm for La and Lc, respectively, was chosen for 
this simulation. Equations 4.15 and 4.16 were used to determine the position of each 
sample zone before the separation voltage is applied. With an initial injection of sample 
on the anodic end of the capillary for 2 sec at 25 mbar, Linj,1 was calculated to be 0.35 cm. 
A 25 mbar, 3 sec injection of buffer pushes these analytes another 0.52 cm into the 
capillary for a total of 0.87 cm at the front of the cation sample plug. The injection of the 
second sample on the cathodic end of the capillary for 2 sec at 15 mbar, creates a sample 
zone width (Linj,2 and L2I) of 0.21 cm. To determine the length from end of the capillary 
to the front of the sample plug, LFI, equation 4.16 was used and a value of 0.31 cm was 
determined. 
 
The calculated values of LFI and L2I were subtracted from Lc and La, respectively, to 
obtain new migration distances of 3.83 cm for anions and 8.19 cm for anions. It is 
important to note that the initial injection of sample and the PT step are applied to the 
cations to ensure that the slowest cation has reached the detector before the fastest anion. 
The new migration distances were used in conjunction with the electrophoretic mobilities  
in Table 4.1 and equations 4.9-4.12 to generate the simulated electropherogram shown in 
Figure D.2.  
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Figure D.2: Simulated electropherograms of six cations and six anions using DOI-CZE 
generated using rshorter,cation/anion with SeqHI, where Lt= 12.55 cm, La= 3.41 cm, Lc= 8.27 
cm.  
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The combination of sequential hydrodynamic injection and hydrodynamic preliminary 
transport pushes the first sample zone far enough into the capillary before the separation 
voltage is applied so that co-detection is avoided between C6 and A1. Since the migration 
distances are only slightly different from the distances employed under SimEI conditions, 
the migration times observed under both sets of conditions will be very similar. However, 
SeqHI will reflect faster migration times for all analytes, especially the first charge of 
ions introduced into the capillary.   
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